data_5m8i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5m8i _Structure_validation_residue.Date_analyzed 2017-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 121.199 0.523 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.12 -154.6 31.04 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.63 174.13 11.5 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.862 3.041 . . . . 0.0 110.574 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.02 139.67 58.4 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 122.238 -0.289 . . . . 0.0 110.615 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.9 -3.65 84.98 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.631 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.28 -1.46 53.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.786 0.793 . . . . 0.0 112.785 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -92.52 151.45 20.17 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.704 0.402 . . . . 0.0 110.596 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tp -142.63 152.6 42.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.911 0.862 . . . . 0.0 113.213 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.45 145.93 47.43 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 126.516 1.926 . . . . 0.0 114.631 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.17 133.65 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.29 177.17 8.07 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 m170 65.67 16.11 10.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.572 1.549 . . . . 0.0 112.309 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.12 141.94 89.61 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 122.725 0.41 . . . . 0.0 110.524 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.55 164.46 35.53 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.757 2.305 . . . . 0.0 109.621 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -71.3 -8.12 51.55 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -77.31 -10.73 59.61 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.254 0.479 . . . . 0.0 111.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -72.58 158.16 36.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.73 175.98 34.91 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -56.88 -42.29 79.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -77.76 -27.82 50.46 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.656 0.382 . . . . 0.0 111.63 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -76.22 -37.92 57.1 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 tt -75.7 -25.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.8 tp -66.7 -51.75 52.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -65.16 -23.1 67.02 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.22 0.208 . . . . 0.0 111.501 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -76.4 -27.82 56.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.415 -0.178 . . . . 0.0 110.902 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.274 24.8 m-85 -105.37 -11.02 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 118.035 2.605 . . . . 0.0 118.035 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.421 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.1 mtm -66.75 -29.68 2.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.8 Cg_endo -72.5 -9.6 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.096 1.784 . . . . 0.0 112.216 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -86.61 -14.46 42.71 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.847 0.459 . . . . 0.0 111.453 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.64 -174.76 32.93 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -78.14 102.49 7.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.222 -0.575 . . . . 0.0 110.457 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -81.35 122.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.5 mt -81.89 -32.4 11.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 t -155.01 152.31 29.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.734 0.302 . . . . 0.0 110.777 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.58 143.06 21.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.735 0.814 . . . . 0.0 109.304 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.571 ' HE3' ' CZ ' ' A' ' 61' ' ' PHE . 5.1 tmmm? -159.07 143.61 15.6 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 122.885 0.474 . . . . 0.0 110.896 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.63 137.15 43.14 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 169.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.571 ' CZ ' ' HE3' ' A' ' 59' ' ' LYS . 74.4 m-85 -71.55 144.31 49.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mm -133.32 144.31 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 122.7 0.4 . . . . 0.0 110.195 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -89.06 130.93 35.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.9 -11.34 59.8 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.803 -0.561 . . . . 0.0 111.671 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -90.58 -22.6 21.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.07 -13.38 1.87 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.5 m120 61.39 9.34 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.561 1.144 . . . . 0.0 113.091 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -80.41 157.91 26.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 t -69.48 139.52 53.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.593 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.29 7.95 10.23 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.0 m 62.7 24.61 14.65 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.09 169.02 25.49 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.4 -177.67 29.79 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 121.627 0.571 . . . . 0.0 113.233 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -136.67 140.12 42.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.997 1.719 . . . . 0.0 114.177 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -144.22 156.05 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.648 0.779 . . . . 0.0 109.167 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.2 t -147.77 144.54 28.31 Favored 'General case' 0 C--N 1.339 0.151 0 O-C-N 121.901 -0.499 . . . . 0.0 112.022 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.18 165.74 11.88 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -82.27 -9.65 59.41 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.97 150.44 22.73 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.24 0.616 . . . . 0.0 111.141 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.29 -21.78 30.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.04 -38.86 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 O-C-N 121.95 -0.469 . . . . 0.0 111.727 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -75.93 -25.89 56.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.207 0.203 . . . . 0.0 110.703 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.61 -50.82 22.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -68.06 -28.36 67.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.469 -0.144 . . . . 0.0 110.659 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.08 82.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.9 -25.9 66.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.842 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mt -67.18 -51.18 56.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -69.34 -11.89 61.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.57 -28.24 16.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.4 mmm -120.51 -15.71 8.46 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -67.75 136.96 55.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 2.72 73.61 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.138 -0.812 . . . . 0.0 112.91 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.73 117.3 7.28 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.673 1.237 . . . . 0.0 110.429 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.08 129.28 37.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.471 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 tt -146.73 123.9 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.91 -144.75 48.38 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.9 mtm -83.64 13.01 4.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.975 0.91 . . . . 0.0 112.818 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.61 173.43 11.6 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.253 0.621 . . . . 0.0 112.011 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -119.72 137.09 54.14 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.846 0.858 . . . . 0.0 109.051 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.09 135.51 56.45 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -99.32 138.64 36.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.77 139.15 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.482 0.313 . . . . 0.0 110.165 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -154.28 163.62 39.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.676 0.216 . . . . 0.0 111.46 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -73.84 154.14 39.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.244 0.618 . . . . 0.0 110.418 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.504 ' H ' HD23 ' A' ' 104' ' ' LEU . 27.7 ttpp . . . . . 0 C--O 1.232 0.149 0 C-N-CA 123.459 0.704 . . . . 0.0 110.269 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.79 0.328 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.73 -157.75 30.4 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.95 177.64 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.644 2.896 . . . . 0.0 110.336 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.35 141.99 58.56 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.114 -0.366 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.13 0.68 77.7 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.76 -0.466 . . . . 0.0 112.703 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.03 31.57 4.46 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.664 0.732 . . . . 0.0 112.268 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -138.85 139.48 38.16 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 122.102 -0.374 . . . . 0.0 111.439 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.6 mt -127.01 154.9 44.04 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -114.23 144.08 43.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.959 1.704 . . . . 0.0 114.173 171.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.49 135.85 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -139.2 176.85 8.35 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.9 m170 64.87 13.79 8.78 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.23 1.412 . . . . 0.0 112.952 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.61 146.7 98.2 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.17 163.08 40.4 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.352 2.035 . . . . 0.0 109.438 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -68.86 -16.69 63.84 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -172.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -74.9 -11.43 60.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -68.86 158.33 34.71 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.0 178.14 33.54 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -57.03 -42.3 80.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -77.45 -26.0 51.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -73.51 -41.11 63.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -74.09 -25.75 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -64.81 -49.9 68.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -65.36 -25.68 67.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.7 mmm -76.29 -24.15 54.41 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.285 19.5 m-85 -105.07 -9.82 17.57 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.409 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -66.17 -33.43 6.86 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.0 Cg_endo -74.13 -8.48 21.06 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.738 1.656 . . . . 0.0 112.075 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -87.75 -14.9 38.49 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.582 0.353 . . . . 0.0 111.494 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.37 32.86 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -77.6 101.14 6.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.306 -0.526 . . . . 0.0 110.561 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -77.58 118.75 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.33 -35.78 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -158.51 157.14 31.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.814 0.34 . . . . 0.0 110.507 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.19 140.88 15.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.72 133.74 8.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.594 0.235 . . . . 0.0 111.341 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.5 t -93.25 143.26 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.442 ' CD2' ' CZ ' ' A' ' 72' ' ' PHE . 4.9 m-85 -73.08 148.5 43.98 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.7 mm -132.49 144.77 35.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 122.842 0.457 . . . . 0.0 110.203 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.401 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 66.7 t0 -92.22 131.17 37.66 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.33 -12.41 60.26 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 121.741 -0.599 . . . . 0.0 111.393 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -88.37 -23.79 23.28 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.404 0.682 . . . . 0.0 112.692 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -132.93 -14.14 2.75 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.9 t30 62.05 8.66 2.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.927 1.291 . . . . 0.0 112.094 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.17 164.48 18.09 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.932 0.493 . . . . 0.0 110.186 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.6 t -68.28 140.02 55.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.364 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 88.1 mttt -81.06 8.47 8.5 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.704 0.402 . . . . 0.0 111.891 175.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.1 m 63.07 21.32 12.82 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.442 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 4.0 p90 -155.52 167.12 31.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.0 -172.0 28.84 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 121.496 0.498 . . . . 0.0 114.035 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -136.6 145.48 44.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.411 1.884 . . . . 0.0 114.996 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -145.77 152.69 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.314 1.045 . . . . 0.0 109.283 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.3 p -142.79 149.72 39.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.391 0.541 . . . . 0.0 112.193 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.18 165.59 13.61 Favored 'General case' 0 N--CA 1.458 -0.054 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -80.89 -10.52 59.71 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.87 150.31 22.61 Favored Pre-proline 0 N--CA 1.453 -0.291 0 C-N-CA 123.287 0.635 . . . . 0.0 110.88 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.57 -20.95 40.42 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.437 2.758 . . . . 0.0 112.14 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.41 -39.04 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 O-C-N 121.801 -0.562 . . . . 0.0 111.611 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -74.88 -26.22 59.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.65 -48.54 25.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 122.449 -0.157 . . . . 0.0 110.624 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -65.92 -29.71 70.17 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.062 -0.399 . . . . 0.0 111.046 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.59 77.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.76 -26.71 64.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 119.567 -0.254 . . . . 0.0 111.662 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.69 -51.89 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.95 -11.89 59.68 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.71 -28.95 17.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.46 -14.74 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -67.45 136.19 54.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.85 1.53 84.51 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.862 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -66.01 118.95 10.52 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.772 1.286 . . . . 0.0 109.785 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.66 125.55 29.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.954 0.343 . . . . 0.0 111.55 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.0 tt -157.63 135.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.228 0.611 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.32 82.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.403 -0.81 . . . . 0.0 112.194 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 22.4 mmt 63.06 23.34 13.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.276 1.03 . . . . 0.0 113.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -145.35 155.51 43.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -97.81 132.73 43.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.79 -0.569 . . . . 0.0 110.481 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.44 128.34 36.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.24 0.216 . . . . 0.0 111.08 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -90.73 136.08 33.3 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.34 136.95 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -152.71 160.7 43.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 117.972 0.351 . . . . 0.0 111.916 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.15 156.28 38.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.069 0.548 . . . . 0.0 110.42 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.8 tttp . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.454 0.645 . . . . 0.0 112.401 178.78 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.444 0.64 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.75 -156.43 31.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.578 1.085 . . . . 0.0 113.117 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.19 -178.43 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.609 3.539 . . . . 0.0 111.542 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -57.86 130.21 45.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.268 0.627 . . . . 0.0 111.305 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.82 -2.0 70.84 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.498 0.57 . . . . 0.0 113.19 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.76 36.59 0.9 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.714 0.757 . . . . 0.0 111.871 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 140.23 33.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.966 -0.458 . . . . 0.0 111.371 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.18 162.09 26.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 19.7 m-85 -119.72 143.57 47.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 114.917 173.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.16 124.69 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 13.1 m-85 -128.77 179.71 5.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.8 m170 63.25 16.2 9.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.014 1.326 . . . . 0.0 112.836 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.9 142.33 93.34 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 118.144 0.429 . . . . 0.0 109.968 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.61 163.64 36.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.137 2.558 . . . . 0.0 109.722 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -68.81 -17.47 64.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -74.32 -10.29 59.44 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.038 -0.414 . . . . 0.0 112.046 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.03 158.14 36.51 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.9 176.59 33.34 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -56.84 -38.79 73.15 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.656 0.383 . . . . 0.0 110.642 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.04 -42.34 73.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.46 -26.11 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -64.86 -50.5 66.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -69.82 -23.11 63.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.7 -26.76 62.63 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.158 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 28.1 m-85 -104.23 -8.36 19.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 118.108 2.632 . . . . 0.0 118.108 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.402 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -67.33 -32.47 4.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.1 Cg_endo -73.38 -8.33 21.67 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.87 1.703 . . . . 0.0 112.164 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -89.9 -14.34 34.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.053 0.541 . . . . 0.0 111.283 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.02 -175.6 33.72 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -78.28 103.76 8.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.24 -0.565 . . . . 0.0 110.697 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.52 120.78 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.8 mt -84.02 -34.01 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.2 t -152.39 150.89 30.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 111.277 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.69 142.38 16.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.509 0.724 . . . . 0.0 109.209 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.619 ' HE3' ' CE1' ' A' ' 61' ' ' PHE . 3.0 tmmm? -159.87 134.49 7.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.679 0.392 . . . . 0.0 110.592 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.68 136.97 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.619 ' CE1' ' HE3' ' A' ' 59' ' ' LYS . 78.1 m-85 -69.15 150.0 48.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.12 143.27 41.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 122.77 0.428 . . . . 0.0 110.098 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.34 129.41 35.02 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -74.87 -12.48 60.38 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.949 -0.469 . . . . 0.0 111.541 -179.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -89.7 -23.23 21.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -134.71 -13.65 2.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 61.58 11.09 3.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.08 158.69 24.97 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 122.029 -0.42 . . . . 0.0 110.062 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -72.31 135.3 45.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.008 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -81.52 166.84 19.93 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.053 0.454 . . . . 0.0 111.135 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.7 m -79.19 12.05 2.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -157.01 170.82 21.67 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.05 -174.43 25.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.822 0.725 . . . . 0.0 112.447 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -138.62 145.15 40.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.94 152.95 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.24 1.016 . . . . 0.0 110.157 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -147.32 147.8 30.72 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.75 166.56 10.92 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -79.15 -8.56 59.1 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.06 150.8 24.85 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 123.221 0.609 . . . . 0.0 110.902 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -71.67 -16.16 30.17 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.142 2.561 . . . . 0.0 111.656 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.17 -46.8 92.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 118.383 0.538 . . . . 0.0 110.845 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -70.01 -24.6 63.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.841 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.36 -47.18 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.916 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -67.07 -29.7 69.54 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.159 -0.338 . . . . 0.0 110.758 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 -41.52 80.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.43 65.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -66.01 -52.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.79 -12.14 57.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.119 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.46 -31.5 17.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.7 mtp -124.64 -9.06 7.36 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.87 128.04 34.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.8 90.25 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.572 -0.571 . . . . 0.0 112.617 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -62.25 120.03 10.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.447 1.123 . . . . 0.0 111.295 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -76.0 129.77 37.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.981 -0.45 . . . . 0.0 111.516 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.78 122.42 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.03 -143.63 48.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -87.34 16.64 5.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.57 0.748 . . . . 0.0 112.767 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -144.67 172.67 12.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.366 0.53 . . . . 0.0 109.968 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -117.66 143.89 45.74 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.181 0.592 . . . . 0.0 110.372 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.85 133.04 48.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.787 0.435 . . . . 0.0 111.151 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -92.72 136.55 33.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.9 t -134.76 140.46 45.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -155.06 164.35 39.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.366 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.494 HD22 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.86 153.49 41.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.68 0.792 . . . . 0.0 110.188 175.227 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.494 ' H ' HD22 ' A' ' 104' ' ' LEU . 85.1 tttt . . . . . 0 CA--C 1.534 0.33 0 C-N-CA 123.316 0.646 . . . . 0.0 109.599 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.31 -165.5 35.07 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.85 167.56 19.24 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.402 2.735 . . . . 0.0 109.39 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -64.28 138.73 58.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.963 -0.46 . . . . 0.0 110.122 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.72 86.37 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.723 -0.487 . . . . 0.0 112.179 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.06 21.24 16.1 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.463 0.705 . . . . 0.0 112.233 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -125.31 137.52 54.07 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.38 161.86 22.66 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 122.19 0.995 . . . . 0.0 113.653 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -119.08 143.96 46.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.852 1.661 . . . . 0.0 114.555 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.81 129.47 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -134.99 178.89 6.67 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.7 m170 63.96 17.14 10.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.374 1.469 . . . . 0.0 113.293 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.88 142.8 95.88 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 122.767 0.427 . . . . 0.0 110.444 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.96 171.89 17.3 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.792 2.995 . . . . 0.0 110.97 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -68.98 -21.37 64.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.959 0.904 . . . . 0.0 112.448 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -75.63 -6.61 51.24 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.72 158.13 28.38 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.32 175.08 34.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -61.92 -36.64 81.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -75.2 -31.42 60.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.377 0.271 . . . . 0.0 110.726 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -73.34 -38.24 65.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -76.21 -24.77 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.83 -53.0 37.02 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -66.11 -23.52 66.51 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.447 0.166 . . . . 0.0 111.447 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.3 tpp -75.77 -29.43 58.79 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.68 0.392 . . . . 0.0 110.828 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.308 24.6 m-85 -102.11 -8.77 21.12 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.419 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 43.7 mtm -66.36 -30.83 3.81 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.2 Cg_endo -72.28 -10.39 25.62 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.88 1.707 . . . . 0.0 111.789 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -86.2 -14.99 42.31 Favored 'General case' 0 C--N 1.338 0.073 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.14 -171.48 32.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -76.59 103.61 6.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.433 -0.451 . . . . 0.0 110.727 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.51 122.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.3 mt -82.62 -33.54 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -156.42 156.34 33.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.022 0.439 . . . . 0.0 110.399 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.37 149.25 25.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -159.68 141.23 12.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.0 111.403 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 t -115.05 128.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -71.69 157.34 38.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mm -126.32 140.47 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.052 0 C-N-CA 122.493 0.317 . . . . 0.0 110.499 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -87.36 131.28 34.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -75.26 -12.95 60.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.92 0.488 . . . . 0.0 111.5 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -89.72 -21.94 22.45 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.13 -14.43 1.79 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 61.67 8.8 2.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 112.711 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.36 162.21 23.49 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.77 0.428 . . . . 0.0 110.151 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -69.47 136.47 51.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.737 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -76.27 164.18 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.4 m -77.32 10.05 2.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -156.86 172.05 19.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.46 -165.57 19.71 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.367 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -141.41 144.37 34.43 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -147.0 151.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.751 0.82 . . . . 0.0 109.303 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 94.8 p -141.8 149.27 40.16 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -116.83 159.9 21.66 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -77.26 -13.38 59.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.148 0.499 . . . . 0.0 112.012 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.13 149.57 19.78 Favored Pre-proline 0 N--CA 1.456 -0.158 0 C-N-CA 123.223 0.609 . . . . 0.0 110.965 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.11 -21.68 42.25 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.644 2.896 . . . . 0.0 111.94 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.69 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 118.534 0.606 . . . . 0.0 111.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -76.1 -25.56 55.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.286 0.235 . . . . 0.0 110.769 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.32 -48.16 30.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -66.46 -28.42 68.58 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.764 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.89 76.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.13 66.15 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.35 -53.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.48 -11.51 58.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.458 0.303 . . . . 0.0 111.163 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.61 -31.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 119.019 -0.515 . . . . 0.0 112.375 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.4 mtp -128.73 -9.04 5.02 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -61.64 125.11 22.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.27 6.14 89.0 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.824 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.04 119.76 10.73 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.681 1.24 . . . . 0.0 112.333 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -76.92 130.06 37.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.976 0.353 . . . . 0.0 110.963 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -145.09 136.03 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.22 -100.41 0.35 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.1 ptp -139.78 17.21 2.5 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.045 0.938 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -148.02 152.77 37.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.825 0.45 . . . . 0.0 110.181 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -93.36 139.52 30.58 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 122.138 -0.351 . . . . 0.0 111.008 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 89.9 mt -68.49 131.16 44.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.709 0.404 . . . . 0.0 110.987 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -90.82 135.67 33.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.32 136.7 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -152.67 159.81 43.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.651 0.262 . . . . 0.0 111.417 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.501 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -75.75 152.31 37.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.254 0.622 . . . . 0.0 109.658 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.501 ' H ' HD21 ' A' ' 104' ' ' LEU . 26.4 ttpp . . . . . 0 C--O 1.234 0.258 0 C-N-CA 123.239 0.616 . . . . 0.0 109.859 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.53 -173.7 49.13 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.39 0.519 . . . . 0.0 111.966 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.97 165.68 29.21 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.765 2.977 . . . . 0.0 109.877 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.08 131.26 47.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.4 -9.98 69.31 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.41 5.42 51.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.561 0.68 . . . . 0.0 110.969 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -95.52 142.08 28.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.27 159.88 35.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.719 0.771 . . . . 0.0 112.607 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.3 m-85 -122.6 145.89 47.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.824 1.65 . . . . 0.0 114.847 173.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.4 137.46 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.2 m-85 -140.65 179.46 6.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.453 ' CG ' ' HE3' ' A' ' 98' ' ' LYS . 20.1 m170 62.96 17.28 9.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.513 1.125 . . . . 0.0 112.924 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.42 142.51 92.18 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.055 0.388 . . . . 0.0 110.165 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.15 168.14 25.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.169 2.58 . . . . 0.0 109.959 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.05 -16.93 62.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -76.79 -9.67 58.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -72.62 158.08 36.34 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.1 171.73 33.36 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -59.86 -36.02 76.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -74.32 -29.42 61.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.887 0.475 . . . . 0.0 110.924 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -76.49 -42.42 43.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -71.29 -24.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.05 -49.72 73.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -64.9 -24.59 67.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.441 0.296 . . . . 0.0 111.712 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.2 mmm -76.19 -24.2 54.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.385 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 28.7 m-85 -107.32 -12.14 15.41 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.415 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.5 mtm -66.71 -31.15 3.83 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.6 Cg_endo -72.44 -10.65 25.72 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 121.986 1.745 . . . . 0.0 112.091 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -87.6 -14.07 41.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.744 0.418 . . . . 0.0 111.807 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.82 -174.74 33.06 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -75.62 106.52 7.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.343 -0.504 . . . . 0.0 110.382 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.4 122.34 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 78' ' ' ASP . 28.6 mt -87.42 -27.83 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 t -149.8 146.73 27.32 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.915 0.388 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 143.38 24.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.166 0.986 . . . . 0.0 108.534 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.53 142.52 15.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.39 0.276 . . . . 0.0 111.565 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -118.5 131.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 169.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -75.26 146.63 40.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -133.77 145.69 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.174 0.589 . . . . 0.0 110.094 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -85.45 129.09 34.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.92 -11.29 59.94 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.836 -0.54 . . . . 0.0 111.945 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -90.65 -21.81 21.49 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 -11.41 1.46 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.99 10.53 2.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.581 1.152 . . . . 0.0 112.903 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.96 159.97 23.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.118 0.485 . . . . 0.0 110.006 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -70.07 142.71 52.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.807 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -84.29 -0.8 53.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.679 0.792 . . . . 0.0 111.206 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.2 m 61.34 19.44 10.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.94 170.41 22.19 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.39 -168.12 24.88 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 121.368 0.427 . . . . 0.0 113.568 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -140.92 144.19 35.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.968 1.707 . . . . 0.0 114.967 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.1 t -147.39 154.22 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -148.7 145.72 27.8 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.323 0.511 . . . . 0.0 112.107 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.91 162.08 13.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' HA ' HD11 ' A' ' 56' ' ' ILE . 36.0 t0 -77.18 -11.13 59.78 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 174.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.54 146.8 17.39 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 123.128 0.571 . . . . 0.0 110.61 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.18 -21.83 41.6 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.361 2.707 . . . . 0.0 112.626 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.4 p -63.59 -39.18 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 O-C-N 121.885 -0.51 . . . . 0.0 111.509 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -74.17 -24.55 59.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.103 0.161 . . . . 0.0 110.926 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.69 -48.0 35.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 121.395 -0.122 . . . . 0.0 110.683 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -67.15 -29.62 69.38 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.408 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.01 82.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.74 67.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.82 -52.79 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -68.39 -11.01 59.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.383 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.01 -31.56 18.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.2 mtp -123.88 -12.31 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.26 126.75 28.41 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.53 5.17 87.11 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.779 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.07 116.73 7.48 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.813 1.306 . . . . 0.0 110.039 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.67 131.12 40.62 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -144.79 121.61 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.77 -137.52 48.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -86.99 4.8 40.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.453 ' HE3' ' CG ' ' A' ' 35' ' ' HIS . 29.4 ttpt -147.45 161.75 40.43 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 111.34 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -97.39 144.56 27.01 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.738 0.415 . . . . 0.0 110.671 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.4 126.69 30.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.358 0.263 . . . . 0.0 110.843 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -89.57 139.17 30.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.45 138.66 50.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -150.8 162.39 40.83 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.445 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -81.94 147.91 29.0 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.99 -0.444 . . . . 0.0 110.326 175.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.445 ' H ' HD21 ' A' ' 104' ' ' LEU . 86.2 tttt . . . . . 0 CA--C 1.531 0.241 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.951 0.405 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.01 -154.64 29.98 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.07 177.33 5.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.944 3.096 . . . . 0.0 110.52 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.97 137.43 58.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.632 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.24 -1.84 86.1 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.346 0.498 . . . . 0.0 112.561 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.28 36.62 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.757 . . . . 0.0 111.617 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.21 140.48 29.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 111.324 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.1 mt -128.28 152.82 47.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 27.7 m-85 -108.5 140.84 41.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 113.939 169.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.18 123.55 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 23.3 m-85 -126.54 178.04 6.13 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.9 m170 66.1 15.29 10.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.949 1.7 . . . . 0.0 113.091 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.63 137.11 88.11 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.594 0.358 . . . . 0.0 110.183 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.35 173.28 14.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.465 2.777 . . . . 0.0 111.272 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -65.41 -20.81 66.53 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -74.33 -6.92 50.85 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -78.55 158.08 28.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.03 174.98 36.88 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -59.72 -39.1 83.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.009 0.524 . . . . 0.0 110.671 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -75.65 -38.97 58.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -74.03 -25.31 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.06 -52.05 52.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -64.5 -22.82 67.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.359 0.264 . . . . 0.0 111.634 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.6 tpp -76.82 -28.21 55.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.091 0.156 . . . . 0.0 110.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.275 25.0 m-85 -104.88 -11.47 16.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.2 mtm -66.84 -30.99 3.6 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.5 Cg_endo -72.85 -10.36 24.75 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 121.822 1.686 . . . . 0.0 112.18 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.33 -15.77 39.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.691 0.397 . . . . 0.0 112.033 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.36 -173.31 34.21 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -77.96 102.53 7.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.389 -0.477 . . . . 0.0 110.47 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -81.59 124.13 38.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.58 -30.2 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -154.02 148.5 26.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.671 0.389 . . . . 0.0 110.506 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.1 138.6 17.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.01 145.15 18.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.353 0.261 . . . . 0.0 111.133 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.8 t -111.02 135.5 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.462 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 83.8 m-85 -65.95 150.88 47.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.21 142.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.922 0.489 . . . . 0.0 110.442 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -88.21 131.55 34.7 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -74.96 -12.3 60.31 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.618 0.367 . . . . 0.0 111.756 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -90.41 -21.99 21.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.06 -14.92 1.77 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 61.78 9.39 2.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.326 1.051 . . . . 0.0 112.802 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.59 160.76 23.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.853 0.359 . . . . 0.0 110.366 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.4 m -68.33 135.54 52.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.34 0.256 . . . . 0.0 110.826 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -78.61 168.09 20.28 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -76.72 15.11 0.69 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.13 172.11 18.05 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.55 -173.11 23.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.298 0.951 . . . . 0.0 112.58 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -142.01 142.63 32.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.725 1.61 . . . . 0.0 114.978 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -145.66 153.53 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.881 0.872 . . . . 0.0 110.368 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.8 t -147.2 146.47 29.84 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.747 -0.595 . . . . 0.0 112.584 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -111.73 168.68 9.37 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -81.68 -9.74 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.43 151.38 27.12 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 123.434 0.693 . . . . 0.0 111.061 177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -71.59 -18.38 29.14 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.069 2.513 . . . . 0.0 111.52 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.2 t -63.28 -45.9 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 118.39 0.541 . . . . 0.0 111.135 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 m -70.81 -26.55 63.35 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.1 -47.28 52.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.92 -28.21 68.11 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.077 0.399 . . . . 0.0 111.094 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.64 -42.0 78.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.25 65.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.4 mt -66.43 -51.04 62.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.05 -11.81 61.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.62 -28.09 19.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 13.0 ttm -120.6 -23.25 6.11 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.95 126.39 27.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.48 88.01 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.771 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -64.42 121.08 13.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.162 1.481 . . . . 0.0 110.927 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -76.93 124.37 27.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.621 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -161.06 136.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.816 0.846 . . . . 0.0 109.762 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.87 39.4 97.34 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.668 -0.645 . . . . 0.0 112.8 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.4 mtt 62.06 16.16 7.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.901 0.88 . . . . 0.0 113.229 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -141.45 179.47 6.78 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.895 1.278 . . . . 0.0 109.297 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -118.07 138.13 52.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.23 0.212 . . . . 0.0 110.503 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.02 129.44 40.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -92.23 136.17 33.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.36 139.71 49.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -155.37 158.69 39.08 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.737 0.303 . . . . 0.0 111.545 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.498 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.7 155.23 37.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.346 0.658 . . . . 0.0 111.12 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.498 ' H ' HD21 ' A' ' 104' ' ' LEU . 86.9 tttt . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 123.959 0.903 . . . . 0.0 109.772 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.879 0.371 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.67 -167.87 42.8 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.06 172.83 11.28 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.922 3.082 . . . . 0.0 110.854 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -63.53 138.74 58.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.095 -0.378 . . . . 0.0 111.04 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.81 -0.73 89.36 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.392 -0.367 . . . . 0.0 112.384 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.01 31.96 4.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.821 0.849 . . . . 0.0 111.544 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.06 140.55 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.179 -0.326 . . . . 0.0 111.168 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.7 mt -125.8 159.0 33.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.978 0.894 . . . . 0.0 113.153 -171.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -118.13 144.7 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.974 1.709 . . . . 0.0 114.443 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.86 136.57 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.16 179.93 6.47 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.4 m170 63.38 14.88 8.27 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.252 1.421 . . . . 0.0 112.911 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.05 143.32 96.02 Favored Pre-proline 0 N--CA 1.457 -0.121 0 CA-C-N 117.977 0.353 . . . . 0.0 110.132 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.44 168.0 24.77 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.952 2.435 . . . . 0.0 109.892 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -67.79 -17.82 64.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.019 0.527 . . . . 0.0 111.93 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -77.2 -10.22 59.27 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -70.05 158.01 36.48 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 175.95 35.14 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.76 -36.11 73.84 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.263 0.531 . . . . 0.0 110.629 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -80.26 -32.92 38.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 110.908 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -73.22 -38.43 66.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 tt -76.05 -25.17 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -66.08 -52.79 45.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -68.5 -22.27 64.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -72.86 -26.6 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 21.5 m-85 -106.12 -12.81 15.63 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.417 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 48.2 mtm -66.92 -29.8 2.86 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.3 Cg_endo -72.96 -8.97 23.09 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.211 1.825 . . . . 0.0 112.111 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -86.87 -15.02 40.33 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.952 0.342 . . . . 0.0 111.778 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.95 -172.65 32.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -76.16 102.68 5.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 117.107 0.453 . . . . 0.0 109.904 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.63 126.91 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.3 mt -85.92 -30.67 6.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 122.884 0.474 . . . . 0.0 110.671 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -159.5 157.41 29.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.35 0.26 . . . . 0.0 110.694 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.16 142.95 25.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -157.81 134.51 9.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.894 0.478 . . . . 0.0 110.98 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.22 131.89 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -75.02 149.24 39.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.032 0.533 . . . . 0.0 109.711 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -90.23 138.65 31.35 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.62 -10.08 59.61 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.275 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -92.28 -22.96 19.46 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -13.23 2.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 t30 62.12 8.11 2.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.674 1.19 . . . . 0.0 111.875 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.02 162.16 19.45 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.891 0.476 . . . . 0.0 109.826 174.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -66.47 140.41 58.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.35 -0.219 . . . . 0.0 111.159 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -80.6 13.26 2.61 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.6 0.36 . . . . 0.0 111.742 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.1 m 62.09 20.99 12.07 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.49 169.26 24.69 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.96 -172.56 29.53 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 121.636 0.576 . . . . 0.0 113.186 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -137.25 142.36 42.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.091 1.756 . . . . 0.0 114.722 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -144.61 153.42 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 t -143.36 149.46 37.75 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.073 0.397 . . . . 0.0 111.74 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -115.17 159.67 20.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.12 -14.58 61.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.22 0.533 . . . . 0.0 112.083 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.02 149.57 21.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.526 0.73 . . . . 0.0 110.685 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.91 -20.47 38.95 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.377 2.718 . . . . 0.0 112.204 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.31 -39.82 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.551 0.614 . . . . 0.0 111.737 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.3 m -73.34 -25.84 60.78 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.1 -46.43 51.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -66.4 -30.19 70.52 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 122.038 -0.414 . . . . 0.0 110.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.39 -41.51 80.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.74 -26.22 66.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.72 -51.93 56.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -68.49 -10.84 58.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.16 -27.98 17.36 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.9 mmm -120.29 -18.54 7.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -66.32 133.3 50.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.21 86.42 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.785 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -64.6 117.67 7.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.529 1.165 . . . . 0.0 110.448 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -75.39 130.06 38.37 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.108 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -146.19 124.97 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.4 -142.5 47.97 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 61.5 mtt -86.91 8.99 20.76 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -140.87 179.14 6.89 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.059 0.544 . . . . 0.0 111.41 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -118.97 142.96 47.32 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 110.069 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.36 130.95 45.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.683 0.278 . . . . 0.0 111.208 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -90.72 135.73 33.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.9 t -134.84 139.49 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.84 160.68 43.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.742 0.305 . . . . 0.0 111.432 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.43 HD22 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.32 149.11 40.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.43 ' H ' HD22 ' A' ' 104' ' ' LEU . 62.8 tttm . . . . . 0 C--O 1.232 0.147 0 C-N-CA 122.708 0.403 . . . . 0.0 109.918 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.714 0.292 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.58 -172.72 34.97 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.0 174.8 7.31 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.753 2.969 . . . . 0.0 110.443 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -61.1 135.08 57.66 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.76 -0.69 89.44 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.557 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.76 0.34 28.12 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.866 0.833 . . . . 0.0 112.785 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -99.73 146.21 26.79 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.205 0.457 . . . . 0.0 109.802 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.16 156.52 48.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.993 0.901 . . . . 0.0 112.823 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -124.98 147.6 48.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.71 1.604 . . . . 0.0 114.465 175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.62 132.71 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -136.54 177.45 7.84 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.2 m170 64.63 16.14 10.14 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.768 1.627 . . . . 0.0 112.57 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.8 145.22 96.7 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 122.801 0.44 . . . . 0.0 110.205 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.81 160.49 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.068 2.512 . . . . 0.0 108.95 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -73.85 -5.21 39.56 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.11 -10.46 59.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.059 0.391 . . . . 0.0 111.431 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.5 158.25 36.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.79 177.46 32.89 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -57.43 -42.58 82.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -79.98 -27.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.476 0.179 . . . . 0.0 111.107 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -72.28 -39.65 68.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 tt -76.71 -23.93 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.9 tp -66.6 -53.18 37.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -64.7 -23.0 67.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.295 0.238 . . . . 0.0 111.474 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.4 tpp -75.73 -29.45 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.047 0.139 . . . . 0.0 110.702 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 31.5 m-85 -104.95 -9.35 17.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.424 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -67.44 -28.73 2.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.8 Cg_endo -72.19 -10.67 26.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 122.374 1.883 . . . . 0.0 111.787 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -85.76 -14.79 44.16 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.33 -171.74 32.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.53 102.84 6.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.447 -0.443 . . . . 0.0 110.684 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.2 t -83.92 122.85 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 78' ' ' ASP . 13.3 mt -79.69 -34.98 16.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -157.71 156.1 31.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.075 0.464 . . . . 0.0 110.527 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 137.95 15.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.522 0.729 . . . . 0.0 109.048 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.59 134.13 8.76 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.512 0.196 . . . . 0.0 111.517 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 t -94.45 140.6 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -69.67 151.29 46.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -126.85 143.07 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 122.869 0.467 . . . . 0.0 109.975 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -91.59 130.64 37.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.14 -10.09 59.14 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.158 -0.339 . . . . 0.0 111.745 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -87.98 -22.54 24.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.24 0.616 . . . . 0.0 112.384 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -137.35 -14.08 1.52 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 61.65 8.2 2.23 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.882 1.273 . . . . 0.0 113.105 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.74 159.91 23.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.747 0.419 . . . . 0.0 109.878 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -71.24 135.04 47.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.535 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -76.03 166.92 22.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.008 0.432 . . . . 0.0 110.506 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.01 19.38 0.54 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -160.23 172.04 18.11 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.8 -171.9 27.38 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.528 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -136.37 144.88 44.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.579 1.551 . . . . 0.0 115.182 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -147.39 152.53 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.095 0.958 . . . . 0.0 108.431 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.4 p -143.45 147.34 34.42 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.876 -0.515 . . . . 0.0 112.023 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -113.79 159.94 19.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' HD13 ' A' ' 56' ' ' ILE . 11.2 t70 -78.32 -12.42 60.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.05 150.08 21.93 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 122.988 0.515 . . . . 0.0 110.886 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.1 -21.28 36.79 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.46 2.773 . . . . 0.0 112.296 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.34 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 118.72 0.691 . . . . 0.0 111.519 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -75.39 -25.92 58.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.376 0.27 . . . . 0.0 110.677 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.91 -49.92 26.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -68.85 -26.63 65.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.741 0.246 . . . . 0.0 110.483 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.73 -41.76 78.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.54 -27.14 66.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.3 mt -67.33 -52.07 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.34 -12.53 61.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.288 0.235 . . . . 0.0 111.259 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.93 -31.37 19.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.3 mtp -126.01 -9.59 6.56 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.21 125.68 24.88 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.01 87.43 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.854 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -63.73 119.44 9.93 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.639 1.22 . . . . 0.0 111.519 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -75.92 129.61 37.21 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.277 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.1 tt -144.64 120.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.75 -141.9 47.22 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 74.0 mtm -87.59 12.5 12.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -145.02 164.56 30.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.88 0.763 . . . . 0.0 110.673 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -107.1 141.63 38.05 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.855 0.462 . . . . 0.0 110.808 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.43 140.86 58.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.889 0.475 . . . . 0.0 111.442 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -101.94 141.18 35.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.93 137.08 52.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -151.73 160.64 43.52 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 120.887 0.375 . . . . 0.0 111.573 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.21 145.68 32.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.81 0.444 . . . . 0.0 110.463 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 173.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.702 0.763 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.34 -156.54 26.71 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.308 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.34 158.33 55.67 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.928 2.419 . . . . 0.0 108.948 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -63.5 129.38 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.12 -11.57 60.35 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.06 19.34 6.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.673 0.737 . . . . 0.0 110.417 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.14 142.35 47.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -169.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.9 159.85 33.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.015 0.912 . . . . 0.0 113.026 -171.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -125.46 144.05 50.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.411 1.884 . . . . 0.0 114.55 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.3 137.8 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.8 179.71 6.55 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.512 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.4 m170 64.7 17.12 10.78 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.246 1.418 . . . . 0.0 113.05 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.06 139.3 87.66 Favored Pre-proline 0 CA--C 1.529 0.146 0 O-C-N 122.165 -0.335 . . . . 0.0 110.111 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.71 172.13 16.42 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.449 2.766 . . . . 0.0 111.06 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -70.53 -13.09 61.97 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -82.37 -7.08 59.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -77.2 158.44 30.33 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.27 174.76 35.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -58.74 -38.34 78.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -74.97 -29.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.631 0.373 . . . . 0.0 111.032 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.65 -42.52 58.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -72.55 -24.81 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.31 -50.96 67.99 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -64.52 -23.85 67.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.536 0.334 . . . . 0.0 111.797 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.4 mmm -77.61 -23.83 49.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.634 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 33.8 m-85 -108.56 -10.68 15.21 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.409 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -66.23 -31.96 5.02 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.5 Cg_endo -73.15 -9.69 23.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 121.706 1.645 . . . . 0.0 111.779 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -86.97 -14.72 40.91 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.792 0.437 . . . . 0.0 112.079 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.6 32.87 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.57 102.05 5.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.387 -0.478 . . . . 0.0 110.47 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -80.77 120.62 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.61 -31.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -157.98 155.04 28.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.39 0.276 . . . . 0.0 110.834 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.38 29.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 109.346 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -156.99 141.33 16.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.836 0.454 . . . . 0.0 111.516 -174.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.06 130.21 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 168.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -76.44 142.96 40.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.4 mm -132.74 144.18 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.664 0.386 . . . . 0.0 110.534 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.447 ' CA ' ' HE2' ' A' ' 70' ' ' LYS . 61.0 t0 -85.93 130.5 34.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -79.13 -10.65 59.88 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.036 -0.415 . . . . 0.0 111.576 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -90.01 -22.14 22.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.76 -10.92 1.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.74 6.87 1.73 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.362 1.065 . . . . 0.0 112.692 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -79.6 158.21 27.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.8 t -71.43 143.75 50.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.447 ' HE2' ' CA ' ' A' ' 63' ' ' ASP . 71.6 mmtt -77.1 3.34 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.593 0.757 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.3 m 62.65 20.1 11.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -157.59 169.91 23.59 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.66 -169.0 23.35 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.991 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -141.5 141.91 33.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.6 t -147.25 152.52 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 t -147.94 149.06 31.51 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.692 -0.63 . . . . 0.0 111.934 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.87 163.12 14.56 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -79.48 -9.92 59.7 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.423 0.289 . . . . 0.0 110.319 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.3 149.05 19.76 Favored Pre-proline 0 N--CA 1.453 -0.284 0 O-C-N 121.852 -0.53 . . . . 0.0 111.478 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.61 -19.21 42.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.658 2.905 . . . . 0.0 112.356 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.2 -39.92 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.724 -0.61 . . . . 0.0 111.789 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -74.65 -24.64 58.85 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.389 0.276 . . . . 0.0 110.535 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.6 39.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -68.0 -28.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.963 -0.461 . . . . 0.0 111.087 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.99 -42.34 80.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.145 -0.347 . . . . 0.0 110.122 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.25 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.66 -51.2 53.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.86 -11.98 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.407 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.65 -31.44 17.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 52.9 mtp -124.1 -10.92 7.59 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -62.49 126.23 26.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.1 5.75 87.2 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.148 -0.806 . . . . 0.0 112.792 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -65.23 117.32 7.63 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.764 1.282 . . . . 0.0 109.934 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -75.26 129.43 37.44 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.169 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.5 tt -145.05 119.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.72 -142.65 46.96 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 ptp -84.39 8.95 14.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 43.8 tttp -146.89 165.75 28.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.753 0.706 . . . . 0.0 110.428 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -104.49 143.18 33.38 Favored 'General case' 0 C--O 1.229 -0.017 0 C-N-CA 122.731 0.413 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.31 126.32 27.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.198 0.199 . . . . 0.0 110.801 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -87.67 136.47 32.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.73 139.29 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -148.55 161.47 41.6 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 111.405 -172.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.45 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -83.74 151.12 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.45 ' H ' HD21 ' A' ' 104' ' ' LEU . 78.9 tttt . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 123.869 0.868 . . . . 0.0 110.053 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.989 0.423 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.52 -171.6 36.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.34 178.53 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.07 3.18 . . . . 0.0 110.637 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -58.3 134.7 56.8 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.087 -0.383 . . . . 0.0 110.935 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 0.43 88.64 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.829 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.02 8.76 34.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 117.826 0.813 . . . . 0.0 113.166 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -112.28 139.93 47.42 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.16 0.436 . . . . 0.0 110.453 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.62 160.89 30.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.007 0.908 . . . . 0.0 112.936 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -128.35 141.98 51.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.533 1.933 . . . . 0.0 114.647 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.56 137.62 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -141.33 178.38 7.46 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.443 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 17.1 m170 64.12 18.71 11.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.883 1.273 . . . . 0.0 112.961 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.89 145.43 98.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.32 163.45 38.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.867 2.378 . . . . 0.0 109.682 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -69.67 -16.42 63.35 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.87 -9.28 59.43 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.813 -0.554 . . . . 0.0 112.259 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -73.13 158.27 35.63 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.7 33.88 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -57.19 -39.62 75.75 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -74.79 -30.46 61.43 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.003 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -76.02 -38.85 56.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.56 -25.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.6 -51.36 63.11 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -65.21 -22.37 66.88 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.2 tpp -77.15 -27.73 53.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.396 0.278 . . . . 0.0 110.555 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.284 25.3 m-85 -105.03 -12.21 16.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 118.0 2.593 . . . . 0.0 118.0 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 58.4 mtm -66.17 -31.23 4.28 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.1 Cg_endo -72.33 -10.15 25.22 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.907 1.717 . . . . 0.0 112.072 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.33 -15.02 41.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.842 0.457 . . . . 0.0 111.708 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.29 -173.53 32.81 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -77.04 102.79 6.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.497 -0.413 . . . . 0.0 110.421 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.87 123.79 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.89 -33.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -152.41 151.17 30.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.721 0.408 . . . . 0.0 110.794 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.08 140.64 17.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.405 0.682 . . . . 0.0 109.455 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.61 161.72 37.25 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 120.811 0.338 . . . . 0.0 110.842 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.94 139.19 52.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.405 ' CD2' ' CZ ' ' A' ' 72' ' ' PHE . 48.4 m-85 -74.53 142.67 44.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mm -131.91 142.08 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 124.017 0.927 . . . . 0.0 108.554 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -80.78 127.35 32.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -73.22 -9.47 58.74 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.082 -0.386 . . . . 0.0 111.717 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -94.73 -23.6 17.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.19 -10.5 2.57 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.81 11.25 3.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.737 1.215 . . . . 0.0 111.895 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.7 mt -86.02 160.15 19.4 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.887 0.475 . . . . 0.0 109.891 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.5 t -69.56 145.33 52.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.597 0.236 . . . . 0.0 111.43 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -98.04 15.29 24.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.147 0.579 . . . . 0.0 111.195 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.6 p 52.13 29.75 6.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.405 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.8 p90 -155.06 168.96 25.27 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.55 -174.34 27.14 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.273 0.374 . . . . 0.0 112.955 -173.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -139.69 140.75 36.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.261 1.424 . . . . 0.0 114.46 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -146.36 153.74 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 98.0 p -147.89 153.0 38.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 111.532 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -122.54 164.66 17.72 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.08 -9.59 59.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.32 151.02 24.89 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.932 0.493 . . . . 0.0 111.275 176.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.38 -19.5 37.84 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.31 2.673 . . . . 0.0 111.633 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.96 -46.57 95.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 118.548 0.613 . . . . 0.0 111.026 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 m -70.91 -25.93 62.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.129 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.79 -49.03 42.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -68.17 -27.23 66.23 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 117.936 0.334 . . . . 0.0 110.674 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.9 75.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.25 70.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.99 -50.47 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -69.43 -11.16 60.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.243 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.88 -27.39 21.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.6 ttm -120.86 -21.04 6.73 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -58.83 123.34 16.13 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 6.04 88.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.424 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -67.29 142.83 56.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.759 1.279 . . . . 0.0 108.486 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -95.92 128.58 42.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.938 0.335 . . . . 0.0 110.701 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.36 136.88 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.29 -113.35 5.07 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.4 mtm -126.86 14.42 7.43 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.573 0.749 . . . . 0.0 112.282 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 56.5 tttp -151.24 144.54 24.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.309 0.504 . . . . 0.0 110.783 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -82.63 143.3 31.08 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.416 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.98 130.4 42.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.346 0.258 . . . . 0.0 110.496 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -92.02 138.11 31.81 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.71 141.15 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.44 0.296 . . . . 0.0 110.418 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -148.62 161.78 41.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.64 0.257 . . . . 0.0 110.87 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 tt -90.13 140.04 30.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt . . . . . 0 CA--C 1.529 0.17 0 CA-C-N 118.46 0.573 . . . . 0.0 109.62 175.595 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.189 0.519 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.48 -152.38 28.81 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.37 179.23 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.695 2.93 . . . . 0.0 111.172 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.84 135.98 57.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.947 -0.471 . . . . 0.0 111.551 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.15 68.09 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.478 0.561 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.11 39.76 1.0 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.665 0.732 . . . . 0.0 112.013 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.09 140.03 29.23 Favored 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.723 -0.611 . . . . 0.0 111.75 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -128.76 153.77 47.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.931 0.872 . . . . 0.0 113.152 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 16.1 m-85 -110.99 146.87 35.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.562 1.545 . . . . 0.0 114.152 170.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -139.01 124.74 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.4 m-85 -131.28 179.28 6.11 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 17.1 m170 63.32 16.12 9.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.348 1.459 . . . . 0.0 112.335 -176.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.49 144.38 94.25 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.137 0.575 . . . . 0.0 110.329 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.83 162.91 36.65 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.374 2.716 . . . . 0.0 109.248 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.46 -6.22 44.98 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -75.68 -9.99 59.05 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.994 0.361 . . . . 0.0 111.241 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -73.39 158.3 35.28 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.41 176.54 33.75 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -57.24 -39.01 74.7 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.158 0.479 . . . . 0.0 111.975 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -80.02 -33.21 39.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.585 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -72.04 -38.81 69.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.34 -28.35 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.3 tp -66.25 -52.23 49.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -63.91 -22.91 67.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.555 0.342 . . . . 0.0 111.688 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -78.38 -26.04 46.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.645 0.202 . . . . 0.0 110.654 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.296 31.3 m-85 -104.93 -10.53 17.22 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.439 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 56.6 mtm -66.97 -29.32 2.56 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 50' ' ' MET . 84.3 Cg_endo -71.05 -13.11 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.893 1.712 . . . . 0.0 111.906 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -84.35 -15.46 46.4 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 155.19 -175.06 33.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -75.32 105.53 6.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.281 -0.541 . . . . 0.0 110.77 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.04 126.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.3 -30.43 5.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 120.487 0.184 . . . . 0.0 110.578 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -154.6 150.43 27.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.726 0.411 . . . . 0.0 110.577 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.83 141.54 14.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.383 0.673 . . . . 0.0 109.496 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HE3' ' CD2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -156.45 153.26 28.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.43 0.292 . . . . 0.0 110.292 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -107.71 142.87 19.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.551 ' CD2' ' HE3' ' A' ' 59' ' ' LYS . 69.3 m-85 -69.72 148.73 48.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -133.68 146.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.148 0.579 . . . . 0.0 109.965 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -95.19 132.89 39.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -77.36 -12.91 60.01 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.067 0.547 . . . . 0.0 111.75 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -89.78 -23.82 21.65 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.62 -13.43 2.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.2 t30 61.54 10.84 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 112.22 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.86 154.56 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.673 0.389 . . . . 0.0 110.219 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -70.49 134.39 47.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.425 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -84.23 163.69 19.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.105 0.478 . . . . 0.0 110.451 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.6 m -78.87 17.67 0.7 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE1' ' CE1' ' A' ' 61' ' ' PHE . 3.5 p90 -156.59 170.32 22.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.77 -177.59 29.15 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.753 1.168 . . . . 0.0 111.896 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -139.69 144.57 37.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.74 151.95 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.803 0.841 . . . . 0.0 110.082 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 t -143.4 144.0 31.86 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -106.21 164.35 12.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -80.89 -9.22 59.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.271 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.75 150.43 20.36 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 123.138 0.575 . . . . 0.0 111.096 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.69 -18.35 28.84 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.125 2.55 . . . . 0.0 111.858 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.9 -44.77 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 O-C-N 121.817 -0.552 . . . . 0.0 111.282 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -70.65 -26.26 63.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.63 -48.04 35.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -66.07 -28.51 68.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.062 -0.399 . . . . 0.0 110.816 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.59 75.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.228 -0.295 . . . . 0.0 110.322 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.67 66.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mt -66.98 -52.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -66.88 -13.73 61.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.365 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.98 -32.95 18.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.8 mtp -123.82 -11.91 7.63 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -61.85 125.24 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.62 5.96 88.99 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.303 -0.72 . . . . 0.0 112.798 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.12 125.15 22.86 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.46 1.13 . . . . 0.0 112.031 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -78.22 128.38 33.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.685 0.279 . . . . 0.0 110.846 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -149.56 136.51 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.98 -111.1 2.81 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.0 ptp -130.42 15.47 5.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.13 0.572 . . . . 0.0 111.811 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -150.83 142.42 23.57 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.483 0.313 . . . . 0.0 110.291 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -84.41 145.13 28.35 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 122.505 -0.122 . . . . 0.0 111.181 -176.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 81.4 mt -70.78 131.82 44.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.572 0.349 . . . . 0.0 111.647 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.405 ' HD2' ' CD1' ' A' ' 34' ' ' TYR . 17.0 ttmm -91.32 138.6 31.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 170.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.97 137.38 50.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -155.12 160.79 41.22 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.865 0.302 . . . . 0.0 111.715 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.47 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.8 156.23 36.73 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.37 0.668 . . . . 0.0 110.692 176.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.47 ' H ' HD21 ' A' ' 104' ' ' LEU . 87.4 tttt . . . . . 0 N--CA 1.454 -0.23 0 C-N-CA 123.43 0.692 . . . . 0.0 109.534 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.667 0.27 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.42 -155.2 31.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.41 176.7 6.17 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.949 3.099 . . . . 0.0 110.962 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -60.95 137.01 58.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.891 -0.505 . . . . 0.0 111.504 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.05 -2.87 73.61 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.637 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.13 39.24 1.04 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.419 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.65 139.42 29.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.765 -0.584 . . . . 0.0 111.552 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.31 155.03 45.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.757 0.789 . . . . 0.0 112.934 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.2 m-85 -112.27 149.15 32.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.746 1.618 . . . . 0.0 114.355 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -139.01 136.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.6 m-85 -142.4 177.64 8.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 12.7 m170 62.73 16.9 9.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.611 1.564 . . . . 0.0 112.639 -176.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.46 145.04 98.26 Favored Pre-proline 0 CA--C 1.53 0.191 0 O-C-N 122.079 -0.388 . . . . 0.0 110.047 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.34 164.9 34.25 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.842 2.361 . . . . 0.0 109.507 172.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.91 -14.79 62.89 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.25 -8.84 57.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.55 158.23 36.58 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.75 35.29 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.8 -36.9 75.22 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.506 0.653 . . . . 0.0 110.442 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -78.67 -32.62 47.24 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.398 0.279 . . . . 0.0 110.869 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.0 -38.8 61.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.61 -25.8 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.39 -49.89 61.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -64.7 -23.84 67.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.745 0.418 . . . . 0.0 111.558 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -79.89 -25.61 40.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.511 -0.118 . . . . 0.0 110.767 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.293 31.3 m-85 -105.92 -7.76 18.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.414 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 50.1 mtm -66.49 -30.83 3.72 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.5 Cg_endo -72.82 -10.99 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 CA-C-N 121.943 1.73 . . . . 0.0 111.842 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.48 -19.96 37.79 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.76 -167.96 31.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -78.2 99.59 6.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.466 -0.432 . . . . 0.0 110.527 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.48 130.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -90.68 -27.81 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 122.592 0.357 . . . . 0.0 110.76 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 t -155.9 150.8 26.33 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.633 0.373 . . . . 0.0 110.334 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.46 147.03 27.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.377 0.671 . . . . 0.0 109.387 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -157.38 137.88 12.97 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.682 0.393 . . . . 0.0 111.445 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -111.93 136.41 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.404 ' CD2' ' CZ ' ' A' ' 72' ' ' PHE . 49.5 m-85 -78.92 147.33 33.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -173.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -132.58 144.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.063 0.545 . . . . 0.0 110.305 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -90.34 133.16 35.16 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -76.98 -12.56 59.96 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.784 0.434 . . . . 0.0 111.865 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -88.95 -23.92 22.56 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.12 -13.48 2.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 63.68 8.34 3.66 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.12 161.08 22.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.911 0.484 . . . . 0.0 110.038 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -70.52 140.91 51.94 Favored 'General case' 0 CA--C 1.523 -0.062 0 CA-C-O 120.753 0.311 . . . . 0.0 111.052 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -82.59 6.04 18.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m 61.49 22.51 12.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.404 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.1 p90 -154.62 169.11 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.01 -172.28 28.12 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 121.566 0.537 . . . . 0.0 113.185 -174.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.82 143.01 31.96 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.806 1.642 . . . . 0.0 114.713 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -145.99 153.57 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 109.527 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.2 t -143.01 145.13 32.63 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -109.34 164.04 12.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -78.36 -13.21 59.95 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 112.278 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.02 148.11 18.23 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 123.246 0.618 . . . . 0.0 111.17 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.69 -18.54 32.56 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.468 2.779 . . . . 0.0 112.06 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.27 -43.03 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 118.34 0.518 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.1 t -70.68 -32.78 70.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.04 74.67 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -67.88 -28.09 67.22 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.901 -0.5 . . . . 0.0 110.962 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.92 -43.05 72.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.44 -26.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.3 mt -67.73 -51.51 49.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -67.84 -11.22 58.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.86 -0.154 . . . . 0.0 111.284 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.89 -31.33 16.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.4 mtp -125.41 -12.2 6.78 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.98 125.86 25.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.87 6.54 89.36 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.008 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 120.42 11.62 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.693 1.247 . . . . 0.0 111.483 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -76.39 129.63 36.86 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 tt -144.87 120.72 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.27 -140.64 46.6 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.0 mmt -88.52 12.96 13.06 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -146.5 162.59 37.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.848 0.749 . . . . 0.0 111.049 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -105.76 141.27 37.47 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 122.545 0.338 . . . . 0.0 110.946 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 91.5 mt -66.65 133.76 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.749 0.419 . . . . 0.0 111.195 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -92.0 137.89 31.99 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.3 t -134.97 137.13 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -151.4 161.3 42.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -75.77 153.83 36.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.469 0.708 . . . . 0.0 110.409 177.287 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.501 ' H ' HD23 ' A' ' 104' ' ' LEU . 87.1 tttt . . . . . 0 CA--C 1.529 0.144 0 C-N-CA 123.222 0.609 . . . . 0.0 109.834 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 -151.2 25.12 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.79 169.43 17.65 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.808 3.005 . . . . 0.0 110.232 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.83 137.96 58.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.946 -0.471 . . . . 0.0 110.71 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.77 -6.96 79.15 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.156 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.42 39.9 1.06 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.602 0.701 . . . . 0.0 110.418 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.36 28.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.004 -0.435 . . . . 0.0 111.131 -175.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -126.05 158.4 35.49 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -117.59 139.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.94 1.696 . . . . 0.0 113.71 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.72 139.66 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -141.7 175.13 9.95 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 m170 65.42 16.3 10.46 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 113.001 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.16 140.93 93.51 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 122.82 0.448 . . . . 0.0 109.919 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.18 162.88 40.41 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.915 2.41 . . . . 0.0 109.552 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -71.44 -7.19 45.81 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.23 -9.42 58.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 122.055 -0.403 . . . . 0.0 111.054 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -74.06 158.36 34.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.26 173.94 35.44 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -57.16 -39.49 75.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -75.79 -29.24 58.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.097 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.41 -39.61 46.45 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -73.6 -24.65 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.17 -52.0 57.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.65 -23.62 67.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.613 0.365 . . . . 0.0 111.518 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 tpp -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.15 0.18 . . . . 0.0 110.672 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.276 22.6 m-85 -104.12 -11.69 17.17 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 117.878 2.547 . . . . 0.0 117.878 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.426 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.6 mtm -66.8 -31.3 3.92 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.8 Cg_endo -73.01 -10.0 24.15 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.068 1.774 . . . . 0.0 111.881 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.28 -13.81 45.57 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.09 -173.57 32.66 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -75.94 101.32 5.15 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.333 -0.51 . . . . 0.0 110.223 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -79.07 127.75 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.8 mt -83.84 -32.95 8.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.416 0.287 . . . . 0.0 110.379 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -164.9 159.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.94 24.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.423 0.689 . . . . 0.0 109.893 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.7 145.72 17.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.707 0.403 . . . . 0.0 111.172 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.93 138.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.541 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 76.5 m-85 -73.27 144.72 46.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.23 144.33 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.204 0.601 . . . . 0.0 110.197 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.96 130.3 34.99 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.09 -12.79 60.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.08 -0.387 . . . . 0.0 111.672 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.17 -23.71 22.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -133.17 -12.55 2.81 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.5 7.92 2.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.684 1.194 . . . . 0.0 112.021 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.24 160.45 22.98 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.3 t -70.57 141.37 51.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.792 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -78.32 6.94 7.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.64 0.376 . . . . 0.0 111.352 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.9 m 63.21 24.77 14.51 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -157.44 167.68 29.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.28 -173.41 24.8 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 121.531 0.517 . . . . 0.0 113.697 -173.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -139.72 142.68 36.83 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.371 1.868 . . . . 0.0 114.971 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -146.77 152.74 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.878 0.871 . . . . 0.0 109.689 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -141.23 149.45 41.37 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.179 0.445 . . . . 0.0 112.163 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.03 162.42 16.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -76.88 -12.56 59.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.537 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.06 150.8 23.27 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 123.298 0.639 . . . . 0.0 111.176 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.67 -18.61 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.964 2.443 . . . . 0.0 111.73 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.37 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 118.214 0.461 . . . . 0.0 111.095 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -71.02 -26.39 63.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.858 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.87 -47.28 53.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -65.91 -30.53 71.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.13 0.423 . . . . 0.0 110.968 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.37 82.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.68 67.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -66.1 -51.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.63 -12.22 61.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.04 21.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.4 ttm -120.63 -21.77 6.61 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.79 124.35 18.88 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.01 84.97 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.183 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.93 118.2 8.71 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.043 1.421 . . . . 0.0 110.501 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -77.35 129.69 36.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 110.353 -176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 tt -150.44 136.09 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.39 -112.52 4.96 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.05 14.98 8.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.0 112.728 -178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -144.38 172.66 12.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.124 0.97 . . . . 0.0 111.135 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -107.48 139.67 41.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.06 125.08 24.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.73 0.3 . . . . 0.0 110.979 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -87.26 142.82 27.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.0 t -134.95 140.19 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.673 0.389 . . . . 0.0 109.967 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -149.07 152.05 35.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.98 0.354 . . . . 0.0 110.974 -175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.426 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -71.92 148.49 45.99 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.214 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.426 ' H ' HD21 ' A' ' 104' ' ' LEU . 86.8 tttt . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 123.309 0.644 . . . . 0.0 109.392 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.713 0.292 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.67 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.996 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.73 176.38 6.04 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.58 3.52 . . . . 0.0 110.476 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.6 134.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.991 -0.443 . . . . 0.0 111.147 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.04 0.12 84.8 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.628 -0.54 . . . . 0.0 112.857 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 -0.38 57.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.887 0.843 . . . . 0.0 112.193 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -107.72 145.81 32.96 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.28 149.07 52.71 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 105' ' ' LYS . 21.9 m-85 -97.82 142.35 29.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.927 1.691 . . . . 0.0 112.866 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.11 130.04 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -134.41 179.73 6.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.2 m170 64.37 15.55 9.57 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.82 1.648 . . . . 0.0 113.03 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.39 139.51 86.94 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.32 165.05 32.73 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.609 2.873 . . . . 0.0 109.991 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -72.57 -7.14 48.63 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -75.99 -9.78 58.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.138 0.427 . . . . 0.0 110.743 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -75.98 158.12 32.31 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.72 175.73 34.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -56.87 -41.64 78.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -80.82 -26.6 36.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.591 0.234 . . . . 0.0 110.966 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -74.08 -38.47 63.91 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.5 tt -74.69 -25.49 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.5 tp -65.98 -52.19 51.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -64.65 -23.54 67.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.637 0.375 . . . . 0.0 111.595 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.4 tpp -76.58 -27.93 56.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.132 0.173 . . . . 0.0 110.753 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.268 22.0 m-85 -104.68 -11.72 16.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.415 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.6 mtm -66.08 -31.7 4.86 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 50' ' ' MET . 86.1 Cg_endo -72.46 -9.43 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.881 1.707 . . . . 0.0 111.733 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.81 -14.97 43.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.726 0.411 . . . . 0.0 111.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.48 -171.2 32.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.6 102.9 6.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.663 -0.316 . . . . 0.0 110.344 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -79.13 129.25 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mt -87.39 -33.82 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 122.301 0.241 . . . . 0.0 110.703 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.4 t -157.85 155.48 29.75 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.695 0.398 . . . . 0.0 110.239 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.34 138.26 17.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.339 0.656 . . . . 0.0 109.408 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.545 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 5.4 tmmm? -159.93 143.29 14.07 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.739 0.416 . . . . 0.0 111.081 -176.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.8 140.01 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.545 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 78.8 m-85 -72.41 149.43 44.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.44 143.7 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.797 0.839 . . . . 0.0 109.112 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -82.48 128.36 34.19 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -11.15 59.92 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.297 -0.252 . . . . 0.0 111.478 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.23 -22.17 19.18 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -136.44 -10.79 1.89 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 61.68 9.6 2.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.375 1.07 . . . . 0.0 112.984 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.4 153.47 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.161 -0.337 . . . . 0.0 110.153 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.6 t -70.3 137.29 50.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.569 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -83.05 167.5 17.82 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.15 18.18 1.79 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.23 170.39 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.57 -168.68 21.08 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.602 0.62 . . . . 0.0 112.979 -173.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -143.96 142.03 30.51 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -146.02 153.03 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.122 0.969 . . . . 0.0 109.531 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.9 p -142.1 150.85 41.71 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.768 0.427 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -117.53 162.02 18.67 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -77.25 -15.43 59.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.77 150.9 25.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 C-N-CA 123.193 0.597 . . . . 0.0 110.848 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.93 -23.22 34.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.015 2.477 . . . . 0.0 112.177 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.64 -38.29 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.444 0.565 . . . . 0.0 111.548 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -76.21 -26.59 56.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.318 -0.239 . . . . 0.0 110.876 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.86 -47.43 30.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -68.24 -26.97 65.96 Favored 'General case' 0 C--O 1.231 0.112 0 O-C-N 122.243 -0.286 . . . . 0.0 110.258 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.02 73.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -27.78 68.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 119.383 -0.342 . . . . 0.0 111.84 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.3 mt -64.69 -52.21 57.51 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.23 -11.53 57.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.805 -0.14 . . . . 0.0 111.186 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.07 -29.22 15.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.71 -18.27 7.75 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.17 134.86 53.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.98 2.38 77.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.505 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.42 117.9 7.96 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.553 1.176 . . . . 0.0 110.742 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -74.41 129.65 38.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.487 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.9 tt -146.76 124.27 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.71 -145.36 49.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -173.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.27 9.85 11.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.578 0.751 . . . . 0.0 112.698 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -139.38 178.97 6.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.672 0.669 . . . . 0.0 111.514 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -118.79 145.08 45.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 109.966 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 88.5 mt -67.07 133.87 50.74 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 122.496 0.318 . . . . 0.0 110.966 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.48 133.1 41.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.22 140.05 45.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -153.16 159.44 42.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.547 0.339 . . . . 0.0 110.695 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.31 130.06 41.93 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.267 0.627 . . . . 0.0 109.98 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 59.6 tttp . . . . . 0 C--O 1.232 0.147 0 C-N-CA 123.04 0.536 . . . . 0.0 112.086 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.45 -164.41 30.71 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.04 170.44 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.488 2.792 . . . . 0.0 110.254 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -64.32 138.76 58.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.961 -0.462 . . . . 0.0 110.017 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.62 -1.67 87.18 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.541 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.95 13.2 29.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.717 0.758 . . . . 0.0 112.327 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -113.9 138.81 49.81 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.696 0.398 . . . . 0.0 110.186 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.8 mt -123.6 156.59 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 122.076 0.941 . . . . 0.0 113.115 -174.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -117.21 143.17 46.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.973 1.709 . . . . 0.0 114.016 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.64 128.36 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.73 171.17 14.22 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.41 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 18.3 m170 74.15 20.67 2.67 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.209 1.803 . . . . 0.0 112.77 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 72' ' ' PHE . 2.7 mm? -70.4 142.8 89.75 Favored Pre-proline 0 N--CA 1.454 -0.235 0 C-N-CA 123.166 0.586 . . . . 0.0 109.957 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.45 162.78 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.586 2.858 . . . . 0.0 108.991 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.82 -8.05 54.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -76.88 -9.94 59.03 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.266 0.484 . . . . 0.0 110.789 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.44 ' CD1' HD12 ' A' ' 36' ' ' LEU . 5.5 m-85 -75.67 158.44 32.35 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.82 174.92 33.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -60.8 -35.58 76.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -74.36 -29.19 61.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.18 0.592 . . . . 0.0 111.213 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -79.05 -42.08 27.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.81 -23.06 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.2 -49.61 75.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -65.31 -23.67 67.08 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.601 0.361 . . . . 0.0 111.641 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.3 mmm -77.15 -22.44 52.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.638 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 28.1 m-85 -110.1 -10.57 14.67 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.093 2.627 . . . . 0.0 118.093 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.1 mtm -66.21 -32.64 5.74 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.4 -8.19 20.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 121.715 1.648 . . . . 0.0 112.055 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.79 -15.58 38.86 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.97 -172.35 33.3 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -75.93 103.09 5.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.208 -0.583 . . . . 0.0 110.516 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 122.56 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.5 mt -81.64 -30.83 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.05 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.8 t -158.72 154.58 26.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.055 0.455 . . . . 0.0 111.102 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.52 146.33 31.39 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.964 0.906 . . . . 0.0 108.603 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -157.96 145.35 18.25 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -121.73 132.83 69.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -69.71 155.07 41.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -134.08 143.76 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.949 0.5 . . . . 0.0 109.845 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -88.08 132.18 34.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -77.72 -13.06 60.01 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.839 0.456 . . . . 0.0 111.408 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -91.13 -22.27 20.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.276 0.63 . . . . 0.0 112.677 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.7 -12.85 2.0 Allowed 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -174.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 60.52 8.72 1.78 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.647 1.179 . . . . 0.0 112.911 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.46 156.65 30.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.966 0.348 . . . . 0.0 110.739 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.9 t -71.31 135.27 47.31 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.907 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.89 162.75 26.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.084 0.553 . . . . 0.0 110.822 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -81.28 11.0 4.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.448 ' HA ' HD21 ' A' ' 36' ' ' LEU . 4.6 p90 -157.79 172.94 17.58 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.43 -163.86 16.11 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.778 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.26 147.6 35.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.869 1.667 . . . . 0.0 115.404 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.6 t -146.2 152.14 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 t -141.2 143.9 34.46 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.25 159.17 19.61 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -76.23 -11.92 60.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.153 0.501 . . . . 0.0 111.847 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.86 149.7 21.43 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 123.168 0.587 . . . . 0.0 110.886 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.08 -18.23 35.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.344 2.696 . . . . 0.0 112.214 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.41 -46.27 95.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 118.297 0.499 . . . . 0.0 110.758 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.6 m -70.87 -24.04 62.42 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.186 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.6 -48.07 35.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.911 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -67.58 -28.99 68.23 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.045 0.384 . . . . 0.0 110.852 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.64 80.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.36 66.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.871 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.6 mt -65.85 -51.15 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 118.796 0.726 . . . . 0.0 109.173 174.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -68.23 -11.07 58.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.419 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.91 -26.77 16.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 89.2 mmm -120.65 -14.71 8.56 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.07 132.65 48.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.62 4.06 87.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.774 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -63.23 117.64 6.85 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.578 1.189 . . . . 0.0 109.977 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -77.37 130.93 37.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.115 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.97 134.25 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.45 -108.31 1.89 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 65.2 mtt -130.57 17.76 5.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.561 0.745 . . . . 0.0 111.516 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 55.3 tttp -146.59 155.84 42.78 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.69 0.396 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -98.12 140.64 32.14 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.699 -0.626 . . . . 0.0 111.196 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.02 131.58 46.15 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.713 0.405 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -92.8 139.12 30.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -134.83 141.01 44.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-N 118.047 0.385 . . . . 0.0 110.376 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -155.03 163.53 40.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.917 0.326 . . . . 0.0 111.785 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.44 148.66 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.562 0.745 . . . . 0.0 110.259 175.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 CA--C 1.53 0.187 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.941 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.63 0.252 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.77 41.44 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 177.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.3 167.2 24.51 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.409 2.739 . . . . 0.0 109.881 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.42 136.51 57.94 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.09 -0.381 . . . . 0.0 110.091 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 -10.56 73.99 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.132 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.33 6.67 48.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.031 0.532 . . . . 0.0 111.133 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.11 145.51 24.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.92 151.85 49.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.017 0.913 . . . . 0.0 113.097 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.74 145.12 45.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.542 1.937 . . . . 0.0 114.553 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.73 136.7 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.11 178.44 7.17 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.456 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.2 m170 63.88 15.92 9.46 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.31 1.444 . . . . 0.0 112.798 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.43 142.79 94.79 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 117.902 0.319 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.66 166.69 28.68 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.907 2.405 . . . . 0.0 109.566 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -71.2 -14.24 62.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.34 -10.02 59.08 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.84 158.14 36.89 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 175.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.22 177.7 34.8 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -57.32 -40.67 78.41 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -84.95 -26.26 27.29 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.378 -0.201 . . . . 0.0 111.055 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -74.18 -38.28 63.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 tt -75.41 -26.34 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.57 -53.35 53.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -64.23 -23.05 67.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.821 0.448 . . . . 0.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 tpt -79.05 -25.09 43.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.267 -0.271 . . . . 0.0 110.506 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.266 29.0 m-85 -105.83 -10.96 16.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 -178.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 53.8 mtm -66.63 -29.56 2.85 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.2 Cg_endo -72.47 -8.42 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 CA-C-N 121.951 1.733 . . . . 0.0 112.167 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -89.42 -12.07 41.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.959 0.504 . . . . 0.0 111.208 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.49 -176.17 31.6 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -77.96 101.67 6.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.236 -0.567 . . . . 0.0 110.506 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.02 123.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -85.22 -30.84 6.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.9 t -152.85 151.69 30.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 110.661 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 136.32 13.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.87 0.868 . . . . 0.0 108.865 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -158.5 131.05 7.02 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.511 0.196 . . . . 0.0 110.583 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -95.68 134.36 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -69.53 144.64 53.08 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -133.19 144.55 36.0 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 123.168 0.587 . . . . 0.0 109.979 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -88.89 130.69 35.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.54 -11.46 60.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.994 -0.441 . . . . 0.0 111.251 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -89.84 -21.86 22.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.8 -13.72 1.92 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.2 9.12 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.338 1.055 . . . . 0.0 112.954 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -82.25 160.01 23.07 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.709 0.404 . . . . 0.0 109.996 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.2 t -69.51 139.99 53.89 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.341 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -82.53 6.4 17.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.7 m 60.87 22.64 12.72 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.59 168.41 27.23 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.24 -172.12 28.16 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.796 -0.565 . . . . 0.0 113.714 -173.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -136.75 144.38 43.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.151 1.78 . . . . 0.0 114.877 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.1 t -148.33 153.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 91.1 p -146.46 146.64 30.63 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.831 -0.543 . . . . 0.0 112.295 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.46 164.83 12.32 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.64 -11.15 59.96 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.54 149.92 23.71 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 122.984 0.514 . . . . 0.0 110.785 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.29 -18.1 39.4 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.099 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.61 -46.56 94.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-N 118.466 0.576 . . . . 0.0 110.83 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -71.33 -25.36 62.37 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.518 0.327 . . . . 0.0 111.04 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.71 -47.69 52.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.045 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -68.49 -27.83 66.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.143 0.428 . . . . 0.0 110.711 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -40.66 81.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.02 66.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.678 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.3 -52.23 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -68.51 -11.8 60.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.338 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.55 -27.7 17.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 89.0 mmm -120.4 -18.29 7.94 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -65.68 131.81 47.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.07 8.59 85.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 119.089 -0.839 . . . . 0.0 112.51 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -66.38 114.58 5.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.807 1.303 . . . . 0.0 109.103 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.4 129.1 37.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.436 0.562 . . . . 0.0 110.956 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 tt -145.14 122.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.18 -143.3 48.34 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.5 mtm -86.1 12.53 9.41 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.456 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 42.7 tttp -147.06 170.45 17.11 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.698 0.681 . . . . 0.0 110.356 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -111.99 140.7 46.44 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 122.937 0.495 . . . . 0.0 109.902 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.29 132.7 49.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.272 0.229 . . . . 0.0 111.233 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -95.58 139.05 32.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 67.3 t -135.24 140.08 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -154.31 163.7 39.74 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -79.85 150.78 30.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.491 0.717 . . . . 0.0 110.629 175.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.458 ' H ' HD23 ' A' ' 104' ' ' LEU . 64.4 tttp . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 173.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.45 -179.07 46.7 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.69 -178.52 1.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.071 3.181 . . . . 0.0 110.376 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.61 131.14 49.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.117 -0.364 . . . . 0.0 111.019 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.04 1.79 85.9 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 119.526 -0.597 . . . . 0.0 113.189 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.88 7.41 44.93 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -109.67 139.11 45.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.327 0.512 . . . . 0.0 110.359 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.4 mt -126.15 159.37 33.1 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -117.36 141.8 47.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.967 1.707 . . . . 0.0 114.582 171.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.08 132.37 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -135.53 179.97 6.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.0 m170 65.15 23.39 12.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.149 1.379 . . . . 0.0 112.747 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.17 136.46 72.58 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.326 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.78 168.86 23.44 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.537 2.825 . . . . 0.0 110.313 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -69.37 -11.32 60.71 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -80.02 -7.27 58.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -76.1 158.18 32.06 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.94 174.91 35.27 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.85 -36.03 73.91 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 117.202 0.501 . . . . 0.0 110.864 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -78.62 -33.97 46.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.29 0.236 . . . . 0.0 110.886 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -71.28 -39.29 71.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -75.74 -26.74 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.16 -53.81 39.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.556 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 tpt -72.81 -26.65 61.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 25.0 m-85 -103.52 -9.27 19.44 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.408 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 44.7 mtm -66.78 -31.33 3.96 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' MET . 76.9 Cg_endo -71.53 -8.18 22.73 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 121.959 1.735 . . . . 0.0 111.667 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -89.07 -14.76 35.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.825 0.45 . . . . 0.0 110.885 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.88 -174.33 30.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -75.25 105.56 6.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.364 -0.492 . . . . 0.0 110.668 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.73 123.69 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 78' ' ' ASP . 15.5 mt -82.17 -34.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 O-C-N 122.211 -0.306 . . . . 0.0 110.292 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -156.14 156.86 34.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.415 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.33 148.03 26.3 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.682 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.11 131.75 6.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.624 0.369 . . . . 0.0 111.014 -174.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.92 129.36 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -74.32 149.16 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 mm -132.95 153.32 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.776 0.43 . . . . 0.0 110.466 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' H ' ' HE3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -80.04 -10.73 59.79 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -86.24 -23.59 26.35 Favored 'General case' 0 C--O 1.23 0.039 0 C-N-CA 122.817 0.447 . . . . 0.0 112.126 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.0 -14.71 1.36 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.4 6.95 1.56 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.043 0.937 . . . . 0.0 112.812 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.35 162.74 25.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.3 t -67.99 141.75 56.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 110.474 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -73.44 6.39 3.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 111.384 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.8 p 58.35 20.78 7.64 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.491 1.916 . . . . 0.0 112.687 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.19 169.93 23.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.36 -170.23 26.86 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 121.467 0.482 . . . . 0.0 112.404 -175.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -137.63 141.45 41.21 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.664 1.586 . . . . 0.0 114.905 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.8 t -145.12 152.08 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.6 p -143.3 149.57 38.01 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-O 120.923 0.392 . . . . 0.0 112.003 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -114.85 162.54 16.76 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.414 ' HA ' HD13 ' A' ' 56' ' ' ILE . 11.9 t70 -78.3 -11.04 59.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.69 150.28 20.22 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.557 0.743 . . . . 0.0 110.767 176.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.0 -20.57 38.26 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.311 2.674 . . . . 0.0 112.057 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.2 -45.13 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 CA-C-N 118.42 0.554 . . . . 0.0 111.09 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -71.58 -27.3 63.04 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.91 -48.13 39.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -67.0 -27.61 67.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.035 -0.416 . . . . 0.0 110.802 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.16 73.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.31 66.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.99 -51.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -68.28 -12.02 60.36 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.161 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.46 -32.85 20.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.008 -0.52 . . . . 0.0 112.379 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.2 mtp -123.2 -14.77 7.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.23 126.67 28.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.38 2.38 90.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.802 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -62.27 138.75 58.48 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -92.64 130.79 38.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.782 0.719 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.6 tt -144.83 123.98 6.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.33 -143.66 48.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 mmt -84.91 9.2 15.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.659 0.783 . . . . 0.0 113.075 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -140.67 179.11 6.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.554 0.616 . . . . 0.0 111.214 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -118.82 147.74 43.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.41 124.34 19.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.038 0.935 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -94.38 130.42 40.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.95 137.64 51.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 122.243 0.217 . . . . 0.0 110.52 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -153.7 161.25 42.29 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 122.395 -0.191 . . . . 0.0 111.152 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.525 HD22 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -74.86 154.49 38.22 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.525 ' H ' HD22 ' A' ' 104' ' ' LEU . 57.2 tttp . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 122.6 0.36 . . . . 0.0 110.327 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.568 0.223 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 -160.73 35.24 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.87 178.75 3.74 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.042 3.161 . . . . 0.0 110.522 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -60.71 136.09 57.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.961 -0.462 . . . . 0.0 111.328 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.67 -1.67 71.63 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.334 0.492 . . . . 0.0 112.725 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.99 38.76 1.03 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 111.346 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.64 144.59 31.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.029 -0.419 . . . . 0.0 111.308 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.7 mt -129.87 158.07 40.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 25.2 m-85 -112.64 143.83 43.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.407 1.483 . . . . 0.0 114.233 170.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.85 124.95 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.8 m-85 -129.19 179.48 5.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m170 64.02 15.95 9.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.598 1.559 . . . . 0.0 112.335 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.57 141.39 90.47 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 122.842 0.457 . . . . 0.0 110.557 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.88 165.23 32.65 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.307 2.671 . . . . 0.0 109.415 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.47 -5.86 45.0 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.62 -9.2 58.82 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.033 0.379 . . . . 0.0 111.423 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -75.22 158.17 33.36 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.4 175.54 34.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -58.48 -37.35 75.34 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.531 0.665 . . . . 0.0 110.287 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.36 -33.27 37.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.605 0.241 . . . . 0.0 110.914 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -72.73 -38.52 67.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -74.79 -26.13 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.91 -53.26 41.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.513 0.325 . . . . 0.0 111.257 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.2 tpt -80.62 -24.71 38.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.953 0.101 . . . . 0.0 110.748 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.262 21.3 m-85 -104.63 -12.32 16.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -179.212 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.429 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.9 mtm -66.39 -29.87 3.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.9 Cg_endo -71.66 -9.68 25.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 122.068 1.774 . . . . 0.0 111.694 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -87.77 -13.62 41.83 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.094 0.406 . . . . 0.0 111.502 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.32 -175.01 31.9 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -75.45 103.25 5.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.552 -0.381 . . . . 0.0 110.484 -177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.6 t -86.05 124.78 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 78' ' ' ASP . 39.5 mt -86.31 -29.32 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 O-C-N 122.43 -0.169 . . . . 0.0 110.585 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -156.51 154.9 31.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.66 149.11 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.68 0.792 . . . . 0.0 109.361 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -158.31 139.22 13.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.556 0.342 . . . . 0.0 111.658 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 t -118.15 131.04 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -71.73 156.48 39.29 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -133.29 145.35 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 C-N-CA 122.823 0.449 . . . . 0.0 110.027 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -88.4 132.13 34.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -79.04 -14.18 59.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.889 0.476 . . . . 0.0 111.595 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -89.61 -23.64 21.89 Favored 'General case' 0 C--N 1.335 -0.063 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.35 -11.76 2.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 62.0 10.51 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.346 1.059 . . . . 0.0 111.839 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.64 156.37 27.66 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.942 -0.474 . . . . 0.0 110.01 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.6 t -71.29 139.64 50.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.786 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.87 163.89 24.93 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.861 0.464 . . . . 0.0 110.873 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.6 m -84.32 13.18 5.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -158.91 171.98 19.05 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.41 -166.06 18.47 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.511 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.36 142.88 30.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.17 152.81 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.704 0.802 . . . . 0.0 109.782 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 t -144.02 141.08 29.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -104.8 162.69 13.09 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.4 ' HA ' HD12 ' A' ' 56' ' ' ILE . 19.0 t0 -77.99 -12.49 59.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 111.491 174.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.97 149.9 20.44 Favored Pre-proline 0 N--CA 1.451 -0.404 0 C-N-CA 123.088 0.555 . . . . 0.0 110.613 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.92 -21.62 32.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.066 2.511 . . . . 0.0 112.341 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.2 -39.28 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.879 -0.513 . . . . 0.0 111.837 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -73.77 -25.33 60.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.182 0.193 . . . . 0.0 110.586 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.01 -45.84 55.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.29 -30.63 71.09 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.9 0.318 . . . . 0.0 110.875 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.52 82.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.28 -26.37 65.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.4 mt -65.52 -53.07 43.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -67.9 -11.3 58.43 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.99 -29.29 16.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 92.9 mmm -120.43 -16.96 8.29 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -65.0 132.59 49.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 4.83 84.75 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.048 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -63.66 122.83 17.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.727 1.263 . . . . 0.0 111.419 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -76.52 128.96 35.77 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.791 0.329 . . . . 0.0 110.854 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -151.76 136.91 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.6 -111.77 3.5 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.2 ptp -128.7 13.66 6.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.174 0.59 . . . . 0.0 111.89 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -151.85 142.16 22.44 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.169 0.44 . . . . 0.0 110.636 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -81.85 144.7 30.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.243 -0.286 . . . . 0.0 110.702 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.83 127.16 31.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.309 0.244 . . . . 0.0 111.037 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.62 138.31 31.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.21 140.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -153.71 157.23 39.2 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 122.352 -0.217 . . . . 0.0 111.277 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.466 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -78.3 151.79 32.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.002 0.521 . . . . 0.0 109.781 174.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.466 ' H ' HD21 ' A' ' 104' ' ' LEU . 59.7 tttp . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.965 0.412 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.44 -165.78 30.92 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.588 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -69.88 177.5 5.6 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.127 3.218 . . . . 0.0 110.403 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -60.67 137.4 58.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.903 -0.498 . . . . 0.0 110.855 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -3.53 83.51 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.672 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -0.28 39.76 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.679 0.74 . . . . 0.0 112.703 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -102.54 136.26 42.68 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 118.213 0.461 . . . . 0.0 110.314 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.5 mt -124.18 154.58 39.88 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.892 0.853 . . . . 0.0 113.135 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -116.06 145.91 42.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.931 1.692 . . . . 0.0 114.011 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.43 137.82 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.57 176.35 8.96 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 9.4 m170 65.93 16.1 10.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.181 1.392 . . . . 0.0 112.644 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.3 146.19 98.76 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.709 0.403 . . . . 0.0 110.075 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 169.16 22.82 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.319 2.68 . . . . 0.0 109.833 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -68.47 -19.29 64.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.872 0.469 . . . . 0.0 112.206 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.0 -10.57 59.66 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -69.99 158.03 36.39 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.24 175.5 35.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.38 -35.74 72.44 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 117.466 0.633 . . . . 0.0 110.031 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -79.76 -33.16 40.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.913 0.485 . . . . 0.0 111.085 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.11 -39.04 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.2 tt -74.35 -24.96 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.6 tp -65.27 -52.29 55.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -65.22 -22.27 66.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.566 0.346 . . . . 0.0 111.382 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.2 tpp -78.24 -26.78 47.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.269 0.228 . . . . 0.0 110.713 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.266 22.9 m-85 -105.77 -11.57 16.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.415 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.5 mtm -66.91 -31.0 3.56 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 50' ' ' MET . 81.4 Cg_endo -71.97 -9.2 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.745 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -82.78 -24.32 33.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.74 0.416 . . . . 0.0 111.981 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 158.57 -163.52 33.09 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.96 103.04 10.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.556 0.678 . . . . 0.0 110.972 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.4 t -82.4 121.55 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.66 -32.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -157.83 152.4 24.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.965 0.506 . . . . 0.0 111.239 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.09 146.74 31.96 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.891 0.876 . . . . 0.0 109.068 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -156.79 139.26 14.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.76 0.424 . . . . 0.0 111.598 -172.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.45 129.19 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 168.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -72.18 147.84 46.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.5 mm -132.36 141.17 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.819 0.448 . . . . 0.0 110.461 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -90.12 134.85 34.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -77.64 -12.22 59.95 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.65 0.38 . . . . 0.0 111.755 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -87.9 -22.54 24.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.12 -14.64 1.78 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 62.12 8.2 2.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.506 1.122 . . . . 0.0 112.717 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.7 mt -82.42 161.0 22.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.814 0.445 . . . . 0.0 110.329 175.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.5 t -66.87 138.54 57.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -77.56 8.91 3.76 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.009 0.524 . . . . 0.0 111.619 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.5 m 61.91 23.08 13.52 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -156.5 167.45 30.41 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.21 -170.79 24.19 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 121.581 0.545 . . . . 0.0 113.433 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -142.39 142.67 32.44 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.224 1.81 . . . . 0.0 114.744 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.1 t -146.05 153.41 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.5 t -143.31 146.92 33.99 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -117.86 165.57 13.51 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -80.63 -13.31 59.14 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.03 148.58 21.7 Favored Pre-proline 0 C--O 1.233 0.205 0 C-N-CA 123.256 0.623 . . . . 0.0 111.378 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.86 -23.11 41.72 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.508 2.805 . . . . 0.0 112.132 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.74 -38.66 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 O-C-N 121.802 -0.561 . . . . 0.0 111.232 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.6 t -74.72 -29.79 61.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.319 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.01 37.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.26 -28.57 68.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.262 -0.274 . . . . 0.0 110.727 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.57 73.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.47 -26.56 68.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.68 -51.87 57.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 CA-C-N 118.836 0.744 . . . . 0.0 109.001 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.89 -11.81 57.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.37 -27.38 16.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.5 mmm -120.54 -17.27 8.14 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.67 134.66 53.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.72 2.39 85.55 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.839 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.37 120.02 13.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.814 1.307 . . . . 0.0 110.675 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.76 126.87 31.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.63 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.69 135.72 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.442 0.697 . . . . 0.0 109.567 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.72 31.82 76.74 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.518 -0.739 . . . . 0.0 111.828 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.5 mtm 64.64 22.19 12.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -144.75 155.81 43.73 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -97.95 134.62 40.81 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.376 -0.828 . . . . 0.0 111.159 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.8 mt -64.73 130.99 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.66 0.267 . . . . 0.0 111.351 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.52 137.39 32.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.7 t -134.36 135.33 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -150.31 160.51 43.66 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.699 0.227 . . . . 0.0 111.564 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.444 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -76.6 149.29 36.58 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.01 0.524 . . . . 0.0 110.002 177.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.444 ' H ' HD21 ' A' ' 104' ' ' LEU . 85.5 tttt . . . . . 0 C--O 1.234 0.251 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.76 -156.3 20.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.08 175.94 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.94 3.094 . . . . 0.0 110.48 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.44 139.83 58.81 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.87 0.06 88.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.79 -0.45 . . . . 0.0 112.733 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.72 14.76 30.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.613 0.706 . . . . 0.0 112.893 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -119.14 138.62 52.79 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 118.427 0.558 . . . . 0.0 110.588 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.1 mt -125.42 156.88 38.15 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -117.1 141.42 48.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.844 1.658 . . . . 0.0 113.806 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.38 140.73 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.402 ' CD1' ' HD2' ' A' ' 101' ' ' LYS . 12.2 m-85 -144.93 176.57 9.38 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.45 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 16.6 m170 63.97 16.74 10.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.901 1.68 . . . . 0.0 112.984 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.06 141.5 94.28 Favored Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.45 163.03 39.78 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.988 2.459 . . . . 0.0 109.524 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.72 -7.62 49.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -78.56 -10.56 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.091 -0.381 . . . . 0.0 111.134 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.99 158.5 35.34 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.8 174.92 35.17 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -56.82 -38.98 73.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -75.7 -33.21 60.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.784 0.433 . . . . 0.0 111.255 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -71.55 -38.73 70.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 tt -76.52 -24.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.91 -53.62 43.56 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -69.66 -23.37 63.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 tpp -71.58 -27.9 63.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 18.6 m-85 -102.3 -10.08 19.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.404 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 46.2 mtm -65.83 -32.28 5.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.1 Cg_endo -72.33 -8.15 22.18 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.692 1.64 . . . . 0.0 111.894 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.34 -14.18 36.24 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.663 0.385 . . . . 0.0 111.342 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.92 -171.92 31.96 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -77.77 103.09 7.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.39 -0.477 . . . . 0.0 110.373 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -81.66 124.24 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.56 -37.45 16.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -158.44 157.1 31.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.478 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.46 146.82 23.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.84 144.0 16.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.692 0.397 . . . . 0.0 111.143 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.25 139.74 38.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 172.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -75.53 146.69 40.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -132.85 143.65 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 123.246 0.619 . . . . 0.0 110.303 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -90.56 131.7 36.14 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.5 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.38 -9.39 59.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.9 -0.5 . . . . 0.0 111.536 -179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -88.77 -22.26 23.38 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.92 -12.72 1.69 Allowed 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 62.29 7.37 2.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.415 1.086 . . . . 0.0 112.815 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.46 161.07 22.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 t -70.71 142.06 51.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.925 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.13 8.76 4.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.4 m 62.4 26.19 15.62 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.5 165.99 34.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.0 -179.54 27.71 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 121.548 0.527 . . . . 0.0 113.543 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.29 139.72 37.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.163 1.785 . . . . 0.0 113.987 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.35 152.97 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 123.628 0.771 . . . . 0.0 109.669 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.0 t -141.35 143.51 34.05 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.54 0.336 . . . . 0.0 111.898 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -111.88 159.83 17.98 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -75.91 -13.45 60.26 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.68 150.47 23.2 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.545 0.738 . . . . 0.0 110.756 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.9 -22.11 31.92 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.256 2.637 . . . . 0.0 112.465 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.3 -38.91 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 118.336 0.516 . . . . 0.0 111.704 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.7 m -74.3 -25.74 59.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.132 0.173 . . . . 0.0 110.631 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.78 -46.79 43.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -66.81 -30.43 70.62 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 122.271 -0.268 . . . . 0.0 110.737 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.29 80.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -26.75 65.59 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.14 -51.82 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -67.56 -12.09 59.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.31 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.74 -28.82 17.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.1 mmm -120.4 -17.3 8.21 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.88 133.07 51.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.55 2.19 87.55 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.894 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.41 119.05 10.29 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.57 1.185 . . . . 0.0 110.168 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -78.68 126.94 31.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.036 -0.415 . . . . 0.0 111.378 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.7 tt -155.91 135.14 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.307 0.643 . . . . 0.0 109.743 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.12 32.25 75.49 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.416 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm 63.03 24.52 14.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.066 0.947 . . . . 0.0 113.381 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.45 ' HE2' ' CG ' ' A' ' 35' ' ' HIS . 85.2 tttt -144.99 151.48 38.65 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -96.31 134.09 39.87 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.0 mt -64.52 125.94 26.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.22 0.208 . . . . 0.0 110.789 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.402 ' HD2' ' CD1' ' A' ' 34' ' ' TYR . 17.0 ttmm -87.93 139.19 30.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.82 139.48 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -149.21 156.52 42.28 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.743 0.306 . . . . 0.0 111.265 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -74.2 147.99 42.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.814 0.445 . . . . 0.0 109.952 176.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.466 ' H ' HD23 ' A' ' 104' ' ' LEU . 84.6 tttt . . . . . 0 CA--C 1.53 0.184 0 C-N-CA 122.963 0.505 . . . . 0.0 110.785 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 120.372 0.13 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.64 173.42 49.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p -70.48 162.83 28.04 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.234 0.614 . . . . 0.0 111.032 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.0 t -154.11 161.85 41.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.785 0.434 . . . . 0.0 110.366 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.4 ' CD2' ' H ' ' A' ' 7' ' ' HIS . 72.5 t60 -66.54 147.64 53.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.863 0.465 . . . . 0.0 110.852 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -83.87 -1.39 54.34 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.4 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 89.8 m-70 57.38 17.8 3.99 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.107 0.963 . . . . 0.0 113.421 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.52 ' CG ' ' H ' ' A' ' 9' ' ' HIS . 75.1 t60 58.51 173.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.72 1.208 . . . . 0.0 113.352 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.52 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 59.0 t-80 -66.55 153.55 42.7 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.196 0.598 . . . . 0.0 110.405 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -70.74 -25.78 63.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.157 0.583 . . . . 0.0 112.209 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.9 p -152.69 5.13 0.37 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 m 56.67 21.76 6.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.245 0.618 . . . . 0.0 112.579 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.88 -147.81 5.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.35 142.16 58.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.28 130.14 93.62 Favored Pre-proline 0 CA--C 1.529 0.172 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.1 141.71 36.8 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.168 2.579 . . . . 0.0 109.989 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 tpp85 -162.22 156.62 21.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.82 -11.48 83.46 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.582 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.3 p -160.07 159.95 32.55 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.639 0.72 . . . . 0.0 110.271 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -77.66 -23.28 49.69 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.511 0.324 . . . . 0.0 110.666 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.4 ptp 49.37 173.79 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.652 2.381 . . . . 0.0 114.394 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -94.21 152.11 18.96 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.402 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.41 159.34 38.62 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.493 1.117 . . . . 0.0 108.937 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -126.37 158.17 36.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.199 0.523 . . . . 0.0 112.344 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.12 -154.6 31.04 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.63 174.13 11.5 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.862 3.041 . . . . 0.0 110.574 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.02 139.67 58.4 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 122.238 -0.289 . . . . 0.0 110.615 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.9 -3.65 84.98 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.631 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.28 -1.46 53.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.786 0.793 . . . . 0.0 112.785 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -92.52 151.45 20.17 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.704 0.402 . . . . 0.0 110.596 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tp -142.63 152.6 42.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.911 0.862 . . . . 0.0 113.213 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.45 145.93 47.43 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 126.516 1.926 . . . . 0.0 114.631 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.17 133.65 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.29 177.17 8.07 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 m170 65.67 16.11 10.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.572 1.549 . . . . 0.0 112.309 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.12 141.94 89.61 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 122.725 0.41 . . . . 0.0 110.524 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.55 164.46 35.53 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.757 2.305 . . . . 0.0 109.621 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -71.3 -8.12 51.55 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -77.31 -10.73 59.61 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.254 0.479 . . . . 0.0 111.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -72.58 158.16 36.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.73 175.98 34.91 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -56.88 -42.29 79.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -77.76 -27.82 50.46 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.656 0.382 . . . . 0.0 111.63 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -76.22 -37.92 57.1 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 tt -75.7 -25.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.8 tp -66.7 -51.75 52.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -65.16 -23.1 67.02 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.22 0.208 . . . . 0.0 111.501 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -76.4 -27.82 56.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.415 -0.178 . . . . 0.0 110.902 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.274 24.8 m-85 -105.37 -11.02 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 118.035 2.605 . . . . 0.0 118.035 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.421 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.1 mtm -66.75 -29.68 2.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.8 Cg_endo -72.5 -9.6 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.096 1.784 . . . . 0.0 112.216 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -86.61 -14.46 42.71 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.847 0.459 . . . . 0.0 111.453 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.64 -174.76 32.93 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -78.14 102.49 7.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.222 -0.575 . . . . 0.0 110.457 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -81.35 122.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.5 mt -81.89 -32.4 11.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 t -155.01 152.31 29.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.734 0.302 . . . . 0.0 110.777 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.58 143.06 21.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.735 0.814 . . . . 0.0 109.304 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.571 ' HE3' ' CZ ' ' A' ' 61' ' ' PHE . 5.1 tmmm? -159.07 143.61 15.6 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 122.885 0.474 . . . . 0.0 110.896 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.63 137.15 43.14 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 169.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.571 ' CZ ' ' HE3' ' A' ' 59' ' ' LYS . 74.4 m-85 -71.55 144.31 49.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mm -133.32 144.31 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 122.7 0.4 . . . . 0.0 110.195 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -89.06 130.93 35.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.9 -11.34 59.8 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.803 -0.561 . . . . 0.0 111.671 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -90.58 -22.6 21.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.07 -13.38 1.87 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.5 m120 61.39 9.34 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.561 1.144 . . . . 0.0 113.091 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -80.41 157.91 26.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 t -69.48 139.52 53.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.593 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.29 7.95 10.23 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.0 m 62.7 24.61 14.65 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.09 169.02 25.49 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.4 -177.67 29.79 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 121.627 0.571 . . . . 0.0 113.233 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -136.67 140.12 42.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.997 1.719 . . . . 0.0 114.177 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -144.22 156.05 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.648 0.779 . . . . 0.0 109.167 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.2 t -147.77 144.54 28.31 Favored 'General case' 0 C--N 1.339 0.151 0 O-C-N 121.901 -0.499 . . . . 0.0 112.022 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.18 165.74 11.88 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -82.27 -9.65 59.41 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.97 150.44 22.73 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.24 0.616 . . . . 0.0 111.141 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.29 -21.78 30.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.04 -38.86 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 O-C-N 121.95 -0.469 . . . . 0.0 111.727 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -75.93 -25.89 56.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.207 0.203 . . . . 0.0 110.703 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.61 -50.82 22.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -68.06 -28.36 67.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.469 -0.144 . . . . 0.0 110.659 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.08 82.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.9 -25.9 66.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.842 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mt -67.18 -51.18 56.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -69.34 -11.89 61.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.57 -28.24 16.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.4 mmm -120.51 -15.71 8.46 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -67.75 136.96 55.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 2.72 73.61 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.138 -0.812 . . . . 0.0 112.91 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.73 117.3 7.28 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.673 1.237 . . . . 0.0 110.429 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.08 129.28 37.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.471 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 tt -146.73 123.9 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.91 -144.75 48.38 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.9 mtm -83.64 13.01 4.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.975 0.91 . . . . 0.0 112.818 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.61 173.43 11.6 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.253 0.621 . . . . 0.0 112.011 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -119.72 137.09 54.14 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.846 0.858 . . . . 0.0 109.051 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.09 135.51 56.45 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -99.32 138.64 36.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.77 139.15 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.482 0.313 . . . . 0.0 110.165 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -154.28 163.62 39.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.676 0.216 . . . . 0.0 111.46 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -73.84 154.14 39.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.244 0.618 . . . . 0.0 110.418 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.504 ' H ' HD23 ' A' ' 104' ' ' LEU . 27.7 ttpp -68.21 155.64 39.26 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.459 0.704 . . . . 0.0 110.269 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -67.47 157.56 33.94 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.699 0.285 . . . . 0.0 110.317 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.1 t -154.34 154.13 32.8 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.796 0.439 . . . . 0.0 110.87 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -72.57 -16.58 61.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -71.85 -22.4 61.54 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -105.6 -3.03 22.79 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.6 t -75.61 -5.14 43.92 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.455 0.702 . . . . 0.0 111.428 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.98 156.98 73.89 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.458 0.703 . . . . 0.0 111.428 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.2 -15.43 16.14 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.931 3.087 . . . . 0.0 112.105 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.4 m95 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.948 -177.08 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.095 0 C5'-C4'-C3' 111.176 -2.882 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.215 0 O4'-C4'-C3' 108.074 1.838 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.174 0 C5'-C4'-C3' 112.23 -2.18 . 0.033 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . 0.497 H5'' ' C8 ' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.907 1 O4'-C1'-N19 112.311 4.111 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . 0.447 " H5'" " H4'" ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.85 0 O4'-C1'-N19 111.963 3.763 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.35 -178.75 46.38 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.4 t -70.01 166.44 19.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.269 0.628 . . . . 0.0 110.766 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 t -146.84 162.28 38.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.514 0.726 . . . . 0.0 110.345 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 55.92 19.92 3.88 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.009 0.923 . . . . 0.0 111.894 -175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -156.52 172.66 18.16 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.15 0.98 . . . . 0.0 108.939 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -61.09 161.49 8.51 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.847 0.356 . . . . 0.0 110.722 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -57.12 129.04 40.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.04 -174.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 10' ' ' HIS . 82.5 t60 -162.84 168.34 21.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.635 0.774 . . . . 0.0 109.63 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' N ' ' CG ' ' A' ' 9' ' ' HIS . 64.5 t-80 -64.25 160.76 17.95 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.414 0.686 . . . . 0.0 110.666 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.1 p -73.45 4.96 4.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.344 0.658 . . . . 0.0 112.289 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 t -146.5 171.98 14.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.477 0.711 . . . . 0.0 110.325 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.22 171.45 36.1 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.7 tp -148.5 146.44 28.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.472 0.309 . . . . 0.0 110.23 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.8 p -155.48 138.16 10.38 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 123.337 0.655 . . . . 0.0 110.178 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.01 142.46 56.6 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.63 2.22 . . . . 0.0 110.382 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -77.25 164.7 25.35 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.063 0.545 . . . . 0.0 110.999 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.52 -1.46 70.99 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.254 0.454 . . . . 0.0 112.465 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 99.8 p -68.21 160.96 28.15 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.674 0.737 . . . . 0.0 110.83 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -80.62 -7.94 59.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.554 0.341 . . . . 0.0 111.72 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mtm -75.59 167.44 21.89 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.021 0.439 . . . . 0.0 111.403 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -81.14 153.22 27.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.16 0.584 . . . . 0.0 111.064 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -122.46 159.57 27.35 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.5 0.72 . . . . 0.0 110.475 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -131.77 155.28 48.02 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.584 0.354 . . . . 0.0 111.067 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.73 -157.75 30.4 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.95 177.64 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.644 2.896 . . . . 0.0 110.336 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.35 141.99 58.56 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.114 -0.366 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.13 0.68 77.7 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.76 -0.466 . . . . 0.0 112.703 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.03 31.57 4.46 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.664 0.732 . . . . 0.0 112.268 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -138.85 139.48 38.16 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 122.102 -0.374 . . . . 0.0 111.439 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.6 mt -127.01 154.9 44.04 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -114.23 144.08 43.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.959 1.704 . . . . 0.0 114.173 171.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.49 135.85 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -139.2 176.85 8.35 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.451 ' NE2' " H1'" ' B' ' 115' ' ' ' U' . 7.9 m170 64.87 13.79 8.78 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.23 1.412 . . . . 0.0 112.952 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.61 146.7 98.2 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.17 163.08 40.4 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.352 2.035 . . . . 0.0 109.438 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -68.86 -16.69 63.84 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -172.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -74.9 -11.43 60.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -68.86 158.33 34.71 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.0 178.14 33.54 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -57.03 -42.3 80.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -77.45 -26.0 51.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -73.51 -41.11 63.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -74.09 -25.75 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -64.81 -49.9 68.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -65.36 -25.68 67.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.7 mmm -76.29 -24.15 54.41 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.285 19.5 m-85 -105.07 -9.82 17.57 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.409 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -66.17 -33.43 6.86 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.0 Cg_endo -74.13 -8.48 21.06 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.738 1.656 . . . . 0.0 112.075 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -87.75 -14.9 38.49 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.582 0.353 . . . . 0.0 111.494 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.37 32.86 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -77.6 101.14 6.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.306 -0.526 . . . . 0.0 110.561 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -77.58 118.75 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.33 -35.78 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -158.51 157.14 31.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.814 0.34 . . . . 0.0 110.507 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.19 140.88 15.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.72 133.74 8.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.594 0.235 . . . . 0.0 111.341 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.5 t -93.25 143.26 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.442 ' CD2' ' CZ ' ' A' ' 72' ' ' PHE . 4.9 m-85 -73.08 148.5 43.98 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.7 mm -132.49 144.77 35.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 122.842 0.457 . . . . 0.0 110.203 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 66.7 t0 -92.22 131.17 37.66 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.33 -12.41 60.26 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 121.741 -0.599 . . . . 0.0 111.393 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -88.37 -23.79 23.28 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.404 0.682 . . . . 0.0 112.692 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -132.93 -14.14 2.75 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.9 t30 62.05 8.66 2.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.927 1.291 . . . . 0.0 112.094 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.17 164.48 18.09 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.932 0.493 . . . . 0.0 110.186 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.6 t -68.28 140.02 55.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.364 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 88.1 mttt -81.06 8.47 8.5 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.704 0.402 . . . . 0.0 111.891 175.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.1 m 63.07 21.32 12.82 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.442 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 4.0 p90 -155.52 167.12 31.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.0 -172.0 28.84 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 121.496 0.498 . . . . 0.0 114.035 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -136.6 145.48 44.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.411 1.884 . . . . 0.0 114.996 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -145.77 152.69 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.314 1.045 . . . . 0.0 109.283 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.3 p -142.79 149.72 39.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.391 0.541 . . . . 0.0 112.193 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.18 165.59 13.61 Favored 'General case' 0 N--CA 1.458 -0.054 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -80.89 -10.52 59.71 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.87 150.31 22.61 Favored Pre-proline 0 N--CA 1.453 -0.291 0 C-N-CA 123.287 0.635 . . . . 0.0 110.88 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.57 -20.95 40.42 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.437 2.758 . . . . 0.0 112.14 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.41 -39.04 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 O-C-N 121.801 -0.562 . . . . 0.0 111.611 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -74.88 -26.22 59.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.65 -48.54 25.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 122.449 -0.157 . . . . 0.0 110.624 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -65.92 -29.71 70.17 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.062 -0.399 . . . . 0.0 111.046 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.59 77.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.76 -26.71 64.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 119.567 -0.254 . . . . 0.0 111.662 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.69 -51.89 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.95 -11.89 59.68 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.71 -28.95 17.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.46 -14.74 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -67.45 136.19 54.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.85 1.53 84.51 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.862 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -66.01 118.95 10.52 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.772 1.286 . . . . 0.0 109.785 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.66 125.55 29.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.954 0.343 . . . . 0.0 111.55 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.0 tt -157.63 135.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.228 0.611 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.32 82.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.403 -0.81 . . . . 0.0 112.194 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 22.4 mmt 63.06 23.34 13.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.276 1.03 . . . . 0.0 113.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -145.35 155.51 43.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -97.81 132.73 43.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.79 -0.569 . . . . 0.0 110.481 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.44 128.34 36.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.24 0.216 . . . . 0.0 111.08 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -90.73 136.08 33.3 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.34 136.95 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -152.71 160.7 43.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 117.972 0.351 . . . . 0.0 111.916 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.15 156.28 38.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.069 0.548 . . . . 0.0 110.42 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 106' ' ' ARG . 60.8 tttp -70.53 154.57 41.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.454 0.645 . . . . 0.0 112.401 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' N ' ' CG ' ' A' ' 105' ' ' LYS . 86.2 mtt-85 -132.43 160.47 36.3 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.458 1.903 . . . . 0.0 107.987 173.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.7 m -131.49 161.91 31.46 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.763 0.316 . . . . 0.0 111.029 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.35 -21.05 66.49 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -70.84 -10.57 59.84 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.567 0.347 . . . . 0.0 111.393 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -80.34 -7.41 59.06 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.726 0.41 . . . . 0.0 111.341 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.1 t -125.35 -31.14 3.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.971 0.509 . . . . 0.0 111.526 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' HB2' ' HZ3' ' A' ' 112' ' ' LYS . 9.8 mtmp? -73.69 155.96 88.74 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 117.836 0.289 . . . . 0.0 110.326 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.52 4.26 6.5 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.765 2.977 . . . . 0.0 110.6 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.748 -1.12 . . . . 0.0 109.275 -178.705 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.451 " H1'" ' NE2' ' A' ' 35' ' ' HIS . . . . . . . . 0 O4'--C4' 1.419 -2.813 1 O4'-C1'-N19 112.223 4.023 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.786 0 O4'-C1'-N19 111.066 2.866 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.995 0 C3'-C2'-C1' 98.085 -3.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.825 2 O4'-C1'-N19 112.983 4.783 . 0.46 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 2 O4'-C1'-N19 114.017 5.817 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.7 mtm . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.407 0.146 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.38 -8.25 87.91 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.839 -0.423 . . . . 0.0 112.405 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.2 t -68.63 153.39 43.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.74 0.77 . . . . 0.0 111.17 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.6 m -75.19 -6.59 50.45 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.889 0.476 . . . . 0.0 111.485 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.466 ' CG ' ' H ' ' A' ' 6' ' ' HIS . 78.5 t60 59.74 173.11 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.021 1.328 . . . . 0.0 112.444 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.466 ' H ' ' CG ' ' A' ' 5' ' ' HIS . 73.9 t60 -66.26 149.16 50.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.152 0.581 . . . . 0.0 110.38 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -74.68 163.72 27.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.979 0.418 . . . . 0.0 111.253 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -67.98 153.62 43.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.569 0.348 . . . . 0.0 111.184 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -68.21 164.59 20.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.157 0.583 . . . . 0.0 111.061 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -66.31 -10.72 45.44 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.795 0.438 . . . . 0.0 111.399 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.6 m -68.39 -7.09 28.46 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.005 0.522 . . . . 0.0 111.433 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t -66.51 -15.96 63.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.738 0.415 . . . . 0.0 111.089 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.13 -1.35 85.37 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.785 -0.453 . . . . 0.0 112.222 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.6 tp -65.81 144.68 56.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.4 0.68 . . . . 0.0 110.748 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.3 m -133.26 148.43 69.04 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 123.515 0.726 . . . . 0.0 111.931 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.77 21.52 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 124.936 3.757 . . . . 0.0 114.171 -172.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.6 169.75 4.64 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.552 -0.718 . . . . 0.0 110.73 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.07 -2.71 1.63 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.9 m -73.82 -18.45 60.95 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 117.562 0.681 . . . . 0.0 111.487 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 51.63 29.19 5.35 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.243 1.017 . . . . 0.0 113.674 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.5 mtm -74.28 -6.43 47.93 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.022 -0.424 . . . . 0.0 112.095 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -70.04 148.27 49.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.08 0.552 . . . . 0.0 110.497 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -118.28 159.5 23.26 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 123.711 0.804 . . . . 0.0 113.144 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -83.49 164.58 19.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.55 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.75 -156.43 31.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.578 1.085 . . . . 0.0 113.117 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.19 -178.43 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.609 3.539 . . . . 0.0 111.542 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -57.86 130.21 45.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.268 0.627 . . . . 0.0 111.305 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.82 -2.0 70.84 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.498 0.57 . . . . 0.0 113.19 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.76 36.59 0.9 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.714 0.757 . . . . 0.0 111.871 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 140.23 33.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.966 -0.458 . . . . 0.0 111.371 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.18 162.09 26.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 19.7 m-85 -119.72 143.57 47.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 114.917 173.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.16 124.69 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 13.1 m-85 -128.77 179.71 5.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.8 m170 63.25 16.2 9.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.014 1.326 . . . . 0.0 112.836 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.9 142.33 93.34 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 118.144 0.429 . . . . 0.0 109.968 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.61 163.64 36.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.137 2.558 . . . . 0.0 109.722 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -68.81 -17.47 64.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -74.32 -10.29 59.44 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.038 -0.414 . . . . 0.0 112.046 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.03 158.14 36.51 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.9 176.59 33.34 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -56.84 -38.79 73.15 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.656 0.383 . . . . 0.0 110.642 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.04 -42.34 73.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.46 -26.11 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -64.86 -50.5 66.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -69.82 -23.11 63.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.7 -26.76 62.63 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.158 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 28.1 m-85 -104.23 -8.36 19.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 118.108 2.632 . . . . 0.0 118.108 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.402 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -67.33 -32.47 4.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.1 Cg_endo -73.38 -8.33 21.67 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.87 1.703 . . . . 0.0 112.164 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -89.9 -14.34 34.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.053 0.541 . . . . 0.0 111.283 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.02 -175.6 33.72 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -78.28 103.76 8.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.24 -0.565 . . . . 0.0 110.697 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.52 120.78 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.8 mt -84.02 -34.01 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.2 t -152.39 150.89 30.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 111.277 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.69 142.38 16.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.509 0.724 . . . . 0.0 109.209 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.619 ' HE3' ' CE1' ' A' ' 61' ' ' PHE . 3.0 tmmm? -159.87 134.49 7.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.679 0.392 . . . . 0.0 110.592 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.68 136.97 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.619 ' CE1' ' HE3' ' A' ' 59' ' ' LYS . 78.1 m-85 -69.15 150.0 48.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.12 143.27 41.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 122.77 0.428 . . . . 0.0 110.098 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.34 129.41 35.02 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -74.87 -12.48 60.38 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.949 -0.469 . . . . 0.0 111.541 -179.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -89.7 -23.23 21.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -134.71 -13.65 2.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 61.58 11.09 3.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.08 158.69 24.97 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 122.029 -0.42 . . . . 0.0 110.062 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -72.31 135.3 45.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.008 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -81.52 166.84 19.93 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.053 0.454 . . . . 0.0 111.135 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.7 m -79.19 12.05 2.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -157.01 170.82 21.67 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.05 -174.43 25.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.822 0.725 . . . . 0.0 112.447 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -138.62 145.15 40.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.94 152.95 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.24 1.016 . . . . 0.0 110.157 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -147.32 147.8 30.72 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.75 166.56 10.92 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -79.15 -8.56 59.1 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.06 150.8 24.85 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 123.221 0.609 . . . . 0.0 110.902 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -71.67 -16.16 30.17 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.142 2.561 . . . . 0.0 111.656 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.17 -46.8 92.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 118.383 0.538 . . . . 0.0 110.845 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -70.01 -24.6 63.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.841 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.36 -47.18 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.916 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -67.07 -29.7 69.54 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.159 -0.338 . . . . 0.0 110.758 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 -41.52 80.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.43 65.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -66.01 -52.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.79 -12.14 57.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.119 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.46 -31.5 17.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.7 mtp -124.64 -9.06 7.36 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.87 128.04 34.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.8 90.25 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.572 -0.571 . . . . 0.0 112.617 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -62.25 120.03 10.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.447 1.123 . . . . 0.0 111.295 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -76.0 129.77 37.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.981 -0.45 . . . . 0.0 111.516 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.78 122.42 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.03 -143.63 48.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -87.34 16.64 5.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.57 0.748 . . . . 0.0 112.767 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -144.67 172.67 12.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.366 0.53 . . . . 0.0 109.968 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -117.66 143.89 45.74 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.181 0.592 . . . . 0.0 110.372 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.85 133.04 48.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.787 0.435 . . . . 0.0 111.151 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.493 ' HE3' ' C4 ' ' B' ' 116' ' ' ' U' . 17.8 ttmm -92.72 136.55 33.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.9 t -134.76 140.46 45.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -155.06 164.35 39.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.366 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.494 HD22 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.86 153.49 41.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.68 0.792 . . . . 0.0 110.188 175.227 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.494 ' H ' HD22 ' A' ' 104' ' ' LEU . 85.1 tttt -63.22 152.02 38.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.316 0.646 . . . . 0.0 109.599 174.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -64.78 160.09 20.98 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 120.891 0.377 . . . . 0.0 110.248 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.6 t -67.82 150.13 49.0 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.06 0.457 . . . . 0.0 110.924 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.496 ' H ' ' CD ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -71.63 -9.32 58.06 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.009 0.523 . . . . 0.0 110.717 176.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -69.58 -18.55 63.64 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -82.26 -14.65 55.15 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.8 m -83.35 -12.5 56.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.706 0.403 . . . . 0.0 111.029 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.53 152.78 95.32 Favored Pre-proline 0 CA--C 1.528 0.117 0 C-N-CA 122.801 0.44 . . . . 0.0 111.042 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.99 -13.36 23.88 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.726 2.951 . . . . 0.0 111.21 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.2 m95 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.038 -1.458 . . . . 0.0 112.016 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 0 C5'-C4'-C3' 110.328 -3.448 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . 0.493 ' C4 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.414 -3.237 0 O4'-C1'-N19 111.719 3.519 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.353 0 C3'-C2'-C1' 98.704 -3.107 . 0.034 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.958 1 C3'-C2'-C1' 105.505 4.45 . 0.378 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 2 O4'-C1'-N19 112.826 4.626 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.514 0.197 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.28 179.84 48.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -76.78 -0.95 25.71 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.02 0.528 . . . . 0.0 112.253 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 t -154.93 160.76 41.37 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.308 0.643 . . . . 0.0 110.115 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -153.63 -3.16 0.2 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -73.92 161.0 30.59 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.333 0.515 . . . . 0.0 110.801 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -70.78 -18.45 62.75 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -76.69 -10.11 59.15 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.992 -0.443 . . . . 0.0 111.195 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -74.98 -18.4 60.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.72 0.408 . . . . 0.0 110.983 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -83.18 -6.33 59.44 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.31 0.644 . . . . 0.0 111.548 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -70.5 158.54 35.9 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.403 0.281 . . . . 0.0 111.311 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -156.28 161.6 40.21 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.995 0.518 . . . . 0.0 110.111 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.78 169.33 54.47 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.0 tp -153.81 149.43 27.4 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.021 0.528 . . . . 0.0 110.149 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -65.26 133.3 95.49 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 122.875 0.47 . . . . 0.0 111.324 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.77 -3.12 10.66 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.463 2.775 . . . . 0.0 113.255 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -143.61 20.3 1.85 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.23 178.35 28.05 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 123.184 0.421 . . . . 0.0 112.402 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.8 t -157.93 157.48 33.18 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.911 0.484 . . . . 0.0 110.457 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -66.9 -37.3 84.12 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.71 0.404 . . . . 0.0 110.62 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.2 mtm 57.05 156.05 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.403 1.481 . . . . 0.0 113.489 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -126.7 152.24 47.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 121.723 -0.611 . . . . 0.0 110.164 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -137.71 159.08 42.97 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.36 0.664 . . . . 0.0 109.942 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -133.49 153.94 51.22 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.31 -165.5 35.07 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.85 167.56 19.24 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.402 2.735 . . . . 0.0 109.39 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -64.28 138.73 58.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.963 -0.46 . . . . 0.0 110.122 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.72 86.37 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.723 -0.487 . . . . 0.0 112.179 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.06 21.24 16.1 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.463 0.705 . . . . 0.0 112.233 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -125.31 137.52 54.07 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.38 161.86 22.66 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 122.19 0.995 . . . . 0.0 113.653 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -119.08 143.96 46.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.852 1.661 . . . . 0.0 114.555 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.81 129.47 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -134.99 178.89 6.67 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.7 m170 63.96 17.14 10.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.374 1.469 . . . . 0.0 113.293 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.88 142.8 95.88 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 122.767 0.427 . . . . 0.0 110.444 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.96 171.89 17.3 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.792 2.995 . . . . 0.0 110.97 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -68.98 -21.37 64.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.959 0.904 . . . . 0.0 112.448 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -75.63 -6.61 51.24 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.72 158.13 28.38 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.32 175.08 34.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -61.92 -36.64 81.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -75.2 -31.42 60.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.377 0.271 . . . . 0.0 110.726 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -73.34 -38.24 65.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -76.21 -24.77 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.83 -53.0 37.02 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -66.11 -23.52 66.51 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.447 0.166 . . . . 0.0 111.447 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.3 tpp -75.77 -29.43 58.79 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.68 0.392 . . . . 0.0 110.828 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.308 24.6 m-85 -102.11 -8.77 21.12 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.419 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 43.7 mtm -66.36 -30.83 3.81 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.2 Cg_endo -72.28 -10.39 25.62 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.88 1.707 . . . . 0.0 111.789 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -86.2 -14.99 42.31 Favored 'General case' 0 C--N 1.338 0.073 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.14 -171.48 32.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -76.59 103.61 6.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.433 -0.451 . . . . 0.0 110.727 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.51 122.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.3 mt -82.62 -33.54 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -156.42 156.34 33.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.022 0.439 . . . . 0.0 110.399 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.37 149.25 25.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -159.68 141.23 12.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.0 111.403 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 t -115.05 128.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.42 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 41.8 m-85 -71.69 157.34 38.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mm -126.32 140.47 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.052 0 C-N-CA 122.493 0.317 . . . . 0.0 110.499 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -87.36 131.28 34.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -75.26 -12.95 60.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.92 0.488 . . . . 0.0 111.5 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -89.72 -21.94 22.45 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.13 -14.43 1.79 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 61.67 8.8 2.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 112.711 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.36 162.21 23.49 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.77 0.428 . . . . 0.0 110.151 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -69.47 136.47 51.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.737 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -76.27 164.18 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.4 m -77.32 10.05 2.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -156.86 172.05 19.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.46 -165.57 19.71 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.367 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -141.41 144.37 34.43 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -147.0 151.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.751 0.82 . . . . 0.0 109.303 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 94.8 p -141.8 149.27 40.16 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -116.83 159.9 21.66 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -77.26 -13.38 59.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.148 0.499 . . . . 0.0 112.012 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.13 149.57 19.78 Favored Pre-proline 0 N--CA 1.456 -0.158 0 C-N-CA 123.223 0.609 . . . . 0.0 110.965 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.11 -21.68 42.25 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.644 2.896 . . . . 0.0 111.94 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.69 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 118.534 0.606 . . . . 0.0 111.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -76.1 -25.56 55.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.286 0.235 . . . . 0.0 110.769 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.32 -48.16 30.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -66.46 -28.42 68.58 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.764 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.89 76.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.13 66.15 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.35 -53.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.48 -11.51 58.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.458 0.303 . . . . 0.0 111.163 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.61 -31.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 119.019 -0.515 . . . . 0.0 112.375 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.4 mtp -128.73 -9.04 5.02 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -61.64 125.11 22.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.27 6.14 89.0 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.824 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.04 119.76 10.73 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.681 1.24 . . . . 0.0 112.333 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -76.92 130.06 37.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.976 0.353 . . . . 0.0 110.963 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -145.09 136.03 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.22 -100.41 0.35 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.1 ptp -139.78 17.21 2.5 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.045 0.938 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -148.02 152.77 37.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.825 0.45 . . . . 0.0 110.181 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -93.36 139.52 30.58 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 122.138 -0.351 . . . . 0.0 111.008 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 89.9 mt -68.49 131.16 44.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.709 0.404 . . . . 0.0 110.987 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HE3' ' C4 ' ' B' ' 116' ' ' ' U' . 16.6 ttmm -90.82 135.67 33.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 170.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.32 136.7 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -152.67 159.81 43.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.651 0.262 . . . . 0.0 111.417 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.501 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -75.75 152.31 37.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.254 0.622 . . . . 0.0 109.658 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.501 ' H ' HD21 ' A' ' 104' ' ' LEU . 26.4 ttpp -63.51 157.98 22.16 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.239 0.616 . . . . 0.0 109.859 173.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -60.09 158.86 10.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.934 0.494 . . . . 0.0 110.794 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.2 t -151.8 154.86 37.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.755 0.422 . . . . 0.0 110.817 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -73.04 -10.61 59.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.564 0.346 . . . . 0.0 111.501 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -67.61 -14.62 63.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.067 -0.396 . . . . 0.0 111.681 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -78.65 -28.45 45.42 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.6 t -85.75 -31.13 22.56 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.995 -0.441 . . . . 0.0 111.08 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -76.14 154.22 84.47 Favored Pre-proline 0 N--CA 1.457 -0.085 0 C-N-CA 122.863 0.465 . . . . 0.0 111.207 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.78 -12.42 22.01 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.584 2.856 . . . . 0.0 110.929 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.7 m95 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 117.31 -1.329 . . . . 0.0 111.437 178.612 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.928 0 C5'-C4'-C3' 110.089 -3.608 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . 0.406 ' C4 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.083 0 O4'-C1'-N19 111.834 3.634 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.448 0 C3'-C2'-C1' 99.296 -2.449 . 0.18 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.93 1 C3'-C2'-C1' 105.693 4.659 . 0.345 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . 0.42 " H1'" ' CD1' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -3.008 2 O4'-C1'-N19 112.944 4.744 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mtp . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.03 -150.36 51.81 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.8 m -67.43 -9.82 45.41 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.955 0.377 . . . . 0.0 111.84 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 m 54.1 21.82 3.19 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.493 1.117 . . . . 0.0 113.131 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -154.82 150.17 27.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.561 0.744 . . . . 0.0 109.463 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -144.23 163.78 32.64 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.398 0.679 . . . . 0.0 110.639 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -67.65 -6.67 21.55 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -76.09 -12.66 60.16 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.734 0.414 . . . . 0.0 111.119 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -71.29 149.22 46.37 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.214 0.606 . . . . 0.0 110.08 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -69.87 -13.63 62.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -79.27 -11.65 59.95 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.92 0.488 . . . . 0.0 111.256 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -67.29 154.54 41.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.676 0.391 . . . . 0.0 111.683 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.81 -6.59 87.19 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.79 141.36 57.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.239 0.519 . . . . 0.0 110.39 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.06 139.63 11.76 Favored Pre-proline 0 CA--C 1.531 0.232 0 C-N-CA 123.212 0.605 . . . . 0.0 111.125 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.09 145.47 61.15 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.554 2.17 . . . . 0.0 109.939 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -75.93 156.22 34.41 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.687 0.279 . . . . 0.0 111.261 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.29 -2.83 90.32 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.645 -0.53 . . . . 0.0 112.6 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.1 t -66.55 153.29 43.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.777 0.788 . . . . 0.0 111.212 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -155.14 18.44 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.41 0.684 . . . . 0.0 110.294 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 74.7 mtm -69.2 161.64 28.77 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.847 0.459 . . . . 0.0 111.602 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -63.52 152.63 38.02 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.424 0.689 . . . . 0.0 110.449 178.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -139.52 151.29 46.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.403 0.681 . . . . 0.0 110.293 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -87.96 154.22 20.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.874 0.87 . . . . 0.0 112.51 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.53 -173.7 49.13 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.39 0.519 . . . . 0.0 111.966 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.97 165.68 29.21 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.765 2.977 . . . . 0.0 109.877 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.08 131.26 47.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.4 -9.98 69.31 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.41 5.42 51.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.561 0.68 . . . . 0.0 110.969 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -95.52 142.08 28.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.27 159.88 35.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.719 0.771 . . . . 0.0 112.607 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.3 m-85 -122.6 145.89 47.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.824 1.65 . . . . 0.0 114.847 173.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.4 137.46 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.2 m-85 -140.65 179.46 6.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.488 ' HE2' " H1'" ' B' ' 115' ' ' ' U' . 20.1 m170 62.96 17.28 9.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.513 1.125 . . . . 0.0 112.924 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.42 142.51 92.18 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.055 0.388 . . . . 0.0 110.165 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.15 168.14 25.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.169 2.58 . . . . 0.0 109.959 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.05 -16.93 62.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -76.79 -9.67 58.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -72.62 158.08 36.34 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.1 171.73 33.36 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -59.86 -36.02 76.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -74.32 -29.42 61.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.887 0.475 . . . . 0.0 110.924 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -76.49 -42.42 43.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -71.29 -24.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.05 -49.72 73.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -64.9 -24.59 67.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.441 0.296 . . . . 0.0 111.712 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.2 mmm -76.19 -24.2 54.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.385 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 28.7 m-85 -107.32 -12.14 15.41 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.415 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.5 mtm -66.71 -31.15 3.83 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.6 Cg_endo -72.44 -10.65 25.72 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 121.986 1.745 . . . . 0.0 112.091 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -87.6 -14.07 41.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.744 0.418 . . . . 0.0 111.807 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.82 -174.74 33.06 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -75.62 106.52 7.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.343 -0.504 . . . . 0.0 110.382 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.4 122.34 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 78' ' ' ASP . 28.6 mt -87.42 -27.83 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 t -149.8 146.73 27.32 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.915 0.388 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 143.38 24.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.166 0.986 . . . . 0.0 108.534 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.53 142.52 15.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.39 0.276 . . . . 0.0 111.565 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -118.5 131.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 169.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.494 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 40.1 m-85 -75.26 146.63 40.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -172.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -133.77 145.69 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.174 0.589 . . . . 0.0 110.094 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -85.45 129.09 34.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.92 -11.29 59.94 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.836 -0.54 . . . . 0.0 111.945 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -90.65 -21.81 21.49 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 -11.41 1.46 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.99 10.53 2.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.581 1.152 . . . . 0.0 112.903 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.96 159.97 23.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.118 0.485 . . . . 0.0 110.006 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -70.07 142.71 52.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.807 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -84.29 -0.8 53.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.679 0.792 . . . . 0.0 111.206 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.2 m 61.34 19.44 10.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.94 170.41 22.19 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.39 -168.12 24.88 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 121.368 0.427 . . . . 0.0 113.568 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -140.92 144.19 35.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.968 1.707 . . . . 0.0 114.967 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.1 t -147.39 154.22 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -148.7 145.72 27.8 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.323 0.511 . . . . 0.0 112.107 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.91 162.08 13.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' HA ' HD11 ' A' ' 56' ' ' ILE . 36.0 t0 -77.18 -11.13 59.78 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 174.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.54 146.8 17.39 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 123.128 0.571 . . . . 0.0 110.61 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.18 -21.83 41.6 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.361 2.707 . . . . 0.0 112.626 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.4 p -63.59 -39.18 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 O-C-N 121.885 -0.51 . . . . 0.0 111.509 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -74.17 -24.55 59.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.103 0.161 . . . . 0.0 110.926 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.69 -48.0 35.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 121.395 -0.122 . . . . 0.0 110.683 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -67.15 -29.62 69.38 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.408 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.01 82.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.74 67.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.82 -52.79 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -68.39 -11.01 59.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.383 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.01 -31.56 18.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.2 mtp -123.88 -12.31 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.26 126.75 28.41 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.53 5.17 87.11 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.779 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.07 116.73 7.48 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.813 1.306 . . . . 0.0 110.039 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.67 131.12 40.62 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -144.79 121.61 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.77 -137.52 48.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -86.99 4.8 40.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.453 ' HE3' ' CG ' ' A' ' 35' ' ' HIS . 29.4 ttpt -147.45 161.75 40.43 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 111.34 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -97.39 144.56 27.01 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.738 0.415 . . . . 0.0 110.671 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.4 126.69 30.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.358 0.263 . . . . 0.0 110.843 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.492 ' HE3' ' C4 ' ' B' ' 116' ' ' ' U' . 19.9 ttmm -89.57 139.17 30.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.45 138.66 50.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -150.8 162.39 40.83 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.445 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -81.94 147.91 29.0 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.99 -0.444 . . . . 0.0 110.326 175.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.445 ' H ' HD21 ' A' ' 104' ' ' LEU . 86.2 tttt -60.19 144.97 48.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -86.73 159.96 18.98 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.897 0.38 . . . . 0.0 110.944 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.4 t -80.42 156.48 26.62 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -100.35 -3.48 31.08 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.098 0.559 . . . . 0.0 111.667 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -70.3 -12.81 61.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -111.3 -15.99 13.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.9 t -76.89 -22.97 52.61 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.073 0.549 . . . . 0.0 111.368 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -71.94 150.17 92.67 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.24 0.216 . . . . 0.0 110.667 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.66 -17.7 15.83 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.983 3.122 . . . . 0.0 111.686 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.6 m95 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.243 -1.36 . . . . 0.0 111.927 -177.665 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.488 " H1'" ' HE2' ' A' ' 35' ' ' HIS . . . . . . . . 0 O4'--C4' 1.422 -2.575 0 C5'-C4'-C3' 109.777 -3.816 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . 0.492 ' C4 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.127 0 O4'-C1'-N19 111.58 3.38 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.231 0 C3'-C2'-C1' 99.567 -2.148 . 0.036 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.903 2 C3'-C2'-C1' 105.517 4.463 . 0.412 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . 0.494 " H1'" ' CD1' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.876 2 C5'-C4'-C3' 108.693 -4.538 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 110.54 -0.17 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.17 -6.6 88.83 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.3 p -155.88 171.98 19.14 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.776 0.83 . . . . 0.0 109.67 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.1 m 53.52 30.25 10.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.049 0.54 . . . . 0.0 112.212 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -65.75 160.01 23.89 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.98 0.512 . . . . 0.0 110.905 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -67.21 -12.17 59.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.518 0.727 . . . . 0.0 112.518 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -154.81 175.29 13.92 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.215 0.461 . . . . 0.0 110.629 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -141.99 13.03 2.05 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.388 0.675 . . . . 0.0 111.298 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -68.54 174.08 4.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.237 0.615 . . . . 0.0 110.563 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -57.86 -29.05 64.7 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.331 0.253 . . . . 0.0 111.026 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.1 t 58.54 165.11 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.104 1.362 . . . . 0.0 114.28 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.1 p -83.35 -3.92 57.97 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.422 0.689 . . . . 0.0 110.522 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.22 -3.59 5.19 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.0 tp -74.4 -22.7 59.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.528 0.664 . . . . 0.0 111.442 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -68.12 136.93 91.73 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 122.684 0.394 . . . . 0.0 111.393 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.26 -9.38 23.54 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.165 2.577 . . . . 0.0 112.411 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -11.89 61.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.543 0.737 . . . . 0.0 110.902 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.48 15.41 78.24 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.7 t 59.87 156.83 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.504 1.522 . . . . 0.0 113.538 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -80.25 -4.72 54.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.639 0.775 . . . . 0.0 111.716 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.6 ptp -64.8 155.53 33.61 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.867 0.365 . . . . 0.0 110.486 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -64.8 151.78 44.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.114 0.566 . . . . 0.0 110.99 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -133.13 154.97 50.1 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.615 0.766 . . . . 0.0 109.752 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -142.41 154.92 45.01 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.815 0.446 . . . . 0.0 111.376 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.01 -154.64 29.98 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.07 177.33 5.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.944 3.096 . . . . 0.0 110.52 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.97 137.43 58.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.632 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.24 -1.84 86.1 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.346 0.498 . . . . 0.0 112.561 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.28 36.62 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.757 . . . . 0.0 111.617 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.21 140.48 29.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 111.324 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.1 mt -128.28 152.82 47.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 27.7 m-85 -108.5 140.84 41.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 113.939 169.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.18 123.55 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 23.3 m-85 -126.54 178.04 6.13 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.9 m170 66.1 15.29 10.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.949 1.7 . . . . 0.0 113.091 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.63 137.11 88.11 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.594 0.358 . . . . 0.0 110.183 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.35 173.28 14.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.465 2.777 . . . . 0.0 111.272 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -65.41 -20.81 66.53 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -74.33 -6.92 50.85 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -78.55 158.08 28.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.03 174.98 36.88 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -59.72 -39.1 83.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.009 0.524 . . . . 0.0 110.671 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -75.65 -38.97 58.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -74.03 -25.31 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.06 -52.05 52.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -64.5 -22.82 67.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.359 0.264 . . . . 0.0 111.634 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.6 tpp -76.82 -28.21 55.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.091 0.156 . . . . 0.0 110.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.275 25.0 m-85 -104.88 -11.47 16.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.2 mtm -66.84 -30.99 3.6 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.5 Cg_endo -72.85 -10.36 24.75 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 121.822 1.686 . . . . 0.0 112.18 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.33 -15.77 39.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.691 0.397 . . . . 0.0 112.033 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.36 -173.31 34.21 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -77.96 102.53 7.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.389 -0.477 . . . . 0.0 110.47 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -81.59 124.13 38.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.58 -30.2 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -154.02 148.5 26.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.671 0.389 . . . . 0.0 110.506 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.1 138.6 17.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.01 145.15 18.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.353 0.261 . . . . 0.0 111.133 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.8 t -111.02 135.5 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.462 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 83.8 m-85 -65.95 150.88 47.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.21 142.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.922 0.489 . . . . 0.0 110.442 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -88.21 131.55 34.7 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -74.96 -12.3 60.31 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.618 0.367 . . . . 0.0 111.756 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -90.41 -21.99 21.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.06 -14.92 1.77 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 61.78 9.39 2.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.326 1.051 . . . . 0.0 112.802 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.59 160.76 23.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.853 0.359 . . . . 0.0 110.366 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.4 m -68.33 135.54 52.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.34 0.256 . . . . 0.0 110.826 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -78.61 168.09 20.28 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -76.72 15.11 0.69 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.13 172.11 18.05 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.55 -173.11 23.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.298 0.951 . . . . 0.0 112.58 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CE1' ' N1 ' ' B' ' 118' ' ' ' A' . 6.0 t80 -142.01 142.63 32.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.725 1.61 . . . . 0.0 114.978 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -145.66 153.53 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.881 0.872 . . . . 0.0 110.368 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.8 t -147.2 146.47 29.84 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.747 -0.595 . . . . 0.0 112.584 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -111.73 168.68 9.37 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -81.68 -9.74 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.43 151.38 27.12 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 123.434 0.693 . . . . 0.0 111.061 177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -71.59 -18.38 29.14 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.069 2.513 . . . . 0.0 111.52 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.2 t -63.28 -45.9 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 118.39 0.541 . . . . 0.0 111.135 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 m -70.81 -26.55 63.35 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.1 -47.28 52.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.92 -28.21 68.11 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.077 0.399 . . . . 0.0 111.094 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.64 -42.0 78.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.25 65.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.4 mt -66.43 -51.04 62.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.05 -11.81 61.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.62 -28.09 19.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 13.0 ttm -120.6 -23.25 6.11 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.95 126.39 27.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.48 88.01 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.771 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -64.42 121.08 13.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.162 1.481 . . . . 0.0 110.927 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -76.93 124.37 27.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.621 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -161.06 136.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.816 0.846 . . . . 0.0 109.762 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.87 39.4 97.34 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.668 -0.645 . . . . 0.0 112.8 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.4 mtt 62.06 16.16 7.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.901 0.88 . . . . 0.0 113.229 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -141.45 179.47 6.78 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.895 1.278 . . . . 0.0 109.297 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -118.07 138.13 52.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.23 0.212 . . . . 0.0 110.503 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.02 129.44 40.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -92.23 136.17 33.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.36 139.71 49.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -155.37 158.69 39.08 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.737 0.303 . . . . 0.0 111.545 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.498 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.7 155.23 37.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.346 0.658 . . . . 0.0 111.12 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.498 ' H ' HD21 ' A' ' 104' ' ' LEU . 86.9 tttt -69.58 164.59 22.94 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.959 0.903 . . . . 0.0 109.772 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -60.9 154.4 22.32 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 117.91 0.323 . . . . 0.0 110.753 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.0 t -70.72 158.74 35.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.105 0.562 . . . . 0.0 111.033 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -68.64 -12.57 61.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.262 0.225 . . . . 0.0 111.088 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.46 -3.95 58.06 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.432 0.293 . . . . 0.0 110.596 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -131.81 -2.13 3.73 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 89.4 p -77.92 -0.4 27.38 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.767 -0.583 . . . . 0.0 111.21 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 157.24 73.21 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 124.035 0.934 . . . . 0.0 111.857 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.83 -14.18 17.42 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 124.006 3.138 . . . . 0.0 112.245 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.9 m95 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.722 -1.132 . . . . 0.0 112.87 -177.119 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.877 1 C5'-C4'-C3' 108.971 -4.353 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.138 0 O4'-C1'-N19 110.306 2.106 . 0.091 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.823 0 C5'-C4'-C3' 111.774 -2.484 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . 0.478 H5'' ' C8 ' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.928 2 O4'-C1'-N19 112.638 4.438 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.076 2 C5'-C4'-C3' 109.315 -4.123 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.74 169.13 38.34 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m 55.74 13.29 1.01 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.449 1.1 . . . . 0.0 113.827 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.5 t -163.57 157.42 19.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.516 0.727 . . . . 0.0 109.95 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -71.96 -13.7 61.7 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.207 0.203 . . . . 0.0 110.617 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.531 ' CG ' ' H ' ' A' ' 7' ' ' HIS . 68.5 t60 57.53 -177.02 0.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.399 1.08 . . . . 0.0 111.971 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.531 ' H ' ' CG ' ' A' ' 6' ' ' HIS . 45.2 m80 -71.71 4.9 2.82 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.269 0.628 . . . . 0.0 111.748 176.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.6 t60 60.86 167.0 0.09 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.243 1.417 . . . . 0.0 112.599 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -73.19 159.41 33.53 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.166 0.586 . . . . 0.0 111.045 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 60.74 166.41 0.08 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.739 1.216 . . . . 0.0 112.245 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.2 t -69.01 -18.7 64.08 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.96 -0.462 . . . . 0.0 110.954 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 t 57.68 18.2 4.59 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.204 1.002 . . . . 0.0 112.373 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.9 177.01 50.98 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.27 163.92 26.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 111.46 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.39 138.67 12.19 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 123.415 0.686 . . . . 0.0 110.411 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.47 138.34 83.88 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.838 2.359 . . . . 0.0 111.703 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.9 mmt-85 -82.79 170.19 15.31 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.86 0.464 . . . . 0.0 110.552 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.78 -5.94 70.81 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.25 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.2 p -81.43 165.88 20.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.523 0.729 . . . . 0.0 111.107 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -138.64 10.05 2.67 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.224 0.609 . . . . 0.0 111.517 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -74.41 -8.22 55.55 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.961 0.504 . . . . 0.0 111.877 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -86.94 142.76 27.76 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 120.713 0.292 . . . . 0.0 111.259 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -142.25 158.99 43.11 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.388 1.075 . . . . 0.0 109.303 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -141.65 148.65 39.5 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.679 0.392 . . . . 0.0 111.139 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.67 -167.87 42.8 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.06 172.83 11.28 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.922 3.082 . . . . 0.0 110.854 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -63.53 138.74 58.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.095 -0.378 . . . . 0.0 111.04 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.81 -0.73 89.36 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.392 -0.367 . . . . 0.0 112.384 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.01 31.96 4.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.821 0.849 . . . . 0.0 111.544 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.06 140.55 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.179 -0.326 . . . . 0.0 111.168 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.7 mt -125.8 159.0 33.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.978 0.894 . . . . 0.0 113.153 -171.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -118.13 144.7 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.974 1.709 . . . . 0.0 114.443 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.86 136.57 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.16 179.93 6.47 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.4 m170 63.38 14.88 8.27 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.252 1.421 . . . . 0.0 112.911 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.05 143.32 96.02 Favored Pre-proline 0 N--CA 1.457 -0.121 0 CA-C-N 117.977 0.353 . . . . 0.0 110.132 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.44 168.0 24.77 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.952 2.435 . . . . 0.0 109.892 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -67.79 -17.82 64.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.019 0.527 . . . . 0.0 111.93 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -77.2 -10.22 59.27 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -70.05 158.01 36.48 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 175.95 35.14 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.76 -36.11 73.84 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.263 0.531 . . . . 0.0 110.629 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -80.26 -32.92 38.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 110.908 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -73.22 -38.43 66.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 tt -76.05 -25.17 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -66.08 -52.79 45.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -68.5 -22.27 64.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -72.86 -26.6 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 21.5 m-85 -106.12 -12.81 15.63 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.417 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 48.2 mtm -66.92 -29.8 2.86 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.3 Cg_endo -72.96 -8.97 23.09 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.211 1.825 . . . . 0.0 112.111 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -86.87 -15.02 40.33 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.952 0.342 . . . . 0.0 111.778 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.95 -172.65 32.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -76.16 102.68 5.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 117.107 0.453 . . . . 0.0 109.904 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.63 126.91 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.3 mt -85.92 -30.67 6.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 122.884 0.474 . . . . 0.0 110.671 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -159.5 157.41 29.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.35 0.26 . . . . 0.0 110.694 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.16 142.95 25.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -157.81 134.51 9.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.894 0.478 . . . . 0.0 110.98 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.22 131.89 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -75.02 149.24 39.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.032 0.533 . . . . 0.0 109.711 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -90.23 138.65 31.35 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.62 -10.08 59.61 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.275 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -92.28 -22.96 19.46 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -13.23 2.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 t30 62.12 8.11 2.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.674 1.19 . . . . 0.0 111.875 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.02 162.16 19.45 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.891 0.476 . . . . 0.0 109.826 174.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -66.47 140.41 58.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.35 -0.219 . . . . 0.0 111.159 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -80.6 13.26 2.61 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.6 0.36 . . . . 0.0 111.742 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.1 m 62.09 20.99 12.07 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.49 169.26 24.69 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.96 -172.56 29.53 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 121.636 0.576 . . . . 0.0 113.186 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -137.25 142.36 42.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.091 1.756 . . . . 0.0 114.722 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -144.61 153.42 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 t -143.36 149.46 37.75 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.073 0.397 . . . . 0.0 111.74 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -115.17 159.67 20.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.12 -14.58 61.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.22 0.533 . . . . 0.0 112.083 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.02 149.57 21.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.526 0.73 . . . . 0.0 110.685 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.91 -20.47 38.95 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.377 2.718 . . . . 0.0 112.204 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.31 -39.82 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.551 0.614 . . . . 0.0 111.737 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.3 m -73.34 -25.84 60.78 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.1 -46.43 51.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -66.4 -30.19 70.52 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 122.038 -0.414 . . . . 0.0 110.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.39 -41.51 80.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.74 -26.22 66.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.72 -51.93 56.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -68.49 -10.84 58.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.16 -27.98 17.36 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.9 mmm -120.29 -18.54 7.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -66.32 133.3 50.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.21 86.42 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.785 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -64.6 117.67 7.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.529 1.165 . . . . 0.0 110.448 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -75.39 130.06 38.37 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.108 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -146.19 124.97 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.4 -142.5 47.97 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 61.5 mtt -86.91 8.99 20.76 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -140.87 179.14 6.89 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.059 0.544 . . . . 0.0 111.41 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -118.97 142.96 47.32 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 110.069 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.36 130.95 45.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.683 0.278 . . . . 0.0 111.208 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -90.72 135.73 33.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.9 t -134.84 139.49 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.84 160.68 43.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.742 0.305 . . . . 0.0 111.432 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.43 HD22 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.32 149.11 40.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.43 ' H ' HD22 ' A' ' 104' ' ' LEU . 62.8 tttm -62.86 151.19 39.82 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.708 0.403 . . . . 0.0 109.918 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -63.78 158.57 21.46 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.472 0.309 . . . . 0.0 110.866 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.2 t -64.8 151.72 44.62 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.712 0.405 . . . . 0.0 111.457 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.403 ' HD3' ' H ' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -74.41 -12.22 60.45 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.816 0.446 . . . . 0.0 110.985 176.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -65.77 -14.96 62.36 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.357 0.263 . . . . 0.0 111.404 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -80.82 -9.69 59.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.6 p -125.92 -31.17 2.92 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -138.82 158.46 69.93 Favored Pre-proline 0 CA--C 1.527 0.072 0 C-N-CA 123.5 0.72 . . . . 0.0 110.999 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -80.23 4.66 6.62 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.829 3.019 . . . . 0.0 110.659 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 117.061 -1.447 . . . . 0.0 110.103 -177.518 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.776 0 O4'-C1'-N19 111.421 3.221 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.043 0 O4'-C1'-N19 111.72 3.52 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.829 0 O4'-C1'-N19 111.962 3.762 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 2 C3'-C2'-C1' 105.566 4.518 . 0.51 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 1 C5'-C4'-C3' 109.216 -4.189 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mmm . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.71 165.52 53.68 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.4 p -71.95 -16.88 62.1 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 122.339 -0.507 . . . . 0.0 111.618 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p -81.96 -13.91 56.8 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -78.44 -8.21 58.25 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.619 0.368 . . . . 0.0 111.937 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -80.7 6.43 12.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.036 0.38 . . . . 0.0 111.678 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.52 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 9.9 t-160 -149.64 167.87 25.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.233 0.613 . . . . 0.0 110.013 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.52 ' H ' ' CD2' ' A' ' 7' ' ' HIS . 34.7 m80 -67.0 157.84 32.43 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.819 0.448 . . . . 0.0 111.027 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -71.82 160.2 33.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.33 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -73.73 -21.36 60.24 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.881 0.472 . . . . 0.0 111.09 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.4 t -66.76 148.48 51.87 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.759 0.423 . . . . 0.0 111.425 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.2 m -78.61 -1.9 36.43 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 122.824 0.45 . . . . 0.0 111.723 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.46 -171.66 54.2 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.6 tp -150.55 148.61 28.89 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.732 0.413 . . . . 0.0 110.415 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 p -153.83 137.28 10.36 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.364 0.665 . . . . 0.0 109.653 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.71 136.57 33.46 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.741 2.294 . . . . 0.0 110.356 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -148.7 160.95 42.68 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.635 0.774 . . . . 0.0 111.608 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.81 122.38 0.63 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.7 t 58.55 178.81 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.575 1.15 . . . . 0.0 112.236 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -83.27 -3.22 57.22 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.958 0.903 . . . . 0.0 111.899 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.5 mmt -64.25 155.45 31.94 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.92 0.488 . . . . 0.0 111.233 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -73.56 153.45 40.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.138 0.575 . . . . 0.0 112.482 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -126.21 159.47 32.9 Favored 'General case' 0 C--O 1.228 -0.035 0 C-N-CA 123.907 0.883 . . . . 0.0 110.008 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -127.67 151.69 48.64 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.584 0.354 . . . . 0.0 111.169 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.58 -172.72 34.97 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.0 174.8 7.31 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.753 2.969 . . . . 0.0 110.443 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -61.1 135.08 57.66 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.76 -0.69 89.44 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.557 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.76 0.34 28.12 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.866 0.833 . . . . 0.0 112.785 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -99.73 146.21 26.79 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.205 0.457 . . . . 0.0 109.802 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.16 156.52 48.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.993 0.901 . . . . 0.0 112.823 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -124.98 147.6 48.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.71 1.604 . . . . 0.0 114.465 175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.62 132.71 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -136.54 177.45 7.84 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.2 m170 64.63 16.14 10.14 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.768 1.627 . . . . 0.0 112.57 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.8 145.22 96.7 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 122.801 0.44 . . . . 0.0 110.205 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.81 160.49 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.068 2.512 . . . . 0.0 108.95 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -73.85 -5.21 39.56 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.11 -10.46 59.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.059 0.391 . . . . 0.0 111.431 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.5 158.25 36.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.79 177.46 32.89 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -57.43 -42.58 82.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -79.98 -27.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.476 0.179 . . . . 0.0 111.107 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -72.28 -39.65 68.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 tt -76.71 -23.93 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.9 tp -66.6 -53.18 37.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -64.7 -23.0 67.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.295 0.238 . . . . 0.0 111.474 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.4 tpp -75.73 -29.45 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.047 0.139 . . . . 0.0 110.702 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 31.5 m-85 -104.95 -9.35 17.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.424 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -67.44 -28.73 2.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.8 Cg_endo -72.19 -10.67 26.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 122.374 1.883 . . . . 0.0 111.787 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -85.76 -14.79 44.16 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.33 -171.74 32.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.53 102.84 6.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.447 -0.443 . . . . 0.0 110.684 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.2 t -83.92 122.85 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 78' ' ' ASP . 13.3 mt -79.69 -34.98 16.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -157.71 156.1 31.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.075 0.464 . . . . 0.0 110.527 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 137.95 15.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.522 0.729 . . . . 0.0 109.048 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.59 134.13 8.76 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.512 0.196 . . . . 0.0 111.517 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 t -94.45 140.6 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -69.67 151.29 46.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -126.85 143.07 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 122.869 0.467 . . . . 0.0 109.975 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -91.59 130.64 37.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.14 -10.09 59.14 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.158 -0.339 . . . . 0.0 111.745 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -87.98 -22.54 24.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.24 0.616 . . . . 0.0 112.384 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -137.35 -14.08 1.52 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 61.65 8.2 2.23 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.882 1.273 . . . . 0.0 113.105 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.74 159.91 23.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.747 0.419 . . . . 0.0 109.878 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -71.24 135.04 47.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.535 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -76.03 166.92 22.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.008 0.432 . . . . 0.0 110.506 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.01 19.38 0.54 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -160.23 172.04 18.11 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.8 -171.9 27.38 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.528 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -136.37 144.88 44.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.579 1.551 . . . . 0.0 115.182 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -147.39 152.53 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.095 0.958 . . . . 0.0 108.431 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.4 p -143.45 147.34 34.42 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.876 -0.515 . . . . 0.0 112.023 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -113.79 159.94 19.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' HD13 ' A' ' 56' ' ' ILE . 11.2 t70 -78.32 -12.42 60.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.05 150.08 21.93 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 122.988 0.515 . . . . 0.0 110.886 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.1 -21.28 36.79 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.46 2.773 . . . . 0.0 112.296 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.34 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 118.72 0.691 . . . . 0.0 111.519 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -75.39 -25.92 58.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.376 0.27 . . . . 0.0 110.677 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.91 -49.92 26.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -68.85 -26.63 65.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.741 0.246 . . . . 0.0 110.483 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.73 -41.76 78.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.54 -27.14 66.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.3 mt -67.33 -52.07 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.34 -12.53 61.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.288 0.235 . . . . 0.0 111.259 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.93 -31.37 19.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.3 mtp -126.01 -9.59 6.56 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.21 125.68 24.88 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.01 87.43 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.854 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -63.73 119.44 9.93 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.639 1.22 . . . . 0.0 111.519 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -75.92 129.61 37.21 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.277 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.1 tt -144.64 120.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.75 -141.9 47.22 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 74.0 mtm -87.59 12.5 12.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -145.02 164.56 30.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.88 0.763 . . . . 0.0 110.673 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -107.1 141.63 38.05 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.855 0.462 . . . . 0.0 110.808 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.43 140.86 58.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.889 0.475 . . . . 0.0 111.442 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -101.94 141.18 35.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.93 137.08 52.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -151.73 160.64 43.52 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 120.887 0.375 . . . . 0.0 111.573 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.21 145.68 32.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.81 0.444 . . . . 0.0 110.463 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -66.25 159.26 26.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -60.36 155.38 18.11 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.1 p -67.14 157.61 33.25 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -68.86 -10.19 55.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -86.8 -17.39 33.58 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.836 0.289 . . . . 0.0 111.276 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -80.69 -20.0 43.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.6 m -89.36 -11.95 41.8 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.611 0.365 . . . . 0.0 111.757 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -69.2 152.2 96.73 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.839 0.456 . . . . 0.0 111.128 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.27 -13.3 20.91 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.814 3.009 . . . . 0.0 111.488 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 97.4 m95 . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.726 -1.131 . . . . 0.0 112.601 -179.024 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.713 0 O4'-C1'-N19 112.197 3.997 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.977 0 O4'-C1'-N19 111.033 2.833 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.491 0 C1'-O4'-C4' 106.7 -3.222 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . 0.472 H5'' ' C8 ' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.032 1 O4'-C1'-N19 112.604 4.404 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.844 2 O4'-C1'-N19 113.54 5.34 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 120.347 0.118 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.3 178.66 48.63 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 t -155.86 157.87 37.11 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.192 0.597 . . . . 0.0 109.96 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.2 p -70.31 162.64 28.15 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.806 0.442 . . . . 0.0 110.984 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -69.79 161.38 29.94 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.801 0.44 . . . . 0.0 111.023 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.0 m80 59.06 169.36 0.06 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.926 1.29 . . . . 0.0 113.278 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -77.86 -8.5 58.15 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.169 0.588 . . . . 0.0 111.921 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -145.61 161.29 40.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.506 0.722 . . . . 0.0 110.769 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -153.25 167.27 29.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.32 0.648 . . . . 0.0 110.319 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -156.64 171.1 20.93 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.368 0.667 . . . . 0.0 110.122 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.4 t -155.34 160.7 40.93 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 122.89 0.476 . . . . 0.0 110.179 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -69.69 155.96 39.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.202 0.525 . . . . 0.0 110.845 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.99 1.95 57.11 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.879 -0.401 . . . . 0.0 112.98 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.8 tp -72.68 145.61 47.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.802 0.801 . . . . 0.0 110.44 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.483 HG13 ' H ' ' A' ' 17' ' ' ARG . 12.4 t -140.16 132.89 14.84 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 123.558 0.743 . . . . 0.0 110.525 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.21 -9.78 23.61 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.268 2.645 . . . . 0.0 112.543 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.483 ' H ' HG13 ' A' ' 15' ' ' VAL . 25.5 mmt180 -71.54 159.94 33.57 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.982 0.513 . . . . 0.0 111.706 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.77 -37.82 0.03 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.97 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.2 p -164.29 -43.49 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.737 0.768 . . . . 0.0 111.321 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.7 m80 50.79 28.16 3.49 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.25 158.51 28.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.94 0.4 . . . . 0.0 111.063 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -88.47 132.84 34.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.441 -174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -150.05 159.79 44.14 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 125.128 1.371 . . . . 0.0 109.548 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -136.86 158.94 43.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.702 0.763 . . . . 0.0 111.568 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.34 -156.54 26.71 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.308 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.34 158.33 55.67 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.928 2.419 . . . . 0.0 108.948 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -63.5 129.38 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.12 -11.57 60.35 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.06 19.34 6.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.673 0.737 . . . . 0.0 110.417 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.14 142.35 47.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -169.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.9 159.85 33.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.015 0.912 . . . . 0.0 113.026 -171.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -125.46 144.05 50.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.411 1.884 . . . . 0.0 114.55 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.3 137.8 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.8 179.71 6.55 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.512 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.4 m170 64.7 17.12 10.78 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.246 1.418 . . . . 0.0 113.05 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.06 139.3 87.66 Favored Pre-proline 0 CA--C 1.529 0.146 0 O-C-N 122.165 -0.335 . . . . 0.0 110.111 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.71 172.13 16.42 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.449 2.766 . . . . 0.0 111.06 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -70.53 -13.09 61.97 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -82.37 -7.08 59.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -77.2 158.44 30.33 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.27 174.76 35.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -58.74 -38.34 78.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -74.97 -29.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.631 0.373 . . . . 0.0 111.032 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.65 -42.52 58.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -72.55 -24.81 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.31 -50.96 67.99 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -64.52 -23.85 67.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.536 0.334 . . . . 0.0 111.797 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.4 mmm -77.61 -23.83 49.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.634 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 33.8 m-85 -108.56 -10.68 15.21 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.409 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -66.23 -31.96 5.02 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.5 Cg_endo -73.15 -9.69 23.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 121.706 1.645 . . . . 0.0 111.779 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -86.97 -14.72 40.91 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.792 0.437 . . . . 0.0 112.079 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.6 32.87 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.57 102.05 5.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.387 -0.478 . . . . 0.0 110.47 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -80.77 120.62 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.61 -31.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -157.98 155.04 28.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.39 0.276 . . . . 0.0 110.834 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.38 29.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 109.346 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -156.99 141.33 16.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.836 0.454 . . . . 0.0 111.516 -174.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.06 130.21 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 168.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -76.44 142.96 40.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.4 mm -132.74 144.18 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.664 0.386 . . . . 0.0 110.534 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.447 ' CA ' ' HE2' ' A' ' 70' ' ' LYS . 61.0 t0 -85.93 130.5 34.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -79.13 -10.65 59.88 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.036 -0.415 . . . . 0.0 111.576 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -90.01 -22.14 22.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.76 -10.92 1.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.74 6.87 1.73 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.362 1.065 . . . . 0.0 112.692 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -79.6 158.21 27.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.8 t -71.43 143.75 50.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.447 ' HE2' ' CA ' ' A' ' 63' ' ' ASP . 71.6 mmtt -77.1 3.34 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.593 0.757 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.3 m 62.65 20.1 11.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -157.59 169.91 23.59 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.66 -169.0 23.35 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.991 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -141.5 141.91 33.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.6 t -147.25 152.52 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 t -147.94 149.06 31.51 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.692 -0.63 . . . . 0.0 111.934 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.87 163.12 14.56 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -79.48 -9.92 59.7 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.423 0.289 . . . . 0.0 110.319 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.3 149.05 19.76 Favored Pre-proline 0 N--CA 1.453 -0.284 0 O-C-N 121.852 -0.53 . . . . 0.0 111.478 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.61 -19.21 42.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.658 2.905 . . . . 0.0 112.356 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.2 -39.92 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.724 -0.61 . . . . 0.0 111.789 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -74.65 -24.64 58.85 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.389 0.276 . . . . 0.0 110.535 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.6 39.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -68.0 -28.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.963 -0.461 . . . . 0.0 111.087 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.99 -42.34 80.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.145 -0.347 . . . . 0.0 110.122 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.25 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.66 -51.2 53.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.86 -11.98 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.407 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.65 -31.44 17.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 52.9 mtp -124.1 -10.92 7.59 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -62.49 126.23 26.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.1 5.75 87.2 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.148 -0.806 . . . . 0.0 112.792 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -65.23 117.32 7.63 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.764 1.282 . . . . 0.0 109.934 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -75.26 129.43 37.44 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.169 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.5 tt -145.05 119.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.72 -142.65 46.96 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 ptp -84.39 8.95 14.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 43.8 tttp -146.89 165.75 28.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.753 0.706 . . . . 0.0 110.428 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -104.49 143.18 33.38 Favored 'General case' 0 C--O 1.229 -0.017 0 C-N-CA 122.731 0.413 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.31 126.32 27.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.198 0.199 . . . . 0.0 110.801 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.462 ' HE3' ' C5 ' ' B' ' 116' ' ' ' U' . 21.0 ttmm -87.67 136.47 32.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 171.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.73 139.29 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -148.55 161.47 41.6 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 111.405 -172.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.45 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -83.74 151.12 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.45 ' H ' HD21 ' A' ' 104' ' ' LEU . 78.9 tttt -59.86 148.51 34.52 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.869 0.868 . . . . 0.0 110.053 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -70.3 156.17 39.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.924 0.392 . . . . 0.0 110.484 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.3 t -68.03 157.8 34.35 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.492 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -69.47 -20.12 63.75 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 122.258 -0.276 . . . . 0.0 110.758 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -78.41 -17.99 55.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.743 0.417 . . . . 0.0 110.214 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -103.51 -1.64 28.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.7 m -87.26 -5.03 59.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.031 0.532 . . . . 0.0 111.47 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -66.6 151.72 96.01 Favored Pre-proline 0 CA--C 1.528 0.101 0 C-N-CA 123.201 0.601 . . . . 0.0 110.438 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.48 -15.24 22.23 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.709 2.94 . . . . 0.0 111.527 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.9 m95 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.865 -179.587 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.491 ' C6 ' H5'' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.414 -3.259 0 O4'-C1'-N19 111.638 3.438 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . 0.462 ' C5 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.005 0 C5'-C4'-C3' 112.45 -2.033 . 0.095 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.175 0 O4'-C1'-N19 110.415 2.215 . 0.032 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . 0.425 " H4'" " H5'" ' B' ' 119' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.615 2 C3'-C2'-C1' 105.522 4.469 . 0.41 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . 0.425 " H5'" " H4'" ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.572 1 O4'-C1'-N19 113.693 5.493 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttm . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.05 -0.024 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.02 159.86 32.06 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.5 p -81.28 -5.08 57.41 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.06 0.544 . . . . 0.0 112.034 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -154.99 154.48 32.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.802 0.441 . . . . 0.0 110.246 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -146.52 162.47 38.28 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.579 0.752 . . . . 0.0 110.218 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -154.2 157.72 39.23 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 123.097 0.559 . . . . 0.0 109.836 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -71.37 162.72 28.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.332 0.653 . . . . 0.0 111.649 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 57.11 -175.87 0.06 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.46 1.104 . . . . 0.0 112.81 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -150.38 163.61 37.92 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.262 0.625 . . . . 0.0 109.525 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -64.13 -23.76 67.44 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.766 0.426 . . . . 0.0 111.304 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -159.13 139.55 12.3 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.636 0.375 . . . . 0.0 111.064 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.6 p -91.28 -10.15 42.48 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.64 0.376 . . . . 0.0 110.94 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.57 -1.82 77.1 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.39 134.62 54.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 117.339 0.569 . . . . 0.0 110.666 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 m -80.46 160.37 67.61 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.449 0.699 . . . . 0.0 112.694 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.2 129.24 33.8 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.506 2.804 . . . . 0.0 111.859 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.54 176.86 10.59 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 124.087 0.955 . . . . 0.0 109.883 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.49 151.39 23.65 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.3 m 57.53 150.56 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.407 1.483 . . . . 0.0 114.972 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -84.93 -17.15 38.67 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.6 mtm -77.8 -15.31 59.18 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.916 0.486 . . . . 0.0 111.816 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -106.19 152.29 23.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 159.5 44.06 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.752 0.421 . . . . 0.0 110.919 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -112.44 164.32 13.41 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.975 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.52 -171.6 36.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.34 178.53 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.07 3.18 . . . . 0.0 110.637 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -58.3 134.7 56.8 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.087 -0.383 . . . . 0.0 110.935 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 0.43 88.64 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.829 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.02 8.76 34.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 117.826 0.813 . . . . 0.0 113.166 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -112.28 139.93 47.42 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.16 0.436 . . . . 0.0 110.453 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.62 160.89 30.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.007 0.908 . . . . 0.0 112.936 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -128.35 141.98 51.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.533 1.933 . . . . 0.0 114.647 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.56 137.62 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -141.33 178.38 7.46 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.443 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 17.1 m170 64.12 18.71 11.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.883 1.273 . . . . 0.0 112.961 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.89 145.43 98.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.32 163.45 38.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.867 2.378 . . . . 0.0 109.682 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -69.67 -16.42 63.35 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.87 -9.28 59.43 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.813 -0.554 . . . . 0.0 112.259 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -73.13 158.27 35.63 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.7 33.88 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -57.19 -39.62 75.75 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -74.79 -30.46 61.43 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.003 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -76.02 -38.85 56.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.56 -25.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.6 -51.36 63.11 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -65.21 -22.37 66.88 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.2 tpp -77.15 -27.73 53.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.396 0.278 . . . . 0.0 110.555 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.284 25.3 m-85 -105.03 -12.21 16.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 118.0 2.593 . . . . 0.0 118.0 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 58.4 mtm -66.17 -31.23 4.28 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.1 Cg_endo -72.33 -10.15 25.22 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.907 1.717 . . . . 0.0 112.072 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.33 -15.02 41.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.842 0.457 . . . . 0.0 111.708 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.29 -173.53 32.81 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -77.04 102.79 6.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.497 -0.413 . . . . 0.0 110.421 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.87 123.79 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.89 -33.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -152.41 151.17 30.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.721 0.408 . . . . 0.0 110.794 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.08 140.64 17.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.405 0.682 . . . . 0.0 109.455 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.43 ' HE3' ' N3 ' ' B' ' 119' ' ' ' A' . 0.0 OUTLIER -158.61 161.72 37.25 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 120.811 0.338 . . . . 0.0 110.842 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.94 139.19 52.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.405 ' CD2' ' CZ ' ' A' ' 72' ' ' PHE . 48.4 m-85 -74.53 142.67 44.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mm -131.91 142.08 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 124.017 0.927 . . . . 0.0 108.554 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -80.78 127.35 32.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -73.22 -9.47 58.74 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.082 -0.386 . . . . 0.0 111.717 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -94.73 -23.6 17.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.19 -10.5 2.57 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.81 11.25 3.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.737 1.215 . . . . 0.0 111.895 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.7 mt -86.02 160.15 19.4 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.887 0.475 . . . . 0.0 109.891 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.5 t -69.56 145.33 52.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.597 0.236 . . . . 0.0 111.43 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -98.04 15.29 24.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.147 0.579 . . . . 0.0 111.195 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.6 p 52.13 29.75 6.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.405 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.8 p90 -155.06 168.96 25.27 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.55 -174.34 27.14 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.273 0.374 . . . . 0.0 112.955 -173.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -139.69 140.75 36.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.261 1.424 . . . . 0.0 114.46 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -146.36 153.74 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 98.0 p -147.89 153.0 38.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 111.532 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -122.54 164.66 17.72 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.08 -9.59 59.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.32 151.02 24.89 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.932 0.493 . . . . 0.0 111.275 176.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.38 -19.5 37.84 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.31 2.673 . . . . 0.0 111.633 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.96 -46.57 95.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 118.548 0.613 . . . . 0.0 111.026 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 m -70.91 -25.93 62.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.129 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.79 -49.03 42.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -68.17 -27.23 66.23 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 117.936 0.334 . . . . 0.0 110.674 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.9 75.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.25 70.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.99 -50.47 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -69.43 -11.16 60.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.243 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.88 -27.39 21.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.6 ttm -120.86 -21.04 6.73 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -58.83 123.34 16.13 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 6.04 88.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.424 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -67.29 142.83 56.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.759 1.279 . . . . 0.0 108.486 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -95.92 128.58 42.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.938 0.335 . . . . 0.0 110.701 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.36 136.88 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.29 -113.35 5.07 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.4 mtm -126.86 14.42 7.43 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.573 0.749 . . . . 0.0 112.282 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 56.5 tttp -151.24 144.54 24.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.309 0.504 . . . . 0.0 110.783 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -82.63 143.3 31.08 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.416 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.98 130.4 42.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.346 0.258 . . . . 0.0 110.496 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -92.02 138.11 31.81 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.71 141.15 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.44 0.296 . . . . 0.0 110.418 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -148.62 161.78 41.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.64 0.257 . . . . 0.0 110.87 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 tt -90.13 140.04 30.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -63.68 156.57 26.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.46 0.573 . . . . 0.0 109.62 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.5 mtt85 -58.39 146.07 36.11 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.8 p -65.77 151.7 46.02 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.188 0.518 . . . . 0.0 111.374 -175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -69.73 -7.82 42.69 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.331 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -89.3 -9.23 51.32 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.306 0.642 . . . . 0.0 111.565 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.23 -24.28 1.86 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.7 p -71.78 -19.2 62.04 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 122.482 0.313 . . . . 0.0 111.668 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.18 154.15 92.27 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.31 0.644 . . . . 0.0 109.839 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -71.57 -14.53 30.53 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.338 2.692 . . . . 0.0 111.613 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 89.4 m95 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.145 -1.407 . . . . 0.0 112.338 177.284 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.694 0 C5'-C4'-C3' 111.248 -2.834 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.113 0 C5'-C4'-C3' 112.57 -1.954 . 0.248 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.203 0 C5'-C4'-C3' 111.857 -2.429 . 0.04 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . 0.513 H5'' ' C8 ' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.656 0 C3'-C2'-C1' 105.037 3.93 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . 0.431 ' C8 ' H5'' ' B' ' 119' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.965 1 C5'-C4'-C3' 108.619 -4.587 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 119.958 -0.067 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.13 171.49 55.14 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m -75.4 -11.33 60.02 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.0 p -155.18 13.08 0.37 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.594 0.358 . . . . 0.0 111.78 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -153.41 163.46 39.9 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.967 0.507 . . . . 0.0 110.798 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -142.92 173.05 11.89 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.441 0.696 . . . . 0.0 110.528 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -136.01 162.57 32.52 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.261 0.624 . . . . 0.0 110.268 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -155.36 172.49 18.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.091 0.556 . . . . 0.0 110.452 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -152.77 162.85 40.74 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.303 0.641 . . . . 0.0 110.461 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -73.87 151.27 40.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.941 0.401 . . . . 0.0 111.133 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -158.55 158.09 33.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.356 0.662 . . . . 0.0 109.816 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.6 t -67.31 145.68 54.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.603 0.361 . . . . 0.0 111.017 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.34 -170.3 34.47 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.9 tp -151.17 142.85 23.69 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.167 0.587 . . . . 0.0 109.801 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.65 135.32 88.18 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.77 -9.59 22.61 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.312 2.675 . . . . 0.0 111.939 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -67.95 133.51 49.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.624 0.37 . . . . 0.0 110.228 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.66 1.13 44.13 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.571 -0.572 . . . . 0.0 112.742 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 t -71.66 159.26 34.71 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 117.995 0.898 . . . . 0.0 111.03 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -70.85 -11.72 61.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.149 0.579 . . . . 0.0 111.499 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.7 mtm -78.2 139.0 38.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.496 0.319 . . . . 0.0 111.139 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -98.04 152.05 19.7 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.295 0.638 . . . . 0.0 109.563 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -111.69 159.18 18.47 Favored 'General case' 0 C--O 1.23 0.039 0 C-N-CA 122.943 0.497 . . . . 0.0 111.054 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -141.86 155.57 45.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.189 0.519 . . . . 0.0 111.607 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.48 -152.38 28.81 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.37 179.23 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.695 2.93 . . . . 0.0 111.172 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.84 135.98 57.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.947 -0.471 . . . . 0.0 111.551 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.15 68.09 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.478 0.561 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.11 39.76 1.0 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.665 0.732 . . . . 0.0 112.013 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.09 140.03 29.23 Favored 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.723 -0.611 . . . . 0.0 111.75 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -128.76 153.77 47.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.931 0.872 . . . . 0.0 113.152 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 16.1 m-85 -110.99 146.87 35.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.562 1.545 . . . . 0.0 114.152 170.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -139.01 124.74 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.4 m-85 -131.28 179.28 6.11 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 17.1 m170 63.32 16.12 9.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.348 1.459 . . . . 0.0 112.335 -176.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.49 144.38 94.25 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.137 0.575 . . . . 0.0 110.329 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.83 162.91 36.65 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.374 2.716 . . . . 0.0 109.248 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.46 -6.22 44.98 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -75.68 -9.99 59.05 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.994 0.361 . . . . 0.0 111.241 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -73.39 158.3 35.28 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.41 176.54 33.75 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -57.24 -39.01 74.7 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.158 0.479 . . . . 0.0 111.975 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -80.02 -33.21 39.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.585 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -72.04 -38.81 69.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.34 -28.35 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.3 tp -66.25 -52.23 49.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -63.91 -22.91 67.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.555 0.342 . . . . 0.0 111.688 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -78.38 -26.04 46.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.645 0.202 . . . . 0.0 110.654 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.296 31.3 m-85 -104.93 -10.53 17.22 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.439 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 56.6 mtm -66.97 -29.32 2.56 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 50' ' ' MET . 84.3 Cg_endo -71.05 -13.11 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.893 1.712 . . . . 0.0 111.906 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -84.35 -15.46 46.4 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 155.19 -175.06 33.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -75.32 105.53 6.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.281 -0.541 . . . . 0.0 110.77 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.04 126.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.3 -30.43 5.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 120.487 0.184 . . . . 0.0 110.578 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -154.6 150.43 27.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.726 0.411 . . . . 0.0 110.577 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.83 141.54 14.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.383 0.673 . . . . 0.0 109.496 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HE3' ' CD2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -156.45 153.26 28.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.43 0.292 . . . . 0.0 110.292 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -107.71 142.87 19.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.551 ' CD2' ' HE3' ' A' ' 59' ' ' LYS . 69.3 m-85 -69.72 148.73 48.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -133.68 146.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.148 0.579 . . . . 0.0 109.965 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -95.19 132.89 39.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -77.36 -12.91 60.01 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.067 0.547 . . . . 0.0 111.75 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -89.78 -23.82 21.65 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.62 -13.43 2.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.2 t30 61.54 10.84 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 112.22 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.86 154.56 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.673 0.389 . . . . 0.0 110.219 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -70.49 134.39 47.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.425 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -84.23 163.69 19.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.105 0.478 . . . . 0.0 110.451 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.6 m -78.87 17.67 0.7 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE1' ' CE1' ' A' ' 61' ' ' PHE . 3.5 p90 -156.59 170.32 22.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.77 -177.59 29.15 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.753 1.168 . . . . 0.0 111.896 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.425 ' CE1' ' N1 ' ' B' ' 118' ' ' ' A' . 6.7 t80 -139.69 144.57 37.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.74 151.95 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.803 0.841 . . . . 0.0 110.082 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 t -143.4 144.0 31.86 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -106.21 164.35 12.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -80.89 -9.22 59.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.271 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.75 150.43 20.36 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 123.138 0.575 . . . . 0.0 111.096 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.69 -18.35 28.84 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.125 2.55 . . . . 0.0 111.858 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.9 -44.77 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 O-C-N 121.817 -0.552 . . . . 0.0 111.282 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -70.65 -26.26 63.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.63 -48.04 35.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -66.07 -28.51 68.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.062 -0.399 . . . . 0.0 110.816 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.59 75.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.228 -0.295 . . . . 0.0 110.322 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.67 66.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mt -66.98 -52.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -66.88 -13.73 61.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.365 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.98 -32.95 18.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.8 mtp -123.82 -11.91 7.63 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -61.85 125.24 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.62 5.96 88.99 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.303 -0.72 . . . . 0.0 112.798 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.12 125.15 22.86 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.46 1.13 . . . . 0.0 112.031 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -78.22 128.38 33.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.685 0.279 . . . . 0.0 110.846 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -149.56 136.51 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.98 -111.1 2.81 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.0 ptp -130.42 15.47 5.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.13 0.572 . . . . 0.0 111.811 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -150.83 142.42 23.57 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.483 0.313 . . . . 0.0 110.291 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -84.41 145.13 28.35 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 122.505 -0.122 . . . . 0.0 111.181 -176.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 81.4 mt -70.78 131.82 44.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.572 0.349 . . . . 0.0 111.647 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.405 ' HD2' ' CD1' ' A' ' 34' ' ' TYR . 17.0 ttmm -91.32 138.6 31.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 170.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.97 137.38 50.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -155.12 160.79 41.22 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.865 0.302 . . . . 0.0 111.715 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.47 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.8 156.23 36.73 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.37 0.668 . . . . 0.0 110.692 176.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.47 ' H ' HD21 ' A' ' 104' ' ' LEU . 87.4 tttt -67.03 154.41 41.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.43 0.692 . . . . 0.0 109.534 173.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -61.23 148.95 39.24 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-O 120.868 0.366 . . . . 0.0 110.66 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.2 t -154.45 158.4 39.88 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.953 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -75.17 -7.16 53.05 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.559 0.343 . . . . 0.0 111.036 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -69.32 -21.16 63.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.281 -0.262 . . . . 0.0 110.562 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -85.1 -17.61 36.8 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.9 m -80.01 -9.14 59.67 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 122.127 -0.358 . . . . 0.0 111.301 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -67.8 151.61 97.04 Favored Pre-proline 0 N--CA 1.456 -0.168 0 C-N-CA 122.886 0.475 . . . . 0.0 110.753 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.86 -14.55 21.45 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.572 2.848 . . . . 0.0 111.244 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.7 m95 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.708 -1.139 . . . . 0.0 112.24 -179.848 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.858 0 C5'-C4'-C3' 110.239 -3.507 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.954 0 O4'-C1'-N19 111.191 2.991 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 2 O4'-C1'-N19 112.55 4.35 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . 0.425 ' N1 ' ' CE1' ' A' ' 74' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.08 2 C3'-C2'-C1' 105.4 4.333 . 0.558 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.67 2 O4'-C1'-N19 112.66 4.46 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' HG3' ' H ' ' A' ' 3' ' ' SER . 17.3 tpt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.89 -2.43 57.47 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.783 -0.454 . . . . 0.0 113.332 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.484 ' H ' ' HG3' ' A' ' 1' ' ' MET . 44.6 t -155.18 161.59 41.17 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.933 0.866 . . . . 0.0 110.311 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 t -154.75 150.66 27.81 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.056 0.542 . . . . 0.0 109.938 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.8 t60 60.01 165.64 0.07 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.903 1.281 . . . . 0.0 112.63 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -80.53 149.51 29.95 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.776 -0.577 . . . . 0.0 111.395 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -150.67 165.95 31.85 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 124.099 0.96 . . . . 0.0 110.039 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -72.38 9.14 1.1 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.197 0.599 . . . . 0.0 112.006 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -144.57 5.12 1.2 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.626 0.77 . . . . 0.0 111.822 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -71.26 156.39 39.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.203 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.5 t -156.86 157.34 34.73 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.969 0.508 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.4 t -68.98 157.52 36.58 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.66 0.384 . . . . 0.0 111.441 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.13 -13.31 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 tp -71.13 145.46 49.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.545 0.673 . . . . 0.0 110.131 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.427 HG13 ' H ' ' A' ' 17' ' ' ARG . 11.4 t -66.68 131.35 94.04 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 122.443 0.297 . . . . 0.0 111.12 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.18 -13.24 28.37 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.128 2.552 . . . . 0.0 112.472 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.427 ' H ' HG13 ' A' ' 15' ' ' VAL . 2.0 tmm_? -71.58 136.36 47.4 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.745 0.418 . . . . 0.0 110.694 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.43 168.2 31.07 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.1 t -160.43 165.09 31.69 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.053 0.541 . . . . 0.0 110.371 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -73.82 -6.04 44.62 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.195 0.598 . . . . 0.0 111.533 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.5 mtt -69.6 167.04 17.72 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.271 0.629 . . . . 0.0 111.822 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.62 152.6 45.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.591 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.72 158.14 16.94 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 122.905 0.482 . . . . 0.0 110.52 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -141.16 151.03 43.52 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.116 0.566 . . . . 0.0 110.736 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.42 -155.2 31.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.41 176.7 6.17 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.949 3.099 . . . . 0.0 110.962 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -60.95 137.01 58.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.891 -0.505 . . . . 0.0 111.504 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.05 -2.87 73.61 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.637 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.13 39.24 1.04 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.419 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.65 139.42 29.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.765 -0.584 . . . . 0.0 111.552 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.31 155.03 45.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.757 0.789 . . . . 0.0 112.934 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.2 m-85 -112.27 149.15 32.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.746 1.618 . . . . 0.0 114.355 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -139.01 136.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.6 m-85 -142.4 177.64 8.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 12.7 m170 62.73 16.9 9.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.611 1.564 . . . . 0.0 112.639 -176.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.46 145.04 98.26 Favored Pre-proline 0 CA--C 1.53 0.191 0 O-C-N 122.079 -0.388 . . . . 0.0 110.047 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.34 164.9 34.25 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.842 2.361 . . . . 0.0 109.507 172.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.91 -14.79 62.89 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.25 -8.84 57.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.55 158.23 36.58 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.75 35.29 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.8 -36.9 75.22 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.506 0.653 . . . . 0.0 110.442 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -78.67 -32.62 47.24 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.398 0.279 . . . . 0.0 110.869 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.0 -38.8 61.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.61 -25.8 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.39 -49.89 61.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -64.7 -23.84 67.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.745 0.418 . . . . 0.0 111.558 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -79.89 -25.61 40.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.511 -0.118 . . . . 0.0 110.767 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.293 31.3 m-85 -105.92 -7.76 18.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.414 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 50.1 mtm -66.49 -30.83 3.72 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.5 Cg_endo -72.82 -10.99 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 CA-C-N 121.943 1.73 . . . . 0.0 111.842 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.48 -19.96 37.79 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.76 -167.96 31.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -78.2 99.59 6.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.466 -0.432 . . . . 0.0 110.527 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.48 130.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -90.68 -27.81 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 122.592 0.357 . . . . 0.0 110.76 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 t -155.9 150.8 26.33 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.633 0.373 . . . . 0.0 110.334 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.46 147.03 27.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.377 0.671 . . . . 0.0 109.387 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -157.38 137.88 12.97 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.682 0.393 . . . . 0.0 111.445 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -111.93 136.41 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 49.5 m-85 -78.92 147.33 33.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -173.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -132.58 144.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.063 0.545 . . . . 0.0 110.305 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -90.34 133.16 35.16 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -76.98 -12.56 59.96 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.784 0.434 . . . . 0.0 111.865 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -88.95 -23.92 22.56 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.12 -13.48 2.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 63.68 8.34 3.66 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.12 161.08 22.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.911 0.484 . . . . 0.0 110.038 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -70.52 140.91 51.94 Favored 'General case' 0 CA--C 1.523 -0.062 0 CA-C-O 120.753 0.311 . . . . 0.0 111.052 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -82.59 6.04 18.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m 61.49 22.51 12.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.404 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.1 p90 -154.62 169.11 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.01 -172.28 28.12 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 121.566 0.537 . . . . 0.0 113.185 -174.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.82 143.01 31.96 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.806 1.642 . . . . 0.0 114.713 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -145.99 153.57 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 109.527 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.2 t -143.01 145.13 32.63 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -109.34 164.04 12.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -78.36 -13.21 59.95 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 112.278 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.02 148.11 18.23 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 123.246 0.618 . . . . 0.0 111.17 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.69 -18.54 32.56 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.468 2.779 . . . . 0.0 112.06 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.27 -43.03 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 118.34 0.518 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.1 t -70.68 -32.78 70.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.04 74.67 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -67.88 -28.09 67.22 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.901 -0.5 . . . . 0.0 110.962 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.92 -43.05 72.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.44 -26.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.3 mt -67.73 -51.51 49.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -67.84 -11.22 58.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.86 -0.154 . . . . 0.0 111.284 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.89 -31.33 16.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.4 mtp -125.41 -12.2 6.78 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.98 125.86 25.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.87 6.54 89.36 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.008 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 120.42 11.62 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.693 1.247 . . . . 0.0 111.483 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -76.39 129.63 36.86 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 tt -144.87 120.72 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.27 -140.64 46.6 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.0 mmt -88.52 12.96 13.06 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -146.5 162.59 37.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.848 0.749 . . . . 0.0 111.049 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -105.76 141.27 37.47 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 122.545 0.338 . . . . 0.0 110.946 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 91.5 mt -66.65 133.76 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.749 0.419 . . . . 0.0 111.195 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -92.0 137.89 31.99 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.3 t -134.97 137.13 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -151.4 161.3 42.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -75.77 153.83 36.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.469 0.708 . . . . 0.0 110.409 177.287 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.501 ' H ' HD23 ' A' ' 104' ' ' LEU . 87.1 tttt -68.33 158.0 34.43 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.222 0.609 . . . . 0.0 109.834 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -146.45 160.39 42.15 Favored 'General case' 0 CA--C 1.526 0.04 0 C-N-CA 123.314 0.646 . . . . 0.0 110.541 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.0 t -62.31 154.51 27.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 122.863 0.465 . . . . 0.0 111.117 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.65 -6.31 40.06 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.465 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -67.07 -15.36 63.67 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.224 -0.298 . . . . 0.0 110.417 175.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -93.55 -10.97 32.98 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.8 t -80.8 -11.82 59.54 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 122.952 0.501 . . . . 0.0 111.14 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -62.75 153.67 78.03 Favored Pre-proline 0 CA--C 1.534 0.342 0 O-C-N 122.18 -0.325 . . . . 0.0 110.548 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.08 -15.63 23.11 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.706 2.937 . . . . 0.0 111.779 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 117.4 -1.286 . . . . 0.0 112.391 -179.134 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 C5'-C4'-C3' 110.327 -3.449 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.091 0 O4'-C1'-N19 111.07 2.87 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 1 O4'-C1'-N19 112.654 4.454 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.793 2 C3'-C2'-C1' 105.782 4.758 . 0.251 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . 0.47 " H1'" ' CD1' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.928 2 C5'-C4'-C3' 108.696 -4.536 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.758 -0.09 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.51 -5.62 89.76 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.9 p -69.97 160.37 32.03 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 117.651 0.725 . . . . 0.0 111.091 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.6 p -155.99 167.4 30.54 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.737 0.415 . . . . 0.0 110.225 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -153.25 164.42 38.13 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.098 0.559 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -85.63 -4.08 59.06 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.312 0.645 . . . . 0.0 112.476 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -75.66 152.9 37.49 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.988 0.358 . . . . 0.0 111.506 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -148.42 155.52 41.32 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.663 0.785 . . . . 0.0 110.541 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -150.04 -4.15 0.36 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.851 0.461 . . . . 0.0 111.416 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -74.5 166.88 22.79 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.169 0.588 . . . . 0.0 111.087 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.5 t -156.23 159.93 39.35 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 123.104 0.562 . . . . 0.0 109.782 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.7 t -69.45 140.75 54.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.235 -0.29 . . . . 0.0 110.806 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.48 4.77 58.21 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.745 -0.475 . . . . 0.0 112.983 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.8 tp -72.13 -21.36 61.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.132 0.966 . . . . 0.0 111.499 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 11.8 t -69.31 136.63 88.86 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 123.22 0.608 . . . . 0.0 111.377 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 51.3 Cg_exo -58.45 -13.43 16.87 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.855 3.037 . . . . 0.0 114.1 176.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HD2' ' H ' ' A' ' 18' ' ' GLY . 16.8 tpt180 -67.31 150.56 48.85 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.176 0.591 . . . . 0.0 111.25 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.486 ' H ' ' HD2' ' A' ' 17' ' ' ARG . . . -156.76 173.41 34.46 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.5 p -158.13 159.78 36.57 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.131 0.572 . . . . 0.0 110.356 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -80.38 -26.86 38.36 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.47 0.308 . . . . 0.0 111.705 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.8 mtm 55.25 -178.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.242 1.017 . . . . 0.0 113.227 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -136.16 152.27 50.63 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.312 0.645 . . . . 0.0 110.35 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -132.34 159.58 38.79 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.86 0.864 . . . . 0.0 110.15 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -124.27 164.37 19.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 -151.2 25.12 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.79 169.43 17.65 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.808 3.005 . . . . 0.0 110.232 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.83 137.96 58.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.946 -0.471 . . . . 0.0 110.71 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.77 -6.96 79.15 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.156 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.42 39.9 1.06 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.602 0.701 . . . . 0.0 110.418 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.36 28.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.004 -0.435 . . . . 0.0 111.131 -175.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -126.05 158.4 35.49 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -117.59 139.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.94 1.696 . . . . 0.0 113.71 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.72 139.66 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -141.7 175.13 9.95 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 m170 65.42 16.3 10.46 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 113.001 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.16 140.93 93.51 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 122.82 0.448 . . . . 0.0 109.919 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.18 162.88 40.41 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.915 2.41 . . . . 0.0 109.552 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -71.44 -7.19 45.81 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.23 -9.42 58.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 122.055 -0.403 . . . . 0.0 111.054 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -74.06 158.36 34.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.26 173.94 35.44 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -57.16 -39.49 75.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -75.79 -29.24 58.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.097 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.41 -39.61 46.45 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -73.6 -24.65 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.17 -52.0 57.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.65 -23.62 67.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.613 0.365 . . . . 0.0 111.518 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 tpp -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.15 0.18 . . . . 0.0 110.672 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.276 22.6 m-85 -104.12 -11.69 17.17 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 117.878 2.547 . . . . 0.0 117.878 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.426 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.6 mtm -66.8 -31.3 3.92 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.8 Cg_endo -73.01 -10.0 24.15 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.068 1.774 . . . . 0.0 111.881 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.28 -13.81 45.57 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.09 -173.57 32.66 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -75.94 101.32 5.15 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.333 -0.51 . . . . 0.0 110.223 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -79.07 127.75 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.8 mt -83.84 -32.95 8.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.416 0.287 . . . . 0.0 110.379 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -164.9 159.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.94 24.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.423 0.689 . . . . 0.0 109.893 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.7 145.72 17.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.707 0.403 . . . . 0.0 111.172 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.93 138.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.541 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 76.5 m-85 -73.27 144.72 46.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.23 144.33 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.204 0.601 . . . . 0.0 110.197 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.96 130.3 34.99 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.09 -12.79 60.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.08 -0.387 . . . . 0.0 111.672 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.17 -23.71 22.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -133.17 -12.55 2.81 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.5 7.92 2.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.684 1.194 . . . . 0.0 112.021 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.24 160.45 22.98 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.3 t -70.57 141.37 51.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.792 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -78.32 6.94 7.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.64 0.376 . . . . 0.0 111.352 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.9 m 63.21 24.77 14.51 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -157.44 167.68 29.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.28 -173.41 24.8 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 121.531 0.517 . . . . 0.0 113.697 -173.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -139.72 142.68 36.83 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.371 1.868 . . . . 0.0 114.971 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -146.77 152.74 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.878 0.871 . . . . 0.0 109.689 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -141.23 149.45 41.37 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.179 0.445 . . . . 0.0 112.163 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.03 162.42 16.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -76.88 -12.56 59.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.537 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.06 150.8 23.27 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 123.298 0.639 . . . . 0.0 111.176 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.67 -18.61 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.964 2.443 . . . . 0.0 111.73 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.37 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 118.214 0.461 . . . . 0.0 111.095 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -71.02 -26.39 63.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.858 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.87 -47.28 53.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -65.91 -30.53 71.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.13 0.423 . . . . 0.0 110.968 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.37 82.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.68 67.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -66.1 -51.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.63 -12.22 61.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.04 21.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.4 ttm -120.63 -21.77 6.61 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.79 124.35 18.88 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.01 84.97 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.183 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.93 118.2 8.71 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.043 1.421 . . . . 0.0 110.501 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -77.35 129.69 36.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 110.353 -176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 tt -150.44 136.09 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.39 -112.52 4.96 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.05 14.98 8.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.0 112.728 -178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -144.38 172.66 12.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.124 0.97 . . . . 0.0 111.135 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -107.48 139.67 41.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.06 125.08 24.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.73 0.3 . . . . 0.0 110.979 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -87.26 142.82 27.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.0 t -134.95 140.19 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.673 0.389 . . . . 0.0 109.967 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -149.07 152.05 35.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.98 0.354 . . . . 0.0 110.974 -175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.426 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -71.92 148.49 45.99 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.214 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.426 ' H ' HD21 ' A' ' 104' ' ' LEU . 86.8 tttt -66.1 162.05 20.46 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.309 0.644 . . . . 0.0 109.392 173.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -59.24 157.06 11.28 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.7 p -151.74 166.0 32.69 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 122.47 0.308 . . . . 0.0 110.763 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.56 -17.48 63.98 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.492 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -69.34 -24.98 63.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.582 0.353 . . . . 0.0 110.124 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -97.55 -6.91 32.51 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -75.82 -30.88 59.16 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.192 0.197 . . . . 0.0 110.88 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -81.59 151.43 68.38 Favored Pre-proline 0 CA--C 1.529 0.173 0 C-N-CA 123.053 0.541 . . . . 0.0 110.513 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.69 -16.31 16.66 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.722 2.948 . . . . 0.0 111.795 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 92.8 m95 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.52 -1.228 . . . . 0.0 111.795 -178.349 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.532 ' C6 ' H5'' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 C5'-C4'-C3' 109.824 -3.784 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.173 0 O4'-C1'-N19 110.319 2.119 . 0.033 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.924 0 C5'-C4'-C3' 110.545 -3.303 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.889 1 C5'-C4'-C3' 106.893 -5.738 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.674 1 C5'-C4'-C3' 108.83 -4.447 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.718 -0.105 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.49 165.77 54.52 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -77.12 -17.3 58.74 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.78 -0.247 . . . . 0.0 111.368 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.3 p -71.56 160.14 33.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.173 0.511 . . . . 0.0 111.35 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -69.28 154.08 42.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.221 0.609 . . . . 0.0 110.964 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.24 -5.78 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.917 0.487 . . . . 0.0 111.668 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -74.56 -5.42 42.77 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.7 0.4 . . . . 0.0 111.866 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -75.28 -16.7 60.42 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.473 0.309 . . . . 0.0 111.587 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.68 158.47 32.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.058 0.39 . . . . 0.0 111.274 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -154.01 155.34 35.37 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.096 0.558 . . . . 0.0 109.712 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -71.25 -5.01 28.9 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t 56.66 23.09 7.41 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.002 0.921 . . . . 0.0 112.266 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.38 169.3 54.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.2 tp -154.67 147.06 23.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.951 0.501 . . . . 0.0 110.015 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 17' ' ' ARG . 6.9 p -153.16 134.84 8.68 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 122.914 0.486 . . . . 0.0 111.223 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.03 -9.79 22.39 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.199 2.599 . . . . 0.0 112.338 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.438 ' H ' HG22 ' A' ' 15' ' ' VAL . 1.1 tmt_? 51.56 77.41 0.14 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.709 1.204 . . . . 0.0 110.508 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.38 161.26 38.72 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.249 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 t -160.65 -179.49 7.66 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.535 0.734 . . . . 0.0 109.81 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -75.57 24.02 0.12 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.031 0.932 . . . . 0.0 112.562 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.0 mtm -65.49 -25.52 67.52 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 121.875 -0.515 . . . . 0.0 111.88 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -85.66 130.52 34.55 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -86.2 158.47 19.73 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.686 0.395 . . . . 0.0 111.192 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -135.84 155.62 50.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.67 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.996 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.73 176.38 6.04 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.58 3.52 . . . . 0.0 110.476 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.6 134.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.991 -0.443 . . . . 0.0 111.147 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.04 0.12 84.8 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.628 -0.54 . . . . 0.0 112.857 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 -0.38 57.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.887 0.843 . . . . 0.0 112.193 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -107.72 145.81 32.96 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.28 149.07 52.71 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 105' ' ' LYS . 21.9 m-85 -97.82 142.35 29.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.927 1.691 . . . . 0.0 112.866 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.11 130.04 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -134.41 179.73 6.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.2 m170 64.37 15.55 9.57 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.82 1.648 . . . . 0.0 113.03 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.39 139.51 86.94 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.32 165.05 32.73 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.609 2.873 . . . . 0.0 109.991 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -72.57 -7.14 48.63 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -75.99 -9.78 58.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.138 0.427 . . . . 0.0 110.743 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -75.98 158.12 32.31 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.72 175.73 34.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -56.87 -41.64 78.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -80.82 -26.6 36.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.591 0.234 . . . . 0.0 110.966 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -74.08 -38.47 63.91 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.5 tt -74.69 -25.49 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.5 tp -65.98 -52.19 51.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -64.65 -23.54 67.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.637 0.375 . . . . 0.0 111.595 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.4 tpp -76.58 -27.93 56.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.132 0.173 . . . . 0.0 110.753 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.268 22.0 m-85 -104.68 -11.72 16.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.415 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.6 mtm -66.08 -31.7 4.86 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 50' ' ' MET . 86.1 Cg_endo -72.46 -9.43 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.881 1.707 . . . . 0.0 111.733 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.81 -14.97 43.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.726 0.411 . . . . 0.0 111.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.48 -171.2 32.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.6 102.9 6.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.663 -0.316 . . . . 0.0 110.344 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -79.13 129.25 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mt -87.39 -33.82 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 122.301 0.241 . . . . 0.0 110.703 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.4 t -157.85 155.48 29.75 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.695 0.398 . . . . 0.0 110.239 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.34 138.26 17.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.339 0.656 . . . . 0.0 109.408 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.545 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 5.4 tmmm? -159.93 143.29 14.07 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.739 0.416 . . . . 0.0 111.081 -176.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.8 140.01 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.545 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 78.8 m-85 -72.41 149.43 44.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.44 143.7 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.797 0.839 . . . . 0.0 109.112 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -82.48 128.36 34.19 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -11.15 59.92 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.297 -0.252 . . . . 0.0 111.478 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.23 -22.17 19.18 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -136.44 -10.79 1.89 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 61.68 9.6 2.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.375 1.07 . . . . 0.0 112.984 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.4 153.47 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.161 -0.337 . . . . 0.0 110.153 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.6 t -70.3 137.29 50.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.569 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -83.05 167.5 17.82 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.15 18.18 1.79 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.23 170.39 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.57 -168.68 21.08 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.602 0.62 . . . . 0.0 112.979 -173.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -143.96 142.03 30.51 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -146.02 153.03 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.122 0.969 . . . . 0.0 109.531 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.9 p -142.1 150.85 41.71 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.768 0.427 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -117.53 162.02 18.67 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -77.25 -15.43 59.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.77 150.9 25.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 C-N-CA 123.193 0.597 . . . . 0.0 110.848 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.93 -23.22 34.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.015 2.477 . . . . 0.0 112.177 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.64 -38.29 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.444 0.565 . . . . 0.0 111.548 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -76.21 -26.59 56.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.318 -0.239 . . . . 0.0 110.876 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.86 -47.43 30.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -68.24 -26.97 65.96 Favored 'General case' 0 C--O 1.231 0.112 0 O-C-N 122.243 -0.286 . . . . 0.0 110.258 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.02 73.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -27.78 68.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 119.383 -0.342 . . . . 0.0 111.84 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.3 mt -64.69 -52.21 57.51 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.23 -11.53 57.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.805 -0.14 . . . . 0.0 111.186 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.07 -29.22 15.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.71 -18.27 7.75 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.17 134.86 53.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.98 2.38 77.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.505 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.42 117.9 7.96 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.553 1.176 . . . . 0.0 110.742 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -74.41 129.65 38.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.487 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.9 tt -146.76 124.27 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.71 -145.36 49.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -173.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.27 9.85 11.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.578 0.751 . . . . 0.0 112.698 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -139.38 178.97 6.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.672 0.669 . . . . 0.0 111.514 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -118.79 145.08 45.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 109.966 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 88.5 mt -67.07 133.87 50.74 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 122.496 0.318 . . . . 0.0 110.966 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.48 133.1 41.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.22 140.05 45.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -153.16 159.44 42.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.547 0.339 . . . . 0.0 110.695 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.31 130.06 41.93 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.267 0.627 . . . . 0.0 109.98 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 59.6 tttp -87.1 124.36 33.16 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.04 0.536 . . . . 0.0 112.086 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -76.27 159.56 30.48 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.434 0.694 . . . . 0.0 110.766 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.2 t -73.77 156.15 38.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.751 0.42 . . . . 0.0 110.964 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.584 ' HA ' ' HE2' ' A' ' 108' ' ' LYS . 9.1 mmpt? -72.79 -1.54 16.99 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.025 0.53 . . . . 0.0 111.997 176.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -66.39 -20.08 65.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -80.66 -19.46 45.21 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.1 m -85.37 -6.09 59.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.844 0.458 . . . . 0.0 111.671 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -68.77 155.48 93.09 Favored Pre-proline 0 N--CA 1.457 -0.106 0 C-N-CA 122.828 0.451 . . . . 0.0 111.785 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.35 -15.63 15.78 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.731 2.954 . . . . 0.0 111.241 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.3 p90 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.734 -1.603 . . . . 0.0 112.638 -177.787 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.024 1 C5'-C4'-C3' 109.413 -4.058 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.225 0 O4'-C1'-N19 110.434 2.234 . 0.078 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.921 1 C3'-C2'-C1' 105.271 4.19 . 0.115 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . 0.451 H5'' ' C8 ' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.796 2 O4'-C1'-N19 113.319 5.119 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 1 C5'-C4'-C3' 109.014 -4.324 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 120.404 0.145 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.32 -7.03 87.97 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.678 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.7 p 52.53 21.49 1.82 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.229 1.412 . . . . 0.0 113.333 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 m -64.86 154.86 35.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.885 0.474 . . . . 0.0 111.105 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -154.49 -6.01 0.15 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.735 0.414 . . . . 0.0 111.236 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -81.6 -10.29 59.47 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.092 0.557 . . . . 0.0 111.65 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -74.65 157.19 35.77 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.895 0.379 . . . . 0.0 110.739 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -72.27 160.13 32.9 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.857 0.463 . . . . 0.0 110.721 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -150.57 1.72 0.45 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.427 0.291 . . . . 0.0 111.77 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -70.01 -7.77 43.69 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.138 0.426 . . . . 0.0 111.688 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.3 t -73.31 -20.15 60.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.597 0.359 . . . . 0.0 110.858 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -76.74 140.7 40.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.72 0.408 . . . . 0.0 110.416 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.56 -168.11 39.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.62 140.25 56.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p -64.54 132.1 95.29 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -68.04 -12.76 36.24 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.2 2.6 . . . . 0.0 112.095 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -23.49 62.64 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.523 0.329 . . . . 0.0 110.598 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.18 -61.85 0.93 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 m -158.48 154.22 26.43 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 123.572 0.749 . . . . 0.0 110.836 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -96.11 -12.32 24.97 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.58 0.352 . . . . 0.0 111.348 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -75.13 162.72 28.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.26 0.624 . . . . 0.0 111.103 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.435 ' NE2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -65.19 151.3 46.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.882 0.473 . . . . 0.0 110.89 178.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -150.44 142.9 24.39 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.635 0.774 . . . . 0.0 108.927 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -101.09 152.72 20.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.078 0.551 . . . . 0.0 111.632 -171.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.45 -164.41 30.71 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.04 170.44 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.488 2.792 . . . . 0.0 110.254 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -64.32 138.76 58.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.961 -0.462 . . . . 0.0 110.017 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.62 -1.67 87.18 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.541 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.95 13.2 29.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.717 0.758 . . . . 0.0 112.327 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -113.9 138.81 49.81 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.696 0.398 . . . . 0.0 110.186 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.8 mt -123.6 156.59 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 122.076 0.941 . . . . 0.0 113.115 -174.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -117.21 143.17 46.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.973 1.709 . . . . 0.0 114.016 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.64 128.36 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.73 171.17 14.22 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.41 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 18.3 m170 74.15 20.67 2.67 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.209 1.803 . . . . 0.0 112.77 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 72' ' ' PHE . 2.7 mm? -70.4 142.8 89.75 Favored Pre-proline 0 N--CA 1.454 -0.235 0 C-N-CA 123.166 0.586 . . . . 0.0 109.957 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.45 162.78 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.586 2.858 . . . . 0.0 108.991 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.82 -8.05 54.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -76.88 -9.94 59.03 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.266 0.484 . . . . 0.0 110.789 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.44 ' CD1' HD12 ' A' ' 36' ' ' LEU . 5.5 m-85 -75.67 158.44 32.35 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.82 174.92 33.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -60.8 -35.58 76.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -74.36 -29.19 61.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.18 0.592 . . . . 0.0 111.213 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -79.05 -42.08 27.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.81 -23.06 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.2 -49.61 75.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -65.31 -23.67 67.08 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.601 0.361 . . . . 0.0 111.641 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.3 mmm -77.15 -22.44 52.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.638 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 28.1 m-85 -110.1 -10.57 14.67 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.093 2.627 . . . . 0.0 118.093 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.1 mtm -66.21 -32.64 5.74 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.4 -8.19 20.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 121.715 1.648 . . . . 0.0 112.055 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.79 -15.58 38.86 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.97 -172.35 33.3 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -75.93 103.09 5.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.208 -0.583 . . . . 0.0 110.516 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 122.56 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.5 mt -81.64 -30.83 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.05 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.8 t -158.72 154.58 26.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.055 0.455 . . . . 0.0 111.102 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.52 146.33 31.39 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.964 0.906 . . . . 0.0 108.603 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -157.96 145.35 18.25 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -121.73 132.83 69.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -69.71 155.07 41.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -134.08 143.76 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.949 0.5 . . . . 0.0 109.845 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -88.08 132.18 34.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -77.72 -13.06 60.01 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.839 0.456 . . . . 0.0 111.408 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -91.13 -22.27 20.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.276 0.63 . . . . 0.0 112.677 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.7 -12.85 2.0 Allowed 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -174.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 60.52 8.72 1.78 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.647 1.179 . . . . 0.0 112.911 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.46 156.65 30.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.966 0.348 . . . . 0.0 110.739 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.9 t -71.31 135.27 47.31 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.907 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.89 162.75 26.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.084 0.553 . . . . 0.0 110.822 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -81.28 11.0 4.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.448 ' HA ' HD21 ' A' ' 36' ' ' LEU . 4.6 p90 -157.79 172.94 17.58 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.43 -163.86 16.11 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.778 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.26 147.6 35.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.869 1.667 . . . . 0.0 115.404 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.6 t -146.2 152.14 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 t -141.2 143.9 34.46 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.25 159.17 19.61 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -76.23 -11.92 60.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.153 0.501 . . . . 0.0 111.847 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.86 149.7 21.43 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 123.168 0.587 . . . . 0.0 110.886 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.08 -18.23 35.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.344 2.696 . . . . 0.0 112.214 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.41 -46.27 95.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 118.297 0.499 . . . . 0.0 110.758 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.6 m -70.87 -24.04 62.42 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.186 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.6 -48.07 35.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.911 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -67.58 -28.99 68.23 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.045 0.384 . . . . 0.0 110.852 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.64 80.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.36 66.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.871 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.6 mt -65.85 -51.15 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 118.796 0.726 . . . . 0.0 109.173 174.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -68.23 -11.07 58.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.419 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.91 -26.77 16.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 89.2 mmm -120.65 -14.71 8.56 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.07 132.65 48.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.62 4.06 87.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.774 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -63.23 117.64 6.85 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.578 1.189 . . . . 0.0 109.977 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -77.37 130.93 37.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.115 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.97 134.25 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.45 -108.31 1.89 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 65.2 mtt -130.57 17.76 5.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.561 0.745 . . . . 0.0 111.516 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 55.3 tttp -146.59 155.84 42.78 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.69 0.396 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -98.12 140.64 32.14 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.699 -0.626 . . . . 0.0 111.196 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.02 131.58 46.15 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.713 0.405 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.531 ' HE3' ' C4 ' ' B' ' 116' ' ' ' U' . 18.2 ttmm -92.8 139.12 30.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -134.83 141.01 44.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-N 118.047 0.385 . . . . 0.0 110.376 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -155.03 163.53 40.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.917 0.326 . . . . 0.0 111.785 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.44 148.66 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.562 0.745 . . . . 0.0 110.259 175.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -68.36 155.37 39.93 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -59.56 138.39 57.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.017 0.371 . . . . 0.0 111.375 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -74.13 166.58 23.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.724 0.81 . . . . 0.0 109.739 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.74 -19.94 66.07 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.874 -0.516 . . . . 0.0 111.239 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -77.29 -29.06 53.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -103.74 0.17 30.16 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.3 p -68.72 -20.64 64.41 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.148 0.579 . . . . 0.0 111.271 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -138.12 152.99 72.9 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 123.791 0.836 . . . . 0.0 110.732 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.08 -13.97 21.1 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.558 2.839 . . . . 0.0 111.16 177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.1 m95 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.528 -1.225 . . . . 0.0 112.138 179.747 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 C5'-C4'-C3' 109.981 -3.679 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . 0.531 ' C4 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.758 1 C5'-C4'-C3' 108.258 -4.828 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.123 0 C5'-C4'-C3' 109.639 -3.907 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.69 2 C3'-C2'-C1' 105.624 4.582 . 0.305 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 2 C5'-C4'-C3' 109.31 -4.127 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 120.443 0.163 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.25 178.74 48.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.6 t -156.11 160.75 40.21 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.316 0.646 . . . . 0.0 110.15 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.7 t -67.23 152.65 45.35 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.928 0.491 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -155.55 150.6 26.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.968 0.507 . . . . 0.0 110.184 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -154.86 161.64 41.38 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.114 0.566 . . . . 0.0 110.251 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -155.37 165.68 35.88 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 123.053 0.541 . . . . 0.0 110.345 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -151.68 -12.12 0.2 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.392 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -76.02 159.06 31.2 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.974 0.51 . . . . 0.0 110.764 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -73.46 164.11 27.11 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.084 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 t -66.18 152.64 44.37 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.192 0.597 . . . . 0.0 111.141 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.7 t -69.27 -14.31 62.88 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.774 0.429 . . . . 0.0 110.778 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.1 -1.68 80.62 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.973 -0.348 . . . . 0.0 112.232 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.4 tp -63.88 143.94 57.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.834 0.817 . . . . 0.0 110.823 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -152.21 139.13 12.36 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.449 0.699 . . . . 0.0 110.599 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.74 146.71 73.68 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.915 2.41 . . . . 0.0 111.319 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 73.5 mmt-85 -146.82 151.21 36.75 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.364 1.065 . . . . 0.0 110.596 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.43 -21.03 3.07 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.436 1.017 . . . . 0.0 111.892 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 94.7 p -167.3 165.21 15.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.862 0.865 . . . . 0.0 109.487 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -77.87 -17.2 57.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.156 0.183 . . . . 0.0 110.941 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.2 ptp 44.35 32.91 0.77 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 125.911 1.684 . . . . 0.0 114.108 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.413 ' CD ' ' N ' ' A' ' 22' ' ' GLN . 2.8 pm0 -52.41 142.9 16.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.053 0.941 . . . . 0.0 110.859 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -84.99 159.93 20.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.435 0.694 . . . . 0.0 110.385 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -138.08 149.59 46.12 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.581 0.353 . . . . 0.0 110.677 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.77 41.44 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 177.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.3 167.2 24.51 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.409 2.739 . . . . 0.0 109.881 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.42 136.51 57.94 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.09 -0.381 . . . . 0.0 110.091 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 -10.56 73.99 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.132 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.33 6.67 48.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.031 0.532 . . . . 0.0 111.133 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.11 145.51 24.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.92 151.85 49.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.017 0.913 . . . . 0.0 113.097 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.74 145.12 45.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.542 1.937 . . . . 0.0 114.553 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.73 136.7 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.11 178.44 7.17 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.456 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.2 m170 63.88 15.92 9.46 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.31 1.444 . . . . 0.0 112.798 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.43 142.79 94.79 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 117.902 0.319 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.66 166.69 28.68 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.907 2.405 . . . . 0.0 109.566 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -71.2 -14.24 62.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.34 -10.02 59.08 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.84 158.14 36.89 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 175.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.22 177.7 34.8 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -57.32 -40.67 78.41 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -84.95 -26.26 27.29 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.378 -0.201 . . . . 0.0 111.055 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -74.18 -38.28 63.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 tt -75.41 -26.34 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.57 -53.35 53.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -64.23 -23.05 67.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.821 0.448 . . . . 0.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 tpt -79.05 -25.09 43.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.267 -0.271 . . . . 0.0 110.506 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.266 29.0 m-85 -105.83 -10.96 16.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 -178.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 53.8 mtm -66.63 -29.56 2.85 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.2 Cg_endo -72.47 -8.42 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 CA-C-N 121.951 1.733 . . . . 0.0 112.167 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -89.42 -12.07 41.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.959 0.504 . . . . 0.0 111.208 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.49 -176.17 31.6 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -77.96 101.67 6.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.236 -0.567 . . . . 0.0 110.506 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.02 123.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -85.22 -30.84 6.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.9 t -152.85 151.69 30.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 110.661 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 136.32 13.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.87 0.868 . . . . 0.0 108.865 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -158.5 131.05 7.02 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.511 0.196 . . . . 0.0 110.583 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -95.68 134.36 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.402 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 50.5 m-85 -69.53 144.64 53.08 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -174.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -133.19 144.55 36.0 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 123.168 0.587 . . . . 0.0 109.979 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -88.89 130.69 35.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.54 -11.46 60.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.994 -0.441 . . . . 0.0 111.251 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -89.84 -21.86 22.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.8 -13.72 1.92 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.2 9.12 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.338 1.055 . . . . 0.0 112.954 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -82.25 160.01 23.07 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.709 0.404 . . . . 0.0 109.996 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.2 t -69.51 139.99 53.89 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.341 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -82.53 6.4 17.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.7 m 60.87 22.64 12.72 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.59 168.41 27.23 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.24 -172.12 28.16 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.796 -0.565 . . . . 0.0 113.714 -173.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -136.75 144.38 43.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.151 1.78 . . . . 0.0 114.877 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.1 t -148.33 153.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 91.1 p -146.46 146.64 30.63 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.831 -0.543 . . . . 0.0 112.295 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.46 164.83 12.32 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.64 -11.15 59.96 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.54 149.92 23.71 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 122.984 0.514 . . . . 0.0 110.785 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.29 -18.1 39.4 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.099 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.61 -46.56 94.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-N 118.466 0.576 . . . . 0.0 110.83 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -71.33 -25.36 62.37 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.518 0.327 . . . . 0.0 111.04 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.71 -47.69 52.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.045 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -68.49 -27.83 66.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.143 0.428 . . . . 0.0 110.711 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -40.66 81.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.02 66.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.678 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.3 -52.23 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -68.51 -11.8 60.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.338 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.55 -27.7 17.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 89.0 mmm -120.4 -18.29 7.94 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -65.68 131.81 47.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.07 8.59 85.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 119.089 -0.839 . . . . 0.0 112.51 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -66.38 114.58 5.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.807 1.303 . . . . 0.0 109.103 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.4 129.1 37.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.436 0.562 . . . . 0.0 110.956 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 tt -145.14 122.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.18 -143.3 48.34 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.5 mtm -86.1 12.53 9.41 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.456 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 42.7 tttp -147.06 170.45 17.11 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.698 0.681 . . . . 0.0 110.356 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -111.99 140.7 46.44 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 122.937 0.495 . . . . 0.0 109.902 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.29 132.7 49.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.272 0.229 . . . . 0.0 111.233 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.499 ' HE3' ' C5 ' ' B' ' 116' ' ' ' U' . 19.1 ttmm -95.58 139.05 32.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 67.3 t -135.24 140.08 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -154.31 163.7 39.74 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -79.85 150.78 30.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.491 0.717 . . . . 0.0 110.629 175.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.458 ' H ' HD23 ' A' ' 104' ' ' LEU . 64.4 tttp -69.18 154.34 42.2 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.3 mmm-85 -62.78 155.83 25.59 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.718 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -154.06 166.2 33.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.314 0.646 . . . . 0.0 109.951 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -65.67 -11.19 42.89 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.979 -0.451 . . . . 0.0 110.644 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -84.55 -9.22 58.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.63 0.772 . . . . 0.0 112.634 177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -133.52 -9.99 2.83 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.8 t -70.03 -14.46 62.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.572 0.749 . . . . 0.0 111.521 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -65.81 153.89 90.15 Favored Pre-proline 0 C--N 1.34 0.172 0 C-N-CA 123.002 0.521 . . . . 0.0 111.096 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.9 5.19 5.86 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 124.367 3.378 . . . . 0.0 110.86 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.396 -177.154 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.474 ' C6 ' H5'' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 O4'-C1'-N19 111.811 3.611 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . 0.499 ' C5 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.035 0 O4'-C1'-N19 110.466 2.266 . 0.094 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.398 0 C3'-C2'-C1' 98.734 -3.073 . 0.072 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 2 O4'-C1'-N19 113.303 5.103 . 0.436 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . 0.402 " H1'" ' CD1' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.834 1 C5'-C4'-C3' 108.959 -4.361 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.321 0.105 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.48 -12.07 72.86 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.9 -0.389 . . . . 0.0 112.951 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -75.74 -5.64 46.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.68 0.74 . . . . 0.0 111.472 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.2 t 61.95 153.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.228 1.411 . . . . 0.0 113.548 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -82.17 43.78 0.82 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.731 0.812 . . . . 0.0 110.298 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 60.07 15.82 5.43 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 124.786 1.234 . . . . 0.0 113.325 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -83.09 -30.36 28.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.347 -0.221 . . . . 0.0 110.643 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -82.38 -26.97 32.39 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.377 0.271 . . . . 0.0 110.347 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -86.07 174.66 9.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.236 0.615 . . . . 0.0 110.805 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -63.86 153.48 36.64 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -61.41 -26.17 67.68 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.944 0.497 . . . . 0.0 112.144 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.8 p -66.29 -16.76 64.3 Favored 'General case' 0 C--O 1.231 0.106 0 O-C-N 122.049 -0.407 . . . . 0.0 111.435 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 -22.74 52.01 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.9 tp -83.55 -33.61 25.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.32 0.56 . . . . 0.0 110.11 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.1 132.54 5.24 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.969 0.508 . . . . 0.0 111.04 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.56 150.44 40.47 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.101 2.534 . . . . 0.0 110.558 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.84 171.95 18.54 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.318 0.647 . . . . 0.0 109.594 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.72 144.76 10.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 t 58.74 163.75 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.46 1.504 . . . . 0.0 114.005 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -88.46 -10.01 50.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.957 0.903 . . . . 0.0 111.792 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mtm -72.14 164.48 26.13 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.823 0.345 . . . . 0.0 111.385 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -71.35 152.07 43.53 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.553 0.741 . . . . 0.0 109.938 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -100.65 153.52 19.35 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.964 0.411 . . . . 0.0 111.378 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -115.84 151.53 35.08 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.184 0.594 . . . . 0.0 111.143 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.45 -179.07 46.7 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.69 -178.52 1.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.071 3.181 . . . . 0.0 110.376 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.61 131.14 49.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.117 -0.364 . . . . 0.0 111.019 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.04 1.79 85.9 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 119.526 -0.597 . . . . 0.0 113.189 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.88 7.41 44.93 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -109.67 139.11 45.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.327 0.512 . . . . 0.0 110.359 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.4 mt -126.15 159.37 33.1 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -117.36 141.8 47.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.967 1.707 . . . . 0.0 114.582 171.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.08 132.37 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -135.53 179.97 6.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.0 m170 65.15 23.39 12.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.149 1.379 . . . . 0.0 112.747 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.17 136.46 72.58 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.326 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.78 168.86 23.44 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.537 2.825 . . . . 0.0 110.313 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -69.37 -11.32 60.71 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -80.02 -7.27 58.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -76.1 158.18 32.06 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.94 174.91 35.27 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.85 -36.03 73.91 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 117.202 0.501 . . . . 0.0 110.864 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -78.62 -33.97 46.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.29 0.236 . . . . 0.0 110.886 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -71.28 -39.29 71.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -75.74 -26.74 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.16 -53.81 39.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.556 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 tpt -72.81 -26.65 61.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 25.0 m-85 -103.52 -9.27 19.44 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.408 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 44.7 mtm -66.78 -31.33 3.96 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' MET . 76.9 Cg_endo -71.53 -8.18 22.73 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 121.959 1.735 . . . . 0.0 111.667 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -89.07 -14.76 35.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.825 0.45 . . . . 0.0 110.885 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.88 -174.33 30.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -75.25 105.56 6.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.364 -0.492 . . . . 0.0 110.668 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.73 123.69 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 78' ' ' ASP . 15.5 mt -82.17 -34.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 O-C-N 122.211 -0.306 . . . . 0.0 110.292 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -156.14 156.86 34.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.415 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.33 148.03 26.3 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.682 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.11 131.75 6.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.624 0.369 . . . . 0.0 111.014 -174.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.92 129.36 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.494 ' CD2' " H1'" ' B' ' 119' ' ' ' A' . 41.9 m-85 -74.32 149.16 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -174.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 mm -132.95 153.32 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.776 0.43 . . . . 0.0 110.466 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' H ' ' HE3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -80.04 -10.73 59.79 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -86.24 -23.59 26.35 Favored 'General case' 0 C--O 1.23 0.039 0 C-N-CA 122.817 0.447 . . . . 0.0 112.126 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.0 -14.71 1.36 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.4 6.95 1.56 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.043 0.937 . . . . 0.0 112.812 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.35 162.74 25.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.3 t -67.99 141.75 56.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 110.474 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -73.44 6.39 3.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 111.384 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.8 p 58.35 20.78 7.64 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.491 1.916 . . . . 0.0 112.687 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.19 169.93 23.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.36 -170.23 26.86 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 121.467 0.482 . . . . 0.0 112.404 -175.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -137.63 141.45 41.21 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.664 1.586 . . . . 0.0 114.905 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.8 t -145.12 152.08 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.6 p -143.3 149.57 38.01 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-O 120.923 0.392 . . . . 0.0 112.003 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -114.85 162.54 16.76 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.414 ' HA ' HD13 ' A' ' 56' ' ' ILE . 11.9 t70 -78.3 -11.04 59.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.69 150.28 20.22 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.557 0.743 . . . . 0.0 110.767 176.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.0 -20.57 38.26 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.311 2.674 . . . . 0.0 112.057 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.2 -45.13 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 CA-C-N 118.42 0.554 . . . . 0.0 111.09 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -71.58 -27.3 63.04 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.91 -48.13 39.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -67.0 -27.61 67.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.035 -0.416 . . . . 0.0 110.802 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.16 73.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.31 66.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.99 -51.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -68.28 -12.02 60.36 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.161 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.46 -32.85 20.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.008 -0.52 . . . . 0.0 112.379 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.2 mtp -123.2 -14.77 7.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.23 126.67 28.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.38 2.38 90.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.802 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -62.27 138.75 58.48 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -92.64 130.79 38.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.782 0.719 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.6 tt -144.83 123.98 6.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.33 -143.66 48.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 mmt -84.91 9.2 15.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.659 0.783 . . . . 0.0 113.075 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -140.67 179.11 6.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.554 0.616 . . . . 0.0 111.214 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -118.82 147.74 43.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.41 124.34 19.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.038 0.935 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -94.38 130.42 40.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.95 137.64 51.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 122.243 0.217 . . . . 0.0 110.52 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -153.7 161.25 42.29 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 122.395 -0.191 . . . . 0.0 111.152 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.525 HD22 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -74.86 154.49 38.22 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.525 ' H ' HD22 ' A' ' 104' ' ' LEU . 57.2 tttp -61.53 151.96 31.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.6 0.36 . . . . 0.0 110.327 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -64.55 160.3 19.82 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.549 0.34 . . . . 0.0 110.684 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.9 m -63.11 143.86 57.42 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.588 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.01 -8.08 52.47 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -67.26 -17.08 64.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.373 -0.204 . . . . 0.0 110.984 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -80.87 -17.28 51.18 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 t -86.92 -18.08 31.67 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.012 0.525 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -68.09 151.46 97.19 Favored Pre-proline 0 C--N 1.34 0.176 0 C-N-CA 123.133 0.573 . . . . 0.0 110.987 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.04 -5.2 15.66 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.109 3.206 . . . . 0.0 112.608 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.908 -1.52 . . . . 0.0 112.798 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.864 0 O4'-C1'-N19 110.732 2.532 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.3 0 O4'-C1'-N19 110.517 2.317 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.223 0 C3'-C2'-C1' 98.501 -3.332 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.709 2 C3'-C2'-C1' 105.544 4.493 . 0.382 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . 0.494 " H1'" ' CD2' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.882 2 O4'-C1'-N19 112.766 4.566 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.06 9.32 0.09 OUTLIER Glycine 0 CA--C 1.53 0.991 0 CA-C-O 120.037 -0.313 . . . . 0.0 112.319 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -65.98 159.72 25.17 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.502 0.651 . . . . 0.0 111.198 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 t -153.56 157.69 40.1 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.119 0.568 . . . . 0.0 110.276 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -71.99 159.28 34.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.978 0.511 . . . . 0.0 111.376 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -71.01 159.13 35.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.37 0.668 . . . . 0.0 111.131 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -69.36 154.92 41.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.728 0.411 . . . . 0.0 111.128 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -156.07 162.17 40.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.193 0.597 . . . . 0.0 110.273 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -91.44 -1.29 57.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.189 0.596 . . . . 0.0 111.94 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -68.08 150.88 47.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.966 0.348 . . . . 0.0 110.839 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.5 p -154.69 164.59 38.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.016 0.526 . . . . 0.0 110.611 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.6 t -154.89 165.31 37.08 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.666 0.786 . . . . 0.0 109.944 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.95 -154.46 30.63 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.78 165.12 13.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.598 0.359 . . . . 0.0 111.912 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.9 138.95 14.76 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.365 0.666 . . . . 0.0 110.28 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.2 22.55 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.242 3.295 . . . . 0.0 112.856 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -134.0 168.45 18.77 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.493 0.717 . . . . 0.0 111.128 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.4 -9.69 77.95 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.443 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 95.1 p -160.11 166.75 29.22 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.658 0.729 . . . . 0.0 110.479 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -82.7 4.34 25.43 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.0 0.52 . . . . 0.0 111.927 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.5 mtm -69.29 173.24 5.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.1 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -58.5 143.31 46.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.628 0.771 . . . . 0.0 111.362 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.65 159.08 19.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.481 0.712 . . . . 0.0 110.761 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -140.33 150.28 43.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.831 0.452 . . . . 0.0 111.046 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 -160.73 35.24 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.87 178.75 3.74 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.042 3.161 . . . . 0.0 110.522 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -60.71 136.09 57.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.961 -0.462 . . . . 0.0 111.328 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.67 -1.67 71.63 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.334 0.492 . . . . 0.0 112.725 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.99 38.76 1.03 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 111.346 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.64 144.59 31.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.029 -0.419 . . . . 0.0 111.308 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.7 mt -129.87 158.07 40.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 25.2 m-85 -112.64 143.83 43.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.407 1.483 . . . . 0.0 114.233 170.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.85 124.95 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.8 m-85 -129.19 179.48 5.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m170 64.02 15.95 9.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.598 1.559 . . . . 0.0 112.335 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.57 141.39 90.47 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 122.842 0.457 . . . . 0.0 110.557 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.88 165.23 32.65 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.307 2.671 . . . . 0.0 109.415 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.47 -5.86 45.0 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.62 -9.2 58.82 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.033 0.379 . . . . 0.0 111.423 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -75.22 158.17 33.36 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.4 175.54 34.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -58.48 -37.35 75.34 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.531 0.665 . . . . 0.0 110.287 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.36 -33.27 37.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.605 0.241 . . . . 0.0 110.914 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -72.73 -38.52 67.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -74.79 -26.13 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.91 -53.26 41.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.513 0.325 . . . . 0.0 111.257 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.2 tpt -80.62 -24.71 38.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.953 0.101 . . . . 0.0 110.748 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.262 21.3 m-85 -104.63 -12.32 16.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -179.212 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.429 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.9 mtm -66.39 -29.87 3.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.9 Cg_endo -71.66 -9.68 25.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 122.068 1.774 . . . . 0.0 111.694 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -87.77 -13.62 41.83 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.094 0.406 . . . . 0.0 111.502 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.32 -175.01 31.9 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -75.45 103.25 5.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.552 -0.381 . . . . 0.0 110.484 -177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.6 t -86.05 124.78 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 78' ' ' ASP . 39.5 mt -86.31 -29.32 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 O-C-N 122.43 -0.169 . . . . 0.0 110.585 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -156.51 154.9 31.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.66 149.11 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.68 0.792 . . . . 0.0 109.361 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.42 ' HE2' ' N3 ' ' B' ' 119' ' ' ' A' . 54.0 tptt -158.31 139.22 13.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.556 0.342 . . . . 0.0 111.658 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 t -118.15 131.04 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.408 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 42.8 m-85 -71.73 156.48 39.29 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -133.29 145.35 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 C-N-CA 122.823 0.449 . . . . 0.0 110.027 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -88.4 132.13 34.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -79.04 -14.18 59.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.889 0.476 . . . . 0.0 111.595 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -89.61 -23.64 21.89 Favored 'General case' 0 C--N 1.335 -0.063 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.35 -11.76 2.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 62.0 10.51 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.346 1.059 . . . . 0.0 111.839 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.64 156.37 27.66 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.942 -0.474 . . . . 0.0 110.01 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.6 t -71.29 139.64 50.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.786 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.87 163.89 24.93 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.861 0.464 . . . . 0.0 110.873 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.6 m -84.32 13.18 5.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -158.91 171.98 19.05 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.41 -166.06 18.47 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.511 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.36 142.88 30.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.17 152.81 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.704 0.802 . . . . 0.0 109.782 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 t -144.02 141.08 29.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -104.8 162.69 13.09 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.4 ' HA ' HD12 ' A' ' 56' ' ' ILE . 19.0 t0 -77.99 -12.49 59.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 111.491 174.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.97 149.9 20.44 Favored Pre-proline 0 N--CA 1.451 -0.404 0 C-N-CA 123.088 0.555 . . . . 0.0 110.613 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.92 -21.62 32.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.066 2.511 . . . . 0.0 112.341 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.2 -39.28 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.879 -0.513 . . . . 0.0 111.837 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -73.77 -25.33 60.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.182 0.193 . . . . 0.0 110.586 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.01 -45.84 55.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.29 -30.63 71.09 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.9 0.318 . . . . 0.0 110.875 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.52 82.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.28 -26.37 65.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.4 mt -65.52 -53.07 43.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -67.9 -11.3 58.43 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.99 -29.29 16.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 92.9 mmm -120.43 -16.96 8.29 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -65.0 132.59 49.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 4.83 84.75 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.048 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -63.66 122.83 17.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.727 1.263 . . . . 0.0 111.419 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -76.52 128.96 35.77 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.791 0.329 . . . . 0.0 110.854 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -151.76 136.91 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.6 -111.77 3.5 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.2 ptp -128.7 13.66 6.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.174 0.59 . . . . 0.0 111.89 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -151.85 142.16 22.44 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.169 0.44 . . . . 0.0 110.636 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -81.85 144.7 30.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.243 -0.286 . . . . 0.0 110.702 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.83 127.16 31.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.309 0.244 . . . . 0.0 111.037 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.62 138.31 31.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.21 140.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -153.71 157.23 39.2 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 122.352 -0.217 . . . . 0.0 111.277 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.466 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -78.3 151.79 32.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.002 0.521 . . . . 0.0 109.781 174.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.466 ' H ' HD21 ' A' ' 104' ' ' LEU . 59.7 tttp -66.88 147.77 52.81 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -76.03 156.57 33.88 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 120.629 0.252 . . . . 0.0 110.917 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -67.99 151.92 46.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.485 0.314 . . . . 0.0 111.141 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -4.69 31.47 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.47 -18.66 60.59 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -79.93 -12.74 59.71 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.1 t -84.75 -17.61 37.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.941 0.496 . . . . 0.0 110.499 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 34.4 mmtp -69.98 157.88 88.67 Favored Pre-proline 0 N--CA 1.456 -0.156 0 C-N-CA 123.516 0.727 . . . . 0.0 110.744 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 112' ' ' LYS . 89.9 Cg_endo -75.63 -16.05 19.06 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.679 2.919 . . . . 0.0 111.679 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 3.2 p90 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 116.805 -1.569 . . . . 0.0 112.665 -177.519 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.873 0 C5'-C4'-C3' 109.923 -3.718 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.055 0 O4'-C1'-N19 109.906 1.706 . 0.032 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.244 0 C3'-C2'-C1' 99.552 -2.165 . 0.023 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.743 2 C3'-C2'-C1' 105.82 4.8 . 0.353 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . 0.42 ' N3 ' ' HE2' ' A' ' 59' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.894 2 C5'-C4'-C3' 108.155 -4.896 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.586 0.231 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.73 -178.48 48.07 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -67.83 156.66 36.58 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.615 0.366 . . . . 0.0 111.239 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.7 t -155.2 157.0 36.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.247 0.619 . . . . 0.0 110.443 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -155.53 158.69 38.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.194 0.598 . . . . 0.0 110.448 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -154.31 156.92 37.84 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.308 0.643 . . . . 0.0 110.349 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -72.31 158.45 35.79 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.873 0.469 . . . . 0.0 111.248 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -70.44 157.51 37.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.081 0.552 . . . . 0.0 111.036 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -155.18 -29.28 0.1 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.575 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -76.36 -14.22 60.1 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.622 0.369 . . . . 0.0 111.569 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m -69.78 158.43 35.46 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.956 0.502 . . . . 0.0 110.937 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.6 t -73.96 -7.25 51.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.797 0.439 . . . . 0.0 111.589 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.89 -0.89 76.48 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.312 0.482 . . . . 0.0 112.557 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.32 142.69 53.99 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.739 0.77 . . . . 0.0 110.062 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 p -67.7 133.99 92.47 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.415 0.286 . . . . 0.0 111.67 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 18' ' ' GLY . 89.3 Cg_endo -73.6 -9.97 23.2 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.019 2.479 . . . . 0.0 112.066 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.37 -14.89 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.158 1.783 . . . . 0.0 113.697 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 16' ' ' PRO . . . 83.58 148.67 8.52 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.5 t -78.54 160.58 27.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.915 0.486 . . . . 0.0 110.702 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -76.79 -8.86 58.11 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.576 0.351 . . . . 0.0 110.471 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.3 mtm 57.05 27.88 14.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -66.98 152.29 46.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.189 -0.319 . . . . 0.0 110.522 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -108.74 159.74 16.52 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.556 0.742 . . . . 0.0 112.263 -170.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -131.5 153.03 50.22 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.914 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.44 -165.78 30.92 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.588 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -69.88 177.5 5.6 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.127 3.218 . . . . 0.0 110.403 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -60.67 137.4 58.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.903 -0.498 . . . . 0.0 110.855 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -3.53 83.51 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.672 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -0.28 39.76 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.679 0.74 . . . . 0.0 112.703 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -102.54 136.26 42.68 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 118.213 0.461 . . . . 0.0 110.314 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.5 mt -124.18 154.58 39.88 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.892 0.853 . . . . 0.0 113.135 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -116.06 145.91 42.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.931 1.692 . . . . 0.0 114.011 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.43 137.82 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.57 176.35 8.96 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 9.4 m170 65.93 16.1 10.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.181 1.392 . . . . 0.0 112.644 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.3 146.19 98.76 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.709 0.403 . . . . 0.0 110.075 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 169.16 22.82 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.319 2.68 . . . . 0.0 109.833 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -68.47 -19.29 64.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.872 0.469 . . . . 0.0 112.206 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.0 -10.57 59.66 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -69.99 158.03 36.39 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.24 175.5 35.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.38 -35.74 72.44 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 117.466 0.633 . . . . 0.0 110.031 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -79.76 -33.16 40.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.913 0.485 . . . . 0.0 111.085 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.11 -39.04 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.2 tt -74.35 -24.96 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.6 tp -65.27 -52.29 55.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -65.22 -22.27 66.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.566 0.346 . . . . 0.0 111.382 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.2 tpp -78.24 -26.78 47.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.269 0.228 . . . . 0.0 110.713 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.266 22.9 m-85 -105.77 -11.57 16.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.415 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.5 mtm -66.91 -31.0 3.56 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 50' ' ' MET . 81.4 Cg_endo -71.97 -9.2 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.745 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -82.78 -24.32 33.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.74 0.416 . . . . 0.0 111.981 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 158.57 -163.52 33.09 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.96 103.04 10.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.556 0.678 . . . . 0.0 110.972 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.4 t -82.4 121.55 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.66 -32.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -157.83 152.4 24.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.965 0.506 . . . . 0.0 111.239 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.09 146.74 31.96 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.891 0.876 . . . . 0.0 109.068 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.463 ' HE2' ' N3 ' ' B' ' 119' ' ' ' A' . 52.9 tptt -156.79 139.26 14.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.76 0.424 . . . . 0.0 111.598 -172.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.45 129.19 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 168.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -72.18 147.84 46.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.5 mm -132.36 141.17 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.819 0.448 . . . . 0.0 110.461 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -90.12 134.85 34.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -77.64 -12.22 59.95 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.65 0.38 . . . . 0.0 111.755 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -87.9 -22.54 24.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.12 -14.64 1.78 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 62.12 8.2 2.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.506 1.122 . . . . 0.0 112.717 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.7 mt -82.42 161.0 22.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.814 0.445 . . . . 0.0 110.329 175.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.5 t -66.87 138.54 57.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -77.56 8.91 3.76 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.009 0.524 . . . . 0.0 111.619 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.5 m 61.91 23.08 13.52 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -156.5 167.45 30.41 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.21 -170.79 24.19 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 121.581 0.545 . . . . 0.0 113.433 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -142.39 142.67 32.44 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.224 1.81 . . . . 0.0 114.744 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.1 t -146.05 153.41 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.5 t -143.31 146.92 33.99 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -117.86 165.57 13.51 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -80.63 -13.31 59.14 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.03 148.58 21.7 Favored Pre-proline 0 C--O 1.233 0.205 0 C-N-CA 123.256 0.623 . . . . 0.0 111.378 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.86 -23.11 41.72 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.508 2.805 . . . . 0.0 112.132 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.74 -38.66 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 O-C-N 121.802 -0.561 . . . . 0.0 111.232 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.6 t -74.72 -29.79 61.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.319 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.01 37.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.26 -28.57 68.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.262 -0.274 . . . . 0.0 110.727 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.57 73.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.47 -26.56 68.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.68 -51.87 57.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 CA-C-N 118.836 0.744 . . . . 0.0 109.001 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.89 -11.81 57.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.37 -27.38 16.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.5 mmm -120.54 -17.27 8.14 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.67 134.66 53.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.72 2.39 85.55 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.839 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.37 120.02 13.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.814 1.307 . . . . 0.0 110.675 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.76 126.87 31.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.63 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.69 135.72 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.442 0.697 . . . . 0.0 109.567 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.72 31.82 76.74 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.518 -0.739 . . . . 0.0 111.828 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.5 mtm 64.64 22.19 12.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -144.75 155.81 43.73 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -97.95 134.62 40.81 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.376 -0.828 . . . . 0.0 111.159 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.8 mt -64.73 130.99 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.66 0.267 . . . . 0.0 111.351 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.52 137.39 32.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.7 t -134.36 135.33 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -150.31 160.51 43.66 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.699 0.227 . . . . 0.0 111.564 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.444 HD21 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -76.6 149.29 36.58 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.01 0.524 . . . . 0.0 110.002 177.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.444 ' H ' HD21 ' A' ' 104' ' ' LEU . 85.5 tttt -61.52 140.9 58.03 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -75.62 159.47 31.16 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.786 0.327 . . . . 0.0 110.828 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.9 t -66.37 158.49 29.12 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.544 0.338 . . . . 0.0 110.236 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -16.41 63.81 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 122.388 -0.195 . . . . 0.0 111.277 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -85.43 -16.3 40.17 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.61 0.364 . . . . 0.0 111.002 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -86.94 -10.88 52.18 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.9 t -88.76 -17.98 28.71 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.028 0.531 . . . . 0.0 110.784 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.86 151.63 96.24 Favored Pre-proline 0 C--O 1.233 0.227 0 C-N-CA 123.192 0.597 . . . . 0.0 111.214 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.24 -14.01 20.75 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.866 3.044 . . . . 0.0 111.219 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.9 m95 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.993 -179.717 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.186 0 C5'-C4'-C3' 109.694 -3.871 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 O4'-C1'-N19 110.779 2.579 . 0.046 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 C5'-C4'-C3' 109.676 -3.882 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 2 O4'-C1'-N19 112.994 4.794 . 0.517 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . 0.463 ' N3 ' ' HE2' ' A' ' 59' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.119 2 C5'-C4'-C3' 109.054 -4.297 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.273 0.082 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.99 8.74 86.91 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.942 -0.365 . . . . 0.0 112.373 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -72.51 -4.8 32.69 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.603 0.761 . . . . 0.0 112.425 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.5 p -155.85 167.57 30.0 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.299 0.64 . . . . 0.0 110.188 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -69.03 162.64 26.44 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 122.954 0.501 . . . . 0.0 110.971 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -70.91 164.17 25.94 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.061 0.458 . . . . 0.0 111.059 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -66.65 157.27 32.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.839 0.456 . . . . 0.0 111.101 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -80.6 -5.58 57.06 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.807 0.443 . . . . 0.0 111.394 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -77.86 12.63 1.65 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.434 0.694 . . . . 0.0 112.005 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -66.23 168.1 9.19 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.261 0.625 . . . . 0.0 111.207 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.3 t 56.54 25.81 10.25 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.983 0.913 . . . . 0.0 112.21 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.4 p -70.96 -11.15 60.81 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.074 0.549 . . . . 0.0 111.635 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.37 4.14 73.23 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.889 -0.395 . . . . 0.0 112.375 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.83 143.47 57.45 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.656 0.728 . . . . 0.0 110.52 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -155.5 143.01 13.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.96 -20.78 54.87 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.562 2.841 . . . . 0.0 114.181 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.18 151.72 19.75 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 122.722 0.409 . . . . 0.0 110.486 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.92 16.34 0.92 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 t -153.1 -167.28 2.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.94 0.896 . . . . 0.0 108.859 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -68.34 -2.65 8.84 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.78 -0.575 . . . . 0.0 111.817 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.1 ptp -65.77 171.08 4.57 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.705 0.802 . . . . 0.0 110.38 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.7 152.46 37.84 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.666 0.386 . . . . 0.0 110.872 -177.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -141.01 140.63 34.35 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -101.69 154.19 19.1 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.76 -156.3 20.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.08 175.94 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.94 3.094 . . . . 0.0 110.48 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.44 139.83 58.81 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.87 0.06 88.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.79 -0.45 . . . . 0.0 112.733 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.72 14.76 30.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.613 0.706 . . . . 0.0 112.893 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -119.14 138.62 52.79 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 118.427 0.558 . . . . 0.0 110.588 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.1 mt -125.42 156.88 38.15 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -117.1 141.42 48.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.844 1.658 . . . . 0.0 113.806 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.38 140.73 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.402 ' CD1' ' HD2' ' A' ' 101' ' ' LYS . 12.2 m-85 -144.93 176.57 9.38 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.45 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 16.6 m170 63.97 16.74 10.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.901 1.68 . . . . 0.0 112.984 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.06 141.5 94.28 Favored Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.45 163.03 39.78 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.988 2.459 . . . . 0.0 109.524 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.72 -7.62 49.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -78.56 -10.56 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.091 -0.381 . . . . 0.0 111.134 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.99 158.5 35.34 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.8 174.92 35.17 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -56.82 -38.98 73.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -75.7 -33.21 60.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.784 0.433 . . . . 0.0 111.255 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -71.55 -38.73 70.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 tt -76.52 -24.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.91 -53.62 43.56 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -69.66 -23.37 63.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 tpp -71.58 -27.9 63.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 18.6 m-85 -102.3 -10.08 19.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.404 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 46.2 mtm -65.83 -32.28 5.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.1 Cg_endo -72.33 -8.15 22.18 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.692 1.64 . . . . 0.0 111.894 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.34 -14.18 36.24 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.663 0.385 . . . . 0.0 111.342 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.92 -171.92 31.96 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -77.77 103.09 7.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.39 -0.477 . . . . 0.0 110.373 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -81.66 124.24 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.56 -37.45 16.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -158.44 157.1 31.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.478 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.46 146.82 23.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.84 144.0 16.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.692 0.397 . . . . 0.0 111.143 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.25 139.74 38.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 172.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -75.53 146.69 40.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -132.85 143.65 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 123.246 0.619 . . . . 0.0 110.303 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -90.56 131.7 36.14 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.5 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.38 -9.39 59.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.9 -0.5 . . . . 0.0 111.536 -179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -88.77 -22.26 23.38 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.92 -12.72 1.69 Allowed 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 62.29 7.37 2.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.415 1.086 . . . . 0.0 112.815 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.46 161.07 22.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 t -70.71 142.06 51.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.925 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.13 8.76 4.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.4 m 62.4 26.19 15.62 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.5 165.99 34.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.0 -179.54 27.71 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 121.548 0.527 . . . . 0.0 113.543 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.29 139.72 37.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.163 1.785 . . . . 0.0 113.987 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.35 152.97 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 123.628 0.771 . . . . 0.0 109.669 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.0 t -141.35 143.51 34.05 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.54 0.336 . . . . 0.0 111.898 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -111.88 159.83 17.98 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -75.91 -13.45 60.26 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.68 150.47 23.2 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.545 0.738 . . . . 0.0 110.756 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.9 -22.11 31.92 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.256 2.637 . . . . 0.0 112.465 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.3 -38.91 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 118.336 0.516 . . . . 0.0 111.704 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.7 m -74.3 -25.74 59.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.132 0.173 . . . . 0.0 110.631 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.78 -46.79 43.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -66.81 -30.43 70.62 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 122.271 -0.268 . . . . 0.0 110.737 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.29 80.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -26.75 65.59 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.14 -51.82 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -67.56 -12.09 59.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.31 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.74 -28.82 17.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.1 mmm -120.4 -17.3 8.21 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.88 133.07 51.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.55 2.19 87.55 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.894 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.41 119.05 10.29 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.57 1.185 . . . . 0.0 110.168 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -78.68 126.94 31.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.036 -0.415 . . . . 0.0 111.378 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.7 tt -155.91 135.14 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.307 0.643 . . . . 0.0 109.743 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.12 32.25 75.49 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.416 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm 63.03 24.52 14.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.066 0.947 . . . . 0.0 113.381 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.45 ' HE2' ' CG ' ' A' ' 35' ' ' HIS . 85.2 tttt -144.99 151.48 38.65 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -96.31 134.09 39.87 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.0 mt -64.52 125.94 26.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.22 0.208 . . . . 0.0 110.789 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.402 ' HD2' ' CD1' ' A' ' 34' ' ' TYR . 17.0 ttmm -87.93 139.19 30.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.82 139.48 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -149.21 156.52 42.28 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.743 0.306 . . . . 0.0 111.265 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -74.2 147.99 42.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.814 0.445 . . . . 0.0 109.952 176.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.466 ' H ' HD23 ' A' ' 104' ' ' LEU . 84.6 tttt -61.97 157.05 19.53 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.963 0.505 . . . . 0.0 110.785 175.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.425 ' HG2' ' H3 ' ' B' ' 117' ' ' ' U' . 11.2 ptp180 -141.12 160.51 39.94 Favored 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 124.215 1.006 . . . . 0.0 109.118 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 t -62.88 153.09 34.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.2 -19.91 63.14 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.261 -0.275 . . . . 0.0 110.61 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -80.65 -15.98 55.19 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.599 0.359 . . . . 0.0 110.55 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -102.21 -4.91 25.01 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -91.76 -2.35 56.99 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.944 0.497 . . . . 0.0 111.359 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -138.08 152.03 71.08 Favored Pre-proline 0 CA--C 1.529 0.161 0 C-N-CA 123.189 0.596 . . . . 0.0 110.767 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.93 -15.52 20.88 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.691 2.927 . . . . 0.0 111.142 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.9 m95 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.173 -1.394 . . . . 0.0 111.624 -179.926 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.46 0 C5'-C4'-C3' 109.686 -3.876 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.484 0 O4'-C1'-N19 110.869 2.669 . 0.166 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' ' U' . . . . . 0.425 ' H3 ' ' HG2' ' A' ' 106' ' ' ARG . . . . . . . . 0 O4'--C4' 1.417 -3.041 0 C5'-C4'-C3' 110.469 -3.354 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' ' A' . . . . . 0.462 H5'' ' C8 ' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.997 2 O4'-C1'-N19 113.379 5.179 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.443 1 C5'-C4'-C3' 109.305 -4.13 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 121.199 0.523 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.12 -154.6 31.04 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.63 174.13 11.5 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.862 3.041 . . . . 0.0 110.574 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.02 139.67 58.4 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 122.238 -0.289 . . . . 0.0 110.615 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.9 -3.65 84.98 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.631 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.28 -1.46 53.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.786 0.793 . . . . 0.0 112.785 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -92.52 151.45 20.17 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.704 0.402 . . . . 0.0 110.596 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.436 HD13 ' HB1' ' A' ' 83' ' ' ALA . 1.4 tp -142.63 152.6 42.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.911 0.862 . . . . 0.0 113.213 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.45 145.93 47.43 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 126.516 1.926 . . . . 0.0 114.631 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.17 133.65 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.29 177.17 8.07 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 m170 65.67 16.11 10.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.572 1.549 . . . . 0.0 112.309 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.12 141.94 89.61 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 122.725 0.41 . . . . 0.0 110.524 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.55 164.46 35.53 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.757 2.305 . . . . 0.0 109.621 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -71.3 -8.12 51.55 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -77.31 -10.73 59.61 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.254 0.479 . . . . 0.0 111.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -72.58 158.16 36.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.73 175.98 34.91 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -56.88 -42.29 79.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -77.76 -27.82 50.46 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.656 0.382 . . . . 0.0 111.63 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -76.22 -37.92 57.1 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 tt -75.7 -25.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.8 tp -66.7 -51.75 52.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -65.16 -23.1 67.02 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.22 0.208 . . . . 0.0 111.501 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -76.4 -27.82 56.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.415 -0.178 . . . . 0.0 110.902 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.274 24.8 m-85 -105.37 -11.02 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 118.035 2.605 . . . . 0.0 118.035 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.465 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.1 mtm -66.75 -29.68 2.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.8 Cg_endo -72.5 -9.6 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.096 1.784 . . . . 0.0 112.216 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -86.61 -14.46 42.71 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.847 0.459 . . . . 0.0 111.453 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.64 -174.76 32.93 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -78.14 102.49 7.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.222 -0.575 . . . . 0.0 110.457 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -81.35 122.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.5 mt -81.89 -32.4 11.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 t -155.01 152.31 29.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.734 0.302 . . . . 0.0 110.777 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.58 143.06 21.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.735 0.814 . . . . 0.0 109.304 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HE3' ' CZ ' ' A' ' 61' ' ' PHE . 5.1 tmmm? -159.07 143.61 15.6 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 122.885 0.474 . . . . 0.0 110.896 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.63 137.15 43.14 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 169.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CZ ' ' HE3' ' A' ' 59' ' ' LYS . 74.4 m-85 -71.55 144.31 49.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mm -133.32 144.31 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 122.7 0.4 . . . . 0.0 110.195 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -89.06 130.93 35.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.9 -11.34 59.8 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.803 -0.561 . . . . 0.0 111.671 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -90.58 -22.6 21.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.07 -13.38 1.87 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 61.39 9.34 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.561 1.144 . . . . 0.0 113.091 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -80.41 157.91 26.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 t -69.48 139.52 53.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.593 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.29 7.95 10.23 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.0 m 62.7 24.61 14.65 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.09 169.02 25.49 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.4 -177.67 29.79 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 121.627 0.571 . . . . 0.0 113.233 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -136.67 140.12 42.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.997 1.719 . . . . 0.0 114.177 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -144.22 156.05 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.648 0.779 . . . . 0.0 109.167 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.2 t -147.77 144.54 28.31 Favored 'General case' 0 C--N 1.339 0.151 0 O-C-N 121.901 -0.499 . . . . 0.0 112.022 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.18 165.74 11.88 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -82.27 -9.65 59.41 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -153.97 150.44 22.73 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.24 0.616 . . . . 0.0 111.141 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.29 -21.78 30.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.04 -38.86 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 O-C-N 121.95 -0.469 . . . . 0.0 111.727 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -75.93 -25.89 56.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.207 0.203 . . . . 0.0 110.703 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -72.61 -50.82 22.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -68.06 -28.36 67.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.469 -0.144 . . . . 0.0 110.659 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.08 82.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.9 -25.9 66.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.842 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mt -67.18 -51.18 56.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -69.34 -11.89 61.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.57 -28.24 16.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.4 mmm -120.51 -15.71 8.46 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -67.75 136.96 55.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 2.72 73.61 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.138 -0.812 . . . . 0.0 112.91 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.73 117.3 7.28 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.673 1.237 . . . . 0.0 110.429 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.08 129.28 37.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.471 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 tt -146.73 123.9 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.91 -144.75 48.38 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.9 mtm -83.64 13.01 4.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.975 0.91 . . . . 0.0 112.818 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.61 173.43 11.6 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.253 0.621 . . . . 0.0 112.011 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -119.72 137.09 54.14 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.846 0.858 . . . . 0.0 109.051 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.09 135.51 56.45 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -99.32 138.64 36.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.77 139.15 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.482 0.313 . . . . 0.0 110.165 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -154.28 163.62 39.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.676 0.216 . . . . 0.0 111.46 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -73.84 154.14 39.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.244 0.618 . . . . 0.0 110.418 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.5 ' H ' HD23 ' A' ' 104' ' ' LEU . 27.7 ttpp . . . . . 0 C--O 1.232 0.149 0 C-N-CA 123.459 0.704 . . . . 0.0 110.269 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.79 0.328 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.73 -157.75 30.4 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.95 177.64 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.644 2.896 . . . . 0.0 110.336 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.35 141.99 58.56 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.114 -0.366 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.13 0.68 77.7 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.76 -0.466 . . . . 0.0 112.703 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.03 31.57 4.46 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.664 0.732 . . . . 0.0 112.268 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -138.85 139.48 38.16 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 122.102 -0.374 . . . . 0.0 111.439 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.6 mt -127.01 154.9 44.04 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -114.23 144.08 43.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.959 1.704 . . . . 0.0 114.173 171.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.49 135.85 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 72' ' ' PHE . 14.8 m-85 -139.2 176.85 8.35 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.9 m170 64.87 13.79 8.78 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.23 1.412 . . . . 0.0 112.952 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.61 146.7 98.2 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.17 163.08 40.4 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.352 2.035 . . . . 0.0 109.438 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -68.86 -16.69 63.84 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -172.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -74.9 -11.43 60.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -68.86 158.33 34.71 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.0 178.14 33.54 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -57.03 -42.3 80.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -77.45 -26.0 51.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 66.9 m-20 -73.51 -41.11 63.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -74.09 -25.75 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 46' ' ' LEU . 1.9 tm? -64.81 -49.9 68.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -65.36 -25.68 67.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.7 mmm -76.29 -24.15 54.41 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.285 19.5 m-85 -105.07 -9.82 17.57 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.448 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -66.17 -33.43 6.86 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.0 Cg_endo -74.13 -8.48 21.06 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.738 1.656 . . . . 0.0 112.075 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -87.75 -14.9 38.49 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.582 0.353 . . . . 0.0 111.494 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.37 32.86 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -77.6 101.14 6.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.306 -0.526 . . . . 0.0 110.561 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -77.58 118.75 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.33 -35.78 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -158.51 157.14 31.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.814 0.34 . . . . 0.0 110.507 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.19 140.88 15.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.72 133.74 8.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.594 0.235 . . . . 0.0 111.341 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.5 t -93.25 143.26 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.442 ' CD2' ' CZ ' ' A' ' 72' ' ' PHE . 4.9 m-85 -73.08 148.5 43.98 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.7 mm -132.49 144.77 35.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 122.842 0.457 . . . . 0.0 110.203 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.22 131.17 37.66 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.33 -12.41 60.26 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 121.741 -0.599 . . . . 0.0 111.393 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -88.37 -23.79 23.28 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.404 0.682 . . . . 0.0 112.692 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -132.93 -14.14 2.75 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.9 t30 62.05 8.66 2.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.927 1.291 . . . . 0.0 112.094 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.17 164.48 18.09 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.932 0.493 . . . . 0.0 110.186 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.6 t -68.28 140.02 55.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.364 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -81.06 8.47 8.5 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.704 0.402 . . . . 0.0 111.891 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.1 m 63.07 21.32 12.82 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.442 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 4.0 p90 -155.52 167.12 31.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.0 -172.0 28.84 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 121.496 0.498 . . . . 0.0 114.035 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -136.6 145.48 44.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.411 1.884 . . . . 0.0 114.996 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -145.77 152.69 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.314 1.045 . . . . 0.0 109.283 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.3 p -142.79 149.72 39.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.391 0.541 . . . . 0.0 112.193 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.18 165.59 13.61 Favored 'General case' 0 N--CA 1.458 -0.054 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -80.89 -10.52 59.71 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -153.87 150.31 22.61 Favored Pre-proline 0 N--CA 1.453 -0.291 0 C-N-CA 123.287 0.635 . . . . 0.0 110.88 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.57 -20.95 40.42 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.437 2.758 . . . . 0.0 112.14 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.41 -39.04 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 O-C-N 121.801 -0.562 . . . . 0.0 111.611 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -74.88 -26.22 59.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.65 -48.54 25.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 122.449 -0.157 . . . . 0.0 110.624 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -65.92 -29.71 70.17 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.062 -0.399 . . . . 0.0 111.046 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.59 77.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.76 -26.71 64.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 119.567 -0.254 . . . . 0.0 111.662 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.69 -51.89 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.95 -11.89 59.68 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.71 -28.95 17.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.46 -14.74 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -67.45 136.19 54.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.85 1.53 84.51 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.862 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -66.01 118.95 10.52 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.772 1.286 . . . . 0.0 109.785 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.66 125.55 29.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.954 0.343 . . . . 0.0 111.55 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.0 tt -157.63 135.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.228 0.611 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.32 82.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.403 -0.81 . . . . 0.0 112.194 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 22.4 mmt 63.06 23.34 13.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.276 1.03 . . . . 0.0 113.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -145.35 155.51 43.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -97.81 132.73 43.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.79 -0.569 . . . . 0.0 110.481 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.44 128.34 36.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.24 0.216 . . . . 0.0 111.08 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -90.73 136.08 33.3 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.34 136.95 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -152.71 160.7 43.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 117.972 0.351 . . . . 0.0 111.916 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.15 156.28 38.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.069 0.548 . . . . 0.0 110.42 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.8 tttp . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.454 0.645 . . . . 0.0 112.401 178.78 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.444 0.64 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.75 -156.43 31.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.578 1.085 . . . . 0.0 113.117 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.19 -178.43 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.609 3.539 . . . . 0.0 111.542 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -57.86 130.21 45.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.268 0.627 . . . . 0.0 111.305 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.82 -2.0 70.84 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.498 0.57 . . . . 0.0 113.19 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.76 36.59 0.9 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.714 0.757 . . . . 0.0 111.871 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 140.23 33.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.966 -0.458 . . . . 0.0 111.371 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.18 162.09 26.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 19.7 m-85 -119.72 143.57 47.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 114.917 173.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.16 124.69 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 13.1 m-85 -128.77 179.71 5.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.8 m170 63.25 16.2 9.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.014 1.326 . . . . 0.0 112.836 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.9 142.33 93.34 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 118.144 0.429 . . . . 0.0 109.968 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.61 163.64 36.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.137 2.558 . . . . 0.0 109.722 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -68.81 -17.47 64.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -74.32 -10.29 59.44 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.038 -0.414 . . . . 0.0 112.046 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.03 158.14 36.51 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.9 176.59 33.34 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -56.84 -38.79 73.15 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.656 0.383 . . . . 0.0 110.642 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.04 -42.34 73.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.46 -26.11 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.464 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.0 tm? -64.86 -50.5 66.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -69.82 -23.11 63.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.7 -26.76 62.63 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.158 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 28.1 m-85 -104.23 -8.36 19.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 118.108 2.632 . . . . 0.0 118.108 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.44 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -67.33 -32.47 4.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.1 Cg_endo -73.38 -8.33 21.67 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.87 1.703 . . . . 0.0 112.164 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -89.9 -14.34 34.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.053 0.541 . . . . 0.0 111.283 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.02 -175.6 33.72 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -78.28 103.76 8.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.24 -0.565 . . . . 0.0 110.697 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.52 120.78 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.8 mt -84.02 -34.01 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.2 t -152.39 150.89 30.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 111.277 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.69 142.38 16.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.509 0.724 . . . . 0.0 109.209 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.614 ' HE3' ' CE1' ' A' ' 61' ' ' PHE . 3.0 tmmm? -159.87 134.49 7.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.679 0.392 . . . . 0.0 110.592 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.68 136.97 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.614 ' CE1' ' HE3' ' A' ' 59' ' ' LYS . 78.1 m-85 -69.15 150.0 48.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.12 143.27 41.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 122.77 0.428 . . . . 0.0 110.098 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.34 129.41 35.02 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -74.87 -12.48 60.38 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.949 -0.469 . . . . 0.0 111.541 -179.195 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -89.7 -23.23 21.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -134.71 -13.65 2.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 61.58 11.09 3.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.08 158.69 24.97 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 122.029 -0.42 . . . . 0.0 110.062 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -72.31 135.3 45.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.008 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -81.52 166.84 19.93 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.053 0.454 . . . . 0.0 111.135 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.7 m -79.19 12.05 2.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -157.01 170.82 21.67 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.05 -174.43 25.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.822 0.725 . . . . 0.0 112.447 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -138.62 145.15 40.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.94 152.95 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.24 1.016 . . . . 0.0 110.157 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -147.32 147.8 30.72 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.75 166.56 10.92 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -79.15 -8.56 59.1 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -153.06 150.8 24.85 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 123.221 0.609 . . . . 0.0 110.902 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -71.67 -16.16 30.17 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.142 2.561 . . . . 0.0 111.656 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.17 -46.8 92.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 118.383 0.538 . . . . 0.0 110.845 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -70.01 -24.6 63.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.841 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.36 -47.18 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.916 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -67.07 -29.7 69.54 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.159 -0.338 . . . . 0.0 110.758 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 -41.52 80.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.43 65.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -66.01 -52.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.79 -12.14 57.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.119 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.46 -31.5 17.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.7 mtp -124.64 -9.06 7.36 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.87 128.04 34.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.8 90.25 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.572 -0.571 . . . . 0.0 112.617 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -62.25 120.03 10.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.447 1.123 . . . . 0.0 111.295 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -76.0 129.77 37.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.981 -0.45 . . . . 0.0 111.516 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.78 122.42 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.03 -143.63 48.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -87.34 16.64 5.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.57 0.748 . . . . 0.0 112.767 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -144.67 172.67 12.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.366 0.53 . . . . 0.0 109.968 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -117.66 143.89 45.74 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.181 0.592 . . . . 0.0 110.372 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.85 133.04 48.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.787 0.435 . . . . 0.0 111.151 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -92.72 136.55 33.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.9 t -134.76 140.46 45.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -155.06 164.35 39.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.366 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.86 153.49 41.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.68 0.792 . . . . 0.0 110.188 175.227 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.527 ' H ' HD23 ' A' ' 104' ' ' LEU . 85.1 tttt . . . . . 0 CA--C 1.534 0.33 0 C-N-CA 123.316 0.646 . . . . 0.0 109.599 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.31 -165.5 35.07 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.85 167.56 19.24 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.402 2.735 . . . . 0.0 109.39 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -64.28 138.73 58.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.963 -0.46 . . . . 0.0 110.122 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.72 86.37 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.723 -0.487 . . . . 0.0 112.179 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.06 21.24 16.1 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.463 0.705 . . . . 0.0 112.233 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -125.31 137.52 54.07 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.38 161.86 22.66 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 122.19 0.995 . . . . 0.0 113.653 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -119.08 143.96 46.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.852 1.661 . . . . 0.0 114.555 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.81 129.47 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -134.99 178.89 6.67 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.7 m170 63.96 17.14 10.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.374 1.469 . . . . 0.0 113.293 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.88 142.8 95.88 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 122.767 0.427 . . . . 0.0 110.444 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.96 171.89 17.3 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.792 2.995 . . . . 0.0 110.97 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -68.98 -21.37 64.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.959 0.904 . . . . 0.0 112.448 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -75.63 -6.61 51.24 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.72 158.13 28.38 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.32 175.08 34.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -61.92 -36.64 81.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -75.2 -31.42 60.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.377 0.271 . . . . 0.0 110.726 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -73.34 -38.24 65.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -76.21 -24.77 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.5 tm? -66.83 -53.0 37.02 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -66.11 -23.52 66.51 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.447 0.166 . . . . 0.0 111.447 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.3 tpp -75.77 -29.43 58.79 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.68 0.392 . . . . 0.0 110.828 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.308 24.6 m-85 -102.11 -8.77 21.12 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.46 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 43.7 mtm -66.36 -30.83 3.81 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.2 Cg_endo -72.28 -10.39 25.62 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.88 1.707 . . . . 0.0 111.789 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -86.2 -14.99 42.31 Favored 'General case' 0 C--N 1.338 0.073 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.14 -171.48 32.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -76.59 103.61 6.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.433 -0.451 . . . . 0.0 110.727 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.51 122.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.3 mt -82.62 -33.54 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -156.42 156.34 33.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.022 0.439 . . . . 0.0 110.399 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.37 149.25 25.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -159.68 141.23 12.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.0 111.403 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 t -115.05 128.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -71.69 157.34 38.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mm -126.32 140.47 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.052 0 C-N-CA 122.493 0.317 . . . . 0.0 110.499 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -87.36 131.28 34.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -75.26 -12.95 60.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.92 0.488 . . . . 0.0 111.5 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -89.72 -21.94 22.45 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.13 -14.43 1.79 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 61.67 8.8 2.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 112.711 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.36 162.21 23.49 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.77 0.428 . . . . 0.0 110.151 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -69.47 136.47 51.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.737 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -76.27 164.18 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.4 m -77.32 10.05 2.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -156.86 172.05 19.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.46 -165.57 19.71 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.367 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -141.41 144.37 34.43 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -147.0 151.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.751 0.82 . . . . 0.0 109.303 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 94.8 p -141.8 149.27 40.16 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -116.83 159.9 21.66 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -77.26 -13.38 59.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.148 0.499 . . . . 0.0 112.012 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -155.13 149.57 19.78 Favored Pre-proline 0 N--CA 1.456 -0.158 0 C-N-CA 123.223 0.609 . . . . 0.0 110.965 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.11 -21.68 42.25 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.644 2.896 . . . . 0.0 111.94 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.69 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 118.534 0.606 . . . . 0.0 111.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -76.1 -25.56 55.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.286 0.235 . . . . 0.0 110.769 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.32 -48.16 30.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -66.46 -28.42 68.58 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.764 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.89 76.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.13 66.15 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.35 -53.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.48 -11.51 58.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.458 0.303 . . . . 0.0 111.163 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.61 -31.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 119.019 -0.515 . . . . 0.0 112.375 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.4 mtp -128.73 -9.04 5.02 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -61.64 125.11 22.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.27 6.14 89.0 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.824 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.04 119.76 10.73 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.681 1.24 . . . . 0.0 112.333 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -76.92 130.06 37.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.976 0.353 . . . . 0.0 110.963 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -145.09 136.03 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.22 -100.41 0.35 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.1 ptp -139.78 17.21 2.5 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.045 0.938 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -148.02 152.77 37.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.825 0.45 . . . . 0.0 110.181 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -93.36 139.52 30.58 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 122.138 -0.351 . . . . 0.0 111.008 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 89.9 mt -68.49 131.16 44.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.709 0.404 . . . . 0.0 110.987 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -90.82 135.67 33.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.32 136.7 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -152.67 159.81 43.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.651 0.262 . . . . 0.0 111.417 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -75.75 152.31 37.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.254 0.622 . . . . 0.0 109.658 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.522 ' H ' HD23 ' A' ' 104' ' ' LEU . 26.4 ttpp . . . . . 0 C--O 1.234 0.258 0 C-N-CA 123.239 0.616 . . . . 0.0 109.859 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.53 -173.7 49.13 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.39 0.519 . . . . 0.0 111.966 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.97 165.68 29.21 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.765 2.977 . . . . 0.0 109.877 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.08 131.26 47.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.4 -9.98 69.31 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.41 5.42 51.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.561 0.68 . . . . 0.0 110.969 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -95.52 142.08 28.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.27 159.88 35.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.719 0.771 . . . . 0.0 112.607 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.3 m-85 -122.6 145.89 47.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.824 1.65 . . . . 0.0 114.847 173.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.4 137.46 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.2 m-85 -140.65 179.46 6.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.458 ' CG ' ' HE3' ' A' ' 98' ' ' LYS . 20.1 m170 62.96 17.28 9.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.513 1.125 . . . . 0.0 112.924 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.42 142.51 92.18 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.055 0.388 . . . . 0.0 110.165 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.15 168.14 25.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.169 2.58 . . . . 0.0 109.959 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.05 -16.93 62.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -76.79 -9.67 58.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -72.62 158.08 36.34 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.1 171.73 33.36 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -59.86 -36.02 76.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -74.32 -29.42 61.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.887 0.475 . . . . 0.0 110.924 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -76.49 -42.42 43.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -71.29 -24.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.05 -49.72 73.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -64.9 -24.59 67.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.441 0.296 . . . . 0.0 111.712 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.2 mmm -76.19 -24.2 54.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.385 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 28.7 m-85 -107.32 -12.14 15.41 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.5 mtm -66.71 -31.15 3.83 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.6 Cg_endo -72.44 -10.65 25.72 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 121.986 1.745 . . . . 0.0 112.091 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -87.6 -14.07 41.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.744 0.418 . . . . 0.0 111.807 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.82 -174.74 33.06 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -75.62 106.52 7.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.343 -0.504 . . . . 0.0 110.382 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.4 122.34 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.411 HD11 ' HA ' ' A' ' 78' ' ' ASP . 28.6 mt -87.42 -27.83 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 t -149.8 146.73 27.32 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.915 0.388 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 143.38 24.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.166 0.986 . . . . 0.0 108.534 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.53 142.52 15.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.39 0.276 . . . . 0.0 111.565 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -118.5 131.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 169.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -75.26 146.63 40.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -133.77 145.69 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.174 0.589 . . . . 0.0 110.094 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -85.45 129.09 34.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.524 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.92 -11.29 59.94 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.836 -0.54 . . . . 0.0 111.945 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -90.65 -21.81 21.49 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 -11.41 1.46 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.99 10.53 2.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.581 1.152 . . . . 0.0 112.903 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.96 159.97 23.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.118 0.485 . . . . 0.0 110.006 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -70.07 142.71 52.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.807 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -84.29 -0.8 53.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.679 0.792 . . . . 0.0 111.206 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.2 m 61.34 19.44 10.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.94 170.41 22.19 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.39 -168.12 24.88 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 121.368 0.427 . . . . 0.0 113.568 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -140.92 144.19 35.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.968 1.707 . . . . 0.0 114.967 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.1 t -147.39 154.22 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -148.7 145.72 27.8 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.323 0.511 . . . . 0.0 112.107 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.91 162.08 13.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' HD11 ' A' ' 56' ' ' ILE . 36.0 t0 -77.18 -11.13 59.78 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 174.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -154.54 146.8 17.39 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 123.128 0.571 . . . . 0.0 110.61 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.18 -21.83 41.6 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.361 2.707 . . . . 0.0 112.626 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.4 p -63.59 -39.18 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 O-C-N 121.885 -0.51 . . . . 0.0 111.509 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -74.17 -24.55 59.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.103 0.161 . . . . 0.0 110.926 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.69 -48.0 35.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 121.395 -0.122 . . . . 0.0 110.683 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -67.15 -29.62 69.38 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.408 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.01 82.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.74 67.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.82 -52.79 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -68.39 -11.01 59.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.383 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.01 -31.56 18.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.2 mtp -123.88 -12.31 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.26 126.75 28.41 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.53 5.17 87.11 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.779 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.07 116.73 7.48 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.813 1.306 . . . . 0.0 110.039 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.67 131.12 40.62 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -144.79 121.61 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.77 -137.52 48.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -86.99 4.8 40.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HE3' ' CG ' ' A' ' 35' ' ' HIS . 29.4 ttpt -147.45 161.75 40.43 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 111.34 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -97.39 144.56 27.01 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.738 0.415 . . . . 0.0 110.671 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.4 126.69 30.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.358 0.263 . . . . 0.0 110.843 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -89.57 139.17 30.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.45 138.66 50.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -150.8 162.39 40.83 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -81.94 147.91 29.0 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.99 -0.444 . . . . 0.0 110.326 175.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.48 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.2 tttt . . . . . 0 CA--C 1.531 0.241 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.951 0.405 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.01 -154.64 29.98 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.07 177.33 5.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.944 3.096 . . . . 0.0 110.52 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.97 137.43 58.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.632 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.24 -1.84 86.1 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.346 0.498 . . . . 0.0 112.561 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.28 36.62 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.757 . . . . 0.0 111.617 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.21 140.48 29.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 111.324 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.1 mt -128.28 152.82 47.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 27.7 m-85 -108.5 140.84 41.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 113.939 169.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.18 123.55 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 23.3 m-85 -126.54 178.04 6.13 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.9 m170 66.1 15.29 10.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.949 1.7 . . . . 0.0 113.091 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.63 137.11 88.11 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.594 0.358 . . . . 0.0 110.183 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.35 173.28 14.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.465 2.777 . . . . 0.0 111.272 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -65.41 -20.81 66.53 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -74.33 -6.92 50.85 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -78.55 158.08 28.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.03 174.98 36.88 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -59.72 -39.1 83.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.009 0.524 . . . . 0.0 110.671 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -75.65 -38.97 58.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -74.03 -25.31 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.06 -52.05 52.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -64.5 -22.82 67.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.359 0.264 . . . . 0.0 111.634 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.6 tpp -76.82 -28.21 55.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.091 0.156 . . . . 0.0 110.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.275 25.0 m-85 -104.88 -11.47 16.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.48 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.2 mtm -66.84 -30.99 3.6 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.5 Cg_endo -72.85 -10.36 24.75 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 121.822 1.686 . . . . 0.0 112.18 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.33 -15.77 39.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.691 0.397 . . . . 0.0 112.033 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.36 -173.31 34.21 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -77.96 102.53 7.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.389 -0.477 . . . . 0.0 110.47 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -81.59 124.13 38.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.58 -30.2 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -154.02 148.5 26.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.671 0.389 . . . . 0.0 110.506 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.1 138.6 17.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HE3' ' CZ ' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.01 145.15 18.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.353 0.261 . . . . 0.0 111.133 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.8 t -111.02 135.5 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CZ ' ' HE3' ' A' ' 59' ' ' LYS . 83.8 m-85 -65.95 150.88 47.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.21 142.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.922 0.489 . . . . 0.0 110.442 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -88.21 131.55 34.7 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -74.96 -12.3 60.31 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.618 0.367 . . . . 0.0 111.756 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -90.41 -21.99 21.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.06 -14.92 1.77 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 61.78 9.39 2.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.326 1.051 . . . . 0.0 112.802 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.59 160.76 23.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.853 0.359 . . . . 0.0 110.366 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.4 m -68.33 135.54 52.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.34 0.256 . . . . 0.0 110.826 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -78.61 168.09 20.28 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -76.72 15.11 0.69 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.13 172.11 18.05 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.55 -173.11 23.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.298 0.951 . . . . 0.0 112.58 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -142.01 142.63 32.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.725 1.61 . . . . 0.0 114.978 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -145.66 153.53 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.881 0.872 . . . . 0.0 110.368 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.8 t -147.2 146.47 29.84 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.747 -0.595 . . . . 0.0 112.584 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -111.73 168.68 9.37 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -81.68 -9.74 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -152.43 151.38 27.12 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 123.434 0.693 . . . . 0.0 111.061 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -71.59 -18.38 29.14 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.069 2.513 . . . . 0.0 111.52 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.2 t -63.28 -45.9 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 118.39 0.541 . . . . 0.0 111.135 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 m -70.81 -26.55 63.35 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.1 -47.28 52.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.92 -28.21 68.11 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.077 0.399 . . . . 0.0 111.094 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.64 -42.0 78.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.25 65.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.4 mt -66.43 -51.04 62.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.05 -11.81 61.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.62 -28.09 19.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 13.0 ttm -120.6 -23.25 6.11 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.95 126.39 27.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.48 88.01 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.771 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -64.42 121.08 13.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.162 1.481 . . . . 0.0 110.927 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -76.93 124.37 27.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.621 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -161.06 136.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.816 0.846 . . . . 0.0 109.762 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.87 39.4 97.34 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.668 -0.645 . . . . 0.0 112.8 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.4 mtt 62.06 16.16 7.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.901 0.88 . . . . 0.0 113.229 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -141.45 179.47 6.78 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.895 1.278 . . . . 0.0 109.297 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -118.07 138.13 52.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.23 0.212 . . . . 0.0 110.503 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.02 129.44 40.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -92.23 136.17 33.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.36 139.71 49.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -155.37 158.69 39.08 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.737 0.303 . . . . 0.0 111.545 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.7 155.23 37.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.346 0.658 . . . . 0.0 111.12 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.455 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.9 tttt . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 123.959 0.903 . . . . 0.0 109.772 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.879 0.371 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.67 -167.87 42.8 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.06 172.83 11.28 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.922 3.082 . . . . 0.0 110.854 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -63.53 138.74 58.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.095 -0.378 . . . . 0.0 111.04 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.81 -0.73 89.36 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.392 -0.367 . . . . 0.0 112.384 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.01 31.96 4.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.821 0.849 . . . . 0.0 111.544 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.06 140.55 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.179 -0.326 . . . . 0.0 111.168 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.7 mt -125.8 159.0 33.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.978 0.894 . . . . 0.0 113.153 -171.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -118.13 144.7 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.974 1.709 . . . . 0.0 114.443 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.86 136.57 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.16 179.93 6.47 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.4 m170 63.38 14.88 8.27 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.252 1.421 . . . . 0.0 112.911 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.05 143.32 96.02 Favored Pre-proline 0 N--CA 1.457 -0.121 0 CA-C-N 117.977 0.353 . . . . 0.0 110.132 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.44 168.0 24.77 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.952 2.435 . . . . 0.0 109.892 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -67.79 -17.82 64.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.019 0.527 . . . . 0.0 111.93 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -77.2 -10.22 59.27 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -70.05 158.01 36.48 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 175.95 35.14 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.76 -36.11 73.84 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.263 0.531 . . . . 0.0 110.629 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -80.26 -32.92 38.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 110.908 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -73.22 -38.43 66.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 tt -76.05 -25.17 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -66.08 -52.79 45.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -68.5 -22.27 64.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -72.86 -26.6 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 21.5 m-85 -106.12 -12.81 15.63 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.465 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 48.2 mtm -66.92 -29.8 2.86 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.3 Cg_endo -72.96 -8.97 23.09 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.211 1.825 . . . . 0.0 112.111 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -86.87 -15.02 40.33 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.952 0.342 . . . . 0.0 111.778 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.95 -172.65 32.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -76.16 102.68 5.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 117.107 0.453 . . . . 0.0 109.904 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.63 126.91 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.3 mt -85.92 -30.67 6.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 122.884 0.474 . . . . 0.0 110.671 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -159.5 157.41 29.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.35 0.26 . . . . 0.0 110.694 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.16 142.95 25.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -157.81 134.51 9.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.894 0.478 . . . . 0.0 110.98 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.22 131.89 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -75.02 149.24 39.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.032 0.533 . . . . 0.0 109.711 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -90.23 138.65 31.35 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.62 -10.08 59.61 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.275 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -92.28 -22.96 19.46 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -13.23 2.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 t30 62.12 8.11 2.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.674 1.19 . . . . 0.0 111.875 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.02 162.16 19.45 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.891 0.476 . . . . 0.0 109.826 174.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -66.47 140.41 58.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.35 -0.219 . . . . 0.0 111.159 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -80.6 13.26 2.61 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.6 0.36 . . . . 0.0 111.742 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.1 m 62.09 20.99 12.07 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.49 169.26 24.69 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.96 -172.56 29.53 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 121.636 0.576 . . . . 0.0 113.186 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -137.25 142.36 42.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.091 1.756 . . . . 0.0 114.722 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -144.61 153.42 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 t -143.36 149.46 37.75 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.073 0.397 . . . . 0.0 111.74 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -115.17 159.67 20.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.12 -14.58 61.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.22 0.533 . . . . 0.0 112.083 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -154.02 149.57 21.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.526 0.73 . . . . 0.0 110.685 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.91 -20.47 38.95 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.377 2.718 . . . . 0.0 112.204 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.31 -39.82 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.551 0.614 . . . . 0.0 111.737 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.3 m -73.34 -25.84 60.78 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.1 -46.43 51.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -66.4 -30.19 70.52 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 122.038 -0.414 . . . . 0.0 110.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.39 -41.51 80.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.74 -26.22 66.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.72 -51.93 56.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -68.49 -10.84 58.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.16 -27.98 17.36 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.9 mmm -120.29 -18.54 7.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -66.32 133.3 50.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.21 86.42 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.785 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -64.6 117.67 7.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.529 1.165 . . . . 0.0 110.448 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -75.39 130.06 38.37 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.108 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -146.19 124.97 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.4 -142.5 47.97 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 61.5 mtt -86.91 8.99 20.76 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -140.87 179.14 6.89 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.059 0.544 . . . . 0.0 111.41 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -118.97 142.96 47.32 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 110.069 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.36 130.95 45.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.683 0.278 . . . . 0.0 111.208 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -90.72 135.73 33.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.9 t -134.84 139.49 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -151.84 160.68 43.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.742 0.305 . . . . 0.0 111.432 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.32 149.11 40.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.444 ' H ' HD23 ' A' ' 104' ' ' LEU . 62.8 tttm . . . . . 0 C--O 1.232 0.147 0 C-N-CA 122.708 0.403 . . . . 0.0 109.918 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.714 0.292 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.58 -172.72 34.97 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.0 174.8 7.31 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.753 2.969 . . . . 0.0 110.443 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -61.1 135.08 57.66 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.76 -0.69 89.44 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.557 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.76 0.34 28.12 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.866 0.833 . . . . 0.0 112.785 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -99.73 146.21 26.79 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.205 0.457 . . . . 0.0 109.802 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.467 HD13 ' HB1' ' A' ' 83' ' ' ALA . 1.1 mp -136.16 156.52 48.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.993 0.901 . . . . 0.0 112.823 -171.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 15.1 m-85 -124.98 147.6 48.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.71 1.604 . . . . 0.0 114.465 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.62 132.71 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 5.8 m-85 -136.54 177.45 7.84 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 7.2 m170 64.63 16.14 10.14 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.768 1.627 . . . . 0.0 112.57 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.8 145.22 96.7 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 122.801 0.44 . . . . 0.0 110.205 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.81 160.49 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.068 2.512 . . . . 0.0 108.95 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -73.85 -5.21 39.56 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.11 -10.46 59.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.059 0.391 . . . . 0.0 111.431 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.5 158.25 36.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -155.79 177.46 32.89 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -57.43 -42.58 82.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -79.98 -27.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.476 0.179 . . . . 0.0 111.107 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 73.4 m-20 -72.28 -39.65 68.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 tt -76.71 -23.93 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.9 tp -66.6 -53.18 37.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -64.7 -23.0 67.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.295 0.238 . . . . 0.0 111.474 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.4 tpp -75.73 -29.45 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.047 0.139 . . . . 0.0 110.702 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 31.5 m-85 -104.95 -9.35 17.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -67.44 -28.73 2.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.8 Cg_endo -72.19 -10.67 26.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 122.374 1.883 . . . . 0.0 111.787 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -85.76 -14.79 44.16 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.33 -171.74 32.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.53 102.84 6.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.447 -0.443 . . . . 0.0 110.684 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.2 t -83.92 122.85 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -79.69 -34.98 16.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -157.71 156.1 31.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.075 0.464 . . . . 0.0 110.527 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 137.95 15.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.522 0.729 . . . . 0.0 109.048 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.59 134.13 8.76 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.512 0.196 . . . . 0.0 111.517 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 t -94.45 140.6 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -69.67 151.29 46.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -126.85 143.07 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 122.869 0.467 . . . . 0.0 109.975 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -91.59 130.64 37.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.14 -10.09 59.14 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.158 -0.339 . . . . 0.0 111.745 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -87.98 -22.54 24.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.24 0.616 . . . . 0.0 112.384 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -137.35 -14.08 1.52 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 61.65 8.2 2.23 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.882 1.273 . . . . 0.0 113.105 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.74 159.91 23.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.747 0.419 . . . . 0.0 109.878 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -71.24 135.04 47.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.535 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -76.03 166.92 22.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.008 0.432 . . . . 0.0 110.506 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.01 19.38 0.54 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -160.23 172.04 18.11 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.8 -171.9 27.38 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.528 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -136.37 144.88 44.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.579 1.551 . . . . 0.0 115.182 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -147.39 152.53 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.095 0.958 . . . . 0.0 108.431 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.4 p -143.45 147.34 34.42 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.876 -0.515 . . . . 0.0 112.023 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -113.79 159.94 19.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.32 -12.42 60.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -154.05 150.08 21.93 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 122.988 0.515 . . . . 0.0 110.886 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.1 -21.28 36.79 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.46 2.773 . . . . 0.0 112.296 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.34 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 118.72 0.691 . . . . 0.0 111.519 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -75.39 -25.92 58.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.376 0.27 . . . . 0.0 110.677 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.467 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -72.91 -49.92 26.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -68.85 -26.63 65.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.741 0.246 . . . . 0.0 110.483 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.73 -41.76 78.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.54 -27.14 66.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.3 mt -67.33 -52.07 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.34 -12.53 61.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.288 0.235 . . . . 0.0 111.259 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.93 -31.37 19.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.3 mtp -126.01 -9.59 6.56 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.21 125.68 24.88 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.01 87.43 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.854 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -63.73 119.44 9.93 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.639 1.22 . . . . 0.0 111.519 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -75.92 129.61 37.21 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.277 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.1 tt -144.64 120.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.75 -141.9 47.22 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 74.0 mtm -87.59 12.5 12.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -145.02 164.56 30.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.88 0.763 . . . . 0.0 110.673 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -107.1 141.63 38.05 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.855 0.462 . . . . 0.0 110.808 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 87.6 mt -66.43 140.86 58.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.889 0.475 . . . . 0.0 111.442 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -101.94 141.18 35.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.93 137.08 52.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -151.73 160.64 43.52 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 120.887 0.375 . . . . 0.0 111.573 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.21 145.68 32.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.81 0.444 . . . . 0.0 110.463 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 173.931 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.702 0.763 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.34 -156.54 26.71 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.308 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.34 158.33 55.67 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.928 2.419 . . . . 0.0 108.948 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -63.5 129.38 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.12 -11.57 60.35 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.06 19.34 6.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.673 0.737 . . . . 0.0 110.417 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.14 142.35 47.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -169.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.9 159.85 33.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.015 0.912 . . . . 0.0 113.026 -171.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -125.46 144.05 50.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.411 1.884 . . . . 0.0 114.55 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.3 137.8 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.8 179.71 6.55 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.513 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.4 m170 64.7 17.12 10.78 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.246 1.418 . . . . 0.0 113.05 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.06 139.3 87.66 Favored Pre-proline 0 CA--C 1.529 0.146 0 O-C-N 122.165 -0.335 . . . . 0.0 110.111 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.71 172.13 16.42 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.449 2.766 . . . . 0.0 111.06 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -70.53 -13.09 61.97 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -82.37 -7.08 59.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -77.2 158.44 30.33 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.27 174.76 35.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -58.74 -38.34 78.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -74.97 -29.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.631 0.373 . . . . 0.0 111.032 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.65 -42.52 58.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -72.55 -24.81 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.31 -50.96 67.99 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -64.52 -23.85 67.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.536 0.334 . . . . 0.0 111.797 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.4 mmm -77.61 -23.83 49.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.634 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 33.8 m-85 -108.56 -10.68 15.21 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.451 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -66.23 -31.96 5.02 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.5 Cg_endo -73.15 -9.69 23.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 121.706 1.645 . . . . 0.0 111.779 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -86.97 -14.72 40.91 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.792 0.437 . . . . 0.0 112.079 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.6 32.87 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.57 102.05 5.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.387 -0.478 . . . . 0.0 110.47 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -80.77 120.62 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.61 -31.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -157.98 155.04 28.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.39 0.276 . . . . 0.0 110.834 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.38 29.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 109.346 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -156.99 141.33 16.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.836 0.454 . . . . 0.0 111.516 -174.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.06 130.21 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 168.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -76.44 142.96 40.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.4 mm -132.74 144.18 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.664 0.386 . . . . 0.0 110.534 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' CA ' ' HE2' ' A' ' 70' ' ' LYS . 61.0 t0 -85.93 130.5 34.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.511 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -79.13 -10.65 59.88 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.036 -0.415 . . . . 0.0 111.576 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.01 -22.14 22.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.76 -10.92 1.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.74 6.87 1.73 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.362 1.065 . . . . 0.0 112.692 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -79.6 158.21 27.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.8 t -71.43 143.75 50.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HE2' ' CA ' ' A' ' 63' ' ' ASP . 71.6 mmtt -77.1 3.34 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.593 0.757 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.3 m 62.65 20.1 11.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -157.59 169.91 23.59 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.66 -169.0 23.35 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.991 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -141.5 141.91 33.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.6 t -147.25 152.52 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 t -147.94 149.06 31.51 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.692 -0.63 . . . . 0.0 111.934 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.87 163.12 14.56 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -79.48 -9.92 59.7 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.423 0.289 . . . . 0.0 110.319 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -154.3 149.05 19.76 Favored Pre-proline 0 N--CA 1.453 -0.284 0 O-C-N 121.852 -0.53 . . . . 0.0 111.478 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.61 -19.21 42.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.658 2.905 . . . . 0.0 112.356 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.2 -39.92 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.724 -0.61 . . . . 0.0 111.789 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -74.65 -24.64 58.85 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.389 0.276 . . . . 0.0 110.535 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.6 39.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -68.0 -28.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.963 -0.461 . . . . 0.0 111.087 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.99 -42.34 80.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.145 -0.347 . . . . 0.0 110.122 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.25 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.66 -51.2 53.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.86 -11.98 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.407 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.65 -31.44 17.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 52.9 mtp -124.1 -10.92 7.59 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -62.49 126.23 26.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.1 5.75 87.2 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.148 -0.806 . . . . 0.0 112.792 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -65.23 117.32 7.63 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.764 1.282 . . . . 0.0 109.934 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -75.26 129.43 37.44 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.169 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.5 tt -145.05 119.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.72 -142.65 46.96 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 ptp -84.39 8.95 14.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 43.8 tttp -146.89 165.75 28.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.753 0.706 . . . . 0.0 110.428 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -104.49 143.18 33.38 Favored 'General case' 0 C--O 1.229 -0.017 0 C-N-CA 122.731 0.413 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.31 126.32 27.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.198 0.199 . . . . 0.0 110.801 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -87.67 136.47 32.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.73 139.29 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -148.55 161.47 41.6 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 111.405 -172.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -83.74 151.12 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 104' ' ' LEU . 78.9 tttt . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 123.869 0.868 . . . . 0.0 110.053 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.989 0.423 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.52 -171.6 36.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.34 178.53 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.07 3.18 . . . . 0.0 110.637 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -58.3 134.7 56.8 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.087 -0.383 . . . . 0.0 110.935 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 0.43 88.64 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.829 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.02 8.76 34.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 117.826 0.813 . . . . 0.0 113.166 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -112.28 139.93 47.42 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.16 0.436 . . . . 0.0 110.453 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.62 160.89 30.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.007 0.908 . . . . 0.0 112.936 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 20.2 m-85 -128.35 141.98 51.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.533 1.933 . . . . 0.0 114.647 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.56 137.62 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.1 m-85 -141.33 178.38 7.46 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.447 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 17.1 m170 64.12 18.71 11.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.883 1.273 . . . . 0.0 112.961 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.89 145.43 98.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HG2' ' CD2' ' A' ' 40' ' ' PHE . 90.5 Cg_endo -72.32 163.45 38.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.867 2.378 . . . . 0.0 109.682 174.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -69.67 -16.42 63.35 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.87 -9.28 59.43 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.813 -0.554 . . . . 0.0 112.259 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.402 ' CD2' ' HG2' ' A' ' 37' ' ' PRO . 4.0 m-85 -73.13 158.27 35.63 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 175.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.7 33.88 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -57.19 -39.62 75.75 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -74.79 -30.46 61.43 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.003 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -76.02 -38.85 56.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.56 -25.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.6 -51.36 63.11 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -65.21 -22.37 66.88 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.2 tpp -77.15 -27.73 53.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.396 0.278 . . . . 0.0 110.555 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.284 25.3 m-85 -105.03 -12.21 16.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 118.0 2.593 . . . . 0.0 118.0 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 58.4 mtm -66.17 -31.23 4.28 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.1 Cg_endo -72.33 -10.15 25.22 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.907 1.717 . . . . 0.0 112.072 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.33 -15.02 41.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.842 0.457 . . . . 0.0 111.708 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.29 -173.53 32.81 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -77.04 102.79 6.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.497 -0.413 . . . . 0.0 110.421 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.87 123.79 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.89 -33.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -152.41 151.17 30.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.721 0.408 . . . . 0.0 110.794 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.08 140.64 17.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.405 0.682 . . . . 0.0 109.455 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.61 161.72 37.25 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 120.811 0.338 . . . . 0.0 110.842 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.94 139.19 52.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.411 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 48.4 m-85 -74.53 142.67 44.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mm -131.91 142.08 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 124.017 0.927 . . . . 0.0 108.554 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -80.78 127.35 32.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.566 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -73.22 -9.47 58.74 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.082 -0.386 . . . . 0.0 111.717 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -94.73 -23.6 17.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.19 -10.5 2.57 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.81 11.25 3.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.737 1.215 . . . . 0.0 111.895 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.7 mt -86.02 160.15 19.4 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.887 0.475 . . . . 0.0 109.891 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.5 t -69.56 145.33 52.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.597 0.236 . . . . 0.0 111.43 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 61' ' ' PHE . 52.2 mtmt -98.04 15.29 24.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.147 0.579 . . . . 0.0 111.195 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.6 p 52.13 29.75 6.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.405 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.8 p90 -155.06 168.96 25.27 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.55 -174.34 27.14 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.273 0.374 . . . . 0.0 112.955 -173.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -139.69 140.75 36.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.261 1.424 . . . . 0.0 114.46 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -146.36 153.74 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 98.0 p -147.89 153.0 38.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 111.532 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -122.54 164.66 17.72 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.08 -9.59 59.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -153.32 151.02 24.89 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.932 0.493 . . . . 0.0 111.275 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.38 -19.5 37.84 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.31 2.673 . . . . 0.0 111.633 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.96 -46.57 95.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 118.548 0.613 . . . . 0.0 111.026 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 m -70.91 -25.93 62.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.129 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.79 -49.03 42.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -68.17 -27.23 66.23 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 117.936 0.334 . . . . 0.0 110.674 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.9 75.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.25 70.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.99 -50.47 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -69.43 -11.16 60.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.243 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.88 -27.39 21.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.6 ttm -120.86 -21.04 6.73 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -58.83 123.34 16.13 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 6.04 88.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.424 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -67.29 142.83 56.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.759 1.279 . . . . 0.0 108.486 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -95.92 128.58 42.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.938 0.335 . . . . 0.0 110.701 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.36 136.88 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.29 -113.35 5.07 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.4 mtm -126.86 14.42 7.43 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.573 0.749 . . . . 0.0 112.282 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 56.5 tttp -151.24 144.54 24.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.309 0.504 . . . . 0.0 110.783 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -82.63 143.3 31.08 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.416 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.0 mm? -67.98 130.4 42.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.346 0.258 . . . . 0.0 110.496 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -92.02 138.11 31.81 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.71 141.15 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.44 0.296 . . . . 0.0 110.418 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -148.62 161.78 41.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.64 0.257 . . . . 0.0 110.87 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 tt -90.13 140.04 30.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt . . . . . 0 CA--C 1.529 0.17 0 CA-C-N 118.46 0.573 . . . . 0.0 109.62 175.595 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.189 0.519 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.48 -152.38 28.81 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.37 179.23 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.695 2.93 . . . . 0.0 111.172 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.84 135.98 57.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.947 -0.471 . . . . 0.0 111.551 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.15 68.09 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.478 0.561 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.11 39.76 1.0 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.665 0.732 . . . . 0.0 112.013 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.09 140.03 29.23 Favored 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.723 -0.611 . . . . 0.0 111.75 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -128.76 153.77 47.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.931 0.872 . . . . 0.0 113.152 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 16.1 m-85 -110.99 146.87 35.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.562 1.545 . . . . 0.0 114.152 170.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -139.01 124.74 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.4 m-85 -131.28 179.28 6.11 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 17.1 m170 63.32 16.12 9.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.348 1.459 . . . . 0.0 112.335 -176.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.49 144.38 94.25 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.137 0.575 . . . . 0.0 110.329 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.83 162.91 36.65 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.374 2.716 . . . . 0.0 109.248 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.46 -6.22 44.98 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -75.68 -9.99 59.05 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.994 0.361 . . . . 0.0 111.241 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -73.39 158.3 35.28 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.41 176.54 33.75 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -57.24 -39.01 74.7 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.158 0.479 . . . . 0.0 111.975 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -80.02 -33.21 39.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.585 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -72.04 -38.81 69.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.34 -28.35 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.3 tp -66.25 -52.23 49.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -63.91 -22.91 67.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.555 0.342 . . . . 0.0 111.688 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -78.38 -26.04 46.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.645 0.202 . . . . 0.0 110.654 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.296 31.3 m-85 -104.93 -10.53 17.22 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 56.6 mtm -66.97 -29.32 2.56 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 50' ' ' MET . 84.3 Cg_endo -71.05 -13.11 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.893 1.712 . . . . 0.0 111.906 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -84.35 -15.46 46.4 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 155.19 -175.06 33.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -75.32 105.53 6.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.281 -0.541 . . . . 0.0 110.77 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.04 126.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.3 -30.43 5.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 120.487 0.184 . . . . 0.0 110.578 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -154.6 150.43 27.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.726 0.411 . . . . 0.0 110.577 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.83 141.54 14.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.383 0.673 . . . . 0.0 109.496 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.557 ' HE3' ' CD2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -156.45 153.26 28.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.43 0.292 . . . . 0.0 110.292 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -107.71 142.87 19.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD2' ' HE3' ' A' ' 59' ' ' LYS . 69.3 m-85 -69.72 148.73 48.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -133.68 146.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.148 0.579 . . . . 0.0 109.965 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -95.19 132.89 39.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -77.36 -12.91 60.01 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.067 0.547 . . . . 0.0 111.75 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -89.78 -23.82 21.65 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.62 -13.43 2.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.2 t30 61.54 10.84 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 112.22 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.86 154.56 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.673 0.389 . . . . 0.0 110.219 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -70.49 134.39 47.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.425 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -84.23 163.69 19.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.105 0.478 . . . . 0.0 110.451 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.6 m -78.87 17.67 0.7 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE1' ' CE1' ' A' ' 61' ' ' PHE . 3.5 p90 -156.59 170.32 22.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.77 -177.59 29.15 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.753 1.168 . . . . 0.0 111.896 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -139.69 144.57 37.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.74 151.95 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.803 0.841 . . . . 0.0 110.082 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 t -143.4 144.0 31.86 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -106.21 164.35 12.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -80.89 -9.22 59.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.271 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -155.75 150.43 20.36 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 123.138 0.575 . . . . 0.0 111.096 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.69 -18.35 28.84 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.125 2.55 . . . . 0.0 111.858 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.9 -44.77 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 O-C-N 121.817 -0.552 . . . . 0.0 111.282 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -70.65 -26.26 63.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.63 -48.04 35.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -66.07 -28.51 68.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.062 -0.399 . . . . 0.0 110.816 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.59 75.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.228 -0.295 . . . . 0.0 110.322 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.67 66.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mt -66.98 -52.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -66.88 -13.73 61.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.365 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.98 -32.95 18.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.8 mtp -123.82 -11.91 7.63 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -61.85 125.24 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.62 5.96 88.99 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.303 -0.72 . . . . 0.0 112.798 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.12 125.15 22.86 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.46 1.13 . . . . 0.0 112.031 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -78.22 128.38 33.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.685 0.279 . . . . 0.0 110.846 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -149.56 136.51 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.98 -111.1 2.81 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.0 ptp -130.42 15.47 5.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.13 0.572 . . . . 0.0 111.811 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -150.83 142.42 23.57 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.483 0.313 . . . . 0.0 110.291 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -84.41 145.13 28.35 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 122.505 -0.122 . . . . 0.0 111.181 -176.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 81.4 mt -70.78 131.82 44.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.572 0.349 . . . . 0.0 111.647 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -91.32 138.6 31.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 170.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.97 137.38 50.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -155.12 160.79 41.22 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.865 0.302 . . . . 0.0 111.715 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.8 156.23 36.73 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.37 0.668 . . . . 0.0 110.692 176.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.46 ' H ' HD23 ' A' ' 104' ' ' LEU . 87.4 tttt . . . . . 0 N--CA 1.454 -0.23 0 C-N-CA 123.43 0.692 . . . . 0.0 109.534 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.667 0.27 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.42 -155.2 31.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.41 176.7 6.17 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.949 3.099 . . . . 0.0 110.962 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -60.95 137.01 58.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.891 -0.505 . . . . 0.0 111.504 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.05 -2.87 73.61 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.637 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.13 39.24 1.04 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.419 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.65 139.42 29.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.765 -0.584 . . . . 0.0 111.552 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.31 155.03 45.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.757 0.789 . . . . 0.0 112.934 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.2 m-85 -112.27 149.15 32.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.746 1.618 . . . . 0.0 114.355 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -139.01 136.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.6 m-85 -142.4 177.64 8.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 12.7 m170 62.73 16.9 9.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.611 1.564 . . . . 0.0 112.639 -176.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.46 145.04 98.26 Favored Pre-proline 0 CA--C 1.53 0.191 0 O-C-N 122.079 -0.388 . . . . 0.0 110.047 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.34 164.9 34.25 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.842 2.361 . . . . 0.0 109.507 172.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.91 -14.79 62.89 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.25 -8.84 57.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.55 158.23 36.58 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.75 35.29 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.8 -36.9 75.22 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.506 0.653 . . . . 0.0 110.442 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -78.67 -32.62 47.24 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.398 0.279 . . . . 0.0 110.869 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.0 -38.8 61.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.61 -25.8 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.39 -49.89 61.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -64.7 -23.84 67.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.745 0.418 . . . . 0.0 111.558 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -79.89 -25.61 40.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.511 -0.118 . . . . 0.0 110.767 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.293 31.3 m-85 -105.92 -7.76 18.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 50.1 mtm -66.49 -30.83 3.72 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.5 Cg_endo -72.82 -10.99 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 CA-C-N 121.943 1.73 . . . . 0.0 111.842 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.48 -19.96 37.79 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.76 -167.96 31.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -78.2 99.59 6.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.466 -0.432 . . . . 0.0 110.527 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -87.48 130.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 174.614 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -90.68 -27.81 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 122.592 0.357 . . . . 0.0 110.76 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 t -155.9 150.8 26.33 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.633 0.373 . . . . 0.0 110.334 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.46 147.03 27.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.377 0.671 . . . . 0.0 109.387 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -157.38 137.88 12.97 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.682 0.393 . . . . 0.0 111.445 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -111.93 136.41 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.404 ' CD2' ' CZ ' ' A' ' 72' ' ' PHE . 49.5 m-85 -78.92 147.33 33.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -173.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -132.58 144.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.063 0.545 . . . . 0.0 110.305 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -90.34 133.16 35.16 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -76.98 -12.56 59.96 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.784 0.434 . . . . 0.0 111.865 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -88.95 -23.92 22.56 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.12 -13.48 2.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 63.68 8.34 3.66 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.12 161.08 22.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.911 0.484 . . . . 0.0 110.038 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -70.52 140.91 51.94 Favored 'General case' 0 CA--C 1.523 -0.062 0 CA-C-O 120.753 0.311 . . . . 0.0 111.052 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -82.59 6.04 18.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m 61.49 22.51 12.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.404 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.1 p90 -154.62 169.11 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.01 -172.28 28.12 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 121.566 0.537 . . . . 0.0 113.185 -174.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.82 143.01 31.96 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.806 1.642 . . . . 0.0 114.713 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -145.99 153.57 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 109.527 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.2 t -143.01 145.13 32.63 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -109.34 164.04 12.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -78.36 -13.21 59.95 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 112.278 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.02 148.11 18.23 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 123.246 0.618 . . . . 0.0 111.17 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.69 -18.54 32.56 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.468 2.779 . . . . 0.0 112.06 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.27 -43.03 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 118.34 0.518 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.1 t -70.68 -32.78 70.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.04 74.67 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -67.88 -28.09 67.22 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.901 -0.5 . . . . 0.0 110.962 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.92 -43.05 72.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.44 -26.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.3 mt -67.73 -51.51 49.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -67.84 -11.22 58.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.86 -0.154 . . . . 0.0 111.284 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.89 -31.33 16.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.4 mtp -125.41 -12.2 6.78 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.98 125.86 25.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.87 6.54 89.36 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.008 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 120.42 11.62 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.693 1.247 . . . . 0.0 111.483 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -76.39 129.63 36.86 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 tt -144.87 120.72 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.27 -140.64 46.6 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.0 mmt -88.52 12.96 13.06 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -146.5 162.59 37.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.848 0.749 . . . . 0.0 111.049 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -105.76 141.27 37.47 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 122.545 0.338 . . . . 0.0 110.946 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 91.5 mt -66.65 133.76 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.749 0.419 . . . . 0.0 111.195 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -92.0 137.89 31.99 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.3 t -134.97 137.13 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -151.4 161.3 42.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -75.77 153.83 36.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.469 0.708 . . . . 0.0 110.409 177.287 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.504 ' H ' HD23 ' A' ' 104' ' ' LEU . 87.1 tttt . . . . . 0 CA--C 1.529 0.144 0 C-N-CA 123.222 0.609 . . . . 0.0 109.834 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 -151.2 25.12 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.79 169.43 17.65 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.808 3.005 . . . . 0.0 110.232 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.83 137.96 58.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.946 -0.471 . . . . 0.0 110.71 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.77 -6.96 79.15 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.156 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.42 39.9 1.06 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.602 0.701 . . . . 0.0 110.418 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.36 28.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.004 -0.435 . . . . 0.0 111.131 -175.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -126.05 158.4 35.49 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 18.5 m-85 -117.59 139.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.94 1.696 . . . . 0.0 113.71 171.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.72 139.66 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 72' ' ' PHE . 9.8 m-85 -141.7 175.13 9.95 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 m170 65.42 16.3 10.46 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 113.001 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.16 140.93 93.51 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 122.82 0.448 . . . . 0.0 109.919 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.18 162.88 40.41 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.915 2.41 . . . . 0.0 109.552 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -71.44 -7.19 45.81 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.23 -9.42 58.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 122.055 -0.403 . . . . 0.0 111.054 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -74.06 158.36 34.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.26 173.94 35.44 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -57.16 -39.49 75.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -75.79 -29.24 58.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.097 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.41 -39.61 46.45 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -73.6 -24.65 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.17 -52.0 57.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.65 -23.62 67.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.613 0.365 . . . . 0.0 111.518 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 tpp -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.15 0.18 . . . . 0.0 110.672 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.276 22.6 m-85 -104.12 -11.69 17.17 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 117.878 2.547 . . . . 0.0 117.878 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.6 mtm -66.8 -31.3 3.92 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.8 Cg_endo -73.01 -10.0 24.15 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.068 1.774 . . . . 0.0 111.881 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.28 -13.81 45.57 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.09 -173.57 32.66 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -75.94 101.32 5.15 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.333 -0.51 . . . . 0.0 110.223 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -79.07 127.75 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.8 mt -83.84 -32.95 8.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.416 0.287 . . . . 0.0 110.379 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -164.9 159.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.94 24.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.423 0.689 . . . . 0.0 109.893 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.7 145.72 17.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.707 0.403 . . . . 0.0 111.172 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.93 138.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 76.5 m-85 -73.27 144.72 46.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.23 144.33 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.204 0.601 . . . . 0.0 110.197 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.96 130.3 34.99 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.09 -12.79 60.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.08 -0.387 . . . . 0.0 111.672 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.17 -23.71 22.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -133.17 -12.55 2.81 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.5 7.92 2.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.684 1.194 . . . . 0.0 112.021 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.24 160.45 22.98 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.3 t -70.57 141.37 51.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.792 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -78.32 6.94 7.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.64 0.376 . . . . 0.0 111.352 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.9 m 63.21 24.77 14.51 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 34' ' ' TYR . 4.8 p90 -157.44 167.68 29.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.28 -173.41 24.8 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 121.531 0.517 . . . . 0.0 113.697 -173.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -139.72 142.68 36.83 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.371 1.868 . . . . 0.0 114.971 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -146.77 152.74 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.878 0.871 . . . . 0.0 109.689 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -141.23 149.45 41.37 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.179 0.445 . . . . 0.0 112.163 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.03 162.42 16.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -76.88 -12.56 59.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.537 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -154.06 150.8 23.27 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 123.298 0.639 . . . . 0.0 111.176 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.67 -18.61 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.964 2.443 . . . . 0.0 111.73 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.37 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 118.214 0.461 . . . . 0.0 111.095 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -71.02 -26.39 63.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.858 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.87 -47.28 53.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -65.91 -30.53 71.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.13 0.423 . . . . 0.0 110.968 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.37 82.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.68 67.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -66.1 -51.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.63 -12.22 61.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.04 21.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.4 ttm -120.63 -21.77 6.61 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.79 124.35 18.88 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.01 84.97 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.183 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.93 118.2 8.71 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.043 1.421 . . . . 0.0 110.501 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -77.35 129.69 36.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 110.353 -176.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 tt -150.44 136.09 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.39 -112.52 4.96 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.05 14.98 8.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.0 112.728 -178.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -144.38 172.66 12.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.124 0.97 . . . . 0.0 111.135 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -107.48 139.67 41.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.06 125.08 24.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.73 0.3 . . . . 0.0 110.979 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -87.26 142.82 27.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.0 t -134.95 140.19 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.673 0.389 . . . . 0.0 109.967 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -149.07 152.05 35.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.98 0.354 . . . . 0.0 110.974 -175.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -71.92 148.49 45.99 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.214 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.432 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.8 tttt . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 123.309 0.644 . . . . 0.0 109.392 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.713 0.292 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.67 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.996 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.73 176.38 6.04 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.58 3.52 . . . . 0.0 110.476 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.6 134.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.991 -0.443 . . . . 0.0 111.147 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.04 0.12 84.8 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.628 -0.54 . . . . 0.0 112.857 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 -0.38 57.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.887 0.843 . . . . 0.0 112.193 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -107.72 145.81 32.96 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.28 149.07 52.71 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 105' ' ' LYS . 21.9 m-85 -97.82 142.35 29.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.927 1.691 . . . . 0.0 112.866 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.11 130.04 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -134.41 179.73 6.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.2 m170 64.37 15.55 9.57 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.82 1.648 . . . . 0.0 113.03 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.39 139.51 86.94 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.32 165.05 32.73 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.609 2.873 . . . . 0.0 109.991 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -72.57 -7.14 48.63 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -75.99 -9.78 58.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.138 0.427 . . . . 0.0 110.743 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -75.98 158.12 32.31 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.72 175.73 34.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -56.87 -41.64 78.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -80.82 -26.6 36.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.591 0.234 . . . . 0.0 110.966 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 75.4 m-20 -74.08 -38.47 63.91 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.5 tt -74.69 -25.49 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.5 tp -65.98 -52.19 51.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -64.65 -23.54 67.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.637 0.375 . . . . 0.0 111.595 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.4 tpp -76.58 -27.93 56.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.132 0.173 . . . . 0.0 110.753 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.268 22.0 m-85 -104.68 -11.72 16.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.6 mtm -66.08 -31.7 4.86 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 86.1 Cg_endo -72.46 -9.43 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.881 1.707 . . . . 0.0 111.733 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.81 -14.97 43.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.726 0.411 . . . . 0.0 111.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.48 -171.2 32.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.6 102.9 6.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.663 -0.316 . . . . 0.0 110.344 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -79.13 129.25 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mt -87.39 -33.82 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 122.301 0.241 . . . . 0.0 110.703 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.4 t -157.85 155.48 29.75 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.695 0.398 . . . . 0.0 110.239 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.34 138.26 17.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.339 0.656 . . . . 0.0 109.408 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.539 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 5.4 tmmm? -159.93 143.29 14.07 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.739 0.416 . . . . 0.0 111.081 -176.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.8 140.01 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.539 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 78.8 m-85 -72.41 149.43 44.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.44 143.7 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.797 0.839 . . . . 0.0 109.112 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -82.48 128.36 34.19 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.87 -11.15 59.92 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.297 -0.252 . . . . 0.0 111.478 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.23 -22.17 19.18 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -136.44 -10.79 1.89 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 61.68 9.6 2.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.375 1.07 . . . . 0.0 112.984 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.4 153.47 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.161 -0.337 . . . . 0.0 110.153 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.6 t -70.3 137.29 50.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.569 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -83.05 167.5 17.82 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.15 18.18 1.79 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.23 170.39 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.57 -168.68 21.08 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.602 0.62 . . . . 0.0 112.979 -173.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -143.96 142.03 30.51 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -146.02 153.03 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.122 0.969 . . . . 0.0 109.531 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.9 p -142.1 150.85 41.71 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.768 0.427 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -117.53 162.02 18.67 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -77.25 -15.43 59.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -152.77 150.9 25.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 C-N-CA 123.193 0.597 . . . . 0.0 110.848 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.93 -23.22 34.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.015 2.477 . . . . 0.0 112.177 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.64 -38.29 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.444 0.565 . . . . 0.0 111.548 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -76.21 -26.59 56.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.318 -0.239 . . . . 0.0 110.876 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.86 -47.43 30.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -68.24 -26.97 65.96 Favored 'General case' 0 C--O 1.231 0.112 0 O-C-N 122.243 -0.286 . . . . 0.0 110.258 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.02 73.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -27.78 68.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 119.383 -0.342 . . . . 0.0 111.84 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.3 mt -64.69 -52.21 57.51 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.23 -11.53 57.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.805 -0.14 . . . . 0.0 111.186 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.07 -29.22 15.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.71 -18.27 7.75 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.17 134.86 53.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.98 2.38 77.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.505 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.42 117.9 7.96 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.553 1.176 . . . . 0.0 110.742 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -74.41 129.65 38.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.487 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.9 tt -146.76 124.27 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.71 -145.36 49.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -173.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.27 9.85 11.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.578 0.751 . . . . 0.0 112.698 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -139.38 178.97 6.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.672 0.669 . . . . 0.0 111.514 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -118.79 145.08 45.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 109.966 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 88.5 mt -67.07 133.87 50.74 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 122.496 0.318 . . . . 0.0 110.966 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.48 133.1 41.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.22 140.05 45.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -153.16 159.44 42.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.547 0.339 . . . . 0.0 110.695 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.31 130.06 41.93 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.267 0.627 . . . . 0.0 109.98 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.41 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 59.6 tttp . . . . . 0 C--O 1.232 0.147 0 C-N-CA 123.04 0.536 . . . . 0.0 112.086 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.45 -164.41 30.71 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.04 170.44 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.488 2.792 . . . . 0.0 110.254 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -64.32 138.76 58.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.961 -0.462 . . . . 0.0 110.017 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.62 -1.67 87.18 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.541 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.95 13.2 29.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.717 0.758 . . . . 0.0 112.327 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -113.9 138.81 49.81 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.696 0.398 . . . . 0.0 110.186 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.8 mt -123.6 156.59 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 122.076 0.941 . . . . 0.0 113.115 -174.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -117.21 143.17 46.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.973 1.709 . . . . 0.0 114.016 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 HD21 ' A' ' 36' ' ' LEU . 3.0 mp -137.64 128.36 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.73 171.17 14.22 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.413 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 18.3 m170 74.15 20.67 2.67 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.209 1.803 . . . . 0.0 112.77 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.617 HD23 ' HA ' ' A' ' 72' ' ' PHE . 2.7 mm? -70.4 142.8 89.75 Favored Pre-proline 0 N--CA 1.454 -0.235 0 C-N-CA 123.166 0.586 . . . . 0.0 109.957 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.45 162.78 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.586 2.858 . . . . 0.0 108.991 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.82 -8.05 54.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -76.88 -9.94 59.03 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.266 0.484 . . . . 0.0 110.789 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.479 ' CD1' HD12 ' A' ' 36' ' ' LEU . 5.5 m-85 -75.67 158.44 32.35 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.82 174.92 33.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 8.5 p30 -60.8 -35.58 76.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -74.36 -29.19 61.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.18 0.592 . . . . 0.0 111.213 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -79.05 -42.08 27.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.81 -23.06 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.2 -49.61 75.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -65.31 -23.67 67.08 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.601 0.361 . . . . 0.0 111.641 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.3 mmm -77.15 -22.44 52.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.638 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 28.1 m-85 -110.1 -10.57 14.67 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.093 2.627 . . . . 0.0 118.093 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.437 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.1 mtm -66.21 -32.64 5.74 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 50' ' ' MET . 91.8 Cg_endo -74.4 -8.19 20.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 121.715 1.648 . . . . 0.0 112.055 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.79 -15.58 38.86 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.97 -172.35 33.3 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -75.93 103.09 5.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.208 -0.583 . . . . 0.0 110.516 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 122.56 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.5 mt -81.64 -30.83 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.05 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.8 t -158.72 154.58 26.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.055 0.455 . . . . 0.0 111.102 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.52 146.33 31.39 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.964 0.906 . . . . 0.0 108.603 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 42' ' ' ASP . 14.3 tppt? -157.96 145.35 18.25 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -121.73 132.83 69.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -69.71 155.07 41.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -134.08 143.76 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.949 0.5 . . . . 0.0 109.845 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -88.08 132.18 34.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -77.72 -13.06 60.01 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.839 0.456 . . . . 0.0 111.408 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -91.13 -22.27 20.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.276 0.63 . . . . 0.0 112.677 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.7 -12.85 2.0 Allowed 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -174.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 60.52 8.72 1.78 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.647 1.179 . . . . 0.0 112.911 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.46 156.65 30.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.966 0.348 . . . . 0.0 110.739 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.9 t -71.31 135.27 47.31 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.907 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.89 162.75 26.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.084 0.553 . . . . 0.0 110.822 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -81.28 11.0 4.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.617 ' HA ' HD23 ' A' ' 36' ' ' LEU . 4.6 p90 -157.79 172.94 17.58 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.43 -163.86 16.11 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.778 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.26 147.6 35.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.869 1.667 . . . . 0.0 115.404 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.6 t -146.2 152.14 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 t -141.2 143.9 34.46 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.25 159.17 19.61 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -76.23 -11.92 60.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.153 0.501 . . . . 0.0 111.847 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -153.86 149.7 21.43 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 123.168 0.587 . . . . 0.0 110.886 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.08 -18.23 35.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.344 2.696 . . . . 0.0 112.214 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.41 -46.27 95.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 118.297 0.499 . . . . 0.0 110.758 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.6 m -70.87 -24.04 62.42 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.186 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.6 -48.07 35.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.911 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -67.58 -28.99 68.23 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.045 0.384 . . . . 0.0 110.852 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.64 80.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.36 66.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.871 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.6 mt -65.85 -51.15 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 118.796 0.726 . . . . 0.0 109.173 174.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -68.23 -11.07 58.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.419 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.91 -26.77 16.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 89.2 mmm -120.65 -14.71 8.56 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.07 132.65 48.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.62 4.06 87.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.774 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -63.23 117.64 6.85 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.578 1.189 . . . . 0.0 109.977 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -77.37 130.93 37.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.115 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.97 134.25 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.45 -108.31 1.89 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 65.2 mtt -130.57 17.76 5.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.561 0.745 . . . . 0.0 111.516 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 55.3 tttp -146.59 155.84 42.78 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.69 0.396 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -98.12 140.64 32.14 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.699 -0.626 . . . . 0.0 111.196 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.02 131.58 46.15 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.713 0.405 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -92.8 139.12 30.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -134.83 141.01 44.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-N 118.047 0.385 . . . . 0.0 110.376 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -155.03 163.53 40.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.917 0.326 . . . . 0.0 111.785 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.44 148.66 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.562 0.745 . . . . 0.0 110.259 175.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 CA--C 1.53 0.187 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.941 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.63 0.252 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.77 41.44 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 177.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.3 167.2 24.51 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.409 2.739 . . . . 0.0 109.881 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.42 136.51 57.94 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.09 -0.381 . . . . 0.0 110.091 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 -10.56 73.99 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.132 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.33 6.67 48.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.031 0.532 . . . . 0.0 111.133 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.11 145.51 24.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.92 151.85 49.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.017 0.913 . . . . 0.0 113.097 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.74 145.12 45.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.542 1.937 . . . . 0.0 114.553 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.73 136.7 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.11 178.44 7.17 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.461 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.2 m170 63.88 15.92 9.46 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.31 1.444 . . . . 0.0 112.798 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.43 142.79 94.79 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 117.902 0.319 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.66 166.69 28.68 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.907 2.405 . . . . 0.0 109.566 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -71.2 -14.24 62.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.34 -10.02 59.08 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.84 158.14 36.89 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 175.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.22 177.7 34.8 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -57.32 -40.67 78.41 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -84.95 -26.26 27.29 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.378 -0.201 . . . . 0.0 111.055 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -74.18 -38.28 63.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 tt -75.41 -26.34 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.57 -53.35 53.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -64.23 -23.05 67.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.821 0.448 . . . . 0.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 tpt -79.05 -25.09 43.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.267 -0.271 . . . . 0.0 110.506 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.266 29.0 m-85 -105.83 -10.96 16.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 -178.69 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.466 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 53.8 mtm -66.63 -29.56 2.85 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.2 Cg_endo -72.47 -8.42 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 CA-C-N 121.951 1.733 . . . . 0.0 112.167 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -89.42 -12.07 41.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.959 0.504 . . . . 0.0 111.208 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.49 -176.17 31.6 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -77.96 101.67 6.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.236 -0.567 . . . . 0.0 110.506 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.02 123.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -85.22 -30.84 6.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.9 t -152.85 151.69 30.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 110.661 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 136.32 13.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.87 0.868 . . . . 0.0 108.865 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -158.5 131.05 7.02 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.511 0.196 . . . . 0.0 110.583 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -95.68 134.36 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -69.53 144.64 53.08 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -133.19 144.55 36.0 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 123.168 0.587 . . . . 0.0 109.979 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -88.89 130.69 35.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.454 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.54 -11.46 60.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.994 -0.441 . . . . 0.0 111.251 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -89.84 -21.86 22.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.8 -13.72 1.92 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.2 9.12 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.338 1.055 . . . . 0.0 112.954 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -82.25 160.01 23.07 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.709 0.404 . . . . 0.0 109.996 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.2 t -69.51 139.99 53.89 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.341 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -82.53 6.4 17.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.7 m 60.87 22.64 12.72 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.59 168.41 27.23 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.24 -172.12 28.16 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.796 -0.565 . . . . 0.0 113.714 -173.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -136.75 144.38 43.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.151 1.78 . . . . 0.0 114.877 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.1 t -148.33 153.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 91.1 p -146.46 146.64 30.63 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.831 -0.543 . . . . 0.0 112.295 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.46 164.83 12.32 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.64 -11.15 59.96 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.54 149.92 23.71 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 122.984 0.514 . . . . 0.0 110.785 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.29 -18.1 39.4 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.099 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.61 -46.56 94.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-N 118.466 0.576 . . . . 0.0 110.83 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -71.33 -25.36 62.37 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.518 0.327 . . . . 0.0 111.04 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.71 -47.69 52.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.045 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -68.49 -27.83 66.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.143 0.428 . . . . 0.0 110.711 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -40.66 81.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.02 66.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.678 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.3 -52.23 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -68.51 -11.8 60.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.338 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.55 -27.7 17.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 89.0 mmm -120.4 -18.29 7.94 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -65.68 131.81 47.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.07 8.59 85.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 119.089 -0.839 . . . . 0.0 112.51 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -66.38 114.58 5.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.807 1.303 . . . . 0.0 109.103 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.4 129.1 37.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.436 0.562 . . . . 0.0 110.956 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 tt -145.14 122.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.18 -143.3 48.34 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.5 mtm -86.1 12.53 9.41 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 42.7 tttp -147.06 170.45 17.11 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.698 0.681 . . . . 0.0 110.356 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -111.99 140.7 46.44 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 122.937 0.495 . . . . 0.0 109.902 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.29 132.7 49.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.272 0.229 . . . . 0.0 111.233 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -95.58 139.05 32.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 67.3 t -135.24 140.08 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -154.31 163.7 39.74 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -79.85 150.78 30.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.491 0.717 . . . . 0.0 110.629 175.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.444 ' H ' HD23 ' A' ' 104' ' ' LEU . 64.4 tttp . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 173.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.45 -179.07 46.7 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.69 -178.52 1.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.071 3.181 . . . . 0.0 110.376 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.61 131.14 49.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.117 -0.364 . . . . 0.0 111.019 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.04 1.79 85.9 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 119.526 -0.597 . . . . 0.0 113.189 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.88 7.41 44.93 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -109.67 139.11 45.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.327 0.512 . . . . 0.0 110.359 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.4 mt -126.15 159.37 33.1 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -117.36 141.8 47.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.967 1.707 . . . . 0.0 114.582 171.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.08 132.37 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -135.53 179.97 6.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.0 m170 65.15 23.39 12.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.149 1.379 . . . . 0.0 112.747 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.17 136.46 72.58 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.326 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.78 168.86 23.44 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.537 2.825 . . . . 0.0 110.313 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -69.37 -11.32 60.71 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -80.02 -7.27 58.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -76.1 158.18 32.06 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.94 174.91 35.27 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.85 -36.03 73.91 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 117.202 0.501 . . . . 0.0 110.864 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -78.62 -33.97 46.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.29 0.236 . . . . 0.0 110.886 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -71.28 -39.29 71.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -75.74 -26.74 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.446 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.4 tm? -65.16 -53.81 39.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.556 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 tpt -72.81 -26.65 61.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 25.0 m-85 -103.52 -9.27 19.44 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.457 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 44.7 mtm -66.78 -31.33 3.96 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 50' ' ' MET . 76.9 Cg_endo -71.53 -8.18 22.73 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 121.959 1.735 . . . . 0.0 111.667 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -89.07 -14.76 35.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.825 0.45 . . . . 0.0 110.885 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.88 -174.33 30.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -75.25 105.56 6.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.364 -0.492 . . . . 0.0 110.668 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.73 123.69 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.5 mt -82.17 -34.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 O-C-N 122.211 -0.306 . . . . 0.0 110.292 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -156.14 156.86 34.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.415 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.33 148.03 26.3 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.682 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.11 131.75 6.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.624 0.369 . . . . 0.0 111.014 -174.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.92 129.36 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -74.32 149.16 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 mm -132.95 153.32 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.776 0.43 . . . . 0.0 110.466 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HE3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -80.04 -10.73 59.79 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.912 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -86.24 -23.59 26.35 Favored 'General case' 0 C--O 1.23 0.039 0 C-N-CA 122.817 0.447 . . . . 0.0 112.126 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.0 -14.71 1.36 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.4 6.95 1.56 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.043 0.937 . . . . 0.0 112.812 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.35 162.74 25.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.3 t -67.99 141.75 56.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 110.474 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -73.44 6.39 3.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 111.384 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.8 p 58.35 20.78 7.64 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.491 1.916 . . . . 0.0 112.687 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.19 169.93 23.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.36 -170.23 26.86 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 121.467 0.482 . . . . 0.0 112.404 -175.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -137.63 141.45 41.21 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.664 1.586 . . . . 0.0 114.905 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.8 t -145.12 152.08 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.6 p -143.3 149.57 38.01 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-O 120.923 0.392 . . . . 0.0 112.003 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -114.85 162.54 16.76 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -78.3 -11.04 59.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -155.69 150.28 20.22 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.557 0.743 . . . . 0.0 110.767 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.0 -20.57 38.26 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.311 2.674 . . . . 0.0 112.057 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.2 -45.13 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 CA-C-N 118.42 0.554 . . . . 0.0 111.09 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -71.58 -27.3 63.04 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.91 -48.13 39.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -67.0 -27.61 67.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.035 -0.416 . . . . 0.0 110.802 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.16 73.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.31 66.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.99 -51.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -68.28 -12.02 60.36 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.161 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.46 -32.85 20.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.008 -0.52 . . . . 0.0 112.379 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.2 mtp -123.2 -14.77 7.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.23 126.67 28.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.38 2.38 90.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.802 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -62.27 138.75 58.48 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -92.64 130.79 38.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.782 0.719 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.6 tt -144.83 123.98 6.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.33 -143.66 48.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 mmt -84.91 9.2 15.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.659 0.783 . . . . 0.0 113.075 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -140.67 179.11 6.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.554 0.616 . . . . 0.0 111.214 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -118.82 147.74 43.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.41 124.34 19.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.038 0.935 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -94.38 130.42 40.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.95 137.64 51.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 122.243 0.217 . . . . 0.0 110.52 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -153.7 161.25 42.29 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 122.395 -0.191 . . . . 0.0 111.152 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -74.86 154.49 38.22 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.219 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.582 ' H ' HD23 ' A' ' 104' ' ' LEU . 57.2 tttp . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 122.6 0.36 . . . . 0.0 110.327 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.568 0.223 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 -160.73 35.24 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.87 178.75 3.74 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.042 3.161 . . . . 0.0 110.522 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -60.71 136.09 57.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.961 -0.462 . . . . 0.0 111.328 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.67 -1.67 71.63 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.334 0.492 . . . . 0.0 112.725 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.99 38.76 1.03 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 111.346 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.64 144.59 31.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.029 -0.419 . . . . 0.0 111.308 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.7 mt -129.87 158.07 40.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 25.2 m-85 -112.64 143.83 43.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.407 1.483 . . . . 0.0 114.233 170.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.85 124.95 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.8 m-85 -129.19 179.48 5.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m170 64.02 15.95 9.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.598 1.559 . . . . 0.0 112.335 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.57 141.39 90.47 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 122.842 0.457 . . . . 0.0 110.557 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.88 165.23 32.65 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.307 2.671 . . . . 0.0 109.415 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.47 -5.86 45.0 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.62 -9.2 58.82 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.033 0.379 . . . . 0.0 111.423 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -75.22 158.17 33.36 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.4 175.54 34.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -58.48 -37.35 75.34 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.531 0.665 . . . . 0.0 110.287 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.36 -33.27 37.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.605 0.241 . . . . 0.0 110.914 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -72.73 -38.52 67.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -74.79 -26.13 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.91 -53.26 41.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.513 0.325 . . . . 0.0 111.257 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.2 tpt -80.62 -24.71 38.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.953 0.101 . . . . 0.0 110.748 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.262 21.3 m-85 -104.63 -12.32 16.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -179.212 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.479 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.9 mtm -66.39 -29.87 3.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.9 Cg_endo -71.66 -9.68 25.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 122.068 1.774 . . . . 0.0 111.694 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -87.77 -13.62 41.83 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.094 0.406 . . . . 0.0 111.502 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.32 -175.01 31.9 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -75.45 103.25 5.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.552 -0.381 . . . . 0.0 110.484 -177.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.6 t -86.05 124.78 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.5 mt -86.31 -29.32 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 O-C-N 122.43 -0.169 . . . . 0.0 110.585 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -156.51 154.9 31.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.66 149.11 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.68 0.792 . . . . 0.0 109.361 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -158.31 139.22 13.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.556 0.342 . . . . 0.0 111.658 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 t -118.15 131.04 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -71.73 156.48 39.29 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -133.29 145.35 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 C-N-CA 122.823 0.449 . . . . 0.0 110.027 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -88.4 132.13 34.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -79.04 -14.18 59.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.889 0.476 . . . . 0.0 111.595 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -89.61 -23.64 21.89 Favored 'General case' 0 C--N 1.335 -0.063 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.35 -11.76 2.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 62.0 10.51 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.346 1.059 . . . . 0.0 111.839 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.64 156.37 27.66 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.942 -0.474 . . . . 0.0 110.01 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.6 t -71.29 139.64 50.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.786 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.87 163.89 24.93 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.861 0.464 . . . . 0.0 110.873 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.6 m -84.32 13.18 5.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -158.91 171.98 19.05 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.41 -166.06 18.47 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.511 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.36 142.88 30.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.17 152.81 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.704 0.802 . . . . 0.0 109.782 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 t -144.02 141.08 29.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -104.8 162.69 13.09 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -77.99 -12.49 59.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 111.491 174.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -154.97 149.9 20.44 Favored Pre-proline 0 N--CA 1.451 -0.404 0 C-N-CA 123.088 0.555 . . . . 0.0 110.613 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.92 -21.62 32.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.066 2.511 . . . . 0.0 112.341 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.2 -39.28 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.879 -0.513 . . . . 0.0 111.837 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -73.77 -25.33 60.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.182 0.193 . . . . 0.0 110.586 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.01 -45.84 55.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.29 -30.63 71.09 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.9 0.318 . . . . 0.0 110.875 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.52 82.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.28 -26.37 65.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.4 mt -65.52 -53.07 43.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -67.9 -11.3 58.43 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.99 -29.29 16.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 92.9 mmm -120.43 -16.96 8.29 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -65.0 132.59 49.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 4.83 84.75 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.048 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -63.66 122.83 17.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.727 1.263 . . . . 0.0 111.419 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -76.52 128.96 35.77 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.791 0.329 . . . . 0.0 110.854 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -151.76 136.91 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.6 -111.77 3.5 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.2 ptp -128.7 13.66 6.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.174 0.59 . . . . 0.0 111.89 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -151.85 142.16 22.44 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.169 0.44 . . . . 0.0 110.636 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -81.85 144.7 30.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.243 -0.286 . . . . 0.0 110.702 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.83 127.16 31.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.309 0.244 . . . . 0.0 111.037 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.62 138.31 31.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.21 140.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -153.71 157.23 39.2 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 122.352 -0.217 . . . . 0.0 111.277 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -78.3 151.79 32.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.002 0.521 . . . . 0.0 109.781 174.681 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.495 ' H ' HD23 ' A' ' 104' ' ' LEU . 59.7 tttp . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.965 0.412 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.44 -165.78 30.92 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.588 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -69.88 177.5 5.6 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.127 3.218 . . . . 0.0 110.403 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -60.67 137.4 58.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.903 -0.498 . . . . 0.0 110.855 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -3.53 83.51 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.672 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -0.28 39.76 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.679 0.74 . . . . 0.0 112.703 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -102.54 136.26 42.68 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 118.213 0.461 . . . . 0.0 110.314 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.5 mt -124.18 154.58 39.88 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.892 0.853 . . . . 0.0 113.135 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -116.06 145.91 42.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.931 1.692 . . . . 0.0 114.011 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.43 137.82 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.57 176.35 8.96 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 9.4 m170 65.93 16.1 10.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.181 1.392 . . . . 0.0 112.644 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.3 146.19 98.76 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.709 0.403 . . . . 0.0 110.075 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 169.16 22.82 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.319 2.68 . . . . 0.0 109.833 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -68.47 -19.29 64.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.872 0.469 . . . . 0.0 112.206 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.0 -10.57 59.66 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -69.99 158.03 36.39 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.24 175.5 35.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.38 -35.74 72.44 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 117.466 0.633 . . . . 0.0 110.031 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -79.76 -33.16 40.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.913 0.485 . . . . 0.0 111.085 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.11 -39.04 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.2 tt -74.35 -24.96 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.6 tp -65.27 -52.29 55.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -65.22 -22.27 66.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.566 0.346 . . . . 0.0 111.382 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.2 tpp -78.24 -26.78 47.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.269 0.228 . . . . 0.0 110.713 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.266 22.9 m-85 -105.77 -11.57 16.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.458 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.5 mtm -66.91 -31.0 3.56 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 50' ' ' MET . 81.4 Cg_endo -71.97 -9.2 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.745 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -82.78 -24.32 33.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.74 0.416 . . . . 0.0 111.981 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 158.57 -163.52 33.09 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.96 103.04 10.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.556 0.678 . . . . 0.0 110.972 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.4 t -82.4 121.55 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.66 -32.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -157.83 152.4 24.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.965 0.506 . . . . 0.0 111.239 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.09 146.74 31.96 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.891 0.876 . . . . 0.0 109.068 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -156.79 139.26 14.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.76 0.424 . . . . 0.0 111.598 -172.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.45 129.19 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 168.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -72.18 147.84 46.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.5 mm -132.36 141.17 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.819 0.448 . . . . 0.0 110.461 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -90.12 134.85 34.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -77.64 -12.22 59.95 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.65 0.38 . . . . 0.0 111.755 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.9 -22.54 24.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.12 -14.64 1.78 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 62.12 8.2 2.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.506 1.122 . . . . 0.0 112.717 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.7 mt -82.42 161.0 22.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.814 0.445 . . . . 0.0 110.329 175.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.5 t -66.87 138.54 57.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -77.56 8.91 3.76 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.009 0.524 . . . . 0.0 111.619 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.5 m 61.91 23.08 13.52 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -156.5 167.45 30.41 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.21 -170.79 24.19 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 121.581 0.545 . . . . 0.0 113.433 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -142.39 142.67 32.44 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.224 1.81 . . . . 0.0 114.744 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.1 t -146.05 153.41 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.5 t -143.31 146.92 33.99 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -117.86 165.57 13.51 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -80.63 -13.31 59.14 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.03 148.58 21.7 Favored Pre-proline 0 C--O 1.233 0.205 0 C-N-CA 123.256 0.623 . . . . 0.0 111.378 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.86 -23.11 41.72 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.508 2.805 . . . . 0.0 112.132 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.74 -38.66 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 O-C-N 121.802 -0.561 . . . . 0.0 111.232 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.6 t -74.72 -29.79 61.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.319 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.01 37.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.26 -28.57 68.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.262 -0.274 . . . . 0.0 110.727 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.57 73.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.47 -26.56 68.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.68 -51.87 57.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 CA-C-N 118.836 0.744 . . . . 0.0 109.001 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.89 -11.81 57.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.37 -27.38 16.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.5 mmm -120.54 -17.27 8.14 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.67 134.66 53.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.72 2.39 85.55 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.839 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.37 120.02 13.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.814 1.307 . . . . 0.0 110.675 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.76 126.87 31.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.63 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.69 135.72 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.442 0.697 . . . . 0.0 109.567 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.72 31.82 76.74 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.518 -0.739 . . . . 0.0 111.828 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.5 mtm 64.64 22.19 12.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -144.75 155.81 43.73 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -97.95 134.62 40.81 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.376 -0.828 . . . . 0.0 111.159 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.8 mt -64.73 130.99 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.66 0.267 . . . . 0.0 111.351 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.52 137.39 32.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.7 t -134.36 135.33 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -150.31 160.51 43.66 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.699 0.227 . . . . 0.0 111.564 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -76.6 149.29 36.58 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.01 0.524 . . . . 0.0 110.002 177.127 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.477 ' H ' HD23 ' A' ' 104' ' ' LEU . 85.5 tttt . . . . . 0 C--O 1.234 0.251 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.76 -156.3 20.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.08 175.94 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.94 3.094 . . . . 0.0 110.48 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.44 139.83 58.81 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.87 0.06 88.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.79 -0.45 . . . . 0.0 112.733 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.72 14.76 30.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.613 0.706 . . . . 0.0 112.893 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -119.14 138.62 52.79 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 118.427 0.558 . . . . 0.0 110.588 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.1 mt -125.42 156.88 38.15 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -117.1 141.42 48.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.844 1.658 . . . . 0.0 113.806 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.38 140.73 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -144.93 176.57 9.38 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.443 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 16.6 m170 63.97 16.74 10.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.901 1.68 . . . . 0.0 112.984 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.06 141.5 94.28 Favored Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.45 163.03 39.78 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.988 2.459 . . . . 0.0 109.524 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.72 -7.62 49.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -78.56 -10.56 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.091 -0.381 . . . . 0.0 111.134 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.99 158.5 35.34 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.8 174.92 35.17 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -56.82 -38.98 73.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -75.7 -33.21 60.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.784 0.433 . . . . 0.0 111.255 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 73.5 m-20 -71.55 -38.73 70.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 tt -76.52 -24.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.449 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.4 tm? -64.91 -53.62 43.56 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -69.66 -23.37 63.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 tpp -71.58 -27.9 63.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 18.6 m-85 -102.3 -10.08 19.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.44 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 46.2 mtm -65.83 -32.28 5.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.1 Cg_endo -72.33 -8.15 22.18 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.692 1.64 . . . . 0.0 111.894 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.34 -14.18 36.24 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.663 0.385 . . . . 0.0 111.342 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.92 -171.92 31.96 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -77.77 103.09 7.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.39 -0.477 . . . . 0.0 110.373 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -81.66 124.24 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.56 -37.45 16.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -158.44 157.1 31.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.478 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.46 146.82 23.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.84 144.0 16.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.692 0.397 . . . . 0.0 111.143 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.25 139.74 38.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 172.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -75.53 146.69 40.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -132.85 143.65 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 123.246 0.619 . . . . 0.0 110.303 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -90.56 131.7 36.14 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.38 -9.39 59.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.9 -0.5 . . . . 0.0 111.536 -179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -88.77 -22.26 23.38 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.92 -12.72 1.69 Allowed 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 62.29 7.37 2.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.415 1.086 . . . . 0.0 112.815 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.46 161.07 22.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 t -70.71 142.06 51.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.925 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.13 8.76 4.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.4 m 62.4 26.19 15.62 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.5 165.99 34.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.0 -179.54 27.71 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 121.548 0.527 . . . . 0.0 113.543 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.29 139.72 37.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.163 1.785 . . . . 0.0 113.987 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.35 152.97 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 123.628 0.771 . . . . 0.0 109.669 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.0 t -141.35 143.51 34.05 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.54 0.336 . . . . 0.0 111.898 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -111.88 159.83 17.98 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -75.91 -13.45 60.26 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -153.68 150.47 23.2 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.545 0.738 . . . . 0.0 110.756 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.9 -22.11 31.92 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.256 2.637 . . . . 0.0 112.465 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.3 -38.91 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 118.336 0.516 . . . . 0.0 111.704 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.7 m -74.3 -25.74 59.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.132 0.173 . . . . 0.0 110.631 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.78 -46.79 43.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -66.81 -30.43 70.62 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 122.271 -0.268 . . . . 0.0 110.737 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.29 80.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -26.75 65.59 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.14 -51.82 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -67.56 -12.09 59.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.31 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.74 -28.82 17.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.1 mmm -120.4 -17.3 8.21 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.88 133.07 51.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.55 2.19 87.55 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.894 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.41 119.05 10.29 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.57 1.185 . . . . 0.0 110.168 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -78.68 126.94 31.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.036 -0.415 . . . . 0.0 111.378 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.7 tt -155.91 135.14 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.307 0.643 . . . . 0.0 109.743 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.12 32.25 75.49 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.416 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm 63.03 24.52 14.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.066 0.947 . . . . 0.0 113.381 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HE2' ' CG ' ' A' ' 35' ' ' HIS . 85.2 tttt -144.99 151.48 38.65 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -96.31 134.09 39.87 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.0 mt -64.52 125.94 26.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.22 0.208 . . . . 0.0 110.789 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -87.93 139.19 30.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.82 139.48 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -149.21 156.52 42.28 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.743 0.306 . . . . 0.0 111.265 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.514 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -74.2 147.99 42.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.814 0.445 . . . . 0.0 109.952 176.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.514 ' H ' HD23 ' A' ' 104' ' ' LEU . 84.6 tttt . . . . . 0 CA--C 1.53 0.184 0 C-N-CA 122.963 0.505 . . . . 0.0 110.785 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 120.372 0.13 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.64 173.42 49.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p -70.48 162.83 28.04 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.234 0.614 . . . . 0.0 111.032 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.0 t -154.11 161.85 41.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.785 0.434 . . . . 0.0 110.366 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -66.54 147.64 53.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.863 0.465 . . . . 0.0 110.852 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -83.87 -1.39 54.34 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 57.38 17.8 3.99 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.107 0.963 . . . . 0.0 113.421 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.476 ' CG ' ' H ' ' A' ' 9' ' ' HIS . 75.1 t60 58.51 173.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.72 1.208 . . . . 0.0 113.352 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.476 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 59.0 t-80 -66.55 153.55 42.7 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.196 0.598 . . . . 0.0 110.405 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -70.74 -25.78 63.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.157 0.583 . . . . 0.0 112.209 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.9 p -152.69 5.13 0.37 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 m 56.67 21.76 6.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.245 0.618 . . . . 0.0 112.579 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.88 -147.81 5.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.35 142.16 58.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.28 130.14 93.62 Favored Pre-proline 0 CA--C 1.529 0.172 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.1 141.71 36.8 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.168 2.579 . . . . 0.0 109.989 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 tpp85 -162.22 156.62 21.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.82 -11.48 83.46 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.582 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.3 p -160.07 159.95 32.55 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.639 0.72 . . . . 0.0 110.271 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -77.66 -23.28 49.69 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.511 0.324 . . . . 0.0 110.666 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.4 ptp 49.37 173.79 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.652 2.381 . . . . 0.0 114.394 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -94.21 152.11 18.96 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.402 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.41 159.34 38.62 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.493 1.117 . . . . 0.0 108.937 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -126.37 158.17 36.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.199 0.523 . . . . 0.0 112.344 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.12 -154.6 31.04 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.63 174.13 11.5 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.862 3.041 . . . . 0.0 110.574 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.02 139.67 58.4 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 122.238 -0.289 . . . . 0.0 110.615 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.9 -3.65 84.98 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.631 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.28 -1.46 53.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.786 0.793 . . . . 0.0 112.785 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -92.52 151.45 20.17 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.704 0.402 . . . . 0.0 110.596 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD13 ' HB1' ' A' ' 83' ' ' ALA . 1.4 tp -142.63 152.6 42.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.911 0.862 . . . . 0.0 113.213 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.45 145.93 47.43 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 126.516 1.926 . . . . 0.0 114.631 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.17 133.65 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.29 177.17 8.07 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 m170 65.67 16.11 10.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.572 1.549 . . . . 0.0 112.309 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.12 141.94 89.61 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 122.725 0.41 . . . . 0.0 110.524 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.55 164.46 35.53 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.757 2.305 . . . . 0.0 109.621 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -71.3 -8.12 51.55 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -77.31 -10.73 59.61 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.254 0.479 . . . . 0.0 111.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -72.58 158.16 36.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.73 175.98 34.91 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -56.88 -42.29 79.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -77.76 -27.82 50.46 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.656 0.382 . . . . 0.0 111.63 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -76.22 -37.92 57.1 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 tt -75.7 -25.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.8 tp -66.7 -51.75 52.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -65.16 -23.1 67.02 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.22 0.208 . . . . 0.0 111.501 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -76.4 -27.82 56.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.415 -0.178 . . . . 0.0 110.902 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.274 24.8 m-85 -105.37 -11.02 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 118.035 2.605 . . . . 0.0 118.035 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.465 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.1 mtm -66.75 -29.68 2.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.8 Cg_endo -72.5 -9.6 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.096 1.784 . . . . 0.0 112.216 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -86.61 -14.46 42.71 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.847 0.459 . . . . 0.0 111.453 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.64 -174.76 32.93 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -78.14 102.49 7.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.222 -0.575 . . . . 0.0 110.457 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -81.35 122.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.5 mt -81.89 -32.4 11.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 t -155.01 152.31 29.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.734 0.302 . . . . 0.0 110.777 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.58 143.06 21.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.735 0.814 . . . . 0.0 109.304 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HE3' ' CZ ' ' A' ' 61' ' ' PHE . 5.1 tmmm? -159.07 143.61 15.6 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 122.885 0.474 . . . . 0.0 110.896 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.63 137.15 43.14 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 169.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CZ ' ' HE3' ' A' ' 59' ' ' LYS . 74.4 m-85 -71.55 144.31 49.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mm -133.32 144.31 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 122.7 0.4 . . . . 0.0 110.195 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -89.06 130.93 35.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.9 -11.34 59.8 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.803 -0.561 . . . . 0.0 111.671 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -90.58 -22.6 21.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.07 -13.38 1.87 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 61.39 9.34 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.561 1.144 . . . . 0.0 113.091 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -80.41 157.91 26.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 t -69.48 139.52 53.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.593 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.29 7.95 10.23 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.0 m 62.7 24.61 14.65 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.09 169.02 25.49 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.4 -177.67 29.79 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 121.627 0.571 . . . . 0.0 113.233 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -136.67 140.12 42.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.997 1.719 . . . . 0.0 114.177 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -144.22 156.05 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.648 0.779 . . . . 0.0 109.167 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.2 t -147.77 144.54 28.31 Favored 'General case' 0 C--N 1.339 0.151 0 O-C-N 121.901 -0.499 . . . . 0.0 112.022 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.18 165.74 11.88 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -82.27 -9.65 59.41 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -153.97 150.44 22.73 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.24 0.616 . . . . 0.0 111.141 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.29 -21.78 30.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.04 -38.86 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 O-C-N 121.95 -0.469 . . . . 0.0 111.727 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -75.93 -25.89 56.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.207 0.203 . . . . 0.0 110.703 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -72.61 -50.82 22.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -68.06 -28.36 67.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.469 -0.144 . . . . 0.0 110.659 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.08 82.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.9 -25.9 66.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.842 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mt -67.18 -51.18 56.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -69.34 -11.89 61.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.57 -28.24 16.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.4 mmm -120.51 -15.71 8.46 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -67.75 136.96 55.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 2.72 73.61 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.138 -0.812 . . . . 0.0 112.91 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.73 117.3 7.28 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.673 1.237 . . . . 0.0 110.429 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.08 129.28 37.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.471 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 tt -146.73 123.9 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.91 -144.75 48.38 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.9 mtm -83.64 13.01 4.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.975 0.91 . . . . 0.0 112.818 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.61 173.43 11.6 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.253 0.621 . . . . 0.0 112.011 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -119.72 137.09 54.14 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.846 0.858 . . . . 0.0 109.051 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.09 135.51 56.45 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -99.32 138.64 36.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.77 139.15 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.482 0.313 . . . . 0.0 110.165 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -154.28 163.62 39.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.676 0.216 . . . . 0.0 111.46 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -73.84 154.14 39.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.244 0.618 . . . . 0.0 110.418 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.5 ' H ' HD23 ' A' ' 104' ' ' LEU . 27.7 ttpp -68.21 155.64 39.26 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.459 0.704 . . . . 0.0 110.269 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -67.47 157.56 33.94 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.699 0.285 . . . . 0.0 110.317 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.1 t -154.34 154.13 32.8 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.796 0.439 . . . . 0.0 110.87 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -72.57 -16.58 61.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -71.85 -22.4 61.54 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -105.6 -3.03 22.79 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.6 t -75.61 -5.14 43.92 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.455 0.702 . . . . 0.0 111.428 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.98 156.98 73.89 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.458 0.703 . . . . 0.0 111.428 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.2 -15.43 16.14 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.931 3.087 . . . . 0.0 112.105 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.4 m95 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.948 -177.08 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.095 0 C5'-C4'-C3' 111.176 -2.882 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.215 0 O4'-C4'-C3' 108.074 1.838 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.174 0 C5'-C4'-C3' 112.23 -2.18 . 0.033 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . 0.499 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.907 1 O4'-C1'-N19 112.311 4.111 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . 0.434 " H5'" " H4'" ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.85 0 O4'-C1'-N19 111.963 3.763 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.35 -178.75 46.38 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.4 t -70.01 166.44 19.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.269 0.628 . . . . 0.0 110.766 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 t -146.84 162.28 38.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.514 0.726 . . . . 0.0 110.345 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 55.92 19.92 3.88 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.009 0.923 . . . . 0.0 111.894 -175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -156.52 172.66 18.16 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.15 0.98 . . . . 0.0 108.939 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -61.09 161.49 8.51 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.847 0.356 . . . . 0.0 110.722 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -57.12 129.04 40.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.04 -174.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 10' ' ' HIS . 82.5 t60 -162.84 168.34 21.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.635 0.774 . . . . 0.0 109.63 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' N ' ' CG ' ' A' ' 9' ' ' HIS . 64.5 t-80 -64.25 160.76 17.95 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.414 0.686 . . . . 0.0 110.666 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.1 p -73.45 4.96 4.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.344 0.658 . . . . 0.0 112.289 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 t -146.5 171.98 14.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.477 0.711 . . . . 0.0 110.325 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.22 171.45 36.1 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.7 tp -148.5 146.44 28.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.472 0.309 . . . . 0.0 110.23 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.8 p -155.48 138.16 10.38 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 123.337 0.655 . . . . 0.0 110.178 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.01 142.46 56.6 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.63 2.22 . . . . 0.0 110.382 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -77.25 164.7 25.35 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.063 0.545 . . . . 0.0 110.999 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.52 -1.46 70.99 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.254 0.454 . . . . 0.0 112.465 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 99.8 p -68.21 160.96 28.15 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.674 0.737 . . . . 0.0 110.83 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -80.62 -7.94 59.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.554 0.341 . . . . 0.0 111.72 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mtm -75.59 167.44 21.89 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.021 0.439 . . . . 0.0 111.403 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -81.14 153.22 27.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.16 0.584 . . . . 0.0 111.064 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -122.46 159.57 27.35 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.5 0.72 . . . . 0.0 110.475 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -131.77 155.28 48.02 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.584 0.354 . . . . 0.0 111.067 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.73 -157.75 30.4 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.95 177.64 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.644 2.896 . . . . 0.0 110.336 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.35 141.99 58.56 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.114 -0.366 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.13 0.68 77.7 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.76 -0.466 . . . . 0.0 112.703 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.03 31.57 4.46 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.664 0.732 . . . . 0.0 112.268 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -138.85 139.48 38.16 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 122.102 -0.374 . . . . 0.0 111.439 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.6 mt -127.01 154.9 44.04 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -114.23 144.08 43.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.959 1.704 . . . . 0.0 114.173 171.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.49 135.85 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 72' ' ' PHE . 14.8 m-85 -139.2 176.85 8.35 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.445 ' NE2' " H1'" ' B' ' 115' ' ' ' U' . 7.9 m170 64.87 13.79 8.78 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.23 1.412 . . . . 0.0 112.952 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.61 146.7 98.2 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.17 163.08 40.4 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.352 2.035 . . . . 0.0 109.438 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -68.86 -16.69 63.84 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -172.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -74.9 -11.43 60.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -68.86 158.33 34.71 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.0 178.14 33.54 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -57.03 -42.3 80.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -77.45 -26.0 51.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 66.9 m-20 -73.51 -41.11 63.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -74.09 -25.75 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 46' ' ' LEU . 1.9 tm? -64.81 -49.9 68.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -65.36 -25.68 67.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.7 mmm -76.29 -24.15 54.41 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.285 19.5 m-85 -105.07 -9.82 17.57 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.448 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -66.17 -33.43 6.86 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.0 Cg_endo -74.13 -8.48 21.06 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.738 1.656 . . . . 0.0 112.075 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -87.75 -14.9 38.49 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.582 0.353 . . . . 0.0 111.494 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.37 32.86 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -77.6 101.14 6.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.306 -0.526 . . . . 0.0 110.561 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -77.58 118.75 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.33 -35.78 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -158.51 157.14 31.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.814 0.34 . . . . 0.0 110.507 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.19 140.88 15.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.72 133.74 8.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.594 0.235 . . . . 0.0 111.341 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.5 t -93.25 143.26 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.442 ' CD2' ' CZ ' ' A' ' 72' ' ' PHE . 4.9 m-85 -73.08 148.5 43.98 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.7 mm -132.49 144.77 35.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 122.842 0.457 . . . . 0.0 110.203 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.22 131.17 37.66 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.33 -12.41 60.26 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 121.741 -0.599 . . . . 0.0 111.393 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -88.37 -23.79 23.28 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.404 0.682 . . . . 0.0 112.692 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -132.93 -14.14 2.75 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.9 t30 62.05 8.66 2.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.927 1.291 . . . . 0.0 112.094 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.17 164.48 18.09 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.932 0.493 . . . . 0.0 110.186 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.6 t -68.28 140.02 55.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.364 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -81.06 8.47 8.5 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.704 0.402 . . . . 0.0 111.891 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.1 m 63.07 21.32 12.82 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.442 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 4.0 p90 -155.52 167.12 31.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.0 -172.0 28.84 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 121.496 0.498 . . . . 0.0 114.035 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -136.6 145.48 44.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.411 1.884 . . . . 0.0 114.996 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -145.77 152.69 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.314 1.045 . . . . 0.0 109.283 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.3 p -142.79 149.72 39.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.391 0.541 . . . . 0.0 112.193 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.18 165.59 13.61 Favored 'General case' 0 N--CA 1.458 -0.054 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -80.89 -10.52 59.71 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -153.87 150.31 22.61 Favored Pre-proline 0 N--CA 1.453 -0.291 0 C-N-CA 123.287 0.635 . . . . 0.0 110.88 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.57 -20.95 40.42 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.437 2.758 . . . . 0.0 112.14 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.41 -39.04 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 O-C-N 121.801 -0.562 . . . . 0.0 111.611 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -74.88 -26.22 59.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.65 -48.54 25.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 122.449 -0.157 . . . . 0.0 110.624 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -65.92 -29.71 70.17 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.062 -0.399 . . . . 0.0 111.046 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.59 77.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.76 -26.71 64.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 119.567 -0.254 . . . . 0.0 111.662 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.69 -51.89 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.95 -11.89 59.68 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.71 -28.95 17.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.46 -14.74 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -67.45 136.19 54.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.85 1.53 84.51 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.862 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -66.01 118.95 10.52 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.772 1.286 . . . . 0.0 109.785 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.66 125.55 29.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.954 0.343 . . . . 0.0 111.55 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.0 tt -157.63 135.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.228 0.611 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.32 82.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.403 -0.81 . . . . 0.0 112.194 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 22.4 mmt 63.06 23.34 13.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.276 1.03 . . . . 0.0 113.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -145.35 155.51 43.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -97.81 132.73 43.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.79 -0.569 . . . . 0.0 110.481 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.44 128.34 36.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.24 0.216 . . . . 0.0 111.08 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -90.73 136.08 33.3 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.34 136.95 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -152.71 160.7 43.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 117.972 0.351 . . . . 0.0 111.916 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.15 156.28 38.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.069 0.548 . . . . 0.0 110.42 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 106' ' ' ARG . 60.8 tttp -70.53 154.57 41.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.454 0.645 . . . . 0.0 112.401 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' N ' ' CG ' ' A' ' 105' ' ' LYS . 86.2 mtt-85 -132.43 160.47 36.3 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.458 1.903 . . . . 0.0 107.987 173.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.7 m -131.49 161.91 31.46 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.763 0.316 . . . . 0.0 111.029 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.35 -21.05 66.49 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -70.84 -10.57 59.84 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.567 0.347 . . . . 0.0 111.393 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -80.34 -7.41 59.06 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.726 0.41 . . . . 0.0 111.341 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.1 t -125.35 -31.14 3.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.971 0.509 . . . . 0.0 111.526 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.479 ' HZ2' ' HB2' ' A' ' 112' ' ' LYS . 9.8 mtmp? -73.69 155.96 88.74 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 117.836 0.289 . . . . 0.0 110.326 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.52 4.26 6.5 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.765 2.977 . . . . 0.0 110.6 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.748 -1.12 . . . . 0.0 109.275 -178.705 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . 0.445 " H1'" ' NE2' ' A' ' 35' ' ' HIS . . . . . . . . 0 O4'--C4' 1.419 -2.813 1 O4'-C1'-N19 112.223 4.023 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.786 0 O4'-C1'-N19 111.066 2.866 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.995 0 C3'-C2'-C1' 98.085 -3.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.825 2 O4'-C1'-N19 112.983 4.783 . 0.46 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 2 O4'-C1'-N19 114.017 5.817 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.7 mtm . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.407 0.146 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.38 -8.25 87.91 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.839 -0.423 . . . . 0.0 112.405 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.2 t -68.63 153.39 43.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.74 0.77 . . . . 0.0 111.17 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.6 m -75.19 -6.59 50.45 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.889 0.476 . . . . 0.0 111.485 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.416 ' CG ' ' H ' ' A' ' 6' ' ' HIS . 78.5 t60 59.74 173.11 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.021 1.328 . . . . 0.0 112.444 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' H ' ' CG ' ' A' ' 5' ' ' HIS . 73.9 t60 -66.26 149.16 50.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.152 0.581 . . . . 0.0 110.38 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -74.68 163.72 27.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.979 0.418 . . . . 0.0 111.253 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -67.98 153.62 43.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.569 0.348 . . . . 0.0 111.184 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -68.21 164.59 20.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.157 0.583 . . . . 0.0 111.061 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -66.31 -10.72 45.44 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.795 0.438 . . . . 0.0 111.399 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.6 m -68.39 -7.09 28.46 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.005 0.522 . . . . 0.0 111.433 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t -66.51 -15.96 63.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.738 0.415 . . . . 0.0 111.089 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.13 -1.35 85.37 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.785 -0.453 . . . . 0.0 112.222 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.6 tp -65.81 144.68 56.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.4 0.68 . . . . 0.0 110.748 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.3 m -133.26 148.43 69.04 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 123.515 0.726 . . . . 0.0 111.931 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.77 21.52 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 124.936 3.757 . . . . 0.0 114.171 -172.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.6 169.75 4.64 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.552 -0.718 . . . . 0.0 110.73 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.07 -2.71 1.63 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.9 m -73.82 -18.45 60.95 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 117.562 0.681 . . . . 0.0 111.487 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 51.63 29.19 5.35 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.243 1.017 . . . . 0.0 113.674 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.5 mtm -74.28 -6.43 47.93 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.022 -0.424 . . . . 0.0 112.095 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -70.04 148.27 49.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.08 0.552 . . . . 0.0 110.497 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -118.28 159.5 23.26 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 123.711 0.804 . . . . 0.0 113.144 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -83.49 164.58 19.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.55 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.75 -156.43 31.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.578 1.085 . . . . 0.0 113.117 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.19 -178.43 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.609 3.539 . . . . 0.0 111.542 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -57.86 130.21 45.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.268 0.627 . . . . 0.0 111.305 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.82 -2.0 70.84 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.498 0.57 . . . . 0.0 113.19 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.76 36.59 0.9 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.714 0.757 . . . . 0.0 111.871 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 140.23 33.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.966 -0.458 . . . . 0.0 111.371 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.18 162.09 26.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 19.7 m-85 -119.72 143.57 47.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 114.917 173.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.16 124.69 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 13.1 m-85 -128.77 179.71 5.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.8 m170 63.25 16.2 9.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.014 1.326 . . . . 0.0 112.836 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.9 142.33 93.34 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 118.144 0.429 . . . . 0.0 109.968 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.61 163.64 36.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.137 2.558 . . . . 0.0 109.722 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -68.81 -17.47 64.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -74.32 -10.29 59.44 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.038 -0.414 . . . . 0.0 112.046 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.03 158.14 36.51 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.9 176.59 33.34 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -56.84 -38.79 73.15 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.656 0.383 . . . . 0.0 110.642 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.04 -42.34 73.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.46 -26.11 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.464 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.0 tm? -64.86 -50.5 66.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -69.82 -23.11 63.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.7 -26.76 62.63 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.158 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 28.1 m-85 -104.23 -8.36 19.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 118.108 2.632 . . . . 0.0 118.108 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.44 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -67.33 -32.47 4.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.1 Cg_endo -73.38 -8.33 21.67 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.87 1.703 . . . . 0.0 112.164 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -89.9 -14.34 34.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.053 0.541 . . . . 0.0 111.283 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.02 -175.6 33.72 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -78.28 103.76 8.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.24 -0.565 . . . . 0.0 110.697 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.52 120.78 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.8 mt -84.02 -34.01 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.2 t -152.39 150.89 30.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 111.277 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.69 142.38 16.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.509 0.724 . . . . 0.0 109.209 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.614 ' HE3' ' CE1' ' A' ' 61' ' ' PHE . 3.0 tmmm? -159.87 134.49 7.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.679 0.392 . . . . 0.0 110.592 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.68 136.97 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.614 ' CE1' ' HE3' ' A' ' 59' ' ' LYS . 78.1 m-85 -69.15 150.0 48.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.12 143.27 41.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 122.77 0.428 . . . . 0.0 110.098 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.34 129.41 35.02 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -74.87 -12.48 60.38 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.949 -0.469 . . . . 0.0 111.541 -179.195 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -89.7 -23.23 21.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -134.71 -13.65 2.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 61.58 11.09 3.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.08 158.69 24.97 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 122.029 -0.42 . . . . 0.0 110.062 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -72.31 135.3 45.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.008 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -81.52 166.84 19.93 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.053 0.454 . . . . 0.0 111.135 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.7 m -79.19 12.05 2.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -157.01 170.82 21.67 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.05 -174.43 25.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.822 0.725 . . . . 0.0 112.447 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -138.62 145.15 40.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.94 152.95 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.24 1.016 . . . . 0.0 110.157 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -147.32 147.8 30.72 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.75 166.56 10.92 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -79.15 -8.56 59.1 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -153.06 150.8 24.85 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 123.221 0.609 . . . . 0.0 110.902 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -71.67 -16.16 30.17 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.142 2.561 . . . . 0.0 111.656 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.17 -46.8 92.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 118.383 0.538 . . . . 0.0 110.845 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -70.01 -24.6 63.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.841 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.36 -47.18 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.916 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -67.07 -29.7 69.54 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.159 -0.338 . . . . 0.0 110.758 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 -41.52 80.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.43 65.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -66.01 -52.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.79 -12.14 57.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.119 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.46 -31.5 17.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.7 mtp -124.64 -9.06 7.36 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.87 128.04 34.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.8 90.25 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.572 -0.571 . . . . 0.0 112.617 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -62.25 120.03 10.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.447 1.123 . . . . 0.0 111.295 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -76.0 129.77 37.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.981 -0.45 . . . . 0.0 111.516 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.78 122.42 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.03 -143.63 48.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -87.34 16.64 5.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.57 0.748 . . . . 0.0 112.767 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -144.67 172.67 12.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.366 0.53 . . . . 0.0 109.968 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -117.66 143.89 45.74 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.181 0.592 . . . . 0.0 110.372 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.85 133.04 48.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.787 0.435 . . . . 0.0 111.151 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.481 ' HE3' ' C4 ' ' B' ' 116' ' ' ' U' . 17.8 ttmm -92.72 136.55 33.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.9 t -134.76 140.46 45.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -155.06 164.35 39.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.366 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.86 153.49 41.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.68 0.792 . . . . 0.0 110.188 175.227 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.527 ' H ' HD23 ' A' ' 104' ' ' LEU . 85.1 tttt -63.22 152.02 38.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.316 0.646 . . . . 0.0 109.599 174.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -64.78 160.09 20.98 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 120.891 0.377 . . . . 0.0 110.248 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.6 t -67.82 150.13 49.0 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.06 0.457 . . . . 0.0 110.924 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.55 ' H ' ' CD ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -71.63 -9.32 58.06 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.009 0.523 . . . . 0.0 110.717 176.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -69.58 -18.55 63.64 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -82.26 -14.65 55.15 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.8 m -83.35 -12.5 56.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.706 0.403 . . . . 0.0 111.029 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.53 152.78 95.32 Favored Pre-proline 0 CA--C 1.528 0.117 0 C-N-CA 122.801 0.44 . . . . 0.0 111.042 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.99 -13.36 23.88 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.726 2.951 . . . . 0.0 111.21 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.2 m95 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.038 -1.458 . . . . 0.0 112.016 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 0 C5'-C4'-C3' 110.328 -3.448 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . 0.481 ' C4 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.414 -3.237 0 O4'-C1'-N19 111.719 3.519 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.353 0 C3'-C2'-C1' 98.704 -3.107 . 0.034 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.958 1 C3'-C2'-C1' 105.505 4.45 . 0.378 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 2 O4'-C1'-N19 112.826 4.626 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.514 0.197 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.28 179.84 48.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -76.78 -0.95 25.71 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.02 0.528 . . . . 0.0 112.253 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 t -154.93 160.76 41.37 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.308 0.643 . . . . 0.0 110.115 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -153.63 -3.16 0.2 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -73.92 161.0 30.59 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.333 0.515 . . . . 0.0 110.801 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -70.78 -18.45 62.75 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -76.69 -10.11 59.15 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.992 -0.443 . . . . 0.0 111.195 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -74.98 -18.4 60.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.72 0.408 . . . . 0.0 110.983 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -83.18 -6.33 59.44 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.31 0.644 . . . . 0.0 111.548 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -70.5 158.54 35.9 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.403 0.281 . . . . 0.0 111.311 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -156.28 161.6 40.21 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.995 0.518 . . . . 0.0 110.111 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.78 169.33 54.47 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.0 tp -153.81 149.43 27.4 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.021 0.528 . . . . 0.0 110.149 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -65.26 133.3 95.49 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 122.875 0.47 . . . . 0.0 111.324 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.77 -3.12 10.66 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.463 2.775 . . . . 0.0 113.255 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -143.61 20.3 1.85 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.23 178.35 28.05 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 123.184 0.421 . . . . 0.0 112.402 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.8 t -157.93 157.48 33.18 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.911 0.484 . . . . 0.0 110.457 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -66.9 -37.3 84.12 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.71 0.404 . . . . 0.0 110.62 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.2 mtm 57.05 156.05 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.403 1.481 . . . . 0.0 113.489 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -126.7 152.24 47.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 121.723 -0.611 . . . . 0.0 110.164 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -137.71 159.08 42.97 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.36 0.664 . . . . 0.0 109.942 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -133.49 153.94 51.22 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.31 -165.5 35.07 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.85 167.56 19.24 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.402 2.735 . . . . 0.0 109.39 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -64.28 138.73 58.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.963 -0.46 . . . . 0.0 110.122 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.72 86.37 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.723 -0.487 . . . . 0.0 112.179 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.06 21.24 16.1 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.463 0.705 . . . . 0.0 112.233 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -125.31 137.52 54.07 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.38 161.86 22.66 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 122.19 0.995 . . . . 0.0 113.653 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -119.08 143.96 46.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.852 1.661 . . . . 0.0 114.555 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.81 129.47 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -134.99 178.89 6.67 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.7 m170 63.96 17.14 10.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.374 1.469 . . . . 0.0 113.293 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.88 142.8 95.88 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 122.767 0.427 . . . . 0.0 110.444 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.96 171.89 17.3 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.792 2.995 . . . . 0.0 110.97 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -68.98 -21.37 64.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.959 0.904 . . . . 0.0 112.448 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -75.63 -6.61 51.24 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.72 158.13 28.38 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.32 175.08 34.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -61.92 -36.64 81.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -75.2 -31.42 60.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.377 0.271 . . . . 0.0 110.726 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -73.34 -38.24 65.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -76.21 -24.77 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.5 tm? -66.83 -53.0 37.02 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -66.11 -23.52 66.51 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.447 0.166 . . . . 0.0 111.447 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.3 tpp -75.77 -29.43 58.79 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.68 0.392 . . . . 0.0 110.828 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.308 24.6 m-85 -102.11 -8.77 21.12 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.46 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 43.7 mtm -66.36 -30.83 3.81 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.2 Cg_endo -72.28 -10.39 25.62 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.88 1.707 . . . . 0.0 111.789 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -86.2 -14.99 42.31 Favored 'General case' 0 C--N 1.338 0.073 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.14 -171.48 32.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -76.59 103.61 6.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.433 -0.451 . . . . 0.0 110.727 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.51 122.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.3 mt -82.62 -33.54 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -156.42 156.34 33.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.022 0.439 . . . . 0.0 110.399 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.37 149.25 25.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -159.68 141.23 12.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.0 111.403 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 t -115.05 128.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.42 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 41.8 m-85 -71.69 157.34 38.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mm -126.32 140.47 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.052 0 C-N-CA 122.493 0.317 . . . . 0.0 110.499 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -87.36 131.28 34.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -75.26 -12.95 60.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.92 0.488 . . . . 0.0 111.5 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -89.72 -21.94 22.45 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.13 -14.43 1.79 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 61.67 8.8 2.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 112.711 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.36 162.21 23.49 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.77 0.428 . . . . 0.0 110.151 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -69.47 136.47 51.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.737 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -76.27 164.18 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.4 m -77.32 10.05 2.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -156.86 172.05 19.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.46 -165.57 19.71 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.367 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -141.41 144.37 34.43 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -147.0 151.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.751 0.82 . . . . 0.0 109.303 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 94.8 p -141.8 149.27 40.16 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -116.83 159.9 21.66 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -77.26 -13.38 59.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.148 0.499 . . . . 0.0 112.012 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -155.13 149.57 19.78 Favored Pre-proline 0 N--CA 1.456 -0.158 0 C-N-CA 123.223 0.609 . . . . 0.0 110.965 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.11 -21.68 42.25 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.644 2.896 . . . . 0.0 111.94 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.69 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 118.534 0.606 . . . . 0.0 111.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -76.1 -25.56 55.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.286 0.235 . . . . 0.0 110.769 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.32 -48.16 30.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -66.46 -28.42 68.58 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.764 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.89 76.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.13 66.15 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.35 -53.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.48 -11.51 58.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.458 0.303 . . . . 0.0 111.163 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.61 -31.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 119.019 -0.515 . . . . 0.0 112.375 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.4 mtp -128.73 -9.04 5.02 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -61.64 125.11 22.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.27 6.14 89.0 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.824 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.04 119.76 10.73 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.681 1.24 . . . . 0.0 112.333 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -76.92 130.06 37.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.976 0.353 . . . . 0.0 110.963 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -145.09 136.03 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.22 -100.41 0.35 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.1 ptp -139.78 17.21 2.5 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.045 0.938 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -148.02 152.77 37.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.825 0.45 . . . . 0.0 110.181 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -93.36 139.52 30.58 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 122.138 -0.351 . . . . 0.0 111.008 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 89.9 mt -68.49 131.16 44.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.709 0.404 . . . . 0.0 110.987 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.413 ' HE3' ' C5 ' ' B' ' 116' ' ' ' U' . 16.6 ttmm -90.82 135.67 33.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 170.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.32 136.7 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -152.67 159.81 43.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.651 0.262 . . . . 0.0 111.417 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -75.75 152.31 37.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.254 0.622 . . . . 0.0 109.658 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.522 ' H ' HD23 ' A' ' 104' ' ' LEU . 26.4 ttpp -63.51 157.98 22.16 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.239 0.616 . . . . 0.0 109.859 173.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -60.09 158.86 10.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.934 0.494 . . . . 0.0 110.794 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.2 t -151.8 154.86 37.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.755 0.422 . . . . 0.0 110.817 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -73.04 -10.61 59.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.564 0.346 . . . . 0.0 111.501 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -67.61 -14.62 63.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.067 -0.396 . . . . 0.0 111.681 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -78.65 -28.45 45.42 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.6 t -85.75 -31.13 22.56 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.995 -0.441 . . . . 0.0 111.08 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -76.14 154.22 84.47 Favored Pre-proline 0 N--CA 1.457 -0.085 0 C-N-CA 122.863 0.465 . . . . 0.0 111.207 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.78 -12.42 22.01 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.584 2.856 . . . . 0.0 110.929 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.7 m95 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 117.31 -1.329 . . . . 0.0 111.437 178.612 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.928 0 C5'-C4'-C3' 110.089 -3.608 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . 0.413 ' C5 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.083 0 O4'-C1'-N19 111.834 3.634 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.448 0 C3'-C2'-C1' 99.296 -2.449 . 0.18 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.93 1 C3'-C2'-C1' 105.693 4.659 . 0.345 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . 0.42 " H1'" ' CD1' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -3.008 2 O4'-C1'-N19 112.944 4.744 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mtp . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.03 -150.36 51.81 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.8 m -67.43 -9.82 45.41 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.955 0.377 . . . . 0.0 111.84 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 m 54.1 21.82 3.19 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.493 1.117 . . . . 0.0 113.131 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -154.82 150.17 27.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.561 0.744 . . . . 0.0 109.463 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -144.23 163.78 32.64 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.398 0.679 . . . . 0.0 110.639 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -67.65 -6.67 21.55 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -76.09 -12.66 60.16 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.734 0.414 . . . . 0.0 111.119 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -71.29 149.22 46.37 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.214 0.606 . . . . 0.0 110.08 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -69.87 -13.63 62.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -79.27 -11.65 59.95 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.92 0.488 . . . . 0.0 111.256 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -67.29 154.54 41.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.676 0.391 . . . . 0.0 111.683 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.81 -6.59 87.19 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.79 141.36 57.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.239 0.519 . . . . 0.0 110.39 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.06 139.63 11.76 Favored Pre-proline 0 CA--C 1.531 0.232 0 C-N-CA 123.212 0.605 . . . . 0.0 111.125 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.09 145.47 61.15 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.554 2.17 . . . . 0.0 109.939 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -75.93 156.22 34.41 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.687 0.279 . . . . 0.0 111.261 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.29 -2.83 90.32 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.645 -0.53 . . . . 0.0 112.6 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.1 t -66.55 153.29 43.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.777 0.788 . . . . 0.0 111.212 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -155.14 18.44 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.41 0.684 . . . . 0.0 110.294 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 74.7 mtm -69.2 161.64 28.77 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.847 0.459 . . . . 0.0 111.602 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 22' ' ' GLN . 4.0 pm0 -63.52 152.63 38.02 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.424 0.689 . . . . 0.0 110.449 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -139.52 151.29 46.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.403 0.681 . . . . 0.0 110.293 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -87.96 154.22 20.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.874 0.87 . . . . 0.0 112.51 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.53 -173.7 49.13 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.39 0.519 . . . . 0.0 111.966 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.97 165.68 29.21 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.765 2.977 . . . . 0.0 109.877 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.08 131.26 47.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.4 -9.98 69.31 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.41 5.42 51.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.561 0.68 . . . . 0.0 110.969 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -95.52 142.08 28.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.27 159.88 35.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.719 0.771 . . . . 0.0 112.607 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.3 m-85 -122.6 145.89 47.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.824 1.65 . . . . 0.0 114.847 173.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.4 137.46 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.2 m-85 -140.65 179.46 6.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.458 ' CG ' ' HE3' ' A' ' 98' ' ' LYS . 20.1 m170 62.96 17.28 9.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.513 1.125 . . . . 0.0 112.924 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.42 142.51 92.18 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.055 0.388 . . . . 0.0 110.165 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.15 168.14 25.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.169 2.58 . . . . 0.0 109.959 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.05 -16.93 62.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -76.79 -9.67 58.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -72.62 158.08 36.34 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.1 171.73 33.36 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -59.86 -36.02 76.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -74.32 -29.42 61.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.887 0.475 . . . . 0.0 110.924 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -76.49 -42.42 43.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -71.29 -24.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.05 -49.72 73.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -64.9 -24.59 67.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.441 0.296 . . . . 0.0 111.712 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.2 mmm -76.19 -24.2 54.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.385 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 28.7 m-85 -107.32 -12.14 15.41 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.5 mtm -66.71 -31.15 3.83 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.6 Cg_endo -72.44 -10.65 25.72 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 121.986 1.745 . . . . 0.0 112.091 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -87.6 -14.07 41.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.744 0.418 . . . . 0.0 111.807 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.82 -174.74 33.06 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -75.62 106.52 7.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.343 -0.504 . . . . 0.0 110.382 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.4 122.34 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.411 HD11 ' HA ' ' A' ' 78' ' ' ASP . 28.6 mt -87.42 -27.83 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 t -149.8 146.73 27.32 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.915 0.388 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 143.38 24.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.166 0.986 . . . . 0.0 108.534 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.53 142.52 15.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.39 0.276 . . . . 0.0 111.565 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -118.5 131.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 169.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.49 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 40.1 m-85 -75.26 146.63 40.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -172.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -133.77 145.69 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.174 0.589 . . . . 0.0 110.094 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -85.45 129.09 34.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.92 -11.29 59.94 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.836 -0.54 . . . . 0.0 111.945 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -90.65 -21.81 21.49 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 -11.41 1.46 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.99 10.53 2.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.581 1.152 . . . . 0.0 112.903 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.96 159.97 23.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.118 0.485 . . . . 0.0 110.006 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -70.07 142.71 52.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.807 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -84.29 -0.8 53.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.679 0.792 . . . . 0.0 111.206 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.2 m 61.34 19.44 10.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.94 170.41 22.19 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.39 -168.12 24.88 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 121.368 0.427 . . . . 0.0 113.568 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -140.92 144.19 35.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.968 1.707 . . . . 0.0 114.967 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.1 t -147.39 154.22 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -148.7 145.72 27.8 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.323 0.511 . . . . 0.0 112.107 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.91 162.08 13.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' HD11 ' A' ' 56' ' ' ILE . 36.0 t0 -77.18 -11.13 59.78 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 174.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -154.54 146.8 17.39 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 123.128 0.571 . . . . 0.0 110.61 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.18 -21.83 41.6 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.361 2.707 . . . . 0.0 112.626 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.4 p -63.59 -39.18 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 O-C-N 121.885 -0.51 . . . . 0.0 111.509 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -74.17 -24.55 59.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.103 0.161 . . . . 0.0 110.926 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.69 -48.0 35.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 121.395 -0.122 . . . . 0.0 110.683 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -67.15 -29.62 69.38 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.408 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.01 82.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.74 67.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.82 -52.79 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -68.39 -11.01 59.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.383 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.01 -31.56 18.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.2 mtp -123.88 -12.31 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.26 126.75 28.41 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.53 5.17 87.11 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.779 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.07 116.73 7.48 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.813 1.306 . . . . 0.0 110.039 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.67 131.12 40.62 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -144.79 121.61 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.77 -137.52 48.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -86.99 4.8 40.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HE3' ' CG ' ' A' ' 35' ' ' HIS . 29.4 ttpt -147.45 161.75 40.43 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 111.34 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -97.39 144.56 27.01 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.738 0.415 . . . . 0.0 110.671 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.4 126.69 30.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.358 0.263 . . . . 0.0 110.843 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HE3' ' C4 ' ' B' ' 116' ' ' ' U' . 19.9 ttmm -89.57 139.17 30.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.45 138.66 50.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -150.8 162.39 40.83 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -81.94 147.91 29.0 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.99 -0.444 . . . . 0.0 110.326 175.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.48 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.2 tttt -60.19 144.97 48.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -86.73 159.96 18.98 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.897 0.38 . . . . 0.0 110.944 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.4 t -80.42 156.48 26.62 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -100.35 -3.48 31.08 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.098 0.559 . . . . 0.0 111.667 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -70.3 -12.81 61.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -111.3 -15.99 13.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.9 t -76.89 -22.97 52.61 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.073 0.549 . . . . 0.0 111.368 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -71.94 150.17 92.67 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.24 0.216 . . . . 0.0 110.667 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.66 -17.7 15.83 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.983 3.122 . . . . 0.0 111.686 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.6 m95 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.243 -1.36 . . . . 0.0 111.927 -177.665 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.575 0 C5'-C4'-C3' 109.777 -3.816 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . 0.48 ' C4 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.127 0 O4'-C1'-N19 111.58 3.38 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.231 0 C3'-C2'-C1' 99.567 -2.148 . 0.036 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.903 2 C3'-C2'-C1' 105.517 4.463 . 0.412 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . 0.49 " H1'" ' CD1' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.876 2 C5'-C4'-C3' 108.693 -4.538 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 110.54 -0.17 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.17 -6.6 88.83 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.3 p -155.88 171.98 19.14 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.776 0.83 . . . . 0.0 109.67 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.1 m 53.52 30.25 10.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.049 0.54 . . . . 0.0 112.212 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -65.75 160.01 23.89 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.98 0.512 . . . . 0.0 110.905 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -67.21 -12.17 59.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.518 0.727 . . . . 0.0 112.518 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -154.81 175.29 13.92 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.215 0.461 . . . . 0.0 110.629 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -141.99 13.03 2.05 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.388 0.675 . . . . 0.0 111.298 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -68.54 174.08 4.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.237 0.615 . . . . 0.0 110.563 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -57.86 -29.05 64.7 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.331 0.253 . . . . 0.0 111.026 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.1 t 58.54 165.11 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.104 1.362 . . . . 0.0 114.28 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.1 p -83.35 -3.92 57.97 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.422 0.689 . . . . 0.0 110.522 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.22 -3.59 5.19 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.0 tp -74.4 -22.7 59.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.528 0.664 . . . . 0.0 111.442 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -68.12 136.93 91.73 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 122.684 0.394 . . . . 0.0 111.393 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.26 -9.38 23.54 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.165 2.577 . . . . 0.0 112.411 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -11.89 61.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.543 0.737 . . . . 0.0 110.902 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.48 15.41 78.24 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.7 t 59.87 156.83 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.504 1.522 . . . . 0.0 113.538 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -80.25 -4.72 54.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.639 0.775 . . . . 0.0 111.716 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.6 ptp -64.8 155.53 33.61 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.867 0.365 . . . . 0.0 110.486 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 22' ' ' GLN . 3.3 pm0 -64.8 151.78 44.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.114 0.566 . . . . 0.0 110.99 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -133.13 154.97 50.1 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.615 0.766 . . . . 0.0 109.752 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -142.41 154.92 45.01 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.815 0.446 . . . . 0.0 111.376 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.01 -154.64 29.98 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.07 177.33 5.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.944 3.096 . . . . 0.0 110.52 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.97 137.43 58.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.632 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.24 -1.84 86.1 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.346 0.498 . . . . 0.0 112.561 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.28 36.62 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.757 . . . . 0.0 111.617 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.21 140.48 29.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 111.324 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.1 mt -128.28 152.82 47.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 27.7 m-85 -108.5 140.84 41.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 113.939 169.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.18 123.55 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 23.3 m-85 -126.54 178.04 6.13 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.9 m170 66.1 15.29 10.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.949 1.7 . . . . 0.0 113.091 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.63 137.11 88.11 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.594 0.358 . . . . 0.0 110.183 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.35 173.28 14.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.465 2.777 . . . . 0.0 111.272 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -65.41 -20.81 66.53 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -74.33 -6.92 50.85 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -78.55 158.08 28.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.03 174.98 36.88 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -59.72 -39.1 83.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.009 0.524 . . . . 0.0 110.671 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -75.65 -38.97 58.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -74.03 -25.31 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.06 -52.05 52.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -64.5 -22.82 67.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.359 0.264 . . . . 0.0 111.634 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.6 tpp -76.82 -28.21 55.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.091 0.156 . . . . 0.0 110.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.275 25.0 m-85 -104.88 -11.47 16.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.48 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.2 mtm -66.84 -30.99 3.6 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.5 Cg_endo -72.85 -10.36 24.75 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 121.822 1.686 . . . . 0.0 112.18 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.33 -15.77 39.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.691 0.397 . . . . 0.0 112.033 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.36 -173.31 34.21 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -77.96 102.53 7.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.389 -0.477 . . . . 0.0 110.47 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -81.59 124.13 38.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.58 -30.2 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -154.02 148.5 26.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.671 0.389 . . . . 0.0 110.506 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.1 138.6 17.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HE3' ' CZ ' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.01 145.15 18.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.353 0.261 . . . . 0.0 111.133 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.8 t -111.02 135.5 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CZ ' ' HE3' ' A' ' 59' ' ' LYS . 83.8 m-85 -65.95 150.88 47.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.21 142.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.922 0.489 . . . . 0.0 110.442 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -88.21 131.55 34.7 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -74.96 -12.3 60.31 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.618 0.367 . . . . 0.0 111.756 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -90.41 -21.99 21.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.06 -14.92 1.77 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 61.78 9.39 2.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.326 1.051 . . . . 0.0 112.802 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.59 160.76 23.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.853 0.359 . . . . 0.0 110.366 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.4 m -68.33 135.54 52.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.34 0.256 . . . . 0.0 110.826 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -78.61 168.09 20.28 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -76.72 15.11 0.69 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.13 172.11 18.05 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.55 -173.11 23.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.298 0.951 . . . . 0.0 112.58 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CE1' ' N1 ' ' B' ' 118' ' ' ' A' . 6.0 t80 -142.01 142.63 32.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.725 1.61 . . . . 0.0 114.978 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -145.66 153.53 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.881 0.872 . . . . 0.0 110.368 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.8 t -147.2 146.47 29.84 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.747 -0.595 . . . . 0.0 112.584 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -111.73 168.68 9.37 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -81.68 -9.74 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -152.43 151.38 27.12 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 123.434 0.693 . . . . 0.0 111.061 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -71.59 -18.38 29.14 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.069 2.513 . . . . 0.0 111.52 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.2 t -63.28 -45.9 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 118.39 0.541 . . . . 0.0 111.135 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 m -70.81 -26.55 63.35 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.1 -47.28 52.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.92 -28.21 68.11 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.077 0.399 . . . . 0.0 111.094 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.64 -42.0 78.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.25 65.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.4 mt -66.43 -51.04 62.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.05 -11.81 61.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.62 -28.09 19.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 13.0 ttm -120.6 -23.25 6.11 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.95 126.39 27.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.48 88.01 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.771 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -64.42 121.08 13.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.162 1.481 . . . . 0.0 110.927 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -76.93 124.37 27.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.621 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -161.06 136.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.816 0.846 . . . . 0.0 109.762 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.87 39.4 97.34 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.668 -0.645 . . . . 0.0 112.8 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.4 mtt 62.06 16.16 7.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.901 0.88 . . . . 0.0 113.229 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -141.45 179.47 6.78 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.895 1.278 . . . . 0.0 109.297 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -118.07 138.13 52.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.23 0.212 . . . . 0.0 110.503 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.02 129.44 40.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -92.23 136.17 33.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.36 139.71 49.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -155.37 158.69 39.08 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.737 0.303 . . . . 0.0 111.545 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.7 155.23 37.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.346 0.658 . . . . 0.0 111.12 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.455 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.9 tttt -69.58 164.59 22.94 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.959 0.903 . . . . 0.0 109.772 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -60.9 154.4 22.32 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 117.91 0.323 . . . . 0.0 110.753 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.0 t -70.72 158.74 35.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.105 0.562 . . . . 0.0 111.033 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -68.64 -12.57 61.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.262 0.225 . . . . 0.0 111.088 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.46 -3.95 58.06 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.432 0.293 . . . . 0.0 110.596 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -131.81 -2.13 3.73 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 89.4 p -77.92 -0.4 27.38 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.767 -0.583 . . . . 0.0 111.21 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 157.24 73.21 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 124.035 0.934 . . . . 0.0 111.857 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.83 -14.18 17.42 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 124.006 3.138 . . . . 0.0 112.245 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.9 m95 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.722 -1.132 . . . . 0.0 112.87 -177.119 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.877 1 C5'-C4'-C3' 108.971 -4.353 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.138 0 O4'-C1'-N19 110.306 2.106 . 0.091 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.823 0 C5'-C4'-C3' 111.774 -2.484 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . 0.486 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.928 2 O4'-C1'-N19 112.638 4.438 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.076 2 C5'-C4'-C3' 109.315 -4.123 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.74 169.13 38.34 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m 55.74 13.29 1.01 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.449 1.1 . . . . 0.0 113.827 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.5 t -163.57 157.42 19.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.516 0.727 . . . . 0.0 109.95 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -71.96 -13.7 61.7 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.207 0.203 . . . . 0.0 110.617 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.485 ' CG ' ' H ' ' A' ' 7' ' ' HIS . 68.5 t60 57.53 -177.02 0.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.399 1.08 . . . . 0.0 111.971 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.485 ' H ' ' CG ' ' A' ' 6' ' ' HIS . 45.2 m80 -71.71 4.9 2.82 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.269 0.628 . . . . 0.0 111.748 176.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.6 t60 60.86 167.0 0.09 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.243 1.417 . . . . 0.0 112.599 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -73.19 159.41 33.53 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.166 0.586 . . . . 0.0 111.045 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 60.74 166.41 0.08 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.739 1.216 . . . . 0.0 112.245 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.2 t -69.01 -18.7 64.08 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.96 -0.462 . . . . 0.0 110.954 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 t 57.68 18.2 4.59 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.204 1.002 . . . . 0.0 112.373 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.9 177.01 50.98 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.27 163.92 26.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 111.46 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.39 138.67 12.19 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 123.415 0.686 . . . . 0.0 110.411 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.47 138.34 83.88 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.838 2.359 . . . . 0.0 111.703 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.9 mmt-85 -82.79 170.19 15.31 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.86 0.464 . . . . 0.0 110.552 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.78 -5.94 70.81 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.25 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.2 p -81.43 165.88 20.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.523 0.729 . . . . 0.0 111.107 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -138.64 10.05 2.67 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.224 0.609 . . . . 0.0 111.517 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -74.41 -8.22 55.55 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.961 0.504 . . . . 0.0 111.877 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -86.94 142.76 27.76 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 120.713 0.292 . . . . 0.0 111.259 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 3.5 mppt? -142.25 158.99 43.11 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.388 1.075 . . . . 0.0 109.303 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -141.65 148.65 39.5 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.679 0.392 . . . . 0.0 111.139 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.67 -167.87 42.8 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.06 172.83 11.28 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.922 3.082 . . . . 0.0 110.854 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -63.53 138.74 58.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.095 -0.378 . . . . 0.0 111.04 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.81 -0.73 89.36 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.392 -0.367 . . . . 0.0 112.384 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.01 31.96 4.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.821 0.849 . . . . 0.0 111.544 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.06 140.55 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.179 -0.326 . . . . 0.0 111.168 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.7 mt -125.8 159.0 33.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.978 0.894 . . . . 0.0 113.153 -171.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -118.13 144.7 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.974 1.709 . . . . 0.0 114.443 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.86 136.57 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.16 179.93 6.47 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.4 m170 63.38 14.88 8.27 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.252 1.421 . . . . 0.0 112.911 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.05 143.32 96.02 Favored Pre-proline 0 N--CA 1.457 -0.121 0 CA-C-N 117.977 0.353 . . . . 0.0 110.132 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.44 168.0 24.77 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.952 2.435 . . . . 0.0 109.892 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -67.79 -17.82 64.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.019 0.527 . . . . 0.0 111.93 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -77.2 -10.22 59.27 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -70.05 158.01 36.48 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 175.95 35.14 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.76 -36.11 73.84 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.263 0.531 . . . . 0.0 110.629 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -80.26 -32.92 38.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 110.908 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -73.22 -38.43 66.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 tt -76.05 -25.17 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -66.08 -52.79 45.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -68.5 -22.27 64.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -72.86 -26.6 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 21.5 m-85 -106.12 -12.81 15.63 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.465 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 48.2 mtm -66.92 -29.8 2.86 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.3 Cg_endo -72.96 -8.97 23.09 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.211 1.825 . . . . 0.0 112.111 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -86.87 -15.02 40.33 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.952 0.342 . . . . 0.0 111.778 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.95 -172.65 32.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -76.16 102.68 5.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 117.107 0.453 . . . . 0.0 109.904 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.63 126.91 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.3 mt -85.92 -30.67 6.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 122.884 0.474 . . . . 0.0 110.671 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -159.5 157.41 29.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.35 0.26 . . . . 0.0 110.694 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.16 142.95 25.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -157.81 134.51 9.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.894 0.478 . . . . 0.0 110.98 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.22 131.89 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -75.02 149.24 39.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.032 0.533 . . . . 0.0 109.711 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -90.23 138.65 31.35 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.62 -10.08 59.61 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.275 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -92.28 -22.96 19.46 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -13.23 2.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 t30 62.12 8.11 2.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.674 1.19 . . . . 0.0 111.875 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.02 162.16 19.45 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.891 0.476 . . . . 0.0 109.826 174.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -66.47 140.41 58.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.35 -0.219 . . . . 0.0 111.159 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -80.6 13.26 2.61 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.6 0.36 . . . . 0.0 111.742 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.1 m 62.09 20.99 12.07 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.49 169.26 24.69 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.96 -172.56 29.53 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 121.636 0.576 . . . . 0.0 113.186 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -137.25 142.36 42.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.091 1.756 . . . . 0.0 114.722 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -144.61 153.42 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 t -143.36 149.46 37.75 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.073 0.397 . . . . 0.0 111.74 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -115.17 159.67 20.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.12 -14.58 61.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.22 0.533 . . . . 0.0 112.083 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -154.02 149.57 21.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.526 0.73 . . . . 0.0 110.685 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.91 -20.47 38.95 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.377 2.718 . . . . 0.0 112.204 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.31 -39.82 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.551 0.614 . . . . 0.0 111.737 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.3 m -73.34 -25.84 60.78 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.1 -46.43 51.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -66.4 -30.19 70.52 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 122.038 -0.414 . . . . 0.0 110.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.39 -41.51 80.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.74 -26.22 66.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.72 -51.93 56.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -68.49 -10.84 58.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.16 -27.98 17.36 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.9 mmm -120.29 -18.54 7.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -66.32 133.3 50.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.21 86.42 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.785 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -64.6 117.67 7.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.529 1.165 . . . . 0.0 110.448 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -75.39 130.06 38.37 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.108 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -146.19 124.97 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.4 -142.5 47.97 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 61.5 mtt -86.91 8.99 20.76 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -140.87 179.14 6.89 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.059 0.544 . . . . 0.0 111.41 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -118.97 142.96 47.32 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 110.069 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.36 130.95 45.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.683 0.278 . . . . 0.0 111.208 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -90.72 135.73 33.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.9 t -134.84 139.49 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -151.84 160.68 43.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.742 0.305 . . . . 0.0 111.432 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.32 149.11 40.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.444 ' H ' HD23 ' A' ' 104' ' ' LEU . 62.8 tttm -62.86 151.19 39.82 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.708 0.403 . . . . 0.0 109.918 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -63.78 158.57 21.46 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.472 0.309 . . . . 0.0 110.866 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.2 t -64.8 151.72 44.62 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.712 0.405 . . . . 0.0 111.457 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.473 ' H ' ' HD3' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -74.41 -12.22 60.45 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.816 0.446 . . . . 0.0 110.985 176.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -65.77 -14.96 62.36 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.357 0.263 . . . . 0.0 111.404 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -80.82 -9.69 59.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.6 p -125.92 -31.17 2.92 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -138.82 158.46 69.93 Favored Pre-proline 0 CA--C 1.527 0.072 0 C-N-CA 123.5 0.72 . . . . 0.0 110.999 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -80.23 4.66 6.62 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.829 3.019 . . . . 0.0 110.659 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 117.061 -1.447 . . . . 0.0 110.103 -177.518 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.776 0 O4'-C1'-N19 111.421 3.221 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.043 0 O4'-C1'-N19 111.72 3.52 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.829 0 O4'-C1'-N19 111.962 3.762 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 2 C3'-C2'-C1' 105.566 4.518 . 0.51 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 1 C5'-C4'-C3' 109.216 -4.189 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mmm . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.71 165.52 53.68 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.4 p -71.95 -16.88 62.1 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 122.339 -0.507 . . . . 0.0 111.618 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p -81.96 -13.91 56.8 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -78.44 -8.21 58.25 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.619 0.368 . . . . 0.0 111.937 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -80.7 6.43 12.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.036 0.38 . . . . 0.0 111.678 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -149.64 167.87 25.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.233 0.613 . . . . 0.0 110.013 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -67.0 157.84 32.43 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.819 0.448 . . . . 0.0 111.027 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -71.82 160.2 33.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.33 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -73.73 -21.36 60.24 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.881 0.472 . . . . 0.0 111.09 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.4 t -66.76 148.48 51.87 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.759 0.423 . . . . 0.0 111.425 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.2 m -78.61 -1.9 36.43 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 122.824 0.45 . . . . 0.0 111.723 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.46 -171.66 54.2 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.6 tp -150.55 148.61 28.89 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.732 0.413 . . . . 0.0 110.415 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 p -153.83 137.28 10.36 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.364 0.665 . . . . 0.0 109.653 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.71 136.57 33.46 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.741 2.294 . . . . 0.0 110.356 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 21.5 mmt85 -148.7 160.95 42.68 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.635 0.774 . . . . 0.0 111.608 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.81 122.38 0.63 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.7 t 58.55 178.81 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.575 1.15 . . . . 0.0 112.236 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -83.27 -3.22 57.22 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.958 0.903 . . . . 0.0 111.899 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.5 mmt -64.25 155.45 31.94 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.92 0.488 . . . . 0.0 111.233 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -73.56 153.45 40.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.138 0.575 . . . . 0.0 112.482 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -126.21 159.47 32.9 Favored 'General case' 0 C--O 1.228 -0.035 0 C-N-CA 123.907 0.883 . . . . 0.0 110.008 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -127.67 151.69 48.64 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.584 0.354 . . . . 0.0 111.169 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.58 -172.72 34.97 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.0 174.8 7.31 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.753 2.969 . . . . 0.0 110.443 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -61.1 135.08 57.66 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.76 -0.69 89.44 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.557 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.76 0.34 28.12 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.866 0.833 . . . . 0.0 112.785 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -99.73 146.21 26.79 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.205 0.457 . . . . 0.0 109.802 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.467 HD13 ' HB1' ' A' ' 83' ' ' ALA . 1.1 mp -136.16 156.52 48.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.993 0.901 . . . . 0.0 112.823 -171.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 15.1 m-85 -124.98 147.6 48.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.71 1.604 . . . . 0.0 114.465 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.62 132.71 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 5.8 m-85 -136.54 177.45 7.84 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 7.2 m170 64.63 16.14 10.14 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.768 1.627 . . . . 0.0 112.57 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.8 145.22 96.7 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 122.801 0.44 . . . . 0.0 110.205 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.81 160.49 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.068 2.512 . . . . 0.0 108.95 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -73.85 -5.21 39.56 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.11 -10.46 59.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.059 0.391 . . . . 0.0 111.431 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.5 158.25 36.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -155.79 177.46 32.89 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -57.43 -42.58 82.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -79.98 -27.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.476 0.179 . . . . 0.0 111.107 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 73.4 m-20 -72.28 -39.65 68.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 tt -76.71 -23.93 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.9 tp -66.6 -53.18 37.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -64.7 -23.0 67.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.295 0.238 . . . . 0.0 111.474 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.4 tpp -75.73 -29.45 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.047 0.139 . . . . 0.0 110.702 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 31.5 m-85 -104.95 -9.35 17.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -67.44 -28.73 2.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.8 Cg_endo -72.19 -10.67 26.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 122.374 1.883 . . . . 0.0 111.787 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -85.76 -14.79 44.16 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.33 -171.74 32.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.53 102.84 6.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.447 -0.443 . . . . 0.0 110.684 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.2 t -83.92 122.85 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -79.69 -34.98 16.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -157.71 156.1 31.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.075 0.464 . . . . 0.0 110.527 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 137.95 15.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.522 0.729 . . . . 0.0 109.048 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.59 134.13 8.76 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.512 0.196 . . . . 0.0 111.517 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 t -94.45 140.6 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -69.67 151.29 46.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -126.85 143.07 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 122.869 0.467 . . . . 0.0 109.975 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -91.59 130.64 37.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.14 -10.09 59.14 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.158 -0.339 . . . . 0.0 111.745 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -87.98 -22.54 24.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.24 0.616 . . . . 0.0 112.384 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -137.35 -14.08 1.52 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 61.65 8.2 2.23 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.882 1.273 . . . . 0.0 113.105 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.74 159.91 23.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.747 0.419 . . . . 0.0 109.878 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -71.24 135.04 47.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.535 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -76.03 166.92 22.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.008 0.432 . . . . 0.0 110.506 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.01 19.38 0.54 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -160.23 172.04 18.11 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.8 -171.9 27.38 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.528 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -136.37 144.88 44.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.579 1.551 . . . . 0.0 115.182 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -147.39 152.53 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.095 0.958 . . . . 0.0 108.431 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.4 p -143.45 147.34 34.42 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.876 -0.515 . . . . 0.0 112.023 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -113.79 159.94 19.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.32 -12.42 60.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -154.05 150.08 21.93 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 122.988 0.515 . . . . 0.0 110.886 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.1 -21.28 36.79 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.46 2.773 . . . . 0.0 112.296 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.34 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 118.72 0.691 . . . . 0.0 111.519 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -75.39 -25.92 58.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.376 0.27 . . . . 0.0 110.677 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.467 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -72.91 -49.92 26.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -68.85 -26.63 65.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.741 0.246 . . . . 0.0 110.483 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.73 -41.76 78.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.54 -27.14 66.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.3 mt -67.33 -52.07 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.34 -12.53 61.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.288 0.235 . . . . 0.0 111.259 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.93 -31.37 19.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.3 mtp -126.01 -9.59 6.56 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.21 125.68 24.88 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.01 87.43 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.854 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -63.73 119.44 9.93 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.639 1.22 . . . . 0.0 111.519 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -75.92 129.61 37.21 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.277 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.1 tt -144.64 120.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.75 -141.9 47.22 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 74.0 mtm -87.59 12.5 12.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -145.02 164.56 30.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.88 0.763 . . . . 0.0 110.673 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -107.1 141.63 38.05 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.855 0.462 . . . . 0.0 110.808 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 87.6 mt -66.43 140.86 58.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.889 0.475 . . . . 0.0 111.442 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -101.94 141.18 35.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.93 137.08 52.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -151.73 160.64 43.52 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 120.887 0.375 . . . . 0.0 111.573 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.21 145.68 32.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.81 0.444 . . . . 0.0 110.463 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -66.25 159.26 26.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -60.36 155.38 18.11 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.1 p -67.14 157.61 33.25 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -68.86 -10.19 55.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -86.8 -17.39 33.58 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.836 0.289 . . . . 0.0 111.276 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -80.69 -20.0 43.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.6 m -89.36 -11.95 41.8 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.611 0.365 . . . . 0.0 111.757 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -69.2 152.2 96.73 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.839 0.456 . . . . 0.0 111.128 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.27 -13.3 20.91 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.814 3.009 . . . . 0.0 111.488 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 97.4 m95 . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.726 -1.131 . . . . 0.0 112.601 -179.024 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.713 0 O4'-C1'-N19 112.197 3.997 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.977 0 O4'-C1'-N19 111.033 2.833 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.491 0 C1'-O4'-C4' 106.7 -3.222 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . 0.49 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.032 1 O4'-C1'-N19 112.604 4.404 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.844 2 O4'-C1'-N19 113.54 5.34 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 120.347 0.118 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.3 178.66 48.63 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 t -155.86 157.87 37.11 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.192 0.597 . . . . 0.0 109.96 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.2 p -70.31 162.64 28.15 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.806 0.442 . . . . 0.0 110.984 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -69.79 161.38 29.94 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.801 0.44 . . . . 0.0 111.023 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.0 m80 59.06 169.36 0.06 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.926 1.29 . . . . 0.0 113.278 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -77.86 -8.5 58.15 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.169 0.588 . . . . 0.0 111.921 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -145.61 161.29 40.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.506 0.722 . . . . 0.0 110.769 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -153.25 167.27 29.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.32 0.648 . . . . 0.0 110.319 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -156.64 171.1 20.93 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.368 0.667 . . . . 0.0 110.122 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.4 t -155.34 160.7 40.93 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 122.89 0.476 . . . . 0.0 110.179 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -69.69 155.96 39.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.202 0.525 . . . . 0.0 110.845 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.99 1.95 57.11 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.879 -0.401 . . . . 0.0 112.98 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.8 tp -72.68 145.61 47.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.802 0.801 . . . . 0.0 110.44 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 17' ' ' ARG . 12.4 t -140.16 132.89 14.84 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 123.558 0.743 . . . . 0.0 110.525 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.21 -9.78 23.61 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.268 2.645 . . . . 0.0 112.543 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' H ' HG12 ' A' ' 15' ' ' VAL . 25.5 mmt180 -71.54 159.94 33.57 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.982 0.513 . . . . 0.0 111.706 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.77 -37.82 0.03 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.97 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.2 p -164.29 -43.49 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.737 0.768 . . . . 0.0 111.321 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.7 m80 50.79 28.16 3.49 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.25 158.51 28.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.94 0.4 . . . . 0.0 111.063 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -88.47 132.84 34.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.441 -174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -150.05 159.79 44.14 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 125.128 1.371 . . . . 0.0 109.548 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -136.86 158.94 43.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.702 0.763 . . . . 0.0 111.568 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.34 -156.54 26.71 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.308 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.34 158.33 55.67 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.928 2.419 . . . . 0.0 108.948 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -63.5 129.38 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.12 -11.57 60.35 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.06 19.34 6.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.673 0.737 . . . . 0.0 110.417 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.14 142.35 47.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -169.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.9 159.85 33.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.015 0.912 . . . . 0.0 113.026 -171.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -125.46 144.05 50.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.411 1.884 . . . . 0.0 114.55 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.3 137.8 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.8 179.71 6.55 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.513 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.4 m170 64.7 17.12 10.78 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.246 1.418 . . . . 0.0 113.05 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.06 139.3 87.66 Favored Pre-proline 0 CA--C 1.529 0.146 0 O-C-N 122.165 -0.335 . . . . 0.0 110.111 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.71 172.13 16.42 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.449 2.766 . . . . 0.0 111.06 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -70.53 -13.09 61.97 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -82.37 -7.08 59.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -77.2 158.44 30.33 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.27 174.76 35.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -58.74 -38.34 78.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -74.97 -29.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.631 0.373 . . . . 0.0 111.032 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.65 -42.52 58.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -72.55 -24.81 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.31 -50.96 67.99 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -64.52 -23.85 67.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.536 0.334 . . . . 0.0 111.797 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.4 mmm -77.61 -23.83 49.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.634 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 33.8 m-85 -108.56 -10.68 15.21 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.451 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -66.23 -31.96 5.02 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.5 Cg_endo -73.15 -9.69 23.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 121.706 1.645 . . . . 0.0 111.779 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -86.97 -14.72 40.91 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.792 0.437 . . . . 0.0 112.079 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.6 32.87 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.57 102.05 5.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.387 -0.478 . . . . 0.0 110.47 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -80.77 120.62 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.61 -31.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -157.98 155.04 28.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.39 0.276 . . . . 0.0 110.834 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.38 29.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 109.346 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -156.99 141.33 16.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.836 0.454 . . . . 0.0 111.516 -174.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.06 130.21 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 168.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -76.44 142.96 40.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.4 mm -132.74 144.18 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.664 0.386 . . . . 0.0 110.534 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' CA ' ' HE2' ' A' ' 70' ' ' LYS . 61.0 t0 -85.93 130.5 34.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.511 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -79.13 -10.65 59.88 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.036 -0.415 . . . . 0.0 111.576 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.01 -22.14 22.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.76 -10.92 1.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.74 6.87 1.73 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.362 1.065 . . . . 0.0 112.692 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -79.6 158.21 27.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.8 t -71.43 143.75 50.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HE2' ' CA ' ' A' ' 63' ' ' ASP . 71.6 mmtt -77.1 3.34 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.593 0.757 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.3 m 62.65 20.1 11.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -157.59 169.91 23.59 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.66 -169.0 23.35 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.991 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -141.5 141.91 33.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.6 t -147.25 152.52 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 t -147.94 149.06 31.51 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.692 -0.63 . . . . 0.0 111.934 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.87 163.12 14.56 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -79.48 -9.92 59.7 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.423 0.289 . . . . 0.0 110.319 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -154.3 149.05 19.76 Favored Pre-proline 0 N--CA 1.453 -0.284 0 O-C-N 121.852 -0.53 . . . . 0.0 111.478 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.61 -19.21 42.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.658 2.905 . . . . 0.0 112.356 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.2 -39.92 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.724 -0.61 . . . . 0.0 111.789 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -74.65 -24.64 58.85 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.389 0.276 . . . . 0.0 110.535 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.6 39.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -68.0 -28.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.963 -0.461 . . . . 0.0 111.087 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.99 -42.34 80.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.145 -0.347 . . . . 0.0 110.122 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.25 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.66 -51.2 53.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.86 -11.98 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.407 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.65 -31.44 17.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 52.9 mtp -124.1 -10.92 7.59 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -62.49 126.23 26.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.1 5.75 87.2 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.148 -0.806 . . . . 0.0 112.792 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -65.23 117.32 7.63 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.764 1.282 . . . . 0.0 109.934 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -75.26 129.43 37.44 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.169 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.5 tt -145.05 119.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.72 -142.65 46.96 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 ptp -84.39 8.95 14.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 43.8 tttp -146.89 165.75 28.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.753 0.706 . . . . 0.0 110.428 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -104.49 143.18 33.38 Favored 'General case' 0 C--O 1.229 -0.017 0 C-N-CA 122.731 0.413 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.31 126.32 27.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.198 0.199 . . . . 0.0 110.801 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HE3' ' C5 ' ' B' ' 116' ' ' ' U' . 21.0 ttmm -87.67 136.47 32.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 171.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.73 139.29 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -148.55 161.47 41.6 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 111.405 -172.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -83.74 151.12 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 104' ' ' LEU . 78.9 tttt -59.86 148.51 34.52 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.869 0.868 . . . . 0.0 110.053 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -70.3 156.17 39.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.924 0.392 . . . . 0.0 110.484 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.3 t -68.03 157.8 34.35 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.492 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -69.47 -20.12 63.75 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 122.258 -0.276 . . . . 0.0 110.758 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -78.41 -17.99 55.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.743 0.417 . . . . 0.0 110.214 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -103.51 -1.64 28.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.7 m -87.26 -5.03 59.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.031 0.532 . . . . 0.0 111.47 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -66.6 151.72 96.01 Favored Pre-proline 0 CA--C 1.528 0.101 0 C-N-CA 123.201 0.601 . . . . 0.0 110.438 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.48 -15.24 22.23 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.709 2.94 . . . . 0.0 111.527 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.9 m95 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.865 -179.587 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . 0.499 ' C6 ' H5'' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.414 -3.259 0 O4'-C1'-N19 111.638 3.438 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . 0.457 ' C5 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.005 0 C5'-C4'-C3' 112.45 -2.033 . 0.095 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.175 0 O4'-C1'-N19 110.415 2.215 . 0.032 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . 0.441 " H4'" " H5'" ' B' ' 119' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.615 2 C3'-C2'-C1' 105.522 4.469 . 0.41 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . 0.441 " H5'" " H4'" ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.572 1 O4'-C1'-N19 113.693 5.493 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttm . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.05 -0.024 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.02 159.86 32.06 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.5 p -81.28 -5.08 57.41 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.06 0.544 . . . . 0.0 112.034 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -154.99 154.48 32.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.802 0.441 . . . . 0.0 110.246 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -146.52 162.47 38.28 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.579 0.752 . . . . 0.0 110.218 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -154.2 157.72 39.23 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 123.097 0.559 . . . . 0.0 109.836 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -71.37 162.72 28.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.332 0.653 . . . . 0.0 111.649 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 57.11 -175.87 0.06 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.46 1.104 . . . . 0.0 112.81 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -150.38 163.61 37.92 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.262 0.625 . . . . 0.0 109.525 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -64.13 -23.76 67.44 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.766 0.426 . . . . 0.0 111.304 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -159.13 139.55 12.3 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.636 0.375 . . . . 0.0 111.064 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.6 p -91.28 -10.15 42.48 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.64 0.376 . . . . 0.0 110.94 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.57 -1.82 77.1 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.39 134.62 54.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 117.339 0.569 . . . . 0.0 110.666 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 m -80.46 160.37 67.61 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.449 0.699 . . . . 0.0 112.694 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.2 129.24 33.8 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.506 2.804 . . . . 0.0 111.859 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.54 176.86 10.59 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 124.087 0.955 . . . . 0.0 109.883 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.49 151.39 23.65 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.3 m 57.53 150.56 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.407 1.483 . . . . 0.0 114.972 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -84.93 -17.15 38.67 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.6 mtm -77.8 -15.31 59.18 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.916 0.486 . . . . 0.0 111.816 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -106.19 152.29 23.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 159.5 44.06 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.752 0.421 . . . . 0.0 110.919 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -112.44 164.32 13.41 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.975 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.52 -171.6 36.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.34 178.53 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.07 3.18 . . . . 0.0 110.637 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -58.3 134.7 56.8 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.087 -0.383 . . . . 0.0 110.935 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 0.43 88.64 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.829 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.02 8.76 34.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 117.826 0.813 . . . . 0.0 113.166 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -112.28 139.93 47.42 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.16 0.436 . . . . 0.0 110.453 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.62 160.89 30.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.007 0.908 . . . . 0.0 112.936 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 20.2 m-85 -128.35 141.98 51.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.533 1.933 . . . . 0.0 114.647 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.56 137.62 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.1 m-85 -141.33 178.38 7.46 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.447 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 17.1 m170 64.12 18.71 11.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.883 1.273 . . . . 0.0 112.961 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.89 145.43 98.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HG2' ' CD2' ' A' ' 40' ' ' PHE . 90.5 Cg_endo -72.32 163.45 38.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.867 2.378 . . . . 0.0 109.682 174.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -69.67 -16.42 63.35 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.87 -9.28 59.43 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.813 -0.554 . . . . 0.0 112.259 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.402 ' CD2' ' HG2' ' A' ' 37' ' ' PRO . 4.0 m-85 -73.13 158.27 35.63 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 175.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.7 33.88 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -57.19 -39.62 75.75 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -74.79 -30.46 61.43 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.003 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -76.02 -38.85 56.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.56 -25.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.6 -51.36 63.11 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -65.21 -22.37 66.88 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.2 tpp -77.15 -27.73 53.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.396 0.278 . . . . 0.0 110.555 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.284 25.3 m-85 -105.03 -12.21 16.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 118.0 2.593 . . . . 0.0 118.0 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 58.4 mtm -66.17 -31.23 4.28 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.1 Cg_endo -72.33 -10.15 25.22 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.907 1.717 . . . . 0.0 112.072 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.33 -15.02 41.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.842 0.457 . . . . 0.0 111.708 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.29 -173.53 32.81 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -77.04 102.79 6.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.497 -0.413 . . . . 0.0 110.421 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.87 123.79 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.89 -33.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -152.41 151.17 30.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.721 0.408 . . . . 0.0 110.794 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.08 140.64 17.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.405 0.682 . . . . 0.0 109.455 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' HE3' ' N3 ' ' B' ' 119' ' ' ' A' . 0.0 OUTLIER -158.61 161.72 37.25 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 120.811 0.338 . . . . 0.0 110.842 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.94 139.19 52.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.411 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 48.4 m-85 -74.53 142.67 44.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mm -131.91 142.08 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 124.017 0.927 . . . . 0.0 108.554 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -80.78 127.35 32.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.566 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -73.22 -9.47 58.74 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.082 -0.386 . . . . 0.0 111.717 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -94.73 -23.6 17.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.19 -10.5 2.57 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.81 11.25 3.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.737 1.215 . . . . 0.0 111.895 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.7 mt -86.02 160.15 19.4 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.887 0.475 . . . . 0.0 109.891 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.5 t -69.56 145.33 52.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.597 0.236 . . . . 0.0 111.43 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 61' ' ' PHE . 52.2 mtmt -98.04 15.29 24.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.147 0.579 . . . . 0.0 111.195 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.6 p 52.13 29.75 6.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.405 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.8 p90 -155.06 168.96 25.27 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.55 -174.34 27.14 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.273 0.374 . . . . 0.0 112.955 -173.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -139.69 140.75 36.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.261 1.424 . . . . 0.0 114.46 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -146.36 153.74 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 98.0 p -147.89 153.0 38.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 111.532 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -122.54 164.66 17.72 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.08 -9.59 59.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -153.32 151.02 24.89 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.932 0.493 . . . . 0.0 111.275 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.38 -19.5 37.84 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.31 2.673 . . . . 0.0 111.633 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.96 -46.57 95.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 118.548 0.613 . . . . 0.0 111.026 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 m -70.91 -25.93 62.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.129 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.79 -49.03 42.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -68.17 -27.23 66.23 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 117.936 0.334 . . . . 0.0 110.674 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.9 75.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.25 70.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.99 -50.47 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -69.43 -11.16 60.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.243 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.88 -27.39 21.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.6 ttm -120.86 -21.04 6.73 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -58.83 123.34 16.13 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 6.04 88.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.424 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -67.29 142.83 56.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.759 1.279 . . . . 0.0 108.486 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -95.92 128.58 42.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.938 0.335 . . . . 0.0 110.701 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.36 136.88 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.29 -113.35 5.07 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.4 mtm -126.86 14.42 7.43 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.573 0.749 . . . . 0.0 112.282 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 56.5 tttp -151.24 144.54 24.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.309 0.504 . . . . 0.0 110.783 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -82.63 143.3 31.08 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.416 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.0 mm? -67.98 130.4 42.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.346 0.258 . . . . 0.0 110.496 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -92.02 138.11 31.81 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.71 141.15 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.44 0.296 . . . . 0.0 110.418 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -148.62 161.78 41.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.64 0.257 . . . . 0.0 110.87 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 tt -90.13 140.04 30.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -63.68 156.57 26.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.46 0.573 . . . . 0.0 109.62 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 106' ' ' ARG . 67.5 mtt85 -58.39 146.07 36.11 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.8 p -65.77 151.7 46.02 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.188 0.518 . . . . 0.0 111.374 -175.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -69.73 -7.82 42.69 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.331 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -89.3 -9.23 51.32 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.306 0.642 . . . . 0.0 111.565 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.23 -24.28 1.86 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.7 p -71.78 -19.2 62.04 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 122.482 0.313 . . . . 0.0 111.668 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.18 154.15 92.27 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.31 0.644 . . . . 0.0 109.839 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -71.57 -14.53 30.53 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.338 2.692 . . . . 0.0 111.613 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 89.4 m95 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.145 -1.407 . . . . 0.0 112.338 177.284 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.694 0 C5'-C4'-C3' 111.248 -2.834 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.113 0 C5'-C4'-C3' 112.57 -1.954 . 0.248 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.203 0 C5'-C4'-C3' 111.857 -2.429 . 0.04 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . 0.513 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.656 0 C3'-C2'-C1' 105.037 3.93 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . 0.44 ' C8 ' H5'' ' B' ' 119' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.965 1 C5'-C4'-C3' 108.619 -4.587 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 119.958 -0.067 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.13 171.49 55.14 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m -75.4 -11.33 60.02 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.0 p -155.18 13.08 0.37 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.594 0.358 . . . . 0.0 111.78 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -153.41 163.46 39.9 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.967 0.507 . . . . 0.0 110.798 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -142.92 173.05 11.89 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.441 0.696 . . . . 0.0 110.528 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -136.01 162.57 32.52 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.261 0.624 . . . . 0.0 110.268 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -155.36 172.49 18.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.091 0.556 . . . . 0.0 110.452 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -152.77 162.85 40.74 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.303 0.641 . . . . 0.0 110.461 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -73.87 151.27 40.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.941 0.401 . . . . 0.0 111.133 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -158.55 158.09 33.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.356 0.662 . . . . 0.0 109.816 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.6 t -67.31 145.68 54.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.603 0.361 . . . . 0.0 111.017 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.34 -170.3 34.47 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.9 tp -151.17 142.85 23.69 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.167 0.587 . . . . 0.0 109.801 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 17' ' ' ARG . 4.6 p -69.65 135.32 88.18 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.77 -9.59 22.61 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.312 2.675 . . . . 0.0 111.939 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.425 ' H ' HG22 ' A' ' 15' ' ' VAL . 16.7 tpt180 -67.95 133.51 49.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.624 0.37 . . . . 0.0 110.228 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.66 1.13 44.13 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.571 -0.572 . . . . 0.0 112.742 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 t -71.66 159.26 34.71 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 117.995 0.898 . . . . 0.0 111.03 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -70.85 -11.72 61.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.149 0.579 . . . . 0.0 111.499 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.7 mtm -78.2 139.0 38.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.496 0.319 . . . . 0.0 111.139 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -98.04 152.05 19.7 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.295 0.638 . . . . 0.0 109.563 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -111.69 159.18 18.47 Favored 'General case' 0 C--O 1.23 0.039 0 C-N-CA 122.943 0.497 . . . . 0.0 111.054 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -141.86 155.57 45.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.189 0.519 . . . . 0.0 111.607 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.48 -152.38 28.81 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.37 179.23 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.695 2.93 . . . . 0.0 111.172 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.84 135.98 57.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.947 -0.471 . . . . 0.0 111.551 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.15 68.09 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.478 0.561 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.11 39.76 1.0 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.665 0.732 . . . . 0.0 112.013 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.09 140.03 29.23 Favored 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.723 -0.611 . . . . 0.0 111.75 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -128.76 153.77 47.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.931 0.872 . . . . 0.0 113.152 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 16.1 m-85 -110.99 146.87 35.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.562 1.545 . . . . 0.0 114.152 170.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -139.01 124.74 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.4 m-85 -131.28 179.28 6.11 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 17.1 m170 63.32 16.12 9.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.348 1.459 . . . . 0.0 112.335 -176.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.49 144.38 94.25 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.137 0.575 . . . . 0.0 110.329 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.83 162.91 36.65 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.374 2.716 . . . . 0.0 109.248 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.46 -6.22 44.98 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -75.68 -9.99 59.05 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.994 0.361 . . . . 0.0 111.241 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -73.39 158.3 35.28 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.41 176.54 33.75 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -57.24 -39.01 74.7 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.158 0.479 . . . . 0.0 111.975 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -80.02 -33.21 39.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.585 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -72.04 -38.81 69.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.34 -28.35 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.3 tp -66.25 -52.23 49.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -63.91 -22.91 67.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.555 0.342 . . . . 0.0 111.688 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -78.38 -26.04 46.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.645 0.202 . . . . 0.0 110.654 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.296 31.3 m-85 -104.93 -10.53 17.22 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 56.6 mtm -66.97 -29.32 2.56 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 50' ' ' MET . 84.3 Cg_endo -71.05 -13.11 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.893 1.712 . . . . 0.0 111.906 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -84.35 -15.46 46.4 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 155.19 -175.06 33.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -75.32 105.53 6.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.281 -0.541 . . . . 0.0 110.77 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.04 126.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.3 -30.43 5.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 120.487 0.184 . . . . 0.0 110.578 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -154.6 150.43 27.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.726 0.411 . . . . 0.0 110.577 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.83 141.54 14.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.383 0.673 . . . . 0.0 109.496 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.557 ' HE3' ' CD2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -156.45 153.26 28.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.43 0.292 . . . . 0.0 110.292 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -107.71 142.87 19.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD2' ' HE3' ' A' ' 59' ' ' LYS . 69.3 m-85 -69.72 148.73 48.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -133.68 146.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.148 0.579 . . . . 0.0 109.965 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -95.19 132.89 39.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -77.36 -12.91 60.01 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.067 0.547 . . . . 0.0 111.75 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -89.78 -23.82 21.65 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.62 -13.43 2.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.2 t30 61.54 10.84 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 112.22 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.86 154.56 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.673 0.389 . . . . 0.0 110.219 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -70.49 134.39 47.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.425 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -84.23 163.69 19.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.105 0.478 . . . . 0.0 110.451 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.6 m -78.87 17.67 0.7 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE1' ' CE1' ' A' ' 61' ' ' PHE . 3.5 p90 -156.59 170.32 22.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.77 -177.59 29.15 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.753 1.168 . . . . 0.0 111.896 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.425 ' CE1' ' N1 ' ' B' ' 118' ' ' ' A' . 6.7 t80 -139.69 144.57 37.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.74 151.95 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.803 0.841 . . . . 0.0 110.082 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 t -143.4 144.0 31.86 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -106.21 164.35 12.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -80.89 -9.22 59.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.271 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -155.75 150.43 20.36 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 123.138 0.575 . . . . 0.0 111.096 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.69 -18.35 28.84 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.125 2.55 . . . . 0.0 111.858 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.9 -44.77 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 O-C-N 121.817 -0.552 . . . . 0.0 111.282 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -70.65 -26.26 63.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.63 -48.04 35.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -66.07 -28.51 68.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.062 -0.399 . . . . 0.0 110.816 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.59 75.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.228 -0.295 . . . . 0.0 110.322 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.67 66.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mt -66.98 -52.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -66.88 -13.73 61.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.365 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.98 -32.95 18.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.8 mtp -123.82 -11.91 7.63 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -61.85 125.24 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.62 5.96 88.99 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.303 -0.72 . . . . 0.0 112.798 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.12 125.15 22.86 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.46 1.13 . . . . 0.0 112.031 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -78.22 128.38 33.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.685 0.279 . . . . 0.0 110.846 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -149.56 136.51 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.98 -111.1 2.81 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.0 ptp -130.42 15.47 5.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.13 0.572 . . . . 0.0 111.811 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -150.83 142.42 23.57 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.483 0.313 . . . . 0.0 110.291 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -84.41 145.13 28.35 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 122.505 -0.122 . . . . 0.0 111.181 -176.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 81.4 mt -70.78 131.82 44.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.572 0.349 . . . . 0.0 111.647 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -91.32 138.6 31.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 170.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.97 137.38 50.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -155.12 160.79 41.22 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.865 0.302 . . . . 0.0 111.715 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.8 156.23 36.73 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.37 0.668 . . . . 0.0 110.692 176.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.46 ' H ' HD23 ' A' ' 104' ' ' LEU . 87.4 tttt -67.03 154.41 41.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.43 0.692 . . . . 0.0 109.534 173.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -61.23 148.95 39.24 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-O 120.868 0.366 . . . . 0.0 110.66 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.2 t -154.45 158.4 39.88 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.953 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -75.17 -7.16 53.05 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.559 0.343 . . . . 0.0 111.036 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -69.32 -21.16 63.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.281 -0.262 . . . . 0.0 110.562 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -85.1 -17.61 36.8 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.9 m -80.01 -9.14 59.67 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 122.127 -0.358 . . . . 0.0 111.301 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -67.8 151.61 97.04 Favored Pre-proline 0 N--CA 1.456 -0.168 0 C-N-CA 122.886 0.475 . . . . 0.0 110.753 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.86 -14.55 21.45 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.572 2.848 . . . . 0.0 111.244 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.7 m95 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.708 -1.139 . . . . 0.0 112.24 -179.848 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.858 0 C5'-C4'-C3' 110.239 -3.507 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.954 0 O4'-C1'-N19 111.191 2.991 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 2 O4'-C1'-N19 112.55 4.35 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . 0.425 ' N1 ' ' CE1' ' A' ' 74' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.08 2 C3'-C2'-C1' 105.4 4.333 . 0.558 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.67 2 O4'-C1'-N19 112.66 4.46 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.502 ' HG3' ' H ' ' A' ' 3' ' ' SER . 17.3 tpt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.89 -2.43 57.47 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.783 -0.454 . . . . 0.0 113.332 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.502 ' H ' ' HG3' ' A' ' 1' ' ' MET . 44.6 t -155.18 161.59 41.17 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.933 0.866 . . . . 0.0 110.311 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 t -154.75 150.66 27.81 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.056 0.542 . . . . 0.0 109.938 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.8 t60 60.01 165.64 0.07 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.903 1.281 . . . . 0.0 112.63 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -80.53 149.51 29.95 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.776 -0.577 . . . . 0.0 111.395 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -150.67 165.95 31.85 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 124.099 0.96 . . . . 0.0 110.039 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -72.38 9.14 1.1 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.197 0.599 . . . . 0.0 112.006 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -144.57 5.12 1.2 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.626 0.77 . . . . 0.0 111.822 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -71.26 156.39 39.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.203 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.5 t -156.86 157.34 34.73 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.969 0.508 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.4 t -68.98 157.52 36.58 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.66 0.384 . . . . 0.0 111.441 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.13 -13.31 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 tp -71.13 145.46 49.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.545 0.673 . . . . 0.0 110.131 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 17' ' ' ARG . 11.4 t -66.68 131.35 94.04 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 122.443 0.297 . . . . 0.0 111.12 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.18 -13.24 28.37 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.128 2.552 . . . . 0.0 112.472 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.455 ' H ' HG12 ' A' ' 15' ' ' VAL . 2.0 tmm_? -71.58 136.36 47.4 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.745 0.418 . . . . 0.0 110.694 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.43 168.2 31.07 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.1 t -160.43 165.09 31.69 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.053 0.541 . . . . 0.0 110.371 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -73.82 -6.04 44.62 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.195 0.598 . . . . 0.0 111.533 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.5 mtt -69.6 167.04 17.72 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.271 0.629 . . . . 0.0 111.822 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -67.62 152.6 45.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.591 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.72 158.14 16.94 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 122.905 0.482 . . . . 0.0 110.52 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -141.16 151.03 43.52 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.116 0.566 . . . . 0.0 110.736 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.42 -155.2 31.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.41 176.7 6.17 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.949 3.099 . . . . 0.0 110.962 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -60.95 137.01 58.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.891 -0.505 . . . . 0.0 111.504 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.05 -2.87 73.61 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.637 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.13 39.24 1.04 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.419 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.65 139.42 29.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.765 -0.584 . . . . 0.0 111.552 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.31 155.03 45.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.757 0.789 . . . . 0.0 112.934 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.2 m-85 -112.27 149.15 32.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.746 1.618 . . . . 0.0 114.355 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -139.01 136.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.6 m-85 -142.4 177.64 8.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 12.7 m170 62.73 16.9 9.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.611 1.564 . . . . 0.0 112.639 -176.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.46 145.04 98.26 Favored Pre-proline 0 CA--C 1.53 0.191 0 O-C-N 122.079 -0.388 . . . . 0.0 110.047 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.34 164.9 34.25 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.842 2.361 . . . . 0.0 109.507 172.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.91 -14.79 62.89 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.25 -8.84 57.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.55 158.23 36.58 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.75 35.29 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.8 -36.9 75.22 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.506 0.653 . . . . 0.0 110.442 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -78.67 -32.62 47.24 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.398 0.279 . . . . 0.0 110.869 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.0 -38.8 61.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.61 -25.8 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.39 -49.89 61.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -64.7 -23.84 67.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.745 0.418 . . . . 0.0 111.558 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -79.89 -25.61 40.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.511 -0.118 . . . . 0.0 110.767 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.293 31.3 m-85 -105.92 -7.76 18.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 50.1 mtm -66.49 -30.83 3.72 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.5 Cg_endo -72.82 -10.99 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 CA-C-N 121.943 1.73 . . . . 0.0 111.842 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.48 -19.96 37.79 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.76 -167.96 31.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -78.2 99.59 6.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.466 -0.432 . . . . 0.0 110.527 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -87.48 130.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 174.614 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -90.68 -27.81 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 122.592 0.357 . . . . 0.0 110.76 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 t -155.9 150.8 26.33 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.633 0.373 . . . . 0.0 110.334 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.46 147.03 27.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.377 0.671 . . . . 0.0 109.387 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -157.38 137.88 12.97 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.682 0.393 . . . . 0.0 111.445 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -111.93 136.41 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.466 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 49.5 m-85 -78.92 147.33 33.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -173.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -132.58 144.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.063 0.545 . . . . 0.0 110.305 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -90.34 133.16 35.16 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -76.98 -12.56 59.96 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.784 0.434 . . . . 0.0 111.865 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -88.95 -23.92 22.56 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.12 -13.48 2.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 63.68 8.34 3.66 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.12 161.08 22.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.911 0.484 . . . . 0.0 110.038 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -70.52 140.91 51.94 Favored 'General case' 0 CA--C 1.523 -0.062 0 CA-C-O 120.753 0.311 . . . . 0.0 111.052 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -82.59 6.04 18.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m 61.49 22.51 12.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.404 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.1 p90 -154.62 169.11 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.01 -172.28 28.12 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 121.566 0.537 . . . . 0.0 113.185 -174.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.82 143.01 31.96 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.806 1.642 . . . . 0.0 114.713 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -145.99 153.57 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 109.527 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.2 t -143.01 145.13 32.63 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -109.34 164.04 12.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -78.36 -13.21 59.95 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 112.278 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.02 148.11 18.23 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 123.246 0.618 . . . . 0.0 111.17 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.69 -18.54 32.56 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.468 2.779 . . . . 0.0 112.06 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.27 -43.03 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 118.34 0.518 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.1 t -70.68 -32.78 70.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.04 74.67 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -67.88 -28.09 67.22 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.901 -0.5 . . . . 0.0 110.962 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.92 -43.05 72.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.44 -26.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.3 mt -67.73 -51.51 49.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -67.84 -11.22 58.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.86 -0.154 . . . . 0.0 111.284 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.89 -31.33 16.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.4 mtp -125.41 -12.2 6.78 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.98 125.86 25.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.87 6.54 89.36 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.008 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 120.42 11.62 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.693 1.247 . . . . 0.0 111.483 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -76.39 129.63 36.86 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 tt -144.87 120.72 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.27 -140.64 46.6 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.0 mmt -88.52 12.96 13.06 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -146.5 162.59 37.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.848 0.749 . . . . 0.0 111.049 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -105.76 141.27 37.47 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 122.545 0.338 . . . . 0.0 110.946 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 91.5 mt -66.65 133.76 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.749 0.419 . . . . 0.0 111.195 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -92.0 137.89 31.99 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.3 t -134.97 137.13 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -151.4 161.3 42.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -75.77 153.83 36.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.469 0.708 . . . . 0.0 110.409 177.287 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.504 ' H ' HD23 ' A' ' 104' ' ' LEU . 87.1 tttt -68.33 158.0 34.43 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.222 0.609 . . . . 0.0 109.834 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -146.45 160.39 42.15 Favored 'General case' 0 CA--C 1.526 0.04 0 C-N-CA 123.314 0.646 . . . . 0.0 110.541 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.0 t -62.31 154.51 27.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 122.863 0.465 . . . . 0.0 111.117 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.65 -6.31 40.06 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.465 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -67.07 -15.36 63.67 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.224 -0.298 . . . . 0.0 110.417 175.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -93.55 -10.97 32.98 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.8 t -80.8 -11.82 59.54 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 122.952 0.501 . . . . 0.0 111.14 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -62.75 153.67 78.03 Favored Pre-proline 0 CA--C 1.534 0.342 0 O-C-N 122.18 -0.325 . . . . 0.0 110.548 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.08 -15.63 23.11 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.706 2.937 . . . . 0.0 111.779 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 117.4 -1.286 . . . . 0.0 112.391 -179.134 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 C5'-C4'-C3' 110.327 -3.449 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.091 0 O4'-C1'-N19 111.07 2.87 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . 0.401 " H4'" " H5'" ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.39 1 O4'-C1'-N19 112.654 4.454 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . 0.401 " H5'" " H4'" ' B' ' 117' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.793 2 C3'-C2'-C1' 105.782 4.758 . 0.251 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . 0.466 " H1'" ' CD1' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.928 2 C5'-C4'-C3' 108.696 -4.536 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.758 -0.09 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.51 -5.62 89.76 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.9 p -69.97 160.37 32.03 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 117.651 0.725 . . . . 0.0 111.091 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.6 p -155.99 167.4 30.54 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.737 0.415 . . . . 0.0 110.225 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -153.25 164.42 38.13 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.098 0.559 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -85.63 -4.08 59.06 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.312 0.645 . . . . 0.0 112.476 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -75.66 152.9 37.49 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.988 0.358 . . . . 0.0 111.506 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -148.42 155.52 41.32 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.663 0.785 . . . . 0.0 110.541 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -150.04 -4.15 0.36 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.851 0.461 . . . . 0.0 111.416 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -74.5 166.88 22.79 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.169 0.588 . . . . 0.0 111.087 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.5 t -156.23 159.93 39.35 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 123.104 0.562 . . . . 0.0 109.782 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.7 t -69.45 140.75 54.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.235 -0.29 . . . . 0.0 110.806 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.48 4.77 58.21 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.745 -0.475 . . . . 0.0 112.983 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.8 tp -72.13 -21.36 61.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.132 0.966 . . . . 0.0 111.499 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 17' ' ' ARG . 11.8 t -69.31 136.63 88.86 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 123.22 0.608 . . . . 0.0 111.377 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 51.3 Cg_exo -58.45 -13.43 16.87 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.855 3.037 . . . . 0.0 114.1 176.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HD2' ' H ' ' A' ' 18' ' ' GLY . 16.8 tpt180 -67.31 150.56 48.85 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.176 0.591 . . . . 0.0 111.25 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.443 ' H ' ' HD2' ' A' ' 17' ' ' ARG . . . -156.76 173.41 34.46 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.5 p -158.13 159.78 36.57 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.131 0.572 . . . . 0.0 110.356 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -80.38 -26.86 38.36 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.47 0.308 . . . . 0.0 111.705 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.8 mtm 55.25 -178.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.242 1.017 . . . . 0.0 113.227 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -136.16 152.27 50.63 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.312 0.645 . . . . 0.0 110.35 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -132.34 159.58 38.79 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.86 0.864 . . . . 0.0 110.15 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -124.27 164.37 19.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 -151.2 25.12 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.79 169.43 17.65 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.808 3.005 . . . . 0.0 110.232 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.83 137.96 58.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.946 -0.471 . . . . 0.0 110.71 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.77 -6.96 79.15 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.156 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.42 39.9 1.06 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.602 0.701 . . . . 0.0 110.418 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.36 28.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.004 -0.435 . . . . 0.0 111.131 -175.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -126.05 158.4 35.49 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 18.5 m-85 -117.59 139.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.94 1.696 . . . . 0.0 113.71 171.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.72 139.66 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 72' ' ' PHE . 9.8 m-85 -141.7 175.13 9.95 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 m170 65.42 16.3 10.46 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 113.001 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.16 140.93 93.51 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 122.82 0.448 . . . . 0.0 109.919 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.18 162.88 40.41 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.915 2.41 . . . . 0.0 109.552 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -71.44 -7.19 45.81 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.23 -9.42 58.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 122.055 -0.403 . . . . 0.0 111.054 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -74.06 158.36 34.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.26 173.94 35.44 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -57.16 -39.49 75.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -75.79 -29.24 58.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.097 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.41 -39.61 46.45 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -73.6 -24.65 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.17 -52.0 57.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.65 -23.62 67.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.613 0.365 . . . . 0.0 111.518 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 tpp -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.15 0.18 . . . . 0.0 110.672 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.276 22.6 m-85 -104.12 -11.69 17.17 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 117.878 2.547 . . . . 0.0 117.878 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.6 mtm -66.8 -31.3 3.92 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.8 Cg_endo -73.01 -10.0 24.15 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.068 1.774 . . . . 0.0 111.881 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.28 -13.81 45.57 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.09 -173.57 32.66 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -75.94 101.32 5.15 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.333 -0.51 . . . . 0.0 110.223 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -79.07 127.75 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.8 mt -83.84 -32.95 8.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.416 0.287 . . . . 0.0 110.379 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -164.9 159.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.94 24.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.423 0.689 . . . . 0.0 109.893 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.7 145.72 17.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.707 0.403 . . . . 0.0 111.172 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.93 138.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 76.5 m-85 -73.27 144.72 46.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.23 144.33 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.204 0.601 . . . . 0.0 110.197 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.96 130.3 34.99 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.09 -12.79 60.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.08 -0.387 . . . . 0.0 111.672 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.17 -23.71 22.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -133.17 -12.55 2.81 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.5 7.92 2.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.684 1.194 . . . . 0.0 112.021 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.24 160.45 22.98 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.3 t -70.57 141.37 51.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.792 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -78.32 6.94 7.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.64 0.376 . . . . 0.0 111.352 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.9 m 63.21 24.77 14.51 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 34' ' ' TYR . 4.8 p90 -157.44 167.68 29.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.28 -173.41 24.8 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 121.531 0.517 . . . . 0.0 113.697 -173.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -139.72 142.68 36.83 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.371 1.868 . . . . 0.0 114.971 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -146.77 152.74 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.878 0.871 . . . . 0.0 109.689 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -141.23 149.45 41.37 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.179 0.445 . . . . 0.0 112.163 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.03 162.42 16.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -76.88 -12.56 59.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.537 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -154.06 150.8 23.27 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 123.298 0.639 . . . . 0.0 111.176 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.67 -18.61 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.964 2.443 . . . . 0.0 111.73 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.37 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 118.214 0.461 . . . . 0.0 111.095 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -71.02 -26.39 63.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.858 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.87 -47.28 53.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -65.91 -30.53 71.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.13 0.423 . . . . 0.0 110.968 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.37 82.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.68 67.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -66.1 -51.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.63 -12.22 61.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.04 21.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.4 ttm -120.63 -21.77 6.61 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.79 124.35 18.88 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.01 84.97 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.183 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.93 118.2 8.71 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.043 1.421 . . . . 0.0 110.501 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -77.35 129.69 36.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 110.353 -176.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 tt -150.44 136.09 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.39 -112.52 4.96 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.05 14.98 8.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.0 112.728 -178.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -144.38 172.66 12.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.124 0.97 . . . . 0.0 111.135 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -107.48 139.67 41.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.06 125.08 24.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.73 0.3 . . . . 0.0 110.979 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -87.26 142.82 27.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.0 t -134.95 140.19 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.673 0.389 . . . . 0.0 109.967 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -149.07 152.05 35.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.98 0.354 . . . . 0.0 110.974 -175.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -71.92 148.49 45.99 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.214 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.432 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.8 tttt -66.1 162.05 20.46 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.309 0.644 . . . . 0.0 109.392 173.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -59.24 157.06 11.28 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.7 p -151.74 166.0 32.69 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 122.47 0.308 . . . . 0.0 110.763 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.56 -17.48 63.98 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.492 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -69.34 -24.98 63.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.582 0.353 . . . . 0.0 110.124 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -97.55 -6.91 32.51 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -75.82 -30.88 59.16 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.192 0.197 . . . . 0.0 110.88 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -81.59 151.43 68.38 Favored Pre-proline 0 CA--C 1.529 0.173 0 C-N-CA 123.053 0.541 . . . . 0.0 110.513 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.69 -16.31 16.66 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.722 2.948 . . . . 0.0 111.795 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 92.8 m95 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.52 -1.228 . . . . 0.0 111.795 -178.349 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . 0.535 ' C6 ' H5'' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 C5'-C4'-C3' 109.824 -3.784 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.173 0 O4'-C1'-N19 110.319 2.119 . 0.033 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.924 0 C5'-C4'-C3' 110.545 -3.303 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.889 1 C5'-C4'-C3' 106.893 -5.738 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.674 1 C5'-C4'-C3' 108.83 -4.447 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.718 -0.105 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.49 165.77 54.52 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -77.12 -17.3 58.74 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.78 -0.247 . . . . 0.0 111.368 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.3 p -71.56 160.14 33.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.173 0.511 . . . . 0.0 111.35 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -69.28 154.08 42.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.221 0.609 . . . . 0.0 110.964 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.24 -5.78 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.917 0.487 . . . . 0.0 111.668 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -74.56 -5.42 42.77 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.7 0.4 . . . . 0.0 111.866 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -75.28 -16.7 60.42 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.473 0.309 . . . . 0.0 111.587 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.68 158.47 32.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.058 0.39 . . . . 0.0 111.274 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -154.01 155.34 35.37 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.096 0.558 . . . . 0.0 109.712 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -71.25 -5.01 28.9 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t 56.66 23.09 7.41 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.002 0.921 . . . . 0.0 112.266 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.38 169.3 54.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.2 tp -154.67 147.06 23.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.951 0.501 . . . . 0.0 110.015 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 17' ' ' ARG . 6.9 p -153.16 134.84 8.68 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 122.914 0.486 . . . . 0.0 111.223 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.03 -9.79 22.39 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.199 2.599 . . . . 0.0 112.338 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.474 ' H ' HG22 ' A' ' 15' ' ' VAL . 1.1 tmt_? 51.56 77.41 0.14 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.709 1.204 . . . . 0.0 110.508 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.38 161.26 38.72 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.249 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 t -160.65 -179.49 7.66 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.535 0.734 . . . . 0.0 109.81 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -75.57 24.02 0.12 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.031 0.932 . . . . 0.0 112.562 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.0 mtm -65.49 -25.52 67.52 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 121.875 -0.515 . . . . 0.0 111.88 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -85.66 130.52 34.55 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -86.2 158.47 19.73 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.686 0.395 . . . . 0.0 111.192 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -135.84 155.62 50.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.67 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.996 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.73 176.38 6.04 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.58 3.52 . . . . 0.0 110.476 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.6 134.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.991 -0.443 . . . . 0.0 111.147 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.04 0.12 84.8 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.628 -0.54 . . . . 0.0 112.857 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 -0.38 57.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.887 0.843 . . . . 0.0 112.193 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -107.72 145.81 32.96 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.28 149.07 52.71 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 105' ' ' LYS . 21.9 m-85 -97.82 142.35 29.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.927 1.691 . . . . 0.0 112.866 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.11 130.04 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -134.41 179.73 6.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.2 m170 64.37 15.55 9.57 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.82 1.648 . . . . 0.0 113.03 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.39 139.51 86.94 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.32 165.05 32.73 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.609 2.873 . . . . 0.0 109.991 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -72.57 -7.14 48.63 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -75.99 -9.78 58.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.138 0.427 . . . . 0.0 110.743 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -75.98 158.12 32.31 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.72 175.73 34.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -56.87 -41.64 78.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -80.82 -26.6 36.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.591 0.234 . . . . 0.0 110.966 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 75.4 m-20 -74.08 -38.47 63.91 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.5 tt -74.69 -25.49 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.5 tp -65.98 -52.19 51.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -64.65 -23.54 67.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.637 0.375 . . . . 0.0 111.595 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.4 tpp -76.58 -27.93 56.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.132 0.173 . . . . 0.0 110.753 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.268 22.0 m-85 -104.68 -11.72 16.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.6 mtm -66.08 -31.7 4.86 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 86.1 Cg_endo -72.46 -9.43 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.881 1.707 . . . . 0.0 111.733 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.81 -14.97 43.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.726 0.411 . . . . 0.0 111.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.48 -171.2 32.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.6 102.9 6.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.663 -0.316 . . . . 0.0 110.344 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -79.13 129.25 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mt -87.39 -33.82 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 122.301 0.241 . . . . 0.0 110.703 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.4 t -157.85 155.48 29.75 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.695 0.398 . . . . 0.0 110.239 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.34 138.26 17.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.339 0.656 . . . . 0.0 109.408 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.539 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 5.4 tmmm? -159.93 143.29 14.07 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.739 0.416 . . . . 0.0 111.081 -176.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.8 140.01 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.539 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 78.8 m-85 -72.41 149.43 44.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.44 143.7 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.797 0.839 . . . . 0.0 109.112 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -82.48 128.36 34.19 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.87 -11.15 59.92 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.297 -0.252 . . . . 0.0 111.478 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.23 -22.17 19.18 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -136.44 -10.79 1.89 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 61.68 9.6 2.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.375 1.07 . . . . 0.0 112.984 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.4 153.47 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.161 -0.337 . . . . 0.0 110.153 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.6 t -70.3 137.29 50.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.569 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -83.05 167.5 17.82 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.15 18.18 1.79 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.23 170.39 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.57 -168.68 21.08 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.602 0.62 . . . . 0.0 112.979 -173.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -143.96 142.03 30.51 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -146.02 153.03 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.122 0.969 . . . . 0.0 109.531 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.9 p -142.1 150.85 41.71 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.768 0.427 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -117.53 162.02 18.67 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -77.25 -15.43 59.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -152.77 150.9 25.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 C-N-CA 123.193 0.597 . . . . 0.0 110.848 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.93 -23.22 34.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.015 2.477 . . . . 0.0 112.177 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.64 -38.29 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.444 0.565 . . . . 0.0 111.548 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -76.21 -26.59 56.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.318 -0.239 . . . . 0.0 110.876 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.86 -47.43 30.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -68.24 -26.97 65.96 Favored 'General case' 0 C--O 1.231 0.112 0 O-C-N 122.243 -0.286 . . . . 0.0 110.258 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.02 73.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -27.78 68.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 119.383 -0.342 . . . . 0.0 111.84 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.3 mt -64.69 -52.21 57.51 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.23 -11.53 57.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.805 -0.14 . . . . 0.0 111.186 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.07 -29.22 15.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.71 -18.27 7.75 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.17 134.86 53.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.98 2.38 77.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.505 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.42 117.9 7.96 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.553 1.176 . . . . 0.0 110.742 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -74.41 129.65 38.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.487 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.9 tt -146.76 124.27 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.71 -145.36 49.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -173.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.27 9.85 11.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.578 0.751 . . . . 0.0 112.698 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -139.38 178.97 6.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.672 0.669 . . . . 0.0 111.514 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -118.79 145.08 45.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 109.966 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 88.5 mt -67.07 133.87 50.74 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 122.496 0.318 . . . . 0.0 110.966 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.48 133.1 41.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.22 140.05 45.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -153.16 159.44 42.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.547 0.339 . . . . 0.0 110.695 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.31 130.06 41.93 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.267 0.627 . . . . 0.0 109.98 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.41 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 59.6 tttp -87.1 124.36 33.16 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.04 0.536 . . . . 0.0 112.086 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -76.27 159.56 30.48 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.434 0.694 . . . . 0.0 110.766 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.2 t -73.77 156.15 38.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.751 0.42 . . . . 0.0 110.964 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.605 ' HA ' ' HE2' ' A' ' 108' ' ' LYS . 9.1 mmpt? -72.79 -1.54 16.99 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.025 0.53 . . . . 0.0 111.997 176.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -66.39 -20.08 65.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -80.66 -19.46 45.21 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.1 m -85.37 -6.09 59.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.844 0.458 . . . . 0.0 111.671 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -68.77 155.48 93.09 Favored Pre-proline 0 N--CA 1.457 -0.106 0 C-N-CA 122.828 0.451 . . . . 0.0 111.785 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.35 -15.63 15.78 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.731 2.954 . . . . 0.0 111.241 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.3 p90 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.734 -1.603 . . . . 0.0 112.638 -177.787 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.024 1 C5'-C4'-C3' 109.413 -4.058 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.225 0 O4'-C1'-N19 110.434 2.234 . 0.078 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.921 1 C3'-C2'-C1' 105.271 4.19 . 0.115 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . 0.467 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.796 2 O4'-C1'-N19 113.319 5.119 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 1 C5'-C4'-C3' 109.014 -4.324 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 120.404 0.145 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.32 -7.03 87.97 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.678 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.7 p 52.53 21.49 1.82 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.229 1.412 . . . . 0.0 113.333 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 m -64.86 154.86 35.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.885 0.474 . . . . 0.0 111.105 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -154.49 -6.01 0.15 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.735 0.414 . . . . 0.0 111.236 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -81.6 -10.29 59.47 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.092 0.557 . . . . 0.0 111.65 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -74.65 157.19 35.77 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.895 0.379 . . . . 0.0 110.739 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -72.27 160.13 32.9 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.857 0.463 . . . . 0.0 110.721 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -150.57 1.72 0.45 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.427 0.291 . . . . 0.0 111.77 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -70.01 -7.77 43.69 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.138 0.426 . . . . 0.0 111.688 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.3 t -73.31 -20.15 60.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.597 0.359 . . . . 0.0 110.858 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -76.74 140.7 40.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.72 0.408 . . . . 0.0 110.416 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.56 -168.11 39.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.62 140.25 56.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p -64.54 132.1 95.29 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -68.04 -12.76 36.24 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.2 2.6 . . . . 0.0 112.095 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -23.49 62.64 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.523 0.329 . . . . 0.0 110.598 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.18 -61.85 0.93 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 m -158.48 154.22 26.43 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 123.572 0.749 . . . . 0.0 110.836 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -96.11 -12.32 24.97 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.58 0.352 . . . . 0.0 111.348 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -75.13 162.72 28.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.26 0.624 . . . . 0.0 111.103 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.475 ' NE2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -65.19 151.3 46.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.882 0.473 . . . . 0.0 110.89 178.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -150.44 142.9 24.39 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.635 0.774 . . . . 0.0 108.927 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -101.09 152.72 20.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.078 0.551 . . . . 0.0 111.632 -171.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.45 -164.41 30.71 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.04 170.44 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.488 2.792 . . . . 0.0 110.254 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -64.32 138.76 58.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.961 -0.462 . . . . 0.0 110.017 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.62 -1.67 87.18 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.541 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.95 13.2 29.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.717 0.758 . . . . 0.0 112.327 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -113.9 138.81 49.81 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.696 0.398 . . . . 0.0 110.186 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.8 mt -123.6 156.59 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 122.076 0.941 . . . . 0.0 113.115 -174.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -117.21 143.17 46.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.973 1.709 . . . . 0.0 114.016 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 HD21 ' A' ' 36' ' ' LEU . 3.0 mp -137.64 128.36 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.73 171.17 14.22 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.413 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 18.3 m170 74.15 20.67 2.67 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.209 1.803 . . . . 0.0 112.77 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.617 HD23 ' HA ' ' A' ' 72' ' ' PHE . 2.7 mm? -70.4 142.8 89.75 Favored Pre-proline 0 N--CA 1.454 -0.235 0 C-N-CA 123.166 0.586 . . . . 0.0 109.957 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.45 162.78 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.586 2.858 . . . . 0.0 108.991 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.82 -8.05 54.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -76.88 -9.94 59.03 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.266 0.484 . . . . 0.0 110.789 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.479 ' CD1' HD12 ' A' ' 36' ' ' LEU . 5.5 m-85 -75.67 158.44 32.35 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.82 174.92 33.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 8.5 p30 -60.8 -35.58 76.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -74.36 -29.19 61.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.18 0.592 . . . . 0.0 111.213 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -79.05 -42.08 27.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.81 -23.06 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.2 -49.61 75.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -65.31 -23.67 67.08 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.601 0.361 . . . . 0.0 111.641 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.3 mmm -77.15 -22.44 52.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.638 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 28.1 m-85 -110.1 -10.57 14.67 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.093 2.627 . . . . 0.0 118.093 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.437 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.1 mtm -66.21 -32.64 5.74 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 50' ' ' MET . 91.8 Cg_endo -74.4 -8.19 20.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 121.715 1.648 . . . . 0.0 112.055 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.79 -15.58 38.86 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.97 -172.35 33.3 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -75.93 103.09 5.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.208 -0.583 . . . . 0.0 110.516 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 122.56 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.5 mt -81.64 -30.83 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.05 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.8 t -158.72 154.58 26.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.055 0.455 . . . . 0.0 111.102 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.52 146.33 31.39 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.964 0.906 . . . . 0.0 108.603 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 42' ' ' ASP . 14.3 tppt? -157.96 145.35 18.25 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -121.73 132.83 69.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -69.71 155.07 41.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -134.08 143.76 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.949 0.5 . . . . 0.0 109.845 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -88.08 132.18 34.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -77.72 -13.06 60.01 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.839 0.456 . . . . 0.0 111.408 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -91.13 -22.27 20.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.276 0.63 . . . . 0.0 112.677 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.7 -12.85 2.0 Allowed 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -174.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 60.52 8.72 1.78 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.647 1.179 . . . . 0.0 112.911 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.46 156.65 30.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.966 0.348 . . . . 0.0 110.739 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.9 t -71.31 135.27 47.31 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.907 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.89 162.75 26.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.084 0.553 . . . . 0.0 110.822 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -81.28 11.0 4.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.617 ' HA ' HD23 ' A' ' 36' ' ' LEU . 4.6 p90 -157.79 172.94 17.58 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.43 -163.86 16.11 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.778 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.26 147.6 35.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.869 1.667 . . . . 0.0 115.404 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.6 t -146.2 152.14 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 t -141.2 143.9 34.46 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.25 159.17 19.61 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -76.23 -11.92 60.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.153 0.501 . . . . 0.0 111.847 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -153.86 149.7 21.43 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 123.168 0.587 . . . . 0.0 110.886 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.08 -18.23 35.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.344 2.696 . . . . 0.0 112.214 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.41 -46.27 95.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 118.297 0.499 . . . . 0.0 110.758 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.6 m -70.87 -24.04 62.42 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.186 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.6 -48.07 35.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.911 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -67.58 -28.99 68.23 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.045 0.384 . . . . 0.0 110.852 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.64 80.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.36 66.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.871 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.6 mt -65.85 -51.15 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 118.796 0.726 . . . . 0.0 109.173 174.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -68.23 -11.07 58.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.419 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.91 -26.77 16.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 89.2 mmm -120.65 -14.71 8.56 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.07 132.65 48.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.62 4.06 87.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.774 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -63.23 117.64 6.85 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.578 1.189 . . . . 0.0 109.977 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -77.37 130.93 37.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.115 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.97 134.25 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.45 -108.31 1.89 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 65.2 mtt -130.57 17.76 5.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.561 0.745 . . . . 0.0 111.516 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 55.3 tttp -146.59 155.84 42.78 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.69 0.396 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -98.12 140.64 32.14 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.699 -0.626 . . . . 0.0 111.196 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.02 131.58 46.15 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.713 0.405 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.517 ' HE3' ' C4 ' ' B' ' 116' ' ' ' U' . 18.2 ttmm -92.8 139.12 30.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -134.83 141.01 44.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-N 118.047 0.385 . . . . 0.0 110.376 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -155.03 163.53 40.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.917 0.326 . . . . 0.0 111.785 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.44 148.66 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.562 0.745 . . . . 0.0 110.259 175.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -68.36 155.37 39.93 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -59.56 138.39 57.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.017 0.371 . . . . 0.0 111.375 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -74.13 166.58 23.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.724 0.81 . . . . 0.0 109.739 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.74 -19.94 66.07 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.874 -0.516 . . . . 0.0 111.239 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -77.29 -29.06 53.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -103.74 0.17 30.16 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.3 p -68.72 -20.64 64.41 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.148 0.579 . . . . 0.0 111.271 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -138.12 152.99 72.9 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 123.791 0.836 . . . . 0.0 110.732 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.08 -13.97 21.1 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.558 2.839 . . . . 0.0 111.16 177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.1 m95 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.528 -1.225 . . . . 0.0 112.138 179.747 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 C5'-C4'-C3' 109.981 -3.679 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . 0.517 ' C4 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.758 1 C5'-C4'-C3' 108.258 -4.828 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.123 0 C5'-C4'-C3' 109.639 -3.907 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.69 2 C3'-C2'-C1' 105.624 4.582 . 0.305 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 2 C5'-C4'-C3' 109.31 -4.127 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 120.443 0.163 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.25 178.74 48.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.6 t -156.11 160.75 40.21 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.316 0.646 . . . . 0.0 110.15 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.7 t -67.23 152.65 45.35 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.928 0.491 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -155.55 150.6 26.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.968 0.507 . . . . 0.0 110.184 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -154.86 161.64 41.38 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.114 0.566 . . . . 0.0 110.251 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -155.37 165.68 35.88 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 123.053 0.541 . . . . 0.0 110.345 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -151.68 -12.12 0.2 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.392 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -76.02 159.06 31.2 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.974 0.51 . . . . 0.0 110.764 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -73.46 164.11 27.11 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.084 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 t -66.18 152.64 44.37 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.192 0.597 . . . . 0.0 111.141 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.7 t -69.27 -14.31 62.88 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.774 0.429 . . . . 0.0 110.778 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.1 -1.68 80.62 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.973 -0.348 . . . . 0.0 112.232 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.4 tp -63.88 143.94 57.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.834 0.817 . . . . 0.0 110.823 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -152.21 139.13 12.36 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.449 0.699 . . . . 0.0 110.599 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.74 146.71 73.68 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.915 2.41 . . . . 0.0 111.319 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 73.5 mmt-85 -146.82 151.21 36.75 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.364 1.065 . . . . 0.0 110.596 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.43 -21.03 3.07 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.436 1.017 . . . . 0.0 111.892 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 94.7 p -167.3 165.21 15.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.862 0.865 . . . . 0.0 109.487 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -77.87 -17.2 57.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.156 0.183 . . . . 0.0 110.941 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.2 ptp 44.35 32.91 0.77 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 125.911 1.684 . . . . 0.0 114.108 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.429 ' H ' ' CD ' ' A' ' 22' ' ' GLN . 2.8 pm0 -52.41 142.9 16.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.053 0.941 . . . . 0.0 110.859 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -84.99 159.93 20.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.435 0.694 . . . . 0.0 110.385 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -138.08 149.59 46.12 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.581 0.353 . . . . 0.0 110.677 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.77 41.44 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 177.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.3 167.2 24.51 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.409 2.739 . . . . 0.0 109.881 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.42 136.51 57.94 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.09 -0.381 . . . . 0.0 110.091 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 -10.56 73.99 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.132 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.33 6.67 48.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.031 0.532 . . . . 0.0 111.133 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.11 145.51 24.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.92 151.85 49.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.017 0.913 . . . . 0.0 113.097 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.74 145.12 45.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.542 1.937 . . . . 0.0 114.553 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.73 136.7 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.11 178.44 7.17 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.461 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.2 m170 63.88 15.92 9.46 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.31 1.444 . . . . 0.0 112.798 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.43 142.79 94.79 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 117.902 0.319 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.66 166.69 28.68 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.907 2.405 . . . . 0.0 109.566 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -71.2 -14.24 62.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.34 -10.02 59.08 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.84 158.14 36.89 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 175.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.22 177.7 34.8 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -57.32 -40.67 78.41 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -84.95 -26.26 27.29 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.378 -0.201 . . . . 0.0 111.055 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -74.18 -38.28 63.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 tt -75.41 -26.34 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.57 -53.35 53.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -64.23 -23.05 67.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.821 0.448 . . . . 0.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 tpt -79.05 -25.09 43.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.267 -0.271 . . . . 0.0 110.506 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.266 29.0 m-85 -105.83 -10.96 16.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 -178.69 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.466 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 53.8 mtm -66.63 -29.56 2.85 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.2 Cg_endo -72.47 -8.42 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 CA-C-N 121.951 1.733 . . . . 0.0 112.167 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -89.42 -12.07 41.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.959 0.504 . . . . 0.0 111.208 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.49 -176.17 31.6 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -77.96 101.67 6.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.236 -0.567 . . . . 0.0 110.506 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.02 123.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -85.22 -30.84 6.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.9 t -152.85 151.69 30.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 110.661 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 136.32 13.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.87 0.868 . . . . 0.0 108.865 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -158.5 131.05 7.02 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.511 0.196 . . . . 0.0 110.583 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -95.68 134.36 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -69.53 144.64 53.08 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -133.19 144.55 36.0 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 123.168 0.587 . . . . 0.0 109.979 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -88.89 130.69 35.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.454 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.54 -11.46 60.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.994 -0.441 . . . . 0.0 111.251 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -89.84 -21.86 22.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.8 -13.72 1.92 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.2 9.12 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.338 1.055 . . . . 0.0 112.954 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -82.25 160.01 23.07 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.709 0.404 . . . . 0.0 109.996 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.2 t -69.51 139.99 53.89 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.341 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -82.53 6.4 17.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.7 m 60.87 22.64 12.72 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.59 168.41 27.23 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.24 -172.12 28.16 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.796 -0.565 . . . . 0.0 113.714 -173.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -136.75 144.38 43.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.151 1.78 . . . . 0.0 114.877 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.1 t -148.33 153.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 91.1 p -146.46 146.64 30.63 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.831 -0.543 . . . . 0.0 112.295 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.46 164.83 12.32 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.64 -11.15 59.96 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.54 149.92 23.71 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 122.984 0.514 . . . . 0.0 110.785 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.29 -18.1 39.4 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.099 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.61 -46.56 94.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-N 118.466 0.576 . . . . 0.0 110.83 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -71.33 -25.36 62.37 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.518 0.327 . . . . 0.0 111.04 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.71 -47.69 52.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.045 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -68.49 -27.83 66.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.143 0.428 . . . . 0.0 110.711 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -40.66 81.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.02 66.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.678 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.3 -52.23 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -68.51 -11.8 60.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.338 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.55 -27.7 17.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 89.0 mmm -120.4 -18.29 7.94 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -65.68 131.81 47.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.07 8.59 85.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 119.089 -0.839 . . . . 0.0 112.51 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -66.38 114.58 5.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.807 1.303 . . . . 0.0 109.103 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.4 129.1 37.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.436 0.562 . . . . 0.0 110.956 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 tt -145.14 122.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.18 -143.3 48.34 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.5 mtm -86.1 12.53 9.41 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 42.7 tttp -147.06 170.45 17.11 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.698 0.681 . . . . 0.0 110.356 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -111.99 140.7 46.44 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 122.937 0.495 . . . . 0.0 109.902 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.29 132.7 49.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.272 0.229 . . . . 0.0 111.233 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.491 ' HE3' ' C5 ' ' B' ' 116' ' ' ' U' . 19.1 ttmm -95.58 139.05 32.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 67.3 t -135.24 140.08 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -154.31 163.7 39.74 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -79.85 150.78 30.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.491 0.717 . . . . 0.0 110.629 175.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.444 ' H ' HD23 ' A' ' 104' ' ' LEU . 64.4 tttp -69.18 154.34 42.2 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.3 mmm-85 -62.78 155.83 25.59 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.718 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -154.06 166.2 33.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.314 0.646 . . . . 0.0 109.951 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -65.67 -11.19 42.89 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.979 -0.451 . . . . 0.0 110.644 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -84.55 -9.22 58.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.63 0.772 . . . . 0.0 112.634 177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -133.52 -9.99 2.83 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.8 t -70.03 -14.46 62.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.572 0.749 . . . . 0.0 111.521 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -65.81 153.89 90.15 Favored Pre-proline 0 C--N 1.34 0.172 0 C-N-CA 123.002 0.521 . . . . 0.0 111.096 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.9 5.19 5.86 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 124.367 3.378 . . . . 0.0 110.86 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.396 -177.154 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . 0.479 H5'' ' C6 ' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 O4'-C1'-N19 111.811 3.611 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . 0.491 ' C5 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.035 0 O4'-C1'-N19 110.466 2.266 . 0.094 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.398 0 C3'-C2'-C1' 98.734 -3.073 . 0.072 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 2 O4'-C1'-N19 113.303 5.103 . 0.436 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 1 C5'-C4'-C3' 108.959 -4.361 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.321 0.105 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.48 -12.07 72.86 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.9 -0.389 . . . . 0.0 112.951 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -75.74 -5.64 46.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.68 0.74 . . . . 0.0 111.472 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.2 t 61.95 153.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.228 1.411 . . . . 0.0 113.548 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -82.17 43.78 0.82 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.731 0.812 . . . . 0.0 110.298 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 60.07 15.82 5.43 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 124.786 1.234 . . . . 0.0 113.325 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -83.09 -30.36 28.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.347 -0.221 . . . . 0.0 110.643 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -82.38 -26.97 32.39 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.377 0.271 . . . . 0.0 110.347 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -86.07 174.66 9.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.236 0.615 . . . . 0.0 110.805 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -63.86 153.48 36.64 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -61.41 -26.17 67.68 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.944 0.497 . . . . 0.0 112.144 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.8 p -66.29 -16.76 64.3 Favored 'General case' 0 C--O 1.231 0.106 0 O-C-N 122.049 -0.407 . . . . 0.0 111.435 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 -22.74 52.01 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.9 tp -83.55 -33.61 25.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.32 0.56 . . . . 0.0 110.11 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.1 132.54 5.24 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.969 0.508 . . . . 0.0 111.04 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.56 150.44 40.47 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.101 2.534 . . . . 0.0 110.558 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.84 171.95 18.54 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.318 0.647 . . . . 0.0 109.594 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.72 144.76 10.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 t 58.74 163.75 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.46 1.504 . . . . 0.0 114.005 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -88.46 -10.01 50.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.957 0.903 . . . . 0.0 111.792 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mtm -72.14 164.48 26.13 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.823 0.345 . . . . 0.0 111.385 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -71.35 152.07 43.53 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.553 0.741 . . . . 0.0 109.938 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -100.65 153.52 19.35 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.964 0.411 . . . . 0.0 111.378 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -115.84 151.53 35.08 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.184 0.594 . . . . 0.0 111.143 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.45 -179.07 46.7 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.69 -178.52 1.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.071 3.181 . . . . 0.0 110.376 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.61 131.14 49.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.117 -0.364 . . . . 0.0 111.019 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.04 1.79 85.9 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 119.526 -0.597 . . . . 0.0 113.189 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.88 7.41 44.93 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -109.67 139.11 45.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.327 0.512 . . . . 0.0 110.359 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.4 mt -126.15 159.37 33.1 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -117.36 141.8 47.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.967 1.707 . . . . 0.0 114.582 171.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.08 132.37 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -135.53 179.97 6.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.0 m170 65.15 23.39 12.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.149 1.379 . . . . 0.0 112.747 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.17 136.46 72.58 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.326 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.78 168.86 23.44 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.537 2.825 . . . . 0.0 110.313 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -69.37 -11.32 60.71 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -80.02 -7.27 58.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -76.1 158.18 32.06 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.94 174.91 35.27 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.85 -36.03 73.91 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 117.202 0.501 . . . . 0.0 110.864 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -78.62 -33.97 46.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.29 0.236 . . . . 0.0 110.886 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -71.28 -39.29 71.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -75.74 -26.74 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.446 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.4 tm? -65.16 -53.81 39.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.556 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 tpt -72.81 -26.65 61.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 25.0 m-85 -103.52 -9.27 19.44 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.457 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 44.7 mtm -66.78 -31.33 3.96 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 50' ' ' MET . 76.9 Cg_endo -71.53 -8.18 22.73 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 121.959 1.735 . . . . 0.0 111.667 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -89.07 -14.76 35.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.825 0.45 . . . . 0.0 110.885 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.88 -174.33 30.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -75.25 105.56 6.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.364 -0.492 . . . . 0.0 110.668 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.73 123.69 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.5 mt -82.17 -34.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 O-C-N 122.211 -0.306 . . . . 0.0 110.292 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -156.14 156.86 34.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.415 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.33 148.03 26.3 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.682 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.11 131.75 6.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.624 0.369 . . . . 0.0 111.014 -174.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.92 129.36 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CD2' " H1'" ' B' ' 119' ' ' ' A' . 41.9 m-85 -74.32 149.16 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -174.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 mm -132.95 153.32 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.776 0.43 . . . . 0.0 110.466 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HE3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -80.04 -10.73 59.79 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -86.24 -23.59 26.35 Favored 'General case' 0 C--O 1.23 0.039 0 C-N-CA 122.817 0.447 . . . . 0.0 112.126 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.0 -14.71 1.36 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.4 6.95 1.56 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.043 0.937 . . . . 0.0 112.812 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.35 162.74 25.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.3 t -67.99 141.75 56.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 110.474 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -73.44 6.39 3.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 111.384 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.8 p 58.35 20.78 7.64 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.491 1.916 . . . . 0.0 112.687 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.19 169.93 23.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.36 -170.23 26.86 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 121.467 0.482 . . . . 0.0 112.404 -175.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -137.63 141.45 41.21 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.664 1.586 . . . . 0.0 114.905 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.8 t -145.12 152.08 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.6 p -143.3 149.57 38.01 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-O 120.923 0.392 . . . . 0.0 112.003 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -114.85 162.54 16.76 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -78.3 -11.04 59.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -155.69 150.28 20.22 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.557 0.743 . . . . 0.0 110.767 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.0 -20.57 38.26 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.311 2.674 . . . . 0.0 112.057 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.2 -45.13 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 CA-C-N 118.42 0.554 . . . . 0.0 111.09 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -71.58 -27.3 63.04 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.91 -48.13 39.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -67.0 -27.61 67.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.035 -0.416 . . . . 0.0 110.802 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.16 73.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.31 66.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.99 -51.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -68.28 -12.02 60.36 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.161 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.46 -32.85 20.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.008 -0.52 . . . . 0.0 112.379 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.2 mtp -123.2 -14.77 7.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.23 126.67 28.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.38 2.38 90.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.802 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -62.27 138.75 58.48 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -92.64 130.79 38.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.782 0.719 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.6 tt -144.83 123.98 6.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.33 -143.66 48.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 mmt -84.91 9.2 15.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.659 0.783 . . . . 0.0 113.075 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -140.67 179.11 6.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.554 0.616 . . . . 0.0 111.214 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -118.82 147.74 43.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.41 124.34 19.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.038 0.935 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -94.38 130.42 40.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.95 137.64 51.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 122.243 0.217 . . . . 0.0 110.52 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -153.7 161.25 42.29 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 122.395 -0.191 . . . . 0.0 111.152 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -74.86 154.49 38.22 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.219 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.582 ' H ' HD23 ' A' ' 104' ' ' LEU . 57.2 tttp -61.53 151.96 31.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.6 0.36 . . . . 0.0 110.327 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -64.55 160.3 19.82 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.549 0.34 . . . . 0.0 110.684 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.9 m -63.11 143.86 57.42 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.588 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.01 -8.08 52.47 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -67.26 -17.08 64.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.373 -0.204 . . . . 0.0 110.984 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -80.87 -17.28 51.18 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 t -86.92 -18.08 31.67 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.012 0.525 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -68.09 151.46 97.19 Favored Pre-proline 0 C--N 1.34 0.176 0 C-N-CA 123.133 0.573 . . . . 0.0 110.987 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.04 -5.2 15.66 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.109 3.206 . . . . 0.0 112.608 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.908 -1.52 . . . . 0.0 112.798 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.864 0 O4'-C1'-N19 110.732 2.532 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.3 0 O4'-C1'-N19 110.517 2.317 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.223 0 C3'-C2'-C1' 98.501 -3.332 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.709 2 C3'-C2'-C1' 105.544 4.493 . 0.382 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . 0.491 " H1'" ' CD2' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.882 2 O4'-C1'-N19 112.766 4.566 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.06 9.32 0.09 OUTLIER Glycine 0 CA--C 1.53 0.991 0 CA-C-O 120.037 -0.313 . . . . 0.0 112.319 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -65.98 159.72 25.17 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.502 0.651 . . . . 0.0 111.198 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 t -153.56 157.69 40.1 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.119 0.568 . . . . 0.0 110.276 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -71.99 159.28 34.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.978 0.511 . . . . 0.0 111.376 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -71.01 159.13 35.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.37 0.668 . . . . 0.0 111.131 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -69.36 154.92 41.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.728 0.411 . . . . 0.0 111.128 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -156.07 162.17 40.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.193 0.597 . . . . 0.0 110.273 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -91.44 -1.29 57.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.189 0.596 . . . . 0.0 111.94 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -68.08 150.88 47.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.966 0.348 . . . . 0.0 110.839 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.5 p -154.69 164.59 38.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.016 0.526 . . . . 0.0 110.611 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.6 t -154.89 165.31 37.08 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.666 0.786 . . . . 0.0 109.944 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.95 -154.46 30.63 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.78 165.12 13.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.598 0.359 . . . . 0.0 111.912 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.9 138.95 14.76 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.365 0.666 . . . . 0.0 110.28 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.2 22.55 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.242 3.295 . . . . 0.0 112.856 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -134.0 168.45 18.77 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.493 0.717 . . . . 0.0 111.128 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.4 -9.69 77.95 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.443 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 95.1 p -160.11 166.75 29.22 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.658 0.729 . . . . 0.0 110.479 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -82.7 4.34 25.43 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.0 0.52 . . . . 0.0 111.927 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.5 mtm -69.29 173.24 5.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.1 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -58.5 143.31 46.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.628 0.771 . . . . 0.0 111.362 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.65 159.08 19.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.481 0.712 . . . . 0.0 110.761 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -140.33 150.28 43.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.831 0.452 . . . . 0.0 111.046 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 -160.73 35.24 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.87 178.75 3.74 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.042 3.161 . . . . 0.0 110.522 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -60.71 136.09 57.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.961 -0.462 . . . . 0.0 111.328 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.67 -1.67 71.63 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.334 0.492 . . . . 0.0 112.725 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.99 38.76 1.03 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 111.346 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.64 144.59 31.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.029 -0.419 . . . . 0.0 111.308 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.7 mt -129.87 158.07 40.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 25.2 m-85 -112.64 143.83 43.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.407 1.483 . . . . 0.0 114.233 170.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.85 124.95 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.8 m-85 -129.19 179.48 5.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m170 64.02 15.95 9.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.598 1.559 . . . . 0.0 112.335 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.57 141.39 90.47 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 122.842 0.457 . . . . 0.0 110.557 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.88 165.23 32.65 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.307 2.671 . . . . 0.0 109.415 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.47 -5.86 45.0 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.62 -9.2 58.82 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.033 0.379 . . . . 0.0 111.423 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -75.22 158.17 33.36 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.4 175.54 34.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -58.48 -37.35 75.34 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.531 0.665 . . . . 0.0 110.287 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.36 -33.27 37.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.605 0.241 . . . . 0.0 110.914 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -72.73 -38.52 67.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -74.79 -26.13 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.91 -53.26 41.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.513 0.325 . . . . 0.0 111.257 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.2 tpt -80.62 -24.71 38.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.953 0.101 . . . . 0.0 110.748 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.262 21.3 m-85 -104.63 -12.32 16.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -179.212 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.479 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.9 mtm -66.39 -29.87 3.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.9 Cg_endo -71.66 -9.68 25.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 122.068 1.774 . . . . 0.0 111.694 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -87.77 -13.62 41.83 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.094 0.406 . . . . 0.0 111.502 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.32 -175.01 31.9 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -75.45 103.25 5.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.552 -0.381 . . . . 0.0 110.484 -177.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.6 t -86.05 124.78 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.5 mt -86.31 -29.32 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 O-C-N 122.43 -0.169 . . . . 0.0 110.585 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -156.51 154.9 31.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.66 149.11 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.68 0.792 . . . . 0.0 109.361 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.423 ' HE2' ' N3 ' ' B' ' 119' ' ' ' A' . 54.0 tptt -158.31 139.22 13.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.556 0.342 . . . . 0.0 111.658 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 t -118.15 131.04 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.402 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 42.8 m-85 -71.73 156.48 39.29 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -133.29 145.35 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 C-N-CA 122.823 0.449 . . . . 0.0 110.027 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -88.4 132.13 34.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -79.04 -14.18 59.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.889 0.476 . . . . 0.0 111.595 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -89.61 -23.64 21.89 Favored 'General case' 0 C--N 1.335 -0.063 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.35 -11.76 2.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 62.0 10.51 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.346 1.059 . . . . 0.0 111.839 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.64 156.37 27.66 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.942 -0.474 . . . . 0.0 110.01 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.6 t -71.29 139.64 50.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.786 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.87 163.89 24.93 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.861 0.464 . . . . 0.0 110.873 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.6 m -84.32 13.18 5.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -158.91 171.98 19.05 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.41 -166.06 18.47 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.511 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.36 142.88 30.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.17 152.81 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.704 0.802 . . . . 0.0 109.782 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 t -144.02 141.08 29.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -104.8 162.69 13.09 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -77.99 -12.49 59.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 111.491 174.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -154.97 149.9 20.44 Favored Pre-proline 0 N--CA 1.451 -0.404 0 C-N-CA 123.088 0.555 . . . . 0.0 110.613 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.92 -21.62 32.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.066 2.511 . . . . 0.0 112.341 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.2 -39.28 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.879 -0.513 . . . . 0.0 111.837 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -73.77 -25.33 60.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.182 0.193 . . . . 0.0 110.586 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.01 -45.84 55.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.29 -30.63 71.09 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.9 0.318 . . . . 0.0 110.875 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.52 82.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.28 -26.37 65.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.4 mt -65.52 -53.07 43.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -67.9 -11.3 58.43 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.99 -29.29 16.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 92.9 mmm -120.43 -16.96 8.29 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -65.0 132.59 49.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 4.83 84.75 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.048 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -63.66 122.83 17.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.727 1.263 . . . . 0.0 111.419 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -76.52 128.96 35.77 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.791 0.329 . . . . 0.0 110.854 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -151.76 136.91 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.6 -111.77 3.5 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.2 ptp -128.7 13.66 6.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.174 0.59 . . . . 0.0 111.89 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -151.85 142.16 22.44 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.169 0.44 . . . . 0.0 110.636 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -81.85 144.7 30.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.243 -0.286 . . . . 0.0 110.702 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.83 127.16 31.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.309 0.244 . . . . 0.0 111.037 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.62 138.31 31.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.21 140.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -153.71 157.23 39.2 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 122.352 -0.217 . . . . 0.0 111.277 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -78.3 151.79 32.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.002 0.521 . . . . 0.0 109.781 174.681 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.495 ' H ' HD23 ' A' ' 104' ' ' LEU . 59.7 tttp -66.88 147.77 52.81 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -76.03 156.57 33.88 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 120.629 0.252 . . . . 0.0 110.917 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -67.99 151.92 46.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.485 0.314 . . . . 0.0 111.141 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.4 ' HG3' ' H ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -72.37 -4.69 31.47 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 177.409 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.47 -18.66 60.59 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -79.93 -12.74 59.71 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.1 t -84.75 -17.61 37.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.941 0.496 . . . . 0.0 110.499 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 34.4 mmtp -69.98 157.88 88.67 Favored Pre-proline 0 N--CA 1.456 -0.156 0 C-N-CA 123.516 0.727 . . . . 0.0 110.744 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 112' ' ' LYS . 89.9 Cg_endo -75.63 -16.05 19.06 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.679 2.919 . . . . 0.0 111.679 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 3.2 p90 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 116.805 -1.569 . . . . 0.0 112.665 -177.519 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.873 0 C5'-C4'-C3' 109.923 -3.718 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.055 0 O4'-C1'-N19 109.906 1.706 . 0.032 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.244 0 C3'-C2'-C1' 99.552 -2.165 . 0.023 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.743 2 C3'-C2'-C1' 105.82 4.8 . 0.353 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . 0.423 ' N3 ' ' HE2' ' A' ' 59' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.894 2 C5'-C4'-C3' 108.155 -4.896 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.586 0.231 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.73 -178.48 48.07 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -67.83 156.66 36.58 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.615 0.366 . . . . 0.0 111.239 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.7 t -155.2 157.0 36.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.247 0.619 . . . . 0.0 110.443 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -155.53 158.69 38.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.194 0.598 . . . . 0.0 110.448 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -154.31 156.92 37.84 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.308 0.643 . . . . 0.0 110.349 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -72.31 158.45 35.79 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.873 0.469 . . . . 0.0 111.248 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -70.44 157.51 37.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.081 0.552 . . . . 0.0 111.036 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -155.18 -29.28 0.1 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.575 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -76.36 -14.22 60.1 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.622 0.369 . . . . 0.0 111.569 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m -69.78 158.43 35.46 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.956 0.502 . . . . 0.0 110.937 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.6 t -73.96 -7.25 51.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.797 0.439 . . . . 0.0 111.589 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.89 -0.89 76.48 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.312 0.482 . . . . 0.0 112.557 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.32 142.69 53.99 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.739 0.77 . . . . 0.0 110.062 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 17' ' ' ARG . 5.8 p -67.7 133.99 92.47 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.415 0.286 . . . . 0.0 111.67 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' C ' ' H ' ' A' ' 18' ' ' GLY . 89.3 Cg_endo -73.6 -9.97 23.2 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.019 2.479 . . . . 0.0 112.066 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.426 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER 61.37 -14.89 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.158 1.783 . . . . 0.0 113.697 -178.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 16' ' ' PRO . . . 83.58 148.67 8.52 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.5 t -78.54 160.58 27.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.915 0.486 . . . . 0.0 110.702 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -76.79 -8.86 58.11 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.576 0.351 . . . . 0.0 110.471 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.3 mtm 57.05 27.88 14.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -66.98 152.29 46.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.189 -0.319 . . . . 0.0 110.522 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -108.74 159.74 16.52 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.556 0.742 . . . . 0.0 112.263 -170.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -131.5 153.03 50.22 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.914 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.44 -165.78 30.92 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.588 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -69.88 177.5 5.6 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.127 3.218 . . . . 0.0 110.403 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -60.67 137.4 58.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.903 -0.498 . . . . 0.0 110.855 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -3.53 83.51 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.672 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -0.28 39.76 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.679 0.74 . . . . 0.0 112.703 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -102.54 136.26 42.68 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 118.213 0.461 . . . . 0.0 110.314 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.5 mt -124.18 154.58 39.88 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.892 0.853 . . . . 0.0 113.135 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -116.06 145.91 42.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.931 1.692 . . . . 0.0 114.011 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.43 137.82 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.57 176.35 8.96 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 9.4 m170 65.93 16.1 10.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.181 1.392 . . . . 0.0 112.644 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.3 146.19 98.76 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.709 0.403 . . . . 0.0 110.075 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 169.16 22.82 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.319 2.68 . . . . 0.0 109.833 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -68.47 -19.29 64.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.872 0.469 . . . . 0.0 112.206 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.0 -10.57 59.66 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -69.99 158.03 36.39 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.24 175.5 35.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.38 -35.74 72.44 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 117.466 0.633 . . . . 0.0 110.031 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -79.76 -33.16 40.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.913 0.485 . . . . 0.0 111.085 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.11 -39.04 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.2 tt -74.35 -24.96 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.6 tp -65.27 -52.29 55.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -65.22 -22.27 66.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.566 0.346 . . . . 0.0 111.382 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.2 tpp -78.24 -26.78 47.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.269 0.228 . . . . 0.0 110.713 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.266 22.9 m-85 -105.77 -11.57 16.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.458 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.5 mtm -66.91 -31.0 3.56 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 50' ' ' MET . 81.4 Cg_endo -71.97 -9.2 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.745 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -82.78 -24.32 33.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.74 0.416 . . . . 0.0 111.981 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 158.57 -163.52 33.09 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.96 103.04 10.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.556 0.678 . . . . 0.0 110.972 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.4 t -82.4 121.55 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.66 -32.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -157.83 152.4 24.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.965 0.506 . . . . 0.0 111.239 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.09 146.74 31.96 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.891 0.876 . . . . 0.0 109.068 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.457 ' HE2' ' N3 ' ' B' ' 119' ' ' ' A' . 52.9 tptt -156.79 139.26 14.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.76 0.424 . . . . 0.0 111.598 -172.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.45 129.19 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 168.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -72.18 147.84 46.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.5 mm -132.36 141.17 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.819 0.448 . . . . 0.0 110.461 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -90.12 134.85 34.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -77.64 -12.22 59.95 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.65 0.38 . . . . 0.0 111.755 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.9 -22.54 24.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.12 -14.64 1.78 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 62.12 8.2 2.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.506 1.122 . . . . 0.0 112.717 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.7 mt -82.42 161.0 22.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.814 0.445 . . . . 0.0 110.329 175.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.5 t -66.87 138.54 57.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -77.56 8.91 3.76 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.009 0.524 . . . . 0.0 111.619 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.5 m 61.91 23.08 13.52 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -156.5 167.45 30.41 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.21 -170.79 24.19 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 121.581 0.545 . . . . 0.0 113.433 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -142.39 142.67 32.44 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.224 1.81 . . . . 0.0 114.744 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.1 t -146.05 153.41 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.5 t -143.31 146.92 33.99 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -117.86 165.57 13.51 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -80.63 -13.31 59.14 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.03 148.58 21.7 Favored Pre-proline 0 C--O 1.233 0.205 0 C-N-CA 123.256 0.623 . . . . 0.0 111.378 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.86 -23.11 41.72 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.508 2.805 . . . . 0.0 112.132 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.74 -38.66 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 O-C-N 121.802 -0.561 . . . . 0.0 111.232 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.6 t -74.72 -29.79 61.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.319 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.01 37.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.26 -28.57 68.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.262 -0.274 . . . . 0.0 110.727 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.57 73.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.47 -26.56 68.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.68 -51.87 57.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 CA-C-N 118.836 0.744 . . . . 0.0 109.001 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.89 -11.81 57.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.37 -27.38 16.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.5 mmm -120.54 -17.27 8.14 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.67 134.66 53.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.72 2.39 85.55 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.839 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.37 120.02 13.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.814 1.307 . . . . 0.0 110.675 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.76 126.87 31.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.63 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.69 135.72 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.442 0.697 . . . . 0.0 109.567 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.72 31.82 76.74 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.518 -0.739 . . . . 0.0 111.828 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.5 mtm 64.64 22.19 12.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -144.75 155.81 43.73 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -97.95 134.62 40.81 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.376 -0.828 . . . . 0.0 111.159 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.8 mt -64.73 130.99 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.66 0.267 . . . . 0.0 111.351 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.52 137.39 32.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.7 t -134.36 135.33 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -150.31 160.51 43.66 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.699 0.227 . . . . 0.0 111.564 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -76.6 149.29 36.58 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.01 0.524 . . . . 0.0 110.002 177.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.477 ' H ' HD23 ' A' ' 104' ' ' LEU . 85.5 tttt -61.52 140.9 58.03 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -75.62 159.47 31.16 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.786 0.327 . . . . 0.0 110.828 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.9 t -66.37 158.49 29.12 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.544 0.338 . . . . 0.0 110.236 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -16.41 63.81 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 122.388 -0.195 . . . . 0.0 111.277 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -85.43 -16.3 40.17 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.61 0.364 . . . . 0.0 111.002 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -86.94 -10.88 52.18 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.9 t -88.76 -17.98 28.71 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.028 0.531 . . . . 0.0 110.784 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.86 151.63 96.24 Favored Pre-proline 0 C--O 1.233 0.227 0 C-N-CA 123.192 0.597 . . . . 0.0 111.214 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.24 -14.01 20.75 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.866 3.044 . . . . 0.0 111.219 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.9 m95 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.993 -179.717 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.186 0 C5'-C4'-C3' 109.694 -3.871 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 O4'-C1'-N19 110.779 2.579 . 0.046 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 C5'-C4'-C3' 109.676 -3.882 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 2 O4'-C1'-N19 112.994 4.794 . 0.517 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . 0.457 ' N3 ' ' HE2' ' A' ' 59' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.119 2 C5'-C4'-C3' 109.054 -4.297 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.273 0.082 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.99 8.74 86.91 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.942 -0.365 . . . . 0.0 112.373 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -72.51 -4.8 32.69 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.603 0.761 . . . . 0.0 112.425 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.5 p -155.85 167.57 30.0 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.299 0.64 . . . . 0.0 110.188 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -69.03 162.64 26.44 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 122.954 0.501 . . . . 0.0 110.971 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -70.91 164.17 25.94 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.061 0.458 . . . . 0.0 111.059 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -66.65 157.27 32.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.839 0.456 . . . . 0.0 111.101 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -80.6 -5.58 57.06 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.807 0.443 . . . . 0.0 111.394 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -77.86 12.63 1.65 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.434 0.694 . . . . 0.0 112.005 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -66.23 168.1 9.19 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.261 0.625 . . . . 0.0 111.207 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.3 t 56.54 25.81 10.25 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.983 0.913 . . . . 0.0 112.21 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.4 p -70.96 -11.15 60.81 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.074 0.549 . . . . 0.0 111.635 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.37 4.14 73.23 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.889 -0.395 . . . . 0.0 112.375 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.83 143.47 57.45 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.656 0.728 . . . . 0.0 110.52 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -155.5 143.01 13.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.96 -20.78 54.87 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.562 2.841 . . . . 0.0 114.181 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.18 151.72 19.75 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 122.722 0.409 . . . . 0.0 110.486 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.92 16.34 0.92 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 t -153.1 -167.28 2.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.94 0.896 . . . . 0.0 108.859 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -68.34 -2.65 8.84 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.78 -0.575 . . . . 0.0 111.817 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.1 ptp -65.77 171.08 4.57 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.705 0.802 . . . . 0.0 110.38 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.7 152.46 37.84 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.666 0.386 . . . . 0.0 110.872 -177.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -141.01 140.63 34.35 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -101.69 154.19 19.1 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.76 -156.3 20.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.08 175.94 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.94 3.094 . . . . 0.0 110.48 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.44 139.83 58.81 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.87 0.06 88.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.79 -0.45 . . . . 0.0 112.733 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.72 14.76 30.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.613 0.706 . . . . 0.0 112.893 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -119.14 138.62 52.79 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 118.427 0.558 . . . . 0.0 110.588 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.1 mt -125.42 156.88 38.15 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -117.1 141.42 48.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.844 1.658 . . . . 0.0 113.806 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.38 140.73 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -144.93 176.57 9.38 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.443 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 16.6 m170 63.97 16.74 10.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.901 1.68 . . . . 0.0 112.984 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.06 141.5 94.28 Favored Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.45 163.03 39.78 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.988 2.459 . . . . 0.0 109.524 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.72 -7.62 49.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -78.56 -10.56 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.091 -0.381 . . . . 0.0 111.134 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.99 158.5 35.34 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.8 174.92 35.17 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -56.82 -38.98 73.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -75.7 -33.21 60.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.784 0.433 . . . . 0.0 111.255 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 73.5 m-20 -71.55 -38.73 70.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 tt -76.52 -24.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.449 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.4 tm? -64.91 -53.62 43.56 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -69.66 -23.37 63.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 tpp -71.58 -27.9 63.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 18.6 m-85 -102.3 -10.08 19.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.44 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 46.2 mtm -65.83 -32.28 5.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.1 Cg_endo -72.33 -8.15 22.18 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.692 1.64 . . . . 0.0 111.894 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.34 -14.18 36.24 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.663 0.385 . . . . 0.0 111.342 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.92 -171.92 31.96 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -77.77 103.09 7.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.39 -0.477 . . . . 0.0 110.373 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -81.66 124.24 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.56 -37.45 16.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -158.44 157.1 31.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.478 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.46 146.82 23.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.84 144.0 16.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.692 0.397 . . . . 0.0 111.143 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.25 139.74 38.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 172.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -75.53 146.69 40.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -132.85 143.65 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 123.246 0.619 . . . . 0.0 110.303 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -90.56 131.7 36.14 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.38 -9.39 59.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.9 -0.5 . . . . 0.0 111.536 -179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -88.77 -22.26 23.38 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.92 -12.72 1.69 Allowed 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 62.29 7.37 2.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.415 1.086 . . . . 0.0 112.815 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.46 161.07 22.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 t -70.71 142.06 51.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.925 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.13 8.76 4.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.4 m 62.4 26.19 15.62 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.5 165.99 34.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.0 -179.54 27.71 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 121.548 0.527 . . . . 0.0 113.543 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.29 139.72 37.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.163 1.785 . . . . 0.0 113.987 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.35 152.97 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 123.628 0.771 . . . . 0.0 109.669 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.0 t -141.35 143.51 34.05 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.54 0.336 . . . . 0.0 111.898 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -111.88 159.83 17.98 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -75.91 -13.45 60.26 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -153.68 150.47 23.2 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.545 0.738 . . . . 0.0 110.756 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.9 -22.11 31.92 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.256 2.637 . . . . 0.0 112.465 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.3 -38.91 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 118.336 0.516 . . . . 0.0 111.704 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.7 m -74.3 -25.74 59.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.132 0.173 . . . . 0.0 110.631 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.78 -46.79 43.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -66.81 -30.43 70.62 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 122.271 -0.268 . . . . 0.0 110.737 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.29 80.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -26.75 65.59 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.14 -51.82 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -67.56 -12.09 59.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.31 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.74 -28.82 17.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.1 mmm -120.4 -17.3 8.21 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.88 133.07 51.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.55 2.19 87.55 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.894 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.41 119.05 10.29 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.57 1.185 . . . . 0.0 110.168 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -78.68 126.94 31.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.036 -0.415 . . . . 0.0 111.378 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.7 tt -155.91 135.14 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.307 0.643 . . . . 0.0 109.743 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.12 32.25 75.49 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.416 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm 63.03 24.52 14.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.066 0.947 . . . . 0.0 113.381 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HE2' ' CG ' ' A' ' 35' ' ' HIS . 85.2 tttt -144.99 151.48 38.65 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -96.31 134.09 39.87 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.0 mt -64.52 125.94 26.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.22 0.208 . . . . 0.0 110.789 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -87.93 139.19 30.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.82 139.48 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -149.21 156.52 42.28 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.743 0.306 . . . . 0.0 111.265 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.514 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -74.2 147.99 42.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.814 0.445 . . . . 0.0 109.952 176.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.514 ' H ' HD23 ' A' ' 104' ' ' LEU . 84.6 tttt -61.97 157.05 19.53 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.963 0.505 . . . . 0.0 110.785 175.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.439 ' HG2' ' H3 ' ' B' ' 117' ' ' ' U' . 11.2 ptp180 -141.12 160.51 39.94 Favored 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 124.215 1.006 . . . . 0.0 109.118 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 t -62.88 153.09 34.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.2 -19.91 63.14 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.261 -0.275 . . . . 0.0 110.61 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -80.65 -15.98 55.19 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.599 0.359 . . . . 0.0 110.55 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -102.21 -4.91 25.01 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -91.76 -2.35 56.99 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.944 0.497 . . . . 0.0 111.359 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -138.08 152.03 71.08 Favored Pre-proline 0 CA--C 1.529 0.161 0 C-N-CA 123.189 0.596 . . . . 0.0 110.767 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.93 -15.52 20.88 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.691 2.927 . . . . 0.0 111.142 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.9 m95 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.173 -1.394 . . . . 0.0 111.624 -179.926 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.46 0 C5'-C4'-C3' 109.686 -3.876 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.484 0 O4'-C1'-N19 110.869 2.669 . 0.166 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 117' ' ' ' U' . . . . . 0.439 ' H3 ' ' HG2' ' A' ' 106' ' ' ARG . . . . . . . . 0 O4'--C4' 1.417 -3.041 0 C5'-C4'-C3' 110.469 -3.354 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' ' A' . . . . . 0.464 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.997 2 O4'-C1'-N19 113.379 5.179 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.443 1 C5'-C4'-C3' 109.305 -4.13 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 121.199 0.523 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.12 -154.6 31.04 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.63 174.13 11.5 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.862 3.041 . . . . 0.0 110.574 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.02 139.67 58.4 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 122.238 -0.289 . . . . 0.0 110.615 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.9 -3.65 84.98 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.631 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.28 -1.46 53.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.786 0.793 . . . . 0.0 112.785 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -92.52 151.45 20.17 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.704 0.402 . . . . 0.0 110.596 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.436 HD13 ' HB1' ' A' ' 83' ' ' ALA . 1.4 tp -142.63 152.6 42.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.911 0.862 . . . . 0.0 113.213 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.45 145.93 47.43 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 126.516 1.926 . . . . 0.0 114.631 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.17 133.65 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.29 177.17 8.07 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 m170 65.67 16.11 10.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.572 1.549 . . . . 0.0 112.309 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.12 141.94 89.61 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 122.725 0.41 . . . . 0.0 110.524 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.55 164.46 35.53 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.757 2.305 . . . . 0.0 109.621 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -71.3 -8.12 51.55 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -77.31 -10.73 59.61 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.254 0.479 . . . . 0.0 111.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -72.58 158.16 36.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.73 175.98 34.91 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -56.88 -42.29 79.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -77.76 -27.82 50.46 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.656 0.382 . . . . 0.0 111.63 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -76.22 -37.92 57.1 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 tt -75.7 -25.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.8 tp -66.7 -51.75 52.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -65.16 -23.1 67.02 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.22 0.208 . . . . 0.0 111.501 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -76.4 -27.82 56.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.415 -0.178 . . . . 0.0 110.902 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.274 24.8 m-85 -105.37 -11.02 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 118.035 2.605 . . . . 0.0 118.035 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.465 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.1 mtm -66.75 -29.68 2.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.8 Cg_endo -72.5 -9.6 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.096 1.784 . . . . 0.0 112.216 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -86.61 -14.46 42.71 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.847 0.459 . . . . 0.0 111.453 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.64 -174.76 32.93 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -78.14 102.49 7.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.222 -0.575 . . . . 0.0 110.457 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -81.35 122.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.5 mt -81.89 -32.4 11.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 t -155.01 152.31 29.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.734 0.302 . . . . 0.0 110.777 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.58 143.06 21.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.735 0.814 . . . . 0.0 109.304 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HE3' ' CZ ' ' A' ' 61' ' ' PHE . 5.1 tmmm? -159.07 143.61 15.6 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 122.885 0.474 . . . . 0.0 110.896 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.63 137.15 43.14 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 169.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CZ ' ' HE3' ' A' ' 59' ' ' LYS . 74.4 m-85 -71.55 144.31 49.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mm -133.32 144.31 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 122.7 0.4 . . . . 0.0 110.195 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -89.06 130.93 35.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.9 -11.34 59.8 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.803 -0.561 . . . . 0.0 111.671 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -90.58 -22.6 21.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.07 -13.38 1.87 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.5 m120 61.39 9.34 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.561 1.144 . . . . 0.0 113.091 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -80.41 157.91 26.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 t -69.48 139.52 53.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.593 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.29 7.95 10.23 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.0 m 62.7 24.61 14.65 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.09 169.02 25.49 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.4 -177.67 29.79 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 121.627 0.571 . . . . 0.0 113.233 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -136.67 140.12 42.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.997 1.719 . . . . 0.0 114.177 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -144.22 156.05 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.648 0.779 . . . . 0.0 109.167 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.2 t -147.77 144.54 28.31 Favored 'General case' 0 C--N 1.339 0.151 0 O-C-N 121.901 -0.499 . . . . 0.0 112.022 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.18 165.74 11.88 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -82.27 -9.65 59.41 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.97 150.44 22.73 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.24 0.616 . . . . 0.0 111.141 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.29 -21.78 30.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.04 -38.86 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 O-C-N 121.95 -0.469 . . . . 0.0 111.727 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -75.93 -25.89 56.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.207 0.203 . . . . 0.0 110.703 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -72.61 -50.82 22.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -68.06 -28.36 67.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.469 -0.144 . . . . 0.0 110.659 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.08 82.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.9 -25.9 66.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.842 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mt -67.18 -51.18 56.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -69.34 -11.89 61.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.57 -28.24 16.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.4 mmm -120.51 -15.71 8.46 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -67.75 136.96 55.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 2.72 73.61 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.138 -0.812 . . . . 0.0 112.91 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.73 117.3 7.28 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.673 1.237 . . . . 0.0 110.429 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.08 129.28 37.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.471 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 tt -146.73 123.9 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.91 -144.75 48.38 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.9 mtm -83.64 13.01 4.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.975 0.91 . . . . 0.0 112.818 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.61 173.43 11.6 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.253 0.621 . . . . 0.0 112.011 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -119.72 137.09 54.14 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.846 0.858 . . . . 0.0 109.051 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.09 135.51 56.45 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -99.32 138.64 36.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.77 139.15 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.482 0.313 . . . . 0.0 110.165 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -154.28 163.62 39.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.676 0.216 . . . . 0.0 111.46 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -73.84 154.14 39.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.244 0.618 . . . . 0.0 110.418 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.5 ' H ' HD23 ' A' ' 104' ' ' LEU . 27.7 ttpp . . . . . 0 C--O 1.232 0.149 0 C-N-CA 123.459 0.704 . . . . 0.0 110.269 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.79 0.328 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.73 -157.75 30.4 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.95 177.64 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.644 2.896 . . . . 0.0 110.336 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.35 141.99 58.56 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.114 -0.366 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.13 0.68 77.7 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.76 -0.466 . . . . 0.0 112.703 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.03 31.57 4.46 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.664 0.732 . . . . 0.0 112.268 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -138.85 139.48 38.16 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 122.102 -0.374 . . . . 0.0 111.439 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.6 mt -127.01 154.9 44.04 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -114.23 144.08 43.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.959 1.704 . . . . 0.0 114.173 171.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.49 135.85 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 72' ' ' PHE . 14.8 m-85 -139.2 176.85 8.35 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.9 m170 64.87 13.79 8.78 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.23 1.412 . . . . 0.0 112.952 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.61 146.7 98.2 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.17 163.08 40.4 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.352 2.035 . . . . 0.0 109.438 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -68.86 -16.69 63.84 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -172.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -74.9 -11.43 60.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -68.86 158.33 34.71 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.0 178.14 33.54 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -57.03 -42.3 80.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -77.45 -26.0 51.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 66.9 m-20 -73.51 -41.11 63.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -74.09 -25.75 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 46' ' ' LEU . 1.9 tm? -64.81 -49.9 68.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -65.36 -25.68 67.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.7 mmm -76.29 -24.15 54.41 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.285 19.5 m-85 -105.07 -9.82 17.57 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.448 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -66.17 -33.43 6.86 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.0 Cg_endo -74.13 -8.48 21.06 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.738 1.656 . . . . 0.0 112.075 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -87.75 -14.9 38.49 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.582 0.353 . . . . 0.0 111.494 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.37 32.86 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -77.6 101.14 6.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.306 -0.526 . . . . 0.0 110.561 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -77.58 118.75 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.33 -35.78 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -158.51 157.14 31.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.814 0.34 . . . . 0.0 110.507 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.19 140.88 15.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.72 133.74 8.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.594 0.235 . . . . 0.0 111.341 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.5 t -93.25 143.26 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.442 ' CD2' ' CZ ' ' A' ' 72' ' ' PHE . 4.9 m-85 -73.08 148.5 43.98 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.7 mm -132.49 144.77 35.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 122.842 0.457 . . . . 0.0 110.203 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.22 131.17 37.66 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.33 -12.41 60.26 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 121.741 -0.599 . . . . 0.0 111.393 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -88.37 -23.79 23.28 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.404 0.682 . . . . 0.0 112.692 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -132.93 -14.14 2.75 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.9 t30 62.05 8.66 2.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.927 1.291 . . . . 0.0 112.094 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.17 164.48 18.09 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.932 0.493 . . . . 0.0 110.186 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.6 t -68.28 140.02 55.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.364 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -81.06 8.47 8.5 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.704 0.402 . . . . 0.0 111.891 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.1 m 63.07 21.32 12.82 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.442 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 4.0 p90 -155.52 167.12 31.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.0 -172.0 28.84 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 121.496 0.498 . . . . 0.0 114.035 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -136.6 145.48 44.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.411 1.884 . . . . 0.0 114.996 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -145.77 152.69 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.314 1.045 . . . . 0.0 109.283 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.3 p -142.79 149.72 39.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.391 0.541 . . . . 0.0 112.193 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.18 165.59 13.61 Favored 'General case' 0 N--CA 1.458 -0.054 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -80.89 -10.52 59.71 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.87 150.31 22.61 Favored Pre-proline 0 N--CA 1.453 -0.291 0 C-N-CA 123.287 0.635 . . . . 0.0 110.88 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.57 -20.95 40.42 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.437 2.758 . . . . 0.0 112.14 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.41 -39.04 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 O-C-N 121.801 -0.562 . . . . 0.0 111.611 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -74.88 -26.22 59.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.65 -48.54 25.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 122.449 -0.157 . . . . 0.0 110.624 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -65.92 -29.71 70.17 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.062 -0.399 . . . . 0.0 111.046 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.59 77.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.76 -26.71 64.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 119.567 -0.254 . . . . 0.0 111.662 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.69 -51.89 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.95 -11.89 59.68 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.71 -28.95 17.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.46 -14.74 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -67.45 136.19 54.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.85 1.53 84.51 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.862 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -66.01 118.95 10.52 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.772 1.286 . . . . 0.0 109.785 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.66 125.55 29.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.954 0.343 . . . . 0.0 111.55 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.0 tt -157.63 135.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.228 0.611 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.32 82.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.403 -0.81 . . . . 0.0 112.194 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 22.4 mmt 63.06 23.34 13.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.276 1.03 . . . . 0.0 113.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -145.35 155.51 43.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -97.81 132.73 43.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.79 -0.569 . . . . 0.0 110.481 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.44 128.34 36.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.24 0.216 . . . . 0.0 111.08 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -90.73 136.08 33.3 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.34 136.95 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -152.71 160.7 43.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 117.972 0.351 . . . . 0.0 111.916 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.15 156.28 38.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.069 0.548 . . . . 0.0 110.42 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.8 tttp . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.454 0.645 . . . . 0.0 112.401 178.78 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.444 0.64 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.75 -156.43 31.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.578 1.085 . . . . 0.0 113.117 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.19 -178.43 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.609 3.539 . . . . 0.0 111.542 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -57.86 130.21 45.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.268 0.627 . . . . 0.0 111.305 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.82 -2.0 70.84 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.498 0.57 . . . . 0.0 113.19 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.76 36.59 0.9 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.714 0.757 . . . . 0.0 111.871 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 140.23 33.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.966 -0.458 . . . . 0.0 111.371 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.18 162.09 26.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 19.7 m-85 -119.72 143.57 47.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 114.917 173.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.16 124.69 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 13.1 m-85 -128.77 179.71 5.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.8 m170 63.25 16.2 9.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.014 1.326 . . . . 0.0 112.836 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.9 142.33 93.34 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 118.144 0.429 . . . . 0.0 109.968 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.61 163.64 36.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.137 2.558 . . . . 0.0 109.722 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -68.81 -17.47 64.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -74.32 -10.29 59.44 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.038 -0.414 . . . . 0.0 112.046 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.03 158.14 36.51 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.9 176.59 33.34 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -56.84 -38.79 73.15 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.656 0.383 . . . . 0.0 110.642 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.04 -42.34 73.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.46 -26.11 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.464 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.0 tm? -64.86 -50.5 66.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -69.82 -23.11 63.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.7 -26.76 62.63 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.158 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 28.1 m-85 -104.23 -8.36 19.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 118.108 2.632 . . . . 0.0 118.108 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.44 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -67.33 -32.47 4.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.1 Cg_endo -73.38 -8.33 21.67 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.87 1.703 . . . . 0.0 112.164 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -89.9 -14.34 34.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.053 0.541 . . . . 0.0 111.283 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.02 -175.6 33.72 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -78.28 103.76 8.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.24 -0.565 . . . . 0.0 110.697 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.52 120.78 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.8 mt -84.02 -34.01 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.2 t -152.39 150.89 30.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 111.277 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.69 142.38 16.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.509 0.724 . . . . 0.0 109.209 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.614 ' HE3' ' CE1' ' A' ' 61' ' ' PHE . 3.0 tmmm? -159.87 134.49 7.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.679 0.392 . . . . 0.0 110.592 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.68 136.97 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.614 ' CE1' ' HE3' ' A' ' 59' ' ' LYS . 78.1 m-85 -69.15 150.0 48.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.12 143.27 41.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 122.77 0.428 . . . . 0.0 110.098 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.34 129.41 35.02 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -74.87 -12.48 60.38 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.949 -0.469 . . . . 0.0 111.541 -179.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -89.7 -23.23 21.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -134.71 -13.65 2.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 61.58 11.09 3.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.08 158.69 24.97 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 122.029 -0.42 . . . . 0.0 110.062 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -72.31 135.3 45.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.008 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -81.52 166.84 19.93 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.053 0.454 . . . . 0.0 111.135 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.7 m -79.19 12.05 2.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -157.01 170.82 21.67 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.05 -174.43 25.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.822 0.725 . . . . 0.0 112.447 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -138.62 145.15 40.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.94 152.95 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.24 1.016 . . . . 0.0 110.157 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -147.32 147.8 30.72 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.75 166.56 10.92 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -79.15 -8.56 59.1 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.06 150.8 24.85 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 123.221 0.609 . . . . 0.0 110.902 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -71.67 -16.16 30.17 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.142 2.561 . . . . 0.0 111.656 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.17 -46.8 92.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 118.383 0.538 . . . . 0.0 110.845 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -70.01 -24.6 63.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.841 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.36 -47.18 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.916 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -67.07 -29.7 69.54 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.159 -0.338 . . . . 0.0 110.758 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 -41.52 80.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.43 65.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -66.01 -52.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.79 -12.14 57.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.119 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.46 -31.5 17.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.7 mtp -124.64 -9.06 7.36 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.87 128.04 34.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.8 90.25 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.572 -0.571 . . . . 0.0 112.617 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -62.25 120.03 10.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.447 1.123 . . . . 0.0 111.295 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -76.0 129.77 37.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.981 -0.45 . . . . 0.0 111.516 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.78 122.42 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.03 -143.63 48.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -87.34 16.64 5.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.57 0.748 . . . . 0.0 112.767 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -144.67 172.67 12.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.366 0.53 . . . . 0.0 109.968 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -117.66 143.89 45.74 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.181 0.592 . . . . 0.0 110.372 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.85 133.04 48.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.787 0.435 . . . . 0.0 111.151 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -92.72 136.55 33.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.9 t -134.76 140.46 45.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -155.06 164.35 39.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.366 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.86 153.49 41.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.68 0.792 . . . . 0.0 110.188 175.227 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.527 ' H ' HD23 ' A' ' 104' ' ' LEU . 85.1 tttt . . . . . 0 CA--C 1.534 0.33 0 C-N-CA 123.316 0.646 . . . . 0.0 109.599 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.31 -165.5 35.07 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.85 167.56 19.24 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.402 2.735 . . . . 0.0 109.39 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -64.28 138.73 58.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.963 -0.46 . . . . 0.0 110.122 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.72 86.37 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.723 -0.487 . . . . 0.0 112.179 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.06 21.24 16.1 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.463 0.705 . . . . 0.0 112.233 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -125.31 137.52 54.07 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.38 161.86 22.66 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 122.19 0.995 . . . . 0.0 113.653 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -119.08 143.96 46.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.852 1.661 . . . . 0.0 114.555 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.81 129.47 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -134.99 178.89 6.67 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.7 m170 63.96 17.14 10.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.374 1.469 . . . . 0.0 113.293 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.88 142.8 95.88 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 122.767 0.427 . . . . 0.0 110.444 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.96 171.89 17.3 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.792 2.995 . . . . 0.0 110.97 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -68.98 -21.37 64.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.959 0.904 . . . . 0.0 112.448 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -75.63 -6.61 51.24 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.72 158.13 28.38 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.32 175.08 34.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -61.92 -36.64 81.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -75.2 -31.42 60.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.377 0.271 . . . . 0.0 110.726 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -73.34 -38.24 65.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -76.21 -24.77 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.5 tm? -66.83 -53.0 37.02 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -66.11 -23.52 66.51 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.447 0.166 . . . . 0.0 111.447 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.3 tpp -75.77 -29.43 58.79 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.68 0.392 . . . . 0.0 110.828 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.308 24.6 m-85 -102.11 -8.77 21.12 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.46 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 43.7 mtm -66.36 -30.83 3.81 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.2 Cg_endo -72.28 -10.39 25.62 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.88 1.707 . . . . 0.0 111.789 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -86.2 -14.99 42.31 Favored 'General case' 0 C--N 1.338 0.073 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.14 -171.48 32.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -76.59 103.61 6.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.433 -0.451 . . . . 0.0 110.727 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.51 122.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.3 mt -82.62 -33.54 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -156.42 156.34 33.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.022 0.439 . . . . 0.0 110.399 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.37 149.25 25.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -159.68 141.23 12.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.0 111.403 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 t -115.05 128.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -71.69 157.34 38.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mm -126.32 140.47 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.052 0 C-N-CA 122.493 0.317 . . . . 0.0 110.499 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -87.36 131.28 34.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -75.26 -12.95 60.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.92 0.488 . . . . 0.0 111.5 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -89.72 -21.94 22.45 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.13 -14.43 1.79 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 61.67 8.8 2.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 112.711 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.36 162.21 23.49 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.77 0.428 . . . . 0.0 110.151 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -69.47 136.47 51.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.737 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -76.27 164.18 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.4 m -77.32 10.05 2.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -156.86 172.05 19.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.46 -165.57 19.71 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.367 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -141.41 144.37 34.43 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -147.0 151.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.751 0.82 . . . . 0.0 109.303 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 94.8 p -141.8 149.27 40.16 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -116.83 159.9 21.66 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -77.26 -13.38 59.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.148 0.499 . . . . 0.0 112.012 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.13 149.57 19.78 Favored Pre-proline 0 N--CA 1.456 -0.158 0 C-N-CA 123.223 0.609 . . . . 0.0 110.965 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.11 -21.68 42.25 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.644 2.896 . . . . 0.0 111.94 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.69 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 118.534 0.606 . . . . 0.0 111.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -76.1 -25.56 55.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.286 0.235 . . . . 0.0 110.769 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.32 -48.16 30.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -66.46 -28.42 68.58 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.764 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.89 76.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.13 66.15 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.35 -53.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.48 -11.51 58.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.458 0.303 . . . . 0.0 111.163 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.61 -31.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 119.019 -0.515 . . . . 0.0 112.375 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.4 mtp -128.73 -9.04 5.02 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -61.64 125.11 22.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.27 6.14 89.0 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.824 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.04 119.76 10.73 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.681 1.24 . . . . 0.0 112.333 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -76.92 130.06 37.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.976 0.353 . . . . 0.0 110.963 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -145.09 136.03 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.22 -100.41 0.35 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.1 ptp -139.78 17.21 2.5 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.045 0.938 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -148.02 152.77 37.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.825 0.45 . . . . 0.0 110.181 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -93.36 139.52 30.58 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 122.138 -0.351 . . . . 0.0 111.008 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 89.9 mt -68.49 131.16 44.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.709 0.404 . . . . 0.0 110.987 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -90.82 135.67 33.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.32 136.7 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -152.67 159.81 43.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.651 0.262 . . . . 0.0 111.417 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -75.75 152.31 37.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.254 0.622 . . . . 0.0 109.658 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.522 ' H ' HD23 ' A' ' 104' ' ' LEU . 26.4 ttpp . . . . . 0 C--O 1.234 0.258 0 C-N-CA 123.239 0.616 . . . . 0.0 109.859 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.53 -173.7 49.13 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.39 0.519 . . . . 0.0 111.966 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.97 165.68 29.21 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.765 2.977 . . . . 0.0 109.877 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.08 131.26 47.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.4 -9.98 69.31 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.41 5.42 51.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.561 0.68 . . . . 0.0 110.969 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -95.52 142.08 28.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.27 159.88 35.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.719 0.771 . . . . 0.0 112.607 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.3 m-85 -122.6 145.89 47.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.824 1.65 . . . . 0.0 114.847 173.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.4 137.46 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.2 m-85 -140.65 179.46 6.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.458 ' CG ' ' HE3' ' A' ' 98' ' ' LYS . 20.1 m170 62.96 17.28 9.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.513 1.125 . . . . 0.0 112.924 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.42 142.51 92.18 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.055 0.388 . . . . 0.0 110.165 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.15 168.14 25.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.169 2.58 . . . . 0.0 109.959 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.05 -16.93 62.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -76.79 -9.67 58.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -72.62 158.08 36.34 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.1 171.73 33.36 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -59.86 -36.02 76.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -74.32 -29.42 61.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.887 0.475 . . . . 0.0 110.924 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -76.49 -42.42 43.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -71.29 -24.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.05 -49.72 73.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -64.9 -24.59 67.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.441 0.296 . . . . 0.0 111.712 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.2 mmm -76.19 -24.2 54.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.385 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 28.7 m-85 -107.32 -12.14 15.41 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.5 mtm -66.71 -31.15 3.83 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.6 Cg_endo -72.44 -10.65 25.72 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 121.986 1.745 . . . . 0.0 112.091 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -87.6 -14.07 41.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.744 0.418 . . . . 0.0 111.807 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.82 -174.74 33.06 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -75.62 106.52 7.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.343 -0.504 . . . . 0.0 110.382 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.4 122.34 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.411 HD11 ' HA ' ' A' ' 78' ' ' ASP . 28.6 mt -87.42 -27.83 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 t -149.8 146.73 27.32 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.915 0.388 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 143.38 24.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.166 0.986 . . . . 0.0 108.534 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.53 142.52 15.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.39 0.276 . . . . 0.0 111.565 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -118.5 131.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 169.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -75.26 146.63 40.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -133.77 145.69 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.174 0.589 . . . . 0.0 110.094 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -85.45 129.09 34.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.524 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.92 -11.29 59.94 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.836 -0.54 . . . . 0.0 111.945 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -90.65 -21.81 21.49 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 -11.41 1.46 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.99 10.53 2.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.581 1.152 . . . . 0.0 112.903 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.96 159.97 23.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.118 0.485 . . . . 0.0 110.006 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -70.07 142.71 52.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.807 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -84.29 -0.8 53.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.679 0.792 . . . . 0.0 111.206 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.2 m 61.34 19.44 10.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.94 170.41 22.19 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.39 -168.12 24.88 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 121.368 0.427 . . . . 0.0 113.568 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -140.92 144.19 35.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.968 1.707 . . . . 0.0 114.967 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.1 t -147.39 154.22 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -148.7 145.72 27.8 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.323 0.511 . . . . 0.0 112.107 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.91 162.08 13.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' HD11 ' A' ' 56' ' ' ILE . 36.0 t0 -77.18 -11.13 59.78 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 174.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.54 146.8 17.39 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 123.128 0.571 . . . . 0.0 110.61 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.18 -21.83 41.6 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.361 2.707 . . . . 0.0 112.626 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.4 p -63.59 -39.18 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 O-C-N 121.885 -0.51 . . . . 0.0 111.509 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -74.17 -24.55 59.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.103 0.161 . . . . 0.0 110.926 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.69 -48.0 35.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 121.395 -0.122 . . . . 0.0 110.683 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -67.15 -29.62 69.38 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.408 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.01 82.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.74 67.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.82 -52.79 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -68.39 -11.01 59.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.383 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.01 -31.56 18.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.2 mtp -123.88 -12.31 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.26 126.75 28.41 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.53 5.17 87.11 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.779 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.07 116.73 7.48 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.813 1.306 . . . . 0.0 110.039 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.67 131.12 40.62 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -144.79 121.61 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.77 -137.52 48.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -86.99 4.8 40.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HE3' ' CG ' ' A' ' 35' ' ' HIS . 29.4 ttpt -147.45 161.75 40.43 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 111.34 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -97.39 144.56 27.01 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.738 0.415 . . . . 0.0 110.671 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.4 126.69 30.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.358 0.263 . . . . 0.0 110.843 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -89.57 139.17 30.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.45 138.66 50.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -150.8 162.39 40.83 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -81.94 147.91 29.0 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.99 -0.444 . . . . 0.0 110.326 175.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.48 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.2 tttt . . . . . 0 CA--C 1.531 0.241 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.951 0.405 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.01 -154.64 29.98 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.07 177.33 5.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.944 3.096 . . . . 0.0 110.52 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.97 137.43 58.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.632 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.24 -1.84 86.1 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.346 0.498 . . . . 0.0 112.561 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.28 36.62 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.757 . . . . 0.0 111.617 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.21 140.48 29.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 111.324 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.1 mt -128.28 152.82 47.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 27.7 m-85 -108.5 140.84 41.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 113.939 169.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.18 123.55 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 23.3 m-85 -126.54 178.04 6.13 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.9 m170 66.1 15.29 10.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.949 1.7 . . . . 0.0 113.091 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.63 137.11 88.11 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.594 0.358 . . . . 0.0 110.183 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.35 173.28 14.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.465 2.777 . . . . 0.0 111.272 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -65.41 -20.81 66.53 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -74.33 -6.92 50.85 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -78.55 158.08 28.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.03 174.98 36.88 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -59.72 -39.1 83.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.009 0.524 . . . . 0.0 110.671 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -75.65 -38.97 58.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -74.03 -25.31 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.06 -52.05 52.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -64.5 -22.82 67.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.359 0.264 . . . . 0.0 111.634 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.6 tpp -76.82 -28.21 55.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.091 0.156 . . . . 0.0 110.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.275 25.0 m-85 -104.88 -11.47 16.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.48 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.2 mtm -66.84 -30.99 3.6 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.5 Cg_endo -72.85 -10.36 24.75 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 121.822 1.686 . . . . 0.0 112.18 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.33 -15.77 39.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.691 0.397 . . . . 0.0 112.033 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.36 -173.31 34.21 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -77.96 102.53 7.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.389 -0.477 . . . . 0.0 110.47 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -81.59 124.13 38.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.58 -30.2 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -154.02 148.5 26.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.671 0.389 . . . . 0.0 110.506 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.1 138.6 17.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HE3' ' CZ ' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.01 145.15 18.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.353 0.261 . . . . 0.0 111.133 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.8 t -111.02 135.5 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CZ ' ' HE3' ' A' ' 59' ' ' LYS . 83.8 m-85 -65.95 150.88 47.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.21 142.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.922 0.489 . . . . 0.0 110.442 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -88.21 131.55 34.7 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -74.96 -12.3 60.31 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.618 0.367 . . . . 0.0 111.756 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -90.41 -21.99 21.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.06 -14.92 1.77 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 61.78 9.39 2.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.326 1.051 . . . . 0.0 112.802 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.59 160.76 23.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.853 0.359 . . . . 0.0 110.366 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.4 m -68.33 135.54 52.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.34 0.256 . . . . 0.0 110.826 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -78.61 168.09 20.28 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -76.72 15.11 0.69 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.13 172.11 18.05 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.55 -173.11 23.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.298 0.951 . . . . 0.0 112.58 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -142.01 142.63 32.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.725 1.61 . . . . 0.0 114.978 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -145.66 153.53 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.881 0.872 . . . . 0.0 110.368 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.8 t -147.2 146.47 29.84 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.747 -0.595 . . . . 0.0 112.584 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -111.73 168.68 9.37 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -81.68 -9.74 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.43 151.38 27.12 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 123.434 0.693 . . . . 0.0 111.061 177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -71.59 -18.38 29.14 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.069 2.513 . . . . 0.0 111.52 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.2 t -63.28 -45.9 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 118.39 0.541 . . . . 0.0 111.135 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 m -70.81 -26.55 63.35 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.1 -47.28 52.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.92 -28.21 68.11 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.077 0.399 . . . . 0.0 111.094 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.64 -42.0 78.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.25 65.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.4 mt -66.43 -51.04 62.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.05 -11.81 61.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.62 -28.09 19.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 13.0 ttm -120.6 -23.25 6.11 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.95 126.39 27.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.48 88.01 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.771 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -64.42 121.08 13.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.162 1.481 . . . . 0.0 110.927 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -76.93 124.37 27.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.621 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -161.06 136.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.816 0.846 . . . . 0.0 109.762 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.87 39.4 97.34 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.668 -0.645 . . . . 0.0 112.8 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.4 mtt 62.06 16.16 7.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.901 0.88 . . . . 0.0 113.229 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -141.45 179.47 6.78 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.895 1.278 . . . . 0.0 109.297 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -118.07 138.13 52.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.23 0.212 . . . . 0.0 110.503 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.02 129.44 40.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -92.23 136.17 33.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.36 139.71 49.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -155.37 158.69 39.08 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.737 0.303 . . . . 0.0 111.545 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.7 155.23 37.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.346 0.658 . . . . 0.0 111.12 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.455 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.9 tttt . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 123.959 0.903 . . . . 0.0 109.772 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.879 0.371 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.67 -167.87 42.8 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.06 172.83 11.28 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.922 3.082 . . . . 0.0 110.854 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -63.53 138.74 58.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.095 -0.378 . . . . 0.0 111.04 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.81 -0.73 89.36 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.392 -0.367 . . . . 0.0 112.384 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.01 31.96 4.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.821 0.849 . . . . 0.0 111.544 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.06 140.55 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.179 -0.326 . . . . 0.0 111.168 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.7 mt -125.8 159.0 33.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.978 0.894 . . . . 0.0 113.153 -171.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -118.13 144.7 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.974 1.709 . . . . 0.0 114.443 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.86 136.57 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.16 179.93 6.47 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.4 m170 63.38 14.88 8.27 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.252 1.421 . . . . 0.0 112.911 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.05 143.32 96.02 Favored Pre-proline 0 N--CA 1.457 -0.121 0 CA-C-N 117.977 0.353 . . . . 0.0 110.132 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.44 168.0 24.77 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.952 2.435 . . . . 0.0 109.892 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -67.79 -17.82 64.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.019 0.527 . . . . 0.0 111.93 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -77.2 -10.22 59.27 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -70.05 158.01 36.48 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 175.95 35.14 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.76 -36.11 73.84 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.263 0.531 . . . . 0.0 110.629 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -80.26 -32.92 38.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 110.908 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -73.22 -38.43 66.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 tt -76.05 -25.17 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -66.08 -52.79 45.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -68.5 -22.27 64.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -72.86 -26.6 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 21.5 m-85 -106.12 -12.81 15.63 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.465 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 48.2 mtm -66.92 -29.8 2.86 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.3 Cg_endo -72.96 -8.97 23.09 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.211 1.825 . . . . 0.0 112.111 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -86.87 -15.02 40.33 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.952 0.342 . . . . 0.0 111.778 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.95 -172.65 32.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -76.16 102.68 5.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 117.107 0.453 . . . . 0.0 109.904 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.63 126.91 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.3 mt -85.92 -30.67 6.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 122.884 0.474 . . . . 0.0 110.671 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -159.5 157.41 29.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.35 0.26 . . . . 0.0 110.694 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.16 142.95 25.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -157.81 134.51 9.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.894 0.478 . . . . 0.0 110.98 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.22 131.89 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -75.02 149.24 39.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.032 0.533 . . . . 0.0 109.711 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -90.23 138.65 31.35 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.62 -10.08 59.61 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -92.28 -22.96 19.46 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -13.23 2.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 t30 62.12 8.11 2.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.674 1.19 . . . . 0.0 111.875 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.02 162.16 19.45 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.891 0.476 . . . . 0.0 109.826 174.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -66.47 140.41 58.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.35 -0.219 . . . . 0.0 111.159 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -80.6 13.26 2.61 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.6 0.36 . . . . 0.0 111.742 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.1 m 62.09 20.99 12.07 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.49 169.26 24.69 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.96 -172.56 29.53 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 121.636 0.576 . . . . 0.0 113.186 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -137.25 142.36 42.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.091 1.756 . . . . 0.0 114.722 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -144.61 153.42 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 t -143.36 149.46 37.75 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.073 0.397 . . . . 0.0 111.74 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -115.17 159.67 20.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.12 -14.58 61.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.22 0.533 . . . . 0.0 112.083 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.02 149.57 21.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.526 0.73 . . . . 0.0 110.685 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.91 -20.47 38.95 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.377 2.718 . . . . 0.0 112.204 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.31 -39.82 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.551 0.614 . . . . 0.0 111.737 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.3 m -73.34 -25.84 60.78 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.1 -46.43 51.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -66.4 -30.19 70.52 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 122.038 -0.414 . . . . 0.0 110.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.39 -41.51 80.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.74 -26.22 66.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.72 -51.93 56.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -68.49 -10.84 58.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.16 -27.98 17.36 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.9 mmm -120.29 -18.54 7.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -66.32 133.3 50.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.21 86.42 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.785 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -64.6 117.67 7.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.529 1.165 . . . . 0.0 110.448 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -75.39 130.06 38.37 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.108 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -146.19 124.97 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.4 -142.5 47.97 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 61.5 mtt -86.91 8.99 20.76 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -140.87 179.14 6.89 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.059 0.544 . . . . 0.0 111.41 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -118.97 142.96 47.32 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 110.069 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.36 130.95 45.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.683 0.278 . . . . 0.0 111.208 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -90.72 135.73 33.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.9 t -134.84 139.49 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.84 160.68 43.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.742 0.305 . . . . 0.0 111.432 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.32 149.11 40.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.444 ' H ' HD23 ' A' ' 104' ' ' LEU . 62.8 tttm . . . . . 0 C--O 1.232 0.147 0 C-N-CA 122.708 0.403 . . . . 0.0 109.918 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.714 0.292 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.58 -172.72 34.97 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.0 174.8 7.31 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.753 2.969 . . . . 0.0 110.443 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -61.1 135.08 57.66 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.76 -0.69 89.44 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.557 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.76 0.34 28.12 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.866 0.833 . . . . 0.0 112.785 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -99.73 146.21 26.79 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.205 0.457 . . . . 0.0 109.802 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.467 HD13 ' HB1' ' A' ' 83' ' ' ALA . 1.1 mp -136.16 156.52 48.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.993 0.901 . . . . 0.0 112.823 -171.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 15.1 m-85 -124.98 147.6 48.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.71 1.604 . . . . 0.0 114.465 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.62 132.71 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 5.8 m-85 -136.54 177.45 7.84 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 7.2 m170 64.63 16.14 10.14 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.768 1.627 . . . . 0.0 112.57 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.8 145.22 96.7 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 122.801 0.44 . . . . 0.0 110.205 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.81 160.49 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.068 2.512 . . . . 0.0 108.95 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -73.85 -5.21 39.56 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.11 -10.46 59.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.059 0.391 . . . . 0.0 111.431 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.5 158.25 36.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -155.79 177.46 32.89 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -57.43 -42.58 82.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -79.98 -27.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.476 0.179 . . . . 0.0 111.107 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 73.4 m-20 -72.28 -39.65 68.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 tt -76.71 -23.93 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.9 tp -66.6 -53.18 37.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -64.7 -23.0 67.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.295 0.238 . . . . 0.0 111.474 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.4 tpp -75.73 -29.45 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.047 0.139 . . . . 0.0 110.702 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 31.5 m-85 -104.95 -9.35 17.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -67.44 -28.73 2.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.8 Cg_endo -72.19 -10.67 26.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 122.374 1.883 . . . . 0.0 111.787 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -85.76 -14.79 44.16 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.33 -171.74 32.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.53 102.84 6.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.447 -0.443 . . . . 0.0 110.684 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.2 t -83.92 122.85 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -79.69 -34.98 16.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -157.71 156.1 31.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.075 0.464 . . . . 0.0 110.527 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 137.95 15.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.522 0.729 . . . . 0.0 109.048 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.59 134.13 8.76 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.512 0.196 . . . . 0.0 111.517 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 t -94.45 140.6 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -69.67 151.29 46.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -126.85 143.07 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 122.869 0.467 . . . . 0.0 109.975 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -91.59 130.64 37.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.14 -10.09 59.14 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.158 -0.339 . . . . 0.0 111.745 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -87.98 -22.54 24.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.24 0.616 . . . . 0.0 112.384 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -137.35 -14.08 1.52 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 61.65 8.2 2.23 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.882 1.273 . . . . 0.0 113.105 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.74 159.91 23.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.747 0.419 . . . . 0.0 109.878 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -71.24 135.04 47.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.535 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -76.03 166.92 22.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.008 0.432 . . . . 0.0 110.506 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.01 19.38 0.54 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -160.23 172.04 18.11 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.8 -171.9 27.38 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.528 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -136.37 144.88 44.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.579 1.551 . . . . 0.0 115.182 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -147.39 152.53 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.095 0.958 . . . . 0.0 108.431 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.4 p -143.45 147.34 34.42 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.876 -0.515 . . . . 0.0 112.023 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -113.79 159.94 19.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.32 -12.42 60.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.05 150.08 21.93 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 122.988 0.515 . . . . 0.0 110.886 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.1 -21.28 36.79 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.46 2.773 . . . . 0.0 112.296 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.34 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 118.72 0.691 . . . . 0.0 111.519 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -75.39 -25.92 58.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.376 0.27 . . . . 0.0 110.677 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.467 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -72.91 -49.92 26.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -68.85 -26.63 65.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.741 0.246 . . . . 0.0 110.483 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.73 -41.76 78.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.54 -27.14 66.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.3 mt -67.33 -52.07 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.34 -12.53 61.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.288 0.235 . . . . 0.0 111.259 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.93 -31.37 19.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.3 mtp -126.01 -9.59 6.56 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.21 125.68 24.88 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.01 87.43 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.854 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -63.73 119.44 9.93 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.639 1.22 . . . . 0.0 111.519 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -75.92 129.61 37.21 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.277 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.1 tt -144.64 120.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.75 -141.9 47.22 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 74.0 mtm -87.59 12.5 12.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -145.02 164.56 30.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.88 0.763 . . . . 0.0 110.673 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -107.1 141.63 38.05 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.855 0.462 . . . . 0.0 110.808 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 87.6 mt -66.43 140.86 58.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.889 0.475 . . . . 0.0 111.442 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -101.94 141.18 35.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.93 137.08 52.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -151.73 160.64 43.52 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 120.887 0.375 . . . . 0.0 111.573 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.21 145.68 32.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.81 0.444 . . . . 0.0 110.463 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 173.931 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.702 0.763 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.34 -156.54 26.71 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.308 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.34 158.33 55.67 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.928 2.419 . . . . 0.0 108.948 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -63.5 129.38 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.12 -11.57 60.35 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.06 19.34 6.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.673 0.737 . . . . 0.0 110.417 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.14 142.35 47.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -169.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.9 159.85 33.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.015 0.912 . . . . 0.0 113.026 -171.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -125.46 144.05 50.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.411 1.884 . . . . 0.0 114.55 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.3 137.8 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.8 179.71 6.55 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.513 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.4 m170 64.7 17.12 10.78 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.246 1.418 . . . . 0.0 113.05 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.06 139.3 87.66 Favored Pre-proline 0 CA--C 1.529 0.146 0 O-C-N 122.165 -0.335 . . . . 0.0 110.111 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.71 172.13 16.42 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.449 2.766 . . . . 0.0 111.06 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -70.53 -13.09 61.97 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -82.37 -7.08 59.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -77.2 158.44 30.33 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.27 174.76 35.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -58.74 -38.34 78.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -74.97 -29.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.631 0.373 . . . . 0.0 111.032 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.65 -42.52 58.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -72.55 -24.81 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.31 -50.96 67.99 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -64.52 -23.85 67.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.536 0.334 . . . . 0.0 111.797 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.4 mmm -77.61 -23.83 49.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.634 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 33.8 m-85 -108.56 -10.68 15.21 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.451 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -66.23 -31.96 5.02 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.5 Cg_endo -73.15 -9.69 23.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 121.706 1.645 . . . . 0.0 111.779 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -86.97 -14.72 40.91 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.792 0.437 . . . . 0.0 112.079 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.6 32.87 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.57 102.05 5.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.387 -0.478 . . . . 0.0 110.47 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -80.77 120.62 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.61 -31.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -157.98 155.04 28.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.39 0.276 . . . . 0.0 110.834 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.38 29.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 109.346 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -156.99 141.33 16.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.836 0.454 . . . . 0.0 111.516 -174.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.06 130.21 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 168.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -76.44 142.96 40.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.4 mm -132.74 144.18 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.664 0.386 . . . . 0.0 110.534 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' CA ' ' HE2' ' A' ' 70' ' ' LYS . 61.0 t0 -85.93 130.5 34.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.511 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -79.13 -10.65 59.88 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.036 -0.415 . . . . 0.0 111.576 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -90.01 -22.14 22.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.76 -10.92 1.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.74 6.87 1.73 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.362 1.065 . . . . 0.0 112.692 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -79.6 158.21 27.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.8 t -71.43 143.75 50.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HE2' ' CA ' ' A' ' 63' ' ' ASP . 71.6 mmtt -77.1 3.34 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.593 0.757 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.3 m 62.65 20.1 11.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -157.59 169.91 23.59 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.66 -169.0 23.35 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.991 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -141.5 141.91 33.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.6 t -147.25 152.52 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 t -147.94 149.06 31.51 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.692 -0.63 . . . . 0.0 111.934 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.87 163.12 14.56 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -79.48 -9.92 59.7 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.423 0.289 . . . . 0.0 110.319 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.3 149.05 19.76 Favored Pre-proline 0 N--CA 1.453 -0.284 0 O-C-N 121.852 -0.53 . . . . 0.0 111.478 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.61 -19.21 42.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.658 2.905 . . . . 0.0 112.356 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.2 -39.92 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.724 -0.61 . . . . 0.0 111.789 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -74.65 -24.64 58.85 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.389 0.276 . . . . 0.0 110.535 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.6 39.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -68.0 -28.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.963 -0.461 . . . . 0.0 111.087 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.99 -42.34 80.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.145 -0.347 . . . . 0.0 110.122 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.25 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.66 -51.2 53.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.86 -11.98 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.407 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.65 -31.44 17.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 52.9 mtp -124.1 -10.92 7.59 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -62.49 126.23 26.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.1 5.75 87.2 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.148 -0.806 . . . . 0.0 112.792 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -65.23 117.32 7.63 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.764 1.282 . . . . 0.0 109.934 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -75.26 129.43 37.44 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.169 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.5 tt -145.05 119.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.72 -142.65 46.96 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 ptp -84.39 8.95 14.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 43.8 tttp -146.89 165.75 28.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.753 0.706 . . . . 0.0 110.428 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -104.49 143.18 33.38 Favored 'General case' 0 C--O 1.229 -0.017 0 C-N-CA 122.731 0.413 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.31 126.32 27.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.198 0.199 . . . . 0.0 110.801 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -87.67 136.47 32.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.73 139.29 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -148.55 161.47 41.6 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 111.405 -172.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -83.74 151.12 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 104' ' ' LEU . 78.9 tttt . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 123.869 0.868 . . . . 0.0 110.053 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.989 0.423 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.52 -171.6 36.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.34 178.53 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.07 3.18 . . . . 0.0 110.637 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -58.3 134.7 56.8 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.087 -0.383 . . . . 0.0 110.935 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 0.43 88.64 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.829 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.02 8.76 34.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 117.826 0.813 . . . . 0.0 113.166 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -112.28 139.93 47.42 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.16 0.436 . . . . 0.0 110.453 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.62 160.89 30.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.007 0.908 . . . . 0.0 112.936 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 20.2 m-85 -128.35 141.98 51.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.533 1.933 . . . . 0.0 114.647 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.56 137.62 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.1 m-85 -141.33 178.38 7.46 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.447 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 17.1 m170 64.12 18.71 11.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.883 1.273 . . . . 0.0 112.961 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.89 145.43 98.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HG2' ' CD2' ' A' ' 40' ' ' PHE . 90.5 Cg_endo -72.32 163.45 38.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.867 2.378 . . . . 0.0 109.682 174.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -69.67 -16.42 63.35 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.87 -9.28 59.43 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.813 -0.554 . . . . 0.0 112.259 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.402 ' CD2' ' HG2' ' A' ' 37' ' ' PRO . 4.0 m-85 -73.13 158.27 35.63 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 175.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.7 33.88 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -57.19 -39.62 75.75 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -74.79 -30.46 61.43 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.003 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -76.02 -38.85 56.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.56 -25.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.6 -51.36 63.11 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -65.21 -22.37 66.88 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.2 tpp -77.15 -27.73 53.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.396 0.278 . . . . 0.0 110.555 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.284 25.3 m-85 -105.03 -12.21 16.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 118.0 2.593 . . . . 0.0 118.0 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 58.4 mtm -66.17 -31.23 4.28 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.1 Cg_endo -72.33 -10.15 25.22 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.907 1.717 . . . . 0.0 112.072 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.33 -15.02 41.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.842 0.457 . . . . 0.0 111.708 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.29 -173.53 32.81 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -77.04 102.79 6.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.497 -0.413 . . . . 0.0 110.421 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.87 123.79 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.89 -33.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -152.41 151.17 30.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.721 0.408 . . . . 0.0 110.794 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.08 140.64 17.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.405 0.682 . . . . 0.0 109.455 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.61 161.72 37.25 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 120.811 0.338 . . . . 0.0 110.842 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.94 139.19 52.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.411 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 48.4 m-85 -74.53 142.67 44.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mm -131.91 142.08 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 124.017 0.927 . . . . 0.0 108.554 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -80.78 127.35 32.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.566 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -73.22 -9.47 58.74 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.082 -0.386 . . . . 0.0 111.717 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -94.73 -23.6 17.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.19 -10.5 2.57 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.81 11.25 3.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.737 1.215 . . . . 0.0 111.895 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.7 mt -86.02 160.15 19.4 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.887 0.475 . . . . 0.0 109.891 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.5 t -69.56 145.33 52.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.597 0.236 . . . . 0.0 111.43 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 61' ' ' PHE . 52.2 mtmt -98.04 15.29 24.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.147 0.579 . . . . 0.0 111.195 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.6 p 52.13 29.75 6.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.405 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.8 p90 -155.06 168.96 25.27 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.55 -174.34 27.14 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.273 0.374 . . . . 0.0 112.955 -173.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -139.69 140.75 36.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.261 1.424 . . . . 0.0 114.46 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -146.36 153.74 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 98.0 p -147.89 153.0 38.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 111.532 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -122.54 164.66 17.72 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.08 -9.59 59.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.32 151.02 24.89 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.932 0.493 . . . . 0.0 111.275 176.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.38 -19.5 37.84 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.31 2.673 . . . . 0.0 111.633 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.96 -46.57 95.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 118.548 0.613 . . . . 0.0 111.026 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 m -70.91 -25.93 62.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.129 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.79 -49.03 42.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -68.17 -27.23 66.23 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 117.936 0.334 . . . . 0.0 110.674 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.9 75.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.25 70.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.99 -50.47 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -69.43 -11.16 60.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.243 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.88 -27.39 21.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.6 ttm -120.86 -21.04 6.73 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -58.83 123.34 16.13 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 6.04 88.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.424 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -67.29 142.83 56.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.759 1.279 . . . . 0.0 108.486 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -95.92 128.58 42.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.938 0.335 . . . . 0.0 110.701 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.36 136.88 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.29 -113.35 5.07 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.4 mtm -126.86 14.42 7.43 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.573 0.749 . . . . 0.0 112.282 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 56.5 tttp -151.24 144.54 24.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.309 0.504 . . . . 0.0 110.783 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -82.63 143.3 31.08 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.416 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.0 mm? -67.98 130.4 42.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.346 0.258 . . . . 0.0 110.496 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -92.02 138.11 31.81 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.71 141.15 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.44 0.296 . . . . 0.0 110.418 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -148.62 161.78 41.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.64 0.257 . . . . 0.0 110.87 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 tt -90.13 140.04 30.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt . . . . . 0 CA--C 1.529 0.17 0 CA-C-N 118.46 0.573 . . . . 0.0 109.62 175.595 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.189 0.519 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.48 -152.38 28.81 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.37 179.23 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.695 2.93 . . . . 0.0 111.172 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.84 135.98 57.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.947 -0.471 . . . . 0.0 111.551 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.15 68.09 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.478 0.561 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.11 39.76 1.0 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.665 0.732 . . . . 0.0 112.013 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.09 140.03 29.23 Favored 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.723 -0.611 . . . . 0.0 111.75 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -128.76 153.77 47.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.931 0.872 . . . . 0.0 113.152 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 16.1 m-85 -110.99 146.87 35.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.562 1.545 . . . . 0.0 114.152 170.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -139.01 124.74 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.4 m-85 -131.28 179.28 6.11 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 17.1 m170 63.32 16.12 9.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.348 1.459 . . . . 0.0 112.335 -176.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.49 144.38 94.25 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.137 0.575 . . . . 0.0 110.329 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.83 162.91 36.65 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.374 2.716 . . . . 0.0 109.248 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.46 -6.22 44.98 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -75.68 -9.99 59.05 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.994 0.361 . . . . 0.0 111.241 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -73.39 158.3 35.28 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.41 176.54 33.75 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -57.24 -39.01 74.7 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.158 0.479 . . . . 0.0 111.975 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -80.02 -33.21 39.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.585 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -72.04 -38.81 69.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.34 -28.35 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.3 tp -66.25 -52.23 49.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -63.91 -22.91 67.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.555 0.342 . . . . 0.0 111.688 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -78.38 -26.04 46.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.645 0.202 . . . . 0.0 110.654 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.296 31.3 m-85 -104.93 -10.53 17.22 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 56.6 mtm -66.97 -29.32 2.56 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 50' ' ' MET . 84.3 Cg_endo -71.05 -13.11 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.893 1.712 . . . . 0.0 111.906 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -84.35 -15.46 46.4 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 155.19 -175.06 33.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -75.32 105.53 6.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.281 -0.541 . . . . 0.0 110.77 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.04 126.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.3 -30.43 5.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 120.487 0.184 . . . . 0.0 110.578 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -154.6 150.43 27.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.726 0.411 . . . . 0.0 110.577 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.83 141.54 14.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.383 0.673 . . . . 0.0 109.496 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.557 ' HE3' ' CD2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -156.45 153.26 28.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.43 0.292 . . . . 0.0 110.292 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -107.71 142.87 19.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD2' ' HE3' ' A' ' 59' ' ' LYS . 69.3 m-85 -69.72 148.73 48.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -133.68 146.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.148 0.579 . . . . 0.0 109.965 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -95.19 132.89 39.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -77.36 -12.91 60.01 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.067 0.547 . . . . 0.0 111.75 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -89.78 -23.82 21.65 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.62 -13.43 2.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.2 t30 61.54 10.84 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 112.22 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.86 154.56 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.673 0.389 . . . . 0.0 110.219 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -70.49 134.39 47.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.425 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -84.23 163.69 19.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.105 0.478 . . . . 0.0 110.451 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.6 m -78.87 17.67 0.7 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE1' ' CE1' ' A' ' 61' ' ' PHE . 3.5 p90 -156.59 170.32 22.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.77 -177.59 29.15 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.753 1.168 . . . . 0.0 111.896 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -139.69 144.57 37.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.74 151.95 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.803 0.841 . . . . 0.0 110.082 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 t -143.4 144.0 31.86 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -106.21 164.35 12.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -80.89 -9.22 59.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.271 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.75 150.43 20.36 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 123.138 0.575 . . . . 0.0 111.096 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.69 -18.35 28.84 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.125 2.55 . . . . 0.0 111.858 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.9 -44.77 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 O-C-N 121.817 -0.552 . . . . 0.0 111.282 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -70.65 -26.26 63.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.63 -48.04 35.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -66.07 -28.51 68.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.062 -0.399 . . . . 0.0 110.816 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.59 75.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.228 -0.295 . . . . 0.0 110.322 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.67 66.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mt -66.98 -52.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -66.88 -13.73 61.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.365 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.98 -32.95 18.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.8 mtp -123.82 -11.91 7.63 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -61.85 125.24 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.62 5.96 88.99 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.303 -0.72 . . . . 0.0 112.798 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.12 125.15 22.86 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.46 1.13 . . . . 0.0 112.031 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -78.22 128.38 33.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.685 0.279 . . . . 0.0 110.846 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -149.56 136.51 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.98 -111.1 2.81 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.0 ptp -130.42 15.47 5.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.13 0.572 . . . . 0.0 111.811 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -150.83 142.42 23.57 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.483 0.313 . . . . 0.0 110.291 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -84.41 145.13 28.35 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 122.505 -0.122 . . . . 0.0 111.181 -176.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 81.4 mt -70.78 131.82 44.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.572 0.349 . . . . 0.0 111.647 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -91.32 138.6 31.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 170.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.97 137.38 50.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -155.12 160.79 41.22 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.865 0.302 . . . . 0.0 111.715 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.8 156.23 36.73 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.37 0.668 . . . . 0.0 110.692 176.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.46 ' H ' HD23 ' A' ' 104' ' ' LEU . 87.4 tttt . . . . . 0 N--CA 1.454 -0.23 0 C-N-CA 123.43 0.692 . . . . 0.0 109.534 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.667 0.27 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.42 -155.2 31.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.41 176.7 6.17 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.949 3.099 . . . . 0.0 110.962 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -60.95 137.01 58.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.891 -0.505 . . . . 0.0 111.504 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.05 -2.87 73.61 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.637 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.13 39.24 1.04 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.419 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.65 139.42 29.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.765 -0.584 . . . . 0.0 111.552 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.31 155.03 45.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.757 0.789 . . . . 0.0 112.934 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.2 m-85 -112.27 149.15 32.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.746 1.618 . . . . 0.0 114.355 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -139.01 136.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.6 m-85 -142.4 177.64 8.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 12.7 m170 62.73 16.9 9.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.611 1.564 . . . . 0.0 112.639 -176.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.46 145.04 98.26 Favored Pre-proline 0 CA--C 1.53 0.191 0 O-C-N 122.079 -0.388 . . . . 0.0 110.047 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.34 164.9 34.25 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.842 2.361 . . . . 0.0 109.507 172.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.91 -14.79 62.89 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.25 -8.84 57.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.55 158.23 36.58 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.75 35.29 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.8 -36.9 75.22 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.506 0.653 . . . . 0.0 110.442 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -78.67 -32.62 47.24 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.398 0.279 . . . . 0.0 110.869 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.0 -38.8 61.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.61 -25.8 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.39 -49.89 61.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -64.7 -23.84 67.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.745 0.418 . . . . 0.0 111.558 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -79.89 -25.61 40.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.511 -0.118 . . . . 0.0 110.767 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.293 31.3 m-85 -105.92 -7.76 18.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 50.1 mtm -66.49 -30.83 3.72 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.5 Cg_endo -72.82 -10.99 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 CA-C-N 121.943 1.73 . . . . 0.0 111.842 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.48 -19.96 37.79 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.76 -167.96 31.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -78.2 99.59 6.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.466 -0.432 . . . . 0.0 110.527 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -87.48 130.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 174.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -90.68 -27.81 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 122.592 0.357 . . . . 0.0 110.76 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 t -155.9 150.8 26.33 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.633 0.373 . . . . 0.0 110.334 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.46 147.03 27.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.377 0.671 . . . . 0.0 109.387 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -157.38 137.88 12.97 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.682 0.393 . . . . 0.0 111.445 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -111.93 136.41 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.404 ' CD2' ' CZ ' ' A' ' 72' ' ' PHE . 49.5 m-85 -78.92 147.33 33.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -173.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -132.58 144.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.063 0.545 . . . . 0.0 110.305 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -90.34 133.16 35.16 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -76.98 -12.56 59.96 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.784 0.434 . . . . 0.0 111.865 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -88.95 -23.92 22.56 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.12 -13.48 2.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 63.68 8.34 3.66 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.12 161.08 22.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.911 0.484 . . . . 0.0 110.038 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -70.52 140.91 51.94 Favored 'General case' 0 CA--C 1.523 -0.062 0 CA-C-O 120.753 0.311 . . . . 0.0 111.052 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -82.59 6.04 18.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m 61.49 22.51 12.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.404 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.1 p90 -154.62 169.11 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.01 -172.28 28.12 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 121.566 0.537 . . . . 0.0 113.185 -174.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.82 143.01 31.96 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.806 1.642 . . . . 0.0 114.713 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -145.99 153.57 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 109.527 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.2 t -143.01 145.13 32.63 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -109.34 164.04 12.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -78.36 -13.21 59.95 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 112.278 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.02 148.11 18.23 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 123.246 0.618 . . . . 0.0 111.17 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.69 -18.54 32.56 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.468 2.779 . . . . 0.0 112.06 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.27 -43.03 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 118.34 0.518 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.1 t -70.68 -32.78 70.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.04 74.67 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -67.88 -28.09 67.22 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.901 -0.5 . . . . 0.0 110.962 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.92 -43.05 72.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.44 -26.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.3 mt -67.73 -51.51 49.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -67.84 -11.22 58.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.86 -0.154 . . . . 0.0 111.284 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.89 -31.33 16.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.4 mtp -125.41 -12.2 6.78 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.98 125.86 25.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.87 6.54 89.36 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.008 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 120.42 11.62 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.693 1.247 . . . . 0.0 111.483 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -76.39 129.63 36.86 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 tt -144.87 120.72 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.27 -140.64 46.6 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.0 mmt -88.52 12.96 13.06 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -146.5 162.59 37.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.848 0.749 . . . . 0.0 111.049 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -105.76 141.27 37.47 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 122.545 0.338 . . . . 0.0 110.946 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 91.5 mt -66.65 133.76 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.749 0.419 . . . . 0.0 111.195 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -92.0 137.89 31.99 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.3 t -134.97 137.13 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -151.4 161.3 42.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -75.77 153.83 36.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.469 0.708 . . . . 0.0 110.409 177.287 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.504 ' H ' HD23 ' A' ' 104' ' ' LEU . 87.1 tttt . . . . . 0 CA--C 1.529 0.144 0 C-N-CA 123.222 0.609 . . . . 0.0 109.834 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 -151.2 25.12 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.79 169.43 17.65 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.808 3.005 . . . . 0.0 110.232 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.83 137.96 58.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.946 -0.471 . . . . 0.0 110.71 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.77 -6.96 79.15 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.156 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.42 39.9 1.06 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.602 0.701 . . . . 0.0 110.418 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.36 28.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.004 -0.435 . . . . 0.0 111.131 -175.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -126.05 158.4 35.49 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 18.5 m-85 -117.59 139.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.94 1.696 . . . . 0.0 113.71 171.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.72 139.66 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 72' ' ' PHE . 9.8 m-85 -141.7 175.13 9.95 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 m170 65.42 16.3 10.46 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 113.001 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.16 140.93 93.51 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 122.82 0.448 . . . . 0.0 109.919 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.18 162.88 40.41 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.915 2.41 . . . . 0.0 109.552 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -71.44 -7.19 45.81 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.23 -9.42 58.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 122.055 -0.403 . . . . 0.0 111.054 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -74.06 158.36 34.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.26 173.94 35.44 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -57.16 -39.49 75.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -75.79 -29.24 58.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.097 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.41 -39.61 46.45 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -73.6 -24.65 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.17 -52.0 57.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.65 -23.62 67.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.613 0.365 . . . . 0.0 111.518 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 tpp -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.15 0.18 . . . . 0.0 110.672 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.276 22.6 m-85 -104.12 -11.69 17.17 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 117.878 2.547 . . . . 0.0 117.878 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.6 mtm -66.8 -31.3 3.92 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.8 Cg_endo -73.01 -10.0 24.15 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.068 1.774 . . . . 0.0 111.881 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.28 -13.81 45.57 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.09 -173.57 32.66 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -75.94 101.32 5.15 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.333 -0.51 . . . . 0.0 110.223 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -79.07 127.75 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.8 mt -83.84 -32.95 8.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.416 0.287 . . . . 0.0 110.379 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -164.9 159.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.94 24.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.423 0.689 . . . . 0.0 109.893 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.7 145.72 17.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.707 0.403 . . . . 0.0 111.172 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.93 138.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 76.5 m-85 -73.27 144.72 46.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.23 144.33 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.204 0.601 . . . . 0.0 110.197 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.96 130.3 34.99 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.09 -12.79 60.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.08 -0.387 . . . . 0.0 111.672 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.17 -23.71 22.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -133.17 -12.55 2.81 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.5 7.92 2.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.684 1.194 . . . . 0.0 112.021 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.24 160.45 22.98 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.3 t -70.57 141.37 51.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.792 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -78.32 6.94 7.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.64 0.376 . . . . 0.0 111.352 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.9 m 63.21 24.77 14.51 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 34' ' ' TYR . 4.8 p90 -157.44 167.68 29.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.28 -173.41 24.8 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 121.531 0.517 . . . . 0.0 113.697 -173.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -139.72 142.68 36.83 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.371 1.868 . . . . 0.0 114.971 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -146.77 152.74 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.878 0.871 . . . . 0.0 109.689 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -141.23 149.45 41.37 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.179 0.445 . . . . 0.0 112.163 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.03 162.42 16.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -76.88 -12.56 59.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.537 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.06 150.8 23.27 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 123.298 0.639 . . . . 0.0 111.176 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.67 -18.61 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.964 2.443 . . . . 0.0 111.73 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.37 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 118.214 0.461 . . . . 0.0 111.095 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -71.02 -26.39 63.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.858 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.87 -47.28 53.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -65.91 -30.53 71.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.13 0.423 . . . . 0.0 110.968 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.37 82.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.68 67.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -66.1 -51.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.63 -12.22 61.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.04 21.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.4 ttm -120.63 -21.77 6.61 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.79 124.35 18.88 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.01 84.97 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.183 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.93 118.2 8.71 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.043 1.421 . . . . 0.0 110.501 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -77.35 129.69 36.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 110.353 -176.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 tt -150.44 136.09 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.39 -112.52 4.96 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.05 14.98 8.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.0 112.728 -178.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -144.38 172.66 12.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.124 0.97 . . . . 0.0 111.135 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -107.48 139.67 41.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.06 125.08 24.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.73 0.3 . . . . 0.0 110.979 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -87.26 142.82 27.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.0 t -134.95 140.19 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.673 0.389 . . . . 0.0 109.967 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -149.07 152.05 35.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.98 0.354 . . . . 0.0 110.974 -175.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -71.92 148.49 45.99 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.214 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.432 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.8 tttt . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 123.309 0.644 . . . . 0.0 109.392 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.713 0.292 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.67 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.996 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.73 176.38 6.04 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.58 3.52 . . . . 0.0 110.476 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.6 134.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.991 -0.443 . . . . 0.0 111.147 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.04 0.12 84.8 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.628 -0.54 . . . . 0.0 112.857 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 -0.38 57.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.887 0.843 . . . . 0.0 112.193 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -107.72 145.81 32.96 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.28 149.07 52.71 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 105' ' ' LYS . 21.9 m-85 -97.82 142.35 29.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.927 1.691 . . . . 0.0 112.866 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.11 130.04 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -134.41 179.73 6.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.2 m170 64.37 15.55 9.57 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.82 1.648 . . . . 0.0 113.03 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.39 139.51 86.94 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.32 165.05 32.73 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.609 2.873 . . . . 0.0 109.991 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -72.57 -7.14 48.63 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -75.99 -9.78 58.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.138 0.427 . . . . 0.0 110.743 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -75.98 158.12 32.31 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.72 175.73 34.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -56.87 -41.64 78.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -80.82 -26.6 36.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.591 0.234 . . . . 0.0 110.966 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 75.4 m-20 -74.08 -38.47 63.91 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.5 tt -74.69 -25.49 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.5 tp -65.98 -52.19 51.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -64.65 -23.54 67.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.637 0.375 . . . . 0.0 111.595 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.4 tpp -76.58 -27.93 56.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.132 0.173 . . . . 0.0 110.753 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.268 22.0 m-85 -104.68 -11.72 16.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.6 mtm -66.08 -31.7 4.86 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 86.1 Cg_endo -72.46 -9.43 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.881 1.707 . . . . 0.0 111.733 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.81 -14.97 43.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.726 0.411 . . . . 0.0 111.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.48 -171.2 32.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.6 102.9 6.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.663 -0.316 . . . . 0.0 110.344 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -79.13 129.25 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mt -87.39 -33.82 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 122.301 0.241 . . . . 0.0 110.703 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.4 t -157.85 155.48 29.75 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.695 0.398 . . . . 0.0 110.239 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.34 138.26 17.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.339 0.656 . . . . 0.0 109.408 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.539 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 5.4 tmmm? -159.93 143.29 14.07 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.739 0.416 . . . . 0.0 111.081 -176.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.8 140.01 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.539 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 78.8 m-85 -72.41 149.43 44.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.44 143.7 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.797 0.839 . . . . 0.0 109.112 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -82.48 128.36 34.19 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.87 -11.15 59.92 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.297 -0.252 . . . . 0.0 111.478 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.23 -22.17 19.18 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -136.44 -10.79 1.89 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 61.68 9.6 2.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.375 1.07 . . . . 0.0 112.984 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.4 153.47 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.161 -0.337 . . . . 0.0 110.153 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.6 t -70.3 137.29 50.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.569 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -83.05 167.5 17.82 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.15 18.18 1.79 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.23 170.39 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.57 -168.68 21.08 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.602 0.62 . . . . 0.0 112.979 -173.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -143.96 142.03 30.51 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -146.02 153.03 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.122 0.969 . . . . 0.0 109.531 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.9 p -142.1 150.85 41.71 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.768 0.427 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -117.53 162.02 18.67 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -77.25 -15.43 59.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.77 150.9 25.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 C-N-CA 123.193 0.597 . . . . 0.0 110.848 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.93 -23.22 34.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.015 2.477 . . . . 0.0 112.177 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.64 -38.29 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.444 0.565 . . . . 0.0 111.548 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -76.21 -26.59 56.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.318 -0.239 . . . . 0.0 110.876 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.86 -47.43 30.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -68.24 -26.97 65.96 Favored 'General case' 0 C--O 1.231 0.112 0 O-C-N 122.243 -0.286 . . . . 0.0 110.258 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.02 73.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -27.78 68.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 119.383 -0.342 . . . . 0.0 111.84 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.3 mt -64.69 -52.21 57.51 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.23 -11.53 57.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.805 -0.14 . . . . 0.0 111.186 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.07 -29.22 15.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.71 -18.27 7.75 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.17 134.86 53.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.98 2.38 77.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.505 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.42 117.9 7.96 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.553 1.176 . . . . 0.0 110.742 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -74.41 129.65 38.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.487 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.9 tt -146.76 124.27 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.71 -145.36 49.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -173.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.27 9.85 11.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.578 0.751 . . . . 0.0 112.698 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -139.38 178.97 6.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.672 0.669 . . . . 0.0 111.514 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -118.79 145.08 45.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 109.966 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 88.5 mt -67.07 133.87 50.74 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 122.496 0.318 . . . . 0.0 110.966 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.48 133.1 41.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.22 140.05 45.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -153.16 159.44 42.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.547 0.339 . . . . 0.0 110.695 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.31 130.06 41.93 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.267 0.627 . . . . 0.0 109.98 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.41 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 59.6 tttp . . . . . 0 C--O 1.232 0.147 0 C-N-CA 123.04 0.536 . . . . 0.0 112.086 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.789 0.328 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.45 -164.41 30.71 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.04 170.44 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.488 2.792 . . . . 0.0 110.254 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -64.32 138.76 58.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.961 -0.462 . . . . 0.0 110.017 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.62 -1.67 87.18 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.541 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.95 13.2 29.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.717 0.758 . . . . 0.0 112.327 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -113.9 138.81 49.81 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.696 0.398 . . . . 0.0 110.186 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.8 mt -123.6 156.59 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 122.076 0.941 . . . . 0.0 113.115 -174.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -117.21 143.17 46.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.973 1.709 . . . . 0.0 114.016 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 HD21 ' A' ' 36' ' ' LEU . 3.0 mp -137.64 128.36 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.73 171.17 14.22 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.413 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 18.3 m170 74.15 20.67 2.67 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.209 1.803 . . . . 0.0 112.77 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.617 HD23 ' HA ' ' A' ' 72' ' ' PHE . 2.7 mm? -70.4 142.8 89.75 Favored Pre-proline 0 N--CA 1.454 -0.235 0 C-N-CA 123.166 0.586 . . . . 0.0 109.957 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.45 162.78 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.586 2.858 . . . . 0.0 108.991 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.82 -8.05 54.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -76.88 -9.94 59.03 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.266 0.484 . . . . 0.0 110.789 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.479 ' CD1' HD12 ' A' ' 36' ' ' LEU . 5.5 m-85 -75.67 158.44 32.35 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.82 174.92 33.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 8.5 p30 -60.8 -35.58 76.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -74.36 -29.19 61.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.18 0.592 . . . . 0.0 111.213 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -79.05 -42.08 27.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.81 -23.06 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.2 -49.61 75.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -65.31 -23.67 67.08 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.601 0.361 . . . . 0.0 111.641 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.3 mmm -77.15 -22.44 52.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.638 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 28.1 m-85 -110.1 -10.57 14.67 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.093 2.627 . . . . 0.0 118.093 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.437 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.1 mtm -66.21 -32.64 5.74 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 50' ' ' MET . 91.8 Cg_endo -74.4 -8.19 20.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 121.715 1.648 . . . . 0.0 112.055 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.79 -15.58 38.86 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.97 -172.35 33.3 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -75.93 103.09 5.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.208 -0.583 . . . . 0.0 110.516 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 122.56 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.5 mt -81.64 -30.83 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.05 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.8 t -158.72 154.58 26.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.055 0.455 . . . . 0.0 111.102 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.52 146.33 31.39 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.964 0.906 . . . . 0.0 108.603 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 42' ' ' ASP . 14.3 tppt? -157.96 145.35 18.25 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -121.73 132.83 69.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -69.71 155.07 41.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -134.08 143.76 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.949 0.5 . . . . 0.0 109.845 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -88.08 132.18 34.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -77.72 -13.06 60.01 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.839 0.456 . . . . 0.0 111.408 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -91.13 -22.27 20.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.276 0.63 . . . . 0.0 112.677 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.7 -12.85 2.0 Allowed 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -174.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 60.52 8.72 1.78 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.647 1.179 . . . . 0.0 112.911 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.46 156.65 30.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.966 0.348 . . . . 0.0 110.739 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.9 t -71.31 135.27 47.31 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.907 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.89 162.75 26.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.084 0.553 . . . . 0.0 110.822 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -81.28 11.0 4.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.617 ' HA ' HD23 ' A' ' 36' ' ' LEU . 4.6 p90 -157.79 172.94 17.58 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.43 -163.86 16.11 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.778 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.26 147.6 35.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.869 1.667 . . . . 0.0 115.404 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.6 t -146.2 152.14 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 t -141.2 143.9 34.46 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.25 159.17 19.61 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -76.23 -11.92 60.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.153 0.501 . . . . 0.0 111.847 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.86 149.7 21.43 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 123.168 0.587 . . . . 0.0 110.886 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.08 -18.23 35.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.344 2.696 . . . . 0.0 112.214 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.41 -46.27 95.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 118.297 0.499 . . . . 0.0 110.758 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.6 m -70.87 -24.04 62.42 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.186 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.6 -48.07 35.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.911 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -67.58 -28.99 68.23 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.045 0.384 . . . . 0.0 110.852 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.64 80.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.36 66.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.871 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.6 mt -65.85 -51.15 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 118.796 0.726 . . . . 0.0 109.173 174.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -68.23 -11.07 58.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.419 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.91 -26.77 16.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 89.2 mmm -120.65 -14.71 8.56 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.07 132.65 48.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.62 4.06 87.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.774 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -63.23 117.64 6.85 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.578 1.189 . . . . 0.0 109.977 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -77.37 130.93 37.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.115 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.97 134.25 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.45 -108.31 1.89 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 65.2 mtt -130.57 17.76 5.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.561 0.745 . . . . 0.0 111.516 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 55.3 tttp -146.59 155.84 42.78 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.69 0.396 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -98.12 140.64 32.14 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.699 -0.626 . . . . 0.0 111.196 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.02 131.58 46.15 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.713 0.405 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -92.8 139.12 30.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -134.83 141.01 44.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-N 118.047 0.385 . . . . 0.0 110.376 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -155.03 163.53 40.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.917 0.326 . . . . 0.0 111.785 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.44 148.66 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.562 0.745 . . . . 0.0 110.259 175.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 CA--C 1.53 0.187 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.941 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.63 0.252 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.77 41.44 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 177.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.3 167.2 24.51 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.409 2.739 . . . . 0.0 109.881 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.42 136.51 57.94 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.09 -0.381 . . . . 0.0 110.091 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 -10.56 73.99 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.132 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.33 6.67 48.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.031 0.532 . . . . 0.0 111.133 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.11 145.51 24.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.92 151.85 49.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.017 0.913 . . . . 0.0 113.097 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.74 145.12 45.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.542 1.937 . . . . 0.0 114.553 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.73 136.7 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.11 178.44 7.17 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.461 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.2 m170 63.88 15.92 9.46 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.31 1.444 . . . . 0.0 112.798 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.43 142.79 94.79 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 117.902 0.319 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.66 166.69 28.68 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.907 2.405 . . . . 0.0 109.566 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -71.2 -14.24 62.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.34 -10.02 59.08 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.84 158.14 36.89 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 175.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.22 177.7 34.8 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -57.32 -40.67 78.41 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -84.95 -26.26 27.29 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.378 -0.201 . . . . 0.0 111.055 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -74.18 -38.28 63.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 tt -75.41 -26.34 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.57 -53.35 53.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -64.23 -23.05 67.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.821 0.448 . . . . 0.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 tpt -79.05 -25.09 43.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.267 -0.271 . . . . 0.0 110.506 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.266 29.0 m-85 -105.83 -10.96 16.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 -178.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.466 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 53.8 mtm -66.63 -29.56 2.85 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.2 Cg_endo -72.47 -8.42 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 CA-C-N 121.951 1.733 . . . . 0.0 112.167 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -89.42 -12.07 41.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.959 0.504 . . . . 0.0 111.208 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.49 -176.17 31.6 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -77.96 101.67 6.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.236 -0.567 . . . . 0.0 110.506 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.02 123.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -85.22 -30.84 6.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.9 t -152.85 151.69 30.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 110.661 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 136.32 13.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.87 0.868 . . . . 0.0 108.865 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -158.5 131.05 7.02 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.511 0.196 . . . . 0.0 110.583 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -95.68 134.36 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -69.53 144.64 53.08 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -133.19 144.55 36.0 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 123.168 0.587 . . . . 0.0 109.979 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -88.89 130.69 35.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.454 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.54 -11.46 60.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.994 -0.441 . . . . 0.0 111.251 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -89.84 -21.86 22.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.8 -13.72 1.92 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.2 9.12 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.338 1.055 . . . . 0.0 112.954 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -82.25 160.01 23.07 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.709 0.404 . . . . 0.0 109.996 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.2 t -69.51 139.99 53.89 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.341 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -82.53 6.4 17.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.7 m 60.87 22.64 12.72 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.59 168.41 27.23 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.24 -172.12 28.16 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.796 -0.565 . . . . 0.0 113.714 -173.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -136.75 144.38 43.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.151 1.78 . . . . 0.0 114.877 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.1 t -148.33 153.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 91.1 p -146.46 146.64 30.63 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.831 -0.543 . . . . 0.0 112.295 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.46 164.83 12.32 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.64 -11.15 59.96 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.54 149.92 23.71 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 122.984 0.514 . . . . 0.0 110.785 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.29 -18.1 39.4 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.099 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.61 -46.56 94.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-N 118.466 0.576 . . . . 0.0 110.83 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -71.33 -25.36 62.37 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.518 0.327 . . . . 0.0 111.04 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.71 -47.69 52.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.045 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -68.49 -27.83 66.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.143 0.428 . . . . 0.0 110.711 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -40.66 81.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.02 66.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.678 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.3 -52.23 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -68.51 -11.8 60.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.338 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.55 -27.7 17.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 89.0 mmm -120.4 -18.29 7.94 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -65.68 131.81 47.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.07 8.59 85.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 119.089 -0.839 . . . . 0.0 112.51 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -66.38 114.58 5.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.807 1.303 . . . . 0.0 109.103 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.4 129.1 37.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.436 0.562 . . . . 0.0 110.956 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 tt -145.14 122.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.18 -143.3 48.34 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.5 mtm -86.1 12.53 9.41 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 42.7 tttp -147.06 170.45 17.11 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.698 0.681 . . . . 0.0 110.356 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -111.99 140.7 46.44 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 122.937 0.495 . . . . 0.0 109.902 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.29 132.7 49.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.272 0.229 . . . . 0.0 111.233 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -95.58 139.05 32.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 67.3 t -135.24 140.08 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -154.31 163.7 39.74 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -79.85 150.78 30.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.491 0.717 . . . . 0.0 110.629 175.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.444 ' H ' HD23 ' A' ' 104' ' ' LEU . 64.4 tttp . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 173.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.45 -179.07 46.7 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.69 -178.52 1.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.071 3.181 . . . . 0.0 110.376 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.61 131.14 49.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.117 -0.364 . . . . 0.0 111.019 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.04 1.79 85.9 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 119.526 -0.597 . . . . 0.0 113.189 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.88 7.41 44.93 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -109.67 139.11 45.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.327 0.512 . . . . 0.0 110.359 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.4 mt -126.15 159.37 33.1 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -117.36 141.8 47.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.967 1.707 . . . . 0.0 114.582 171.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.08 132.37 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -135.53 179.97 6.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.0 m170 65.15 23.39 12.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.149 1.379 . . . . 0.0 112.747 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.17 136.46 72.58 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.326 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.78 168.86 23.44 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.537 2.825 . . . . 0.0 110.313 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -69.37 -11.32 60.71 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -80.02 -7.27 58.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -76.1 158.18 32.06 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.94 174.91 35.27 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.85 -36.03 73.91 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 117.202 0.501 . . . . 0.0 110.864 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -78.62 -33.97 46.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.29 0.236 . . . . 0.0 110.886 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -71.28 -39.29 71.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -75.74 -26.74 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.446 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.4 tm? -65.16 -53.81 39.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.556 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 tpt -72.81 -26.65 61.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 25.0 m-85 -103.52 -9.27 19.44 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.457 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 44.7 mtm -66.78 -31.33 3.96 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 50' ' ' MET . 76.9 Cg_endo -71.53 -8.18 22.73 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 121.959 1.735 . . . . 0.0 111.667 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -89.07 -14.76 35.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.825 0.45 . . . . 0.0 110.885 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.88 -174.33 30.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -75.25 105.56 6.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.364 -0.492 . . . . 0.0 110.668 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.73 123.69 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.5 mt -82.17 -34.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 O-C-N 122.211 -0.306 . . . . 0.0 110.292 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -156.14 156.86 34.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.415 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.33 148.03 26.3 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.682 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.11 131.75 6.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.624 0.369 . . . . 0.0 111.014 -174.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.92 129.36 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -74.32 149.16 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 mm -132.95 153.32 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.776 0.43 . . . . 0.0 110.466 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HE3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -80.04 -10.73 59.79 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -86.24 -23.59 26.35 Favored 'General case' 0 C--O 1.23 0.039 0 C-N-CA 122.817 0.447 . . . . 0.0 112.126 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.0 -14.71 1.36 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.4 6.95 1.56 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.043 0.937 . . . . 0.0 112.812 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.35 162.74 25.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.3 t -67.99 141.75 56.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 110.474 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -73.44 6.39 3.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 111.384 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.8 p 58.35 20.78 7.64 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.491 1.916 . . . . 0.0 112.687 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.19 169.93 23.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.36 -170.23 26.86 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 121.467 0.482 . . . . 0.0 112.404 -175.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -137.63 141.45 41.21 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.664 1.586 . . . . 0.0 114.905 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.8 t -145.12 152.08 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.6 p -143.3 149.57 38.01 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-O 120.923 0.392 . . . . 0.0 112.003 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -114.85 162.54 16.76 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -78.3 -11.04 59.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.69 150.28 20.22 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.557 0.743 . . . . 0.0 110.767 176.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.0 -20.57 38.26 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.311 2.674 . . . . 0.0 112.057 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.2 -45.13 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 CA-C-N 118.42 0.554 . . . . 0.0 111.09 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -71.58 -27.3 63.04 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.91 -48.13 39.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -67.0 -27.61 67.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.035 -0.416 . . . . 0.0 110.802 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.16 73.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.31 66.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.99 -51.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -68.28 -12.02 60.36 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.161 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.46 -32.85 20.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.008 -0.52 . . . . 0.0 112.379 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.2 mtp -123.2 -14.77 7.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.23 126.67 28.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.38 2.38 90.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.802 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -62.27 138.75 58.48 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -92.64 130.79 38.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.782 0.719 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.6 tt -144.83 123.98 6.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.33 -143.66 48.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 mmt -84.91 9.2 15.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.659 0.783 . . . . 0.0 113.075 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -140.67 179.11 6.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.554 0.616 . . . . 0.0 111.214 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -118.82 147.74 43.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.41 124.34 19.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.038 0.935 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -94.38 130.42 40.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.95 137.64 51.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 122.243 0.217 . . . . 0.0 110.52 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -153.7 161.25 42.29 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 122.395 -0.191 . . . . 0.0 111.152 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -74.86 154.49 38.22 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.582 ' H ' HD23 ' A' ' 104' ' ' LEU . 57.2 tttp . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 122.6 0.36 . . . . 0.0 110.327 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.568 0.223 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 -160.73 35.24 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.87 178.75 3.74 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.042 3.161 . . . . 0.0 110.522 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -60.71 136.09 57.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.961 -0.462 . . . . 0.0 111.328 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.67 -1.67 71.63 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.334 0.492 . . . . 0.0 112.725 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.99 38.76 1.03 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 111.346 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.64 144.59 31.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.029 -0.419 . . . . 0.0 111.308 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.7 mt -129.87 158.07 40.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 25.2 m-85 -112.64 143.83 43.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.407 1.483 . . . . 0.0 114.233 170.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.85 124.95 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.8 m-85 -129.19 179.48 5.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m170 64.02 15.95 9.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.598 1.559 . . . . 0.0 112.335 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.57 141.39 90.47 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 122.842 0.457 . . . . 0.0 110.557 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.88 165.23 32.65 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.307 2.671 . . . . 0.0 109.415 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.47 -5.86 45.0 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.62 -9.2 58.82 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.033 0.379 . . . . 0.0 111.423 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -75.22 158.17 33.36 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.4 175.54 34.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -58.48 -37.35 75.34 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.531 0.665 . . . . 0.0 110.287 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.36 -33.27 37.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.605 0.241 . . . . 0.0 110.914 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -72.73 -38.52 67.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -74.79 -26.13 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.91 -53.26 41.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.513 0.325 . . . . 0.0 111.257 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.2 tpt -80.62 -24.71 38.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.953 0.101 . . . . 0.0 110.748 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.262 21.3 m-85 -104.63 -12.32 16.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -179.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.479 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.9 mtm -66.39 -29.87 3.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.9 Cg_endo -71.66 -9.68 25.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 122.068 1.774 . . . . 0.0 111.694 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -87.77 -13.62 41.83 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.094 0.406 . . . . 0.0 111.502 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.32 -175.01 31.9 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -75.45 103.25 5.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.552 -0.381 . . . . 0.0 110.484 -177.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.6 t -86.05 124.78 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.5 mt -86.31 -29.32 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 O-C-N 122.43 -0.169 . . . . 0.0 110.585 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -156.51 154.9 31.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.66 149.11 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.68 0.792 . . . . 0.0 109.361 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -158.31 139.22 13.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.556 0.342 . . . . 0.0 111.658 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 t -118.15 131.04 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -71.73 156.48 39.29 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -133.29 145.35 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 C-N-CA 122.823 0.449 . . . . 0.0 110.027 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -88.4 132.13 34.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -79.04 -14.18 59.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.889 0.476 . . . . 0.0 111.595 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -89.61 -23.64 21.89 Favored 'General case' 0 C--N 1.335 -0.063 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.35 -11.76 2.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 62.0 10.51 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.346 1.059 . . . . 0.0 111.839 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.64 156.37 27.66 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.942 -0.474 . . . . 0.0 110.01 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.6 t -71.29 139.64 50.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.786 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.87 163.89 24.93 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.861 0.464 . . . . 0.0 110.873 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.6 m -84.32 13.18 5.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -158.91 171.98 19.05 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.41 -166.06 18.47 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.511 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.36 142.88 30.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.17 152.81 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.704 0.802 . . . . 0.0 109.782 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 t -144.02 141.08 29.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -104.8 162.69 13.09 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -77.99 -12.49 59.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 111.491 174.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.97 149.9 20.44 Favored Pre-proline 0 N--CA 1.451 -0.404 0 C-N-CA 123.088 0.555 . . . . 0.0 110.613 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.92 -21.62 32.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.066 2.511 . . . . 0.0 112.341 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.2 -39.28 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.879 -0.513 . . . . 0.0 111.837 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -73.77 -25.33 60.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.182 0.193 . . . . 0.0 110.586 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.01 -45.84 55.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.29 -30.63 71.09 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.9 0.318 . . . . 0.0 110.875 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.52 82.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.28 -26.37 65.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.4 mt -65.52 -53.07 43.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -67.9 -11.3 58.43 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.99 -29.29 16.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 92.9 mmm -120.43 -16.96 8.29 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -65.0 132.59 49.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 4.83 84.75 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.048 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -63.66 122.83 17.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.727 1.263 . . . . 0.0 111.419 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -76.52 128.96 35.77 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.791 0.329 . . . . 0.0 110.854 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -151.76 136.91 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.6 -111.77 3.5 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.2 ptp -128.7 13.66 6.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.174 0.59 . . . . 0.0 111.89 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -151.85 142.16 22.44 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.169 0.44 . . . . 0.0 110.636 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -81.85 144.7 30.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.243 -0.286 . . . . 0.0 110.702 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.83 127.16 31.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.309 0.244 . . . . 0.0 111.037 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.62 138.31 31.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.21 140.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -153.71 157.23 39.2 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 122.352 -0.217 . . . . 0.0 111.277 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -78.3 151.79 32.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.002 0.521 . . . . 0.0 109.781 174.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.495 ' H ' HD23 ' A' ' 104' ' ' LEU . 59.7 tttp . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.965 0.412 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.44 -165.78 30.92 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.588 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -69.88 177.5 5.6 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.127 3.218 . . . . 0.0 110.403 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -60.67 137.4 58.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.903 -0.498 . . . . 0.0 110.855 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -3.53 83.51 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.672 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -0.28 39.76 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.679 0.74 . . . . 0.0 112.703 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -102.54 136.26 42.68 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 118.213 0.461 . . . . 0.0 110.314 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.5 mt -124.18 154.58 39.88 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.892 0.853 . . . . 0.0 113.135 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -116.06 145.91 42.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.931 1.692 . . . . 0.0 114.011 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.43 137.82 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.57 176.35 8.96 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 9.4 m170 65.93 16.1 10.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.181 1.392 . . . . 0.0 112.644 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.3 146.19 98.76 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.709 0.403 . . . . 0.0 110.075 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 169.16 22.82 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.319 2.68 . . . . 0.0 109.833 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -68.47 -19.29 64.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.872 0.469 . . . . 0.0 112.206 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.0 -10.57 59.66 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -69.99 158.03 36.39 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.24 175.5 35.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.38 -35.74 72.44 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 117.466 0.633 . . . . 0.0 110.031 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -79.76 -33.16 40.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.913 0.485 . . . . 0.0 111.085 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.11 -39.04 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.2 tt -74.35 -24.96 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.6 tp -65.27 -52.29 55.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -65.22 -22.27 66.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.566 0.346 . . . . 0.0 111.382 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.2 tpp -78.24 -26.78 47.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.269 0.228 . . . . 0.0 110.713 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.266 22.9 m-85 -105.77 -11.57 16.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.458 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.5 mtm -66.91 -31.0 3.56 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 50' ' ' MET . 81.4 Cg_endo -71.97 -9.2 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.745 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -82.78 -24.32 33.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.74 0.416 . . . . 0.0 111.981 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 158.57 -163.52 33.09 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.96 103.04 10.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.556 0.678 . . . . 0.0 110.972 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.4 t -82.4 121.55 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.66 -32.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -157.83 152.4 24.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.965 0.506 . . . . 0.0 111.239 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.09 146.74 31.96 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.891 0.876 . . . . 0.0 109.068 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -156.79 139.26 14.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.76 0.424 . . . . 0.0 111.598 -172.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.45 129.19 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 168.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -72.18 147.84 46.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.5 mm -132.36 141.17 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.819 0.448 . . . . 0.0 110.461 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -90.12 134.85 34.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -77.64 -12.22 59.95 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.65 0.38 . . . . 0.0 111.755 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -87.9 -22.54 24.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.12 -14.64 1.78 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 62.12 8.2 2.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.506 1.122 . . . . 0.0 112.717 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.7 mt -82.42 161.0 22.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.814 0.445 . . . . 0.0 110.329 175.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.5 t -66.87 138.54 57.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -77.56 8.91 3.76 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.009 0.524 . . . . 0.0 111.619 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.5 m 61.91 23.08 13.52 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -156.5 167.45 30.41 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.21 -170.79 24.19 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 121.581 0.545 . . . . 0.0 113.433 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -142.39 142.67 32.44 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.224 1.81 . . . . 0.0 114.744 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.1 t -146.05 153.41 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.5 t -143.31 146.92 33.99 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -117.86 165.57 13.51 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -80.63 -13.31 59.14 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.03 148.58 21.7 Favored Pre-proline 0 C--O 1.233 0.205 0 C-N-CA 123.256 0.623 . . . . 0.0 111.378 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.86 -23.11 41.72 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.508 2.805 . . . . 0.0 112.132 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.74 -38.66 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 O-C-N 121.802 -0.561 . . . . 0.0 111.232 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.6 t -74.72 -29.79 61.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.319 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.01 37.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.26 -28.57 68.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.262 -0.274 . . . . 0.0 110.727 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.57 73.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.47 -26.56 68.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.68 -51.87 57.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 CA-C-N 118.836 0.744 . . . . 0.0 109.001 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.89 -11.81 57.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.37 -27.38 16.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.5 mmm -120.54 -17.27 8.14 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.67 134.66 53.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.72 2.39 85.55 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.839 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.37 120.02 13.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.814 1.307 . . . . 0.0 110.675 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.76 126.87 31.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.63 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.69 135.72 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.442 0.697 . . . . 0.0 109.567 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.72 31.82 76.74 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.518 -0.739 . . . . 0.0 111.828 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.5 mtm 64.64 22.19 12.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -144.75 155.81 43.73 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -97.95 134.62 40.81 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.376 -0.828 . . . . 0.0 111.159 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.8 mt -64.73 130.99 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.66 0.267 . . . . 0.0 111.351 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.52 137.39 32.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.7 t -134.36 135.33 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -150.31 160.51 43.66 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.699 0.227 . . . . 0.0 111.564 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -76.6 149.29 36.58 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.01 0.524 . . . . 0.0 110.002 177.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.477 ' H ' HD23 ' A' ' 104' ' ' LEU . 85.5 tttt . . . . . 0 C--O 1.234 0.251 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.76 -156.3 20.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.08 175.94 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.94 3.094 . . . . 0.0 110.48 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.44 139.83 58.81 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.87 0.06 88.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.79 -0.45 . . . . 0.0 112.733 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.72 14.76 30.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.613 0.706 . . . . 0.0 112.893 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -119.14 138.62 52.79 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 118.427 0.558 . . . . 0.0 110.588 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.1 mt -125.42 156.88 38.15 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -117.1 141.42 48.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.844 1.658 . . . . 0.0 113.806 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.38 140.73 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -144.93 176.57 9.38 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.443 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 16.6 m170 63.97 16.74 10.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.901 1.68 . . . . 0.0 112.984 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.06 141.5 94.28 Favored Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.45 163.03 39.78 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.988 2.459 . . . . 0.0 109.524 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.72 -7.62 49.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -78.56 -10.56 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.091 -0.381 . . . . 0.0 111.134 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.99 158.5 35.34 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.8 174.92 35.17 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -56.82 -38.98 73.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -75.7 -33.21 60.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.784 0.433 . . . . 0.0 111.255 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 73.5 m-20 -71.55 -38.73 70.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 tt -76.52 -24.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.449 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.4 tm? -64.91 -53.62 43.56 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -69.66 -23.37 63.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 tpp -71.58 -27.9 63.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 18.6 m-85 -102.3 -10.08 19.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.44 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 46.2 mtm -65.83 -32.28 5.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.1 Cg_endo -72.33 -8.15 22.18 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.692 1.64 . . . . 0.0 111.894 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.34 -14.18 36.24 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.663 0.385 . . . . 0.0 111.342 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.92 -171.92 31.96 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -77.77 103.09 7.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.39 -0.477 . . . . 0.0 110.373 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -81.66 124.24 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.56 -37.45 16.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -158.44 157.1 31.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.478 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.46 146.82 23.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.84 144.0 16.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.692 0.397 . . . . 0.0 111.143 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.25 139.74 38.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 172.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -75.53 146.69 40.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -132.85 143.65 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 123.246 0.619 . . . . 0.0 110.303 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -90.56 131.7 36.14 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.38 -9.39 59.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.9 -0.5 . . . . 0.0 111.536 -179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -88.77 -22.26 23.38 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.92 -12.72 1.69 Allowed 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 62.29 7.37 2.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.415 1.086 . . . . 0.0 112.815 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.46 161.07 22.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 t -70.71 142.06 51.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.925 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.13 8.76 4.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.4 m 62.4 26.19 15.62 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.5 165.99 34.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.0 -179.54 27.71 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 121.548 0.527 . . . . 0.0 113.543 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.29 139.72 37.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.163 1.785 . . . . 0.0 113.987 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.35 152.97 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 123.628 0.771 . . . . 0.0 109.669 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.0 t -141.35 143.51 34.05 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.54 0.336 . . . . 0.0 111.898 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -111.88 159.83 17.98 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -75.91 -13.45 60.26 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.68 150.47 23.2 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.545 0.738 . . . . 0.0 110.756 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.9 -22.11 31.92 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.256 2.637 . . . . 0.0 112.465 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.3 -38.91 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 118.336 0.516 . . . . 0.0 111.704 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.7 m -74.3 -25.74 59.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.132 0.173 . . . . 0.0 110.631 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.78 -46.79 43.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -66.81 -30.43 70.62 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 122.271 -0.268 . . . . 0.0 110.737 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.29 80.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -26.75 65.59 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.14 -51.82 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -67.56 -12.09 59.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.31 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.74 -28.82 17.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.1 mmm -120.4 -17.3 8.21 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.88 133.07 51.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.55 2.19 87.55 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.894 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.41 119.05 10.29 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.57 1.185 . . . . 0.0 110.168 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -78.68 126.94 31.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.036 -0.415 . . . . 0.0 111.378 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.7 tt -155.91 135.14 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.307 0.643 . . . . 0.0 109.743 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.12 32.25 75.49 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.416 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm 63.03 24.52 14.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.066 0.947 . . . . 0.0 113.381 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HE2' ' CG ' ' A' ' 35' ' ' HIS . 85.2 tttt -144.99 151.48 38.65 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -96.31 134.09 39.87 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.0 mt -64.52 125.94 26.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.22 0.208 . . . . 0.0 110.789 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -87.93 139.19 30.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.82 139.48 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -149.21 156.52 42.28 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.743 0.306 . . . . 0.0 111.265 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.514 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -74.2 147.99 42.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.814 0.445 . . . . 0.0 109.952 176.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.514 ' H ' HD23 ' A' ' 104' ' ' LEU . 84.6 tttt . . . . . 0 CA--C 1.53 0.184 0 C-N-CA 122.963 0.505 . . . . 0.0 110.785 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 120.372 0.13 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.64 173.42 49.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p -70.48 162.83 28.04 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.234 0.614 . . . . 0.0 111.032 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.0 t -154.11 161.85 41.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.785 0.434 . . . . 0.0 110.366 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.455 ' CD2' ' H ' ' A' ' 7' ' ' HIS . 72.5 t60 -66.54 147.64 53.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.863 0.465 . . . . 0.0 110.852 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -83.87 -1.39 54.34 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.455 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 89.8 m-70 57.38 17.8 3.99 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.107 0.963 . . . . 0.0 113.421 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.476 ' CG ' ' H ' ' A' ' 9' ' ' HIS . 75.1 t60 58.51 173.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.72 1.208 . . . . 0.0 113.352 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.476 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 59.0 t-80 -66.55 153.55 42.7 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.196 0.598 . . . . 0.0 110.405 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -70.74 -25.78 63.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.157 0.583 . . . . 0.0 112.209 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.9 p -152.69 5.13 0.37 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 m 56.67 21.76 6.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.245 0.618 . . . . 0.0 112.579 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.88 -147.81 5.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.35 142.16 58.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -67.28 130.14 93.62 Favored Pre-proline 0 CA--C 1.529 0.172 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.1 141.71 36.8 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.168 2.579 . . . . 0.0 109.989 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 tpp85 -162.22 156.62 21.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.82 -11.48 83.46 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.582 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.3 p -160.07 159.95 32.55 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.639 0.72 . . . . 0.0 110.271 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -77.66 -23.28 49.69 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.511 0.324 . . . . 0.0 110.666 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.4 ptp 49.37 173.79 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.652 2.381 . . . . 0.0 114.394 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -94.21 152.11 18.96 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.402 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.41 159.34 38.62 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.493 1.117 . . . . 0.0 108.937 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -126.37 158.17 36.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.199 0.523 . . . . 0.0 112.344 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.12 -154.6 31.04 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.63 174.13 11.5 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.862 3.041 . . . . 0.0 110.574 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.02 139.67 58.4 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 122.238 -0.289 . . . . 0.0 110.615 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.9 -3.65 84.98 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.631 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.28 -1.46 53.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.786 0.793 . . . . 0.0 112.785 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -92.52 151.45 20.17 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 122.704 0.402 . . . . 0.0 110.596 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD13 ' HB1' ' A' ' 83' ' ' ALA . 1.4 tp -142.63 152.6 42.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.911 0.862 . . . . 0.0 113.213 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.45 145.93 47.43 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 126.516 1.926 . . . . 0.0 114.631 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -138.17 133.65 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.29 177.17 8.07 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 m170 65.67 16.11 10.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.572 1.549 . . . . 0.0 112.309 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.12 141.94 89.61 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 122.725 0.41 . . . . 0.0 110.524 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.55 164.46 35.53 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.757 2.305 . . . . 0.0 109.621 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -71.3 -8.12 51.55 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -77.31 -10.73 59.61 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.254 0.479 . . . . 0.0 111.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -72.58 158.16 36.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.73 175.98 34.91 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -56.88 -42.29 79.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -77.76 -27.82 50.46 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 122.656 0.382 . . . . 0.0 111.63 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -76.22 -37.92 57.1 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 tt -75.7 -25.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.8 tp -66.7 -51.75 52.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -65.16 -23.1 67.02 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.22 0.208 . . . . 0.0 111.501 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -76.4 -27.82 56.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.415 -0.178 . . . . 0.0 110.902 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.274 24.8 m-85 -105.37 -11.02 16.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 118.035 2.605 . . . . 0.0 118.035 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.465 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.1 mtm -66.75 -29.68 2.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.8 Cg_endo -72.5 -9.6 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.096 1.784 . . . . 0.0 112.216 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -86.61 -14.46 42.71 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.847 0.459 . . . . 0.0 111.453 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.64 -174.76 32.93 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -78.14 102.49 7.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.222 -0.575 . . . . 0.0 110.457 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -81.35 122.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.5 mt -81.89 -32.4 11.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 t -155.01 152.31 29.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.734 0.302 . . . . 0.0 110.777 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.58 143.06 21.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.735 0.814 . . . . 0.0 109.304 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HE3' ' CZ ' ' A' ' 61' ' ' PHE . 5.1 tmmm? -159.07 143.61 15.6 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 122.885 0.474 . . . . 0.0 110.896 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.63 137.15 43.14 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 169.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CZ ' ' HE3' ' A' ' 59' ' ' LYS . 74.4 m-85 -71.55 144.31 49.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mm -133.32 144.31 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 122.7 0.4 . . . . 0.0 110.195 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -89.06 130.93 35.43 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.9 -11.34 59.8 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.803 -0.561 . . . . 0.0 111.671 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -90.58 -22.6 21.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.07 -13.38 1.87 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.5 m120 61.39 9.34 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.561 1.144 . . . . 0.0 113.091 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -80.41 157.91 26.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 t -69.48 139.52 53.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.593 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.29 7.95 10.23 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.0 m 62.7 24.61 14.65 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.09 169.02 25.49 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.4 -177.67 29.79 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 121.627 0.571 . . . . 0.0 113.233 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -136.67 140.12 42.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.997 1.719 . . . . 0.0 114.177 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -144.22 156.05 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.648 0.779 . . . . 0.0 109.167 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.2 t -147.77 144.54 28.31 Favored 'General case' 0 C--N 1.339 0.151 0 O-C-N 121.901 -0.499 . . . . 0.0 112.022 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.18 165.74 11.88 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -82.27 -9.65 59.41 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.97 150.44 22.73 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.24 0.616 . . . . 0.0 111.141 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.29 -21.78 30.56 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.107 2.538 . . . . 0.0 111.98 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.04 -38.86 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 O-C-N 121.95 -0.469 . . . . 0.0 111.727 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -75.93 -25.89 56.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.207 0.203 . . . . 0.0 110.703 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -72.61 -50.82 22.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -68.06 -28.36 67.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.469 -0.144 . . . . 0.0 110.659 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.08 82.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.9 -25.9 66.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.842 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mt -67.18 -51.18 56.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -69.34 -11.89 61.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.57 -28.24 16.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 90.4 mmm -120.51 -15.71 8.46 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -67.75 136.96 55.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 2.72 73.61 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.138 -0.812 . . . . 0.0 112.91 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.73 117.3 7.28 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 118.673 1.237 . . . . 0.0 110.429 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.08 129.28 37.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.471 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 tt -146.73 123.9 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.91 -144.75 48.38 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.9 mtm -83.64 13.01 4.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.975 0.91 . . . . 0.0 112.818 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.61 173.43 11.6 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.253 0.621 . . . . 0.0 112.011 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -119.72 137.09 54.14 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.846 0.858 . . . . 0.0 109.051 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.09 135.51 56.45 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -99.32 138.64 36.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.77 139.15 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.482 0.313 . . . . 0.0 110.165 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -154.28 163.62 39.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.676 0.216 . . . . 0.0 111.46 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -73.84 154.14 39.61 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.244 0.618 . . . . 0.0 110.418 174.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.5 ' H ' HD23 ' A' ' 104' ' ' LEU . 27.7 ttpp -68.21 155.64 39.26 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.459 0.704 . . . . 0.0 110.269 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -67.47 157.56 33.94 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.699 0.285 . . . . 0.0 110.317 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.1 t -154.34 154.13 32.8 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.796 0.439 . . . . 0.0 110.87 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -72.57 -16.58 61.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -71.85 -22.4 61.54 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -105.6 -3.03 22.79 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.6 t -75.61 -5.14 43.92 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.455 0.702 . . . . 0.0 111.428 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.98 156.98 73.89 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.458 0.703 . . . . 0.0 111.428 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.2 -15.43 16.14 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.931 3.087 . . . . 0.0 112.105 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.4 m95 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.948 -177.08 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.095 0 C5'-C4'-C3' 111.176 -2.882 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.215 0 O4'-C4'-C3' 108.074 1.838 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.174 0 C5'-C4'-C3' 112.23 -2.18 . 0.033 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . 0.499 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.907 1 O4'-C1'-N19 112.311 4.111 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . 0.434 " H5'" " H4'" ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.85 0 O4'-C1'-N19 111.963 3.763 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.35 -178.75 46.38 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.4 t -70.01 166.44 19.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.269 0.628 . . . . 0.0 110.766 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 t -146.84 162.28 38.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.514 0.726 . . . . 0.0 110.345 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 55.92 19.92 3.88 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.009 0.923 . . . . 0.0 111.894 -175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -156.52 172.66 18.16 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.15 0.98 . . . . 0.0 108.939 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -61.09 161.49 8.51 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.847 0.356 . . . . 0.0 110.722 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -57.12 129.04 40.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.839 0.352 . . . . 0.0 111.04 -174.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 10' ' ' HIS . 82.5 t60 -162.84 168.34 21.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.635 0.774 . . . . 0.0 109.63 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' N ' ' CG ' ' A' ' 9' ' ' HIS . 64.5 t-80 -64.25 160.76 17.95 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.414 0.686 . . . . 0.0 110.666 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.1 p -73.45 4.96 4.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.344 0.658 . . . . 0.0 112.289 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 t -146.5 171.98 14.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.477 0.711 . . . . 0.0 110.325 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.22 171.45 36.1 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.7 tp -148.5 146.44 28.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.472 0.309 . . . . 0.0 110.23 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.8 p -155.48 138.16 10.38 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 123.337 0.655 . . . . 0.0 110.178 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.01 142.46 56.6 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.63 2.22 . . . . 0.0 110.382 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 85.6 mmt-85 -77.25 164.7 25.35 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.063 0.545 . . . . 0.0 110.999 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.52 -1.46 70.99 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.254 0.454 . . . . 0.0 112.465 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 99.8 p -68.21 160.96 28.15 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.674 0.737 . . . . 0.0 110.83 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -80.62 -7.94 59.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.554 0.341 . . . . 0.0 111.72 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mtm -75.59 167.44 21.89 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.021 0.439 . . . . 0.0 111.403 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -81.14 153.22 27.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.16 0.584 . . . . 0.0 111.064 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -122.46 159.57 27.35 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.5 0.72 . . . . 0.0 110.475 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -131.77 155.28 48.02 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.584 0.354 . . . . 0.0 111.067 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.73 -157.75 30.4 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.95 177.64 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.644 2.896 . . . . 0.0 110.336 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.35 141.99 58.56 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.114 -0.366 . . . . 0.0 110.675 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.13 0.68 77.7 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.76 -0.466 . . . . 0.0 112.703 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.03 31.57 4.46 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.664 0.732 . . . . 0.0 112.268 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -138.85 139.48 38.16 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 122.102 -0.374 . . . . 0.0 111.439 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.6 mt -127.01 154.9 44.04 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -114.23 144.08 43.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.959 1.704 . . . . 0.0 114.173 171.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.49 135.85 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 72' ' ' PHE . 14.8 m-85 -139.2 176.85 8.35 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.445 ' NE2' " H1'" ' B' ' 115' ' ' ' U' . 7.9 m170 64.87 13.79 8.78 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.23 1.412 . . . . 0.0 112.952 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.61 146.7 98.2 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.17 163.08 40.4 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.352 2.035 . . . . 0.0 109.438 172.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -68.86 -16.69 63.84 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -172.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -74.9 -11.43 60.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -68.86 158.33 34.71 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.0 178.14 33.54 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -57.03 -42.3 80.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -77.45 -26.0 51.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 66.9 m-20 -73.51 -41.11 63.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -74.09 -25.75 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 46' ' ' LEU . 1.9 tm? -64.81 -49.9 68.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -65.36 -25.68 67.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.7 mmm -76.29 -24.15 54.41 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.285 19.5 m-85 -105.07 -9.82 17.57 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.448 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -66.17 -33.43 6.86 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 50' ' ' MET . 93.0 Cg_endo -74.13 -8.48 21.06 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.738 1.656 . . . . 0.0 112.075 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -87.75 -14.9 38.49 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.582 0.353 . . . . 0.0 111.494 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.37 32.86 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -77.6 101.14 6.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.306 -0.526 . . . . 0.0 110.561 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -77.58 118.75 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.33 -35.78 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -158.51 157.14 31.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.814 0.34 . . . . 0.0 110.507 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.19 140.88 15.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.72 133.74 8.37 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.594 0.235 . . . . 0.0 111.341 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.5 t -93.25 143.26 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.442 ' CD2' ' CZ ' ' A' ' 72' ' ' PHE . 4.9 m-85 -73.08 148.5 43.98 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.7 mm -132.49 144.77 35.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 122.842 0.457 . . . . 0.0 110.203 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.22 131.17 37.66 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.33 -12.41 60.26 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 121.741 -0.599 . . . . 0.0 111.393 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -88.37 -23.79 23.28 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.404 0.682 . . . . 0.0 112.692 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -132.93 -14.14 2.75 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.9 t30 62.05 8.66 2.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.927 1.291 . . . . 0.0 112.094 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.17 164.48 18.09 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.932 0.493 . . . . 0.0 110.186 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.6 t -68.28 140.02 55.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.364 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -81.06 8.47 8.5 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.704 0.402 . . . . 0.0 111.891 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.1 m 63.07 21.32 12.82 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.442 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 4.0 p90 -155.52 167.12 31.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.0 -172.0 28.84 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 121.496 0.498 . . . . 0.0 114.035 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -136.6 145.48 44.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.411 1.884 . . . . 0.0 114.996 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.5 t -145.77 152.69 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.314 1.045 . . . . 0.0 109.283 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.3 p -142.79 149.72 39.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.391 0.541 . . . . 0.0 112.193 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -118.18 165.59 13.61 Favored 'General case' 0 N--CA 1.458 -0.054 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -80.89 -10.52 59.71 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.87 150.31 22.61 Favored Pre-proline 0 N--CA 1.453 -0.291 0 C-N-CA 123.287 0.635 . . . . 0.0 110.88 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.57 -20.95 40.42 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.437 2.758 . . . . 0.0 112.14 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.41 -39.04 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 O-C-N 121.801 -0.562 . . . . 0.0 111.611 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -74.88 -26.22 59.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.65 -48.54 25.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 122.449 -0.157 . . . . 0.0 110.624 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -65.92 -29.71 70.17 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.062 -0.399 . . . . 0.0 111.046 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.59 77.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.76 -26.71 64.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 119.567 -0.254 . . . . 0.0 111.662 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.69 -51.89 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.95 -11.89 59.68 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.71 -28.95 17.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.46 -14.74 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -67.45 136.19 54.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.85 1.53 84.51 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.862 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -66.01 118.95 10.52 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.772 1.286 . . . . 0.0 109.785 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.66 125.55 29.52 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.954 0.343 . . . . 0.0 111.55 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.0 tt -157.63 135.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.228 0.611 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.89 33.32 82.97 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.403 -0.81 . . . . 0.0 112.194 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 22.4 mmt 63.06 23.34 13.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.276 1.03 . . . . 0.0 113.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -145.35 155.51 43.23 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -97.81 132.73 43.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.79 -0.569 . . . . 0.0 110.481 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.44 128.34 36.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.24 0.216 . . . . 0.0 111.08 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -90.73 136.08 33.3 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.34 136.95 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -152.71 160.7 43.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 117.972 0.351 . . . . 0.0 111.916 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.15 156.28 38.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.069 0.548 . . . . 0.0 110.42 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 106' ' ' ARG . 60.8 tttp -70.53 154.57 41.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.454 0.645 . . . . 0.0 112.401 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' N ' ' CG ' ' A' ' 105' ' ' LYS . 86.2 mtt-85 -132.43 160.47 36.3 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.458 1.903 . . . . 0.0 107.987 173.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.7 m -131.49 161.91 31.46 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.763 0.316 . . . . 0.0 111.029 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.35 -21.05 66.49 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -70.84 -10.57 59.84 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.567 0.347 . . . . 0.0 111.393 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -80.34 -7.41 59.06 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.726 0.41 . . . . 0.0 111.341 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.1 t -125.35 -31.14 3.07 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.971 0.509 . . . . 0.0 111.526 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.479 ' HZ2' ' HB2' ' A' ' 112' ' ' LYS . 9.8 mtmp? -73.69 155.96 88.74 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 117.836 0.289 . . . . 0.0 110.326 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.52 4.26 6.5 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.765 2.977 . . . . 0.0 110.6 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.748 -1.12 . . . . 0.0 109.275 -178.705 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . 0.445 " H1'" ' NE2' ' A' ' 35' ' ' HIS . . . . . . . . 0 O4'--C4' 1.419 -2.813 1 O4'-C1'-N19 112.223 4.023 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.786 0 O4'-C1'-N19 111.066 2.866 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.995 0 C3'-C2'-C1' 98.085 -3.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.825 2 O4'-C1'-N19 112.983 4.783 . 0.46 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 2 O4'-C1'-N19 114.017 5.817 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.7 mtm . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.407 0.146 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.38 -8.25 87.91 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.839 -0.423 . . . . 0.0 112.405 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.2 t -68.63 153.39 43.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.74 0.77 . . . . 0.0 111.17 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.6 m -75.19 -6.59 50.45 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.889 0.476 . . . . 0.0 111.485 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.416 ' CG ' ' H ' ' A' ' 6' ' ' HIS . 78.5 t60 59.74 173.11 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.021 1.328 . . . . 0.0 112.444 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' H ' ' CG ' ' A' ' 5' ' ' HIS . 73.9 t60 -66.26 149.16 50.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.152 0.581 . . . . 0.0 110.38 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -74.68 163.72 27.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.979 0.418 . . . . 0.0 111.253 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -67.98 153.62 43.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.569 0.348 . . . . 0.0 111.184 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -68.21 164.59 20.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.157 0.583 . . . . 0.0 111.061 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -66.31 -10.72 45.44 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.795 0.438 . . . . 0.0 111.399 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.6 m -68.39 -7.09 28.46 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.005 0.522 . . . . 0.0 111.433 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t -66.51 -15.96 63.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.738 0.415 . . . . 0.0 111.089 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.13 -1.35 85.37 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.785 -0.453 . . . . 0.0 112.222 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.6 tp -65.81 144.68 56.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.4 0.68 . . . . 0.0 110.748 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.3 m -133.26 148.43 69.04 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 123.515 0.726 . . . . 0.0 111.931 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.77 21.52 0.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 124.936 3.757 . . . . 0.0 114.171 -172.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.6 169.75 4.64 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.552 -0.718 . . . . 0.0 110.73 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.07 -2.71 1.63 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.9 m -73.82 -18.45 60.95 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 117.562 0.681 . . . . 0.0 111.487 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 51.63 29.19 5.35 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.243 1.017 . . . . 0.0 113.674 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.5 mtm -74.28 -6.43 47.93 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.022 -0.424 . . . . 0.0 112.095 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -70.04 148.27 49.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.08 0.552 . . . . 0.0 110.497 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -118.28 159.5 23.26 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 123.711 0.804 . . . . 0.0 113.144 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -83.49 164.58 19.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.55 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.75 -156.43 31.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.578 1.085 . . . . 0.0 113.117 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.19 -178.43 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.609 3.539 . . . . 0.0 111.542 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -57.86 130.21 45.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.268 0.627 . . . . 0.0 111.305 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.82 -2.0 70.84 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.498 0.57 . . . . 0.0 113.19 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.76 36.59 0.9 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.714 0.757 . . . . 0.0 111.871 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 140.23 33.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.966 -0.458 . . . . 0.0 111.371 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.18 162.09 26.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 19.7 m-85 -119.72 143.57 47.7 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.887 1.675 . . . . 0.0 114.917 173.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.16 124.69 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 13.1 m-85 -128.77 179.71 5.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.8 m170 63.25 16.2 9.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.014 1.326 . . . . 0.0 112.836 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.9 142.33 93.34 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-N 118.144 0.429 . . . . 0.0 109.968 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.61 163.64 36.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.137 2.558 . . . . 0.0 109.722 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -68.81 -17.47 64.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -74.32 -10.29 59.44 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.038 -0.414 . . . . 0.0 112.046 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.03 158.14 36.51 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.9 176.59 33.34 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -56.84 -38.79 73.15 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.656 0.383 . . . . 0.0 110.642 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.04 -42.34 73.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.46 -26.11 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.464 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.0 tm? -64.86 -50.5 66.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -69.82 -23.11 63.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.7 -26.76 62.63 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.158 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 28.1 m-85 -104.23 -8.36 19.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 118.108 2.632 . . . . 0.0 118.108 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.44 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 42.1 mtm -67.33 -32.47 4.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.1 Cg_endo -73.38 -8.33 21.67 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.87 1.703 . . . . 0.0 112.164 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -89.9 -14.34 34.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.053 0.541 . . . . 0.0 111.283 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.02 -175.6 33.72 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -78.28 103.76 8.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.24 -0.565 . . . . 0.0 110.697 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -82.52 120.78 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.8 mt -84.02 -34.01 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.2 t -152.39 150.89 30.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 111.277 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.69 142.38 16.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.509 0.724 . . . . 0.0 109.209 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.614 ' HE3' ' CE1' ' A' ' 61' ' ' PHE . 3.0 tmmm? -159.87 134.49 7.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.679 0.392 . . . . 0.0 110.592 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.0 t -94.68 136.97 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 172.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.614 ' CE1' ' HE3' ' A' ' 59' ' ' LYS . 78.1 m-85 -69.15 150.0 48.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.12 143.27 41.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 122.77 0.428 . . . . 0.0 110.098 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.34 129.41 35.02 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -74.87 -12.48 60.38 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.949 -0.469 . . . . 0.0 111.541 -179.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -89.7 -23.23 21.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -134.71 -13.65 2.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 61.58 11.09 3.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.08 158.69 24.97 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 122.029 -0.42 . . . . 0.0 110.062 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -72.31 135.3 45.91 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.008 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -81.52 166.84 19.93 Favored 'General case' 0 C--O 1.23 0.047 0 CA-C-O 121.053 0.454 . . . . 0.0 111.135 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.7 m -79.19 12.05 2.52 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -157.01 170.82 21.67 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.05 -174.43 25.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.822 0.725 . . . . 0.0 112.447 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -138.62 145.15 40.16 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -146.94 152.95 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.24 1.016 . . . . 0.0 110.157 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -147.32 147.8 30.72 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.75 166.56 10.92 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -79.15 -8.56 59.1 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 173.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.06 150.8 24.85 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 123.221 0.609 . . . . 0.0 110.902 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -71.67 -16.16 30.17 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.142 2.561 . . . . 0.0 111.656 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.17 -46.8 92.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 118.383 0.538 . . . . 0.0 110.845 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -70.01 -24.6 63.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.841 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.36 -47.18 51.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.916 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -67.07 -29.7 69.54 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.159 -0.338 . . . . 0.0 110.758 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 -41.52 80.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.41 -26.43 65.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -66.01 -52.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.79 -12.14 57.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.119 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.46 -31.5 17.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.7 mtp -124.64 -9.06 7.36 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.87 128.04 34.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.8 90.25 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.572 -0.571 . . . . 0.0 112.617 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -62.25 120.03 10.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.447 1.123 . . . . 0.0 111.295 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -76.0 129.77 37.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.981 -0.45 . . . . 0.0 111.516 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -144.78 122.42 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.03 -143.63 48.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -87.34 16.64 5.11 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.57 0.748 . . . . 0.0 112.767 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -144.67 172.67 12.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.366 0.53 . . . . 0.0 109.968 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -117.66 143.89 45.74 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.181 0.592 . . . . 0.0 110.372 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.85 133.04 48.48 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.787 0.435 . . . . 0.0 111.151 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.481 ' HE3' ' C4 ' ' B' ' 116' ' ' ' U' . 17.8 ttmm -92.72 136.55 33.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.9 t -134.76 140.46 45.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -155.06 164.35 39.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.615 0.245 . . . . 0.0 111.366 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.86 153.49 41.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.68 0.792 . . . . 0.0 110.188 175.227 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.527 ' H ' HD23 ' A' ' 104' ' ' LEU . 85.1 tttt -63.22 152.02 38.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.316 0.646 . . . . 0.0 109.599 174.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -64.78 160.09 20.98 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 120.891 0.377 . . . . 0.0 110.248 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.6 t -67.82 150.13 49.0 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.06 0.457 . . . . 0.0 110.924 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.55 ' H ' ' CD ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -71.63 -9.32 58.06 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.009 0.523 . . . . 0.0 110.717 176.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -69.58 -18.55 63.64 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -82.26 -14.65 55.15 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.8 m -83.35 -12.5 56.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.706 0.403 . . . . 0.0 111.029 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.53 152.78 95.32 Favored Pre-proline 0 CA--C 1.528 0.117 0 C-N-CA 122.801 0.44 . . . . 0.0 111.042 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.99 -13.36 23.88 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.726 2.951 . . . . 0.0 111.21 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.2 m95 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.038 -1.458 . . . . 0.0 112.016 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 0 C5'-C4'-C3' 110.328 -3.448 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . 0.481 ' C4 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.414 -3.237 0 O4'-C1'-N19 111.719 3.519 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.353 0 C3'-C2'-C1' 98.704 -3.107 . 0.034 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.958 1 C3'-C2'-C1' 105.505 4.45 . 0.378 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 2 O4'-C1'-N19 112.826 4.626 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.514 0.197 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.28 179.84 48.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -76.78 -0.95 25.71 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.02 0.528 . . . . 0.0 112.253 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 t -154.93 160.76 41.37 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.308 0.643 . . . . 0.0 110.115 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -153.63 -3.16 0.2 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -73.92 161.0 30.59 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.333 0.515 . . . . 0.0 110.801 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -70.78 -18.45 62.75 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -76.69 -10.11 59.15 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.992 -0.443 . . . . 0.0 111.195 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -74.98 -18.4 60.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.72 0.408 . . . . 0.0 110.983 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -83.18 -6.33 59.44 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.31 0.644 . . . . 0.0 111.548 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -70.5 158.54 35.9 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.403 0.281 . . . . 0.0 111.311 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -156.28 161.6 40.21 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.995 0.518 . . . . 0.0 110.111 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.78 169.33 54.47 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.0 tp -153.81 149.43 27.4 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.021 0.528 . . . . 0.0 110.149 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -65.26 133.3 95.49 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 122.875 0.47 . . . . 0.0 111.324 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.77 -3.12 10.66 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.463 2.775 . . . . 0.0 113.255 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -143.61 20.3 1.85 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.23 178.35 28.05 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 123.184 0.421 . . . . 0.0 112.402 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.8 t -157.93 157.48 33.18 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.911 0.484 . . . . 0.0 110.457 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -66.9 -37.3 84.12 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.71 0.404 . . . . 0.0 110.62 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.2 mtm 57.05 156.05 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.403 1.481 . . . . 0.0 113.489 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -126.7 152.24 47.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 121.723 -0.611 . . . . 0.0 110.164 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -137.71 159.08 42.97 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.36 0.664 . . . . 0.0 109.942 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -133.49 153.94 51.22 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.31 -165.5 35.07 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.85 167.56 19.24 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.402 2.735 . . . . 0.0 109.39 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -64.28 138.73 58.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.963 -0.46 . . . . 0.0 110.122 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.72 86.37 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.723 -0.487 . . . . 0.0 112.179 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.06 21.24 16.1 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.463 0.705 . . . . 0.0 112.233 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -125.31 137.52 54.07 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.38 161.86 22.66 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 122.19 0.995 . . . . 0.0 113.653 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -119.08 143.96 46.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.852 1.661 . . . . 0.0 114.555 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.81 129.47 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -134.99 178.89 6.67 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.7 m170 63.96 17.14 10.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.374 1.469 . . . . 0.0 113.293 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.88 142.8 95.88 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 122.767 0.427 . . . . 0.0 110.444 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.96 171.89 17.3 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.792 2.995 . . . . 0.0 110.97 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -68.98 -21.37 64.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.959 0.904 . . . . 0.0 112.448 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -75.63 -6.61 51.24 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.72 158.13 28.38 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.32 175.08 34.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -61.92 -36.64 81.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -75.2 -31.42 60.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.377 0.271 . . . . 0.0 110.726 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -73.34 -38.24 65.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -76.21 -24.77 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.5 tm? -66.83 -53.0 37.02 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -66.11 -23.52 66.51 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.447 0.166 . . . . 0.0 111.447 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.3 tpp -75.77 -29.43 58.79 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.68 0.392 . . . . 0.0 110.828 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.308 24.6 m-85 -102.11 -8.77 21.12 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.46 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 43.7 mtm -66.36 -30.83 3.81 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.2 Cg_endo -72.28 -10.39 25.62 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 121.88 1.707 . . . . 0.0 111.789 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -86.2 -14.99 42.31 Favored 'General case' 0 C--N 1.338 0.073 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.14 -171.48 32.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -76.59 103.61 6.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.433 -0.451 . . . . 0.0 110.727 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.51 122.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.3 mt -82.62 -33.54 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -156.42 156.34 33.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.022 0.439 . . . . 0.0 110.399 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.37 149.25 25.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -159.68 141.23 12.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.0 111.403 -174.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 t -115.05 128.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.42 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 41.8 m-85 -71.69 157.34 38.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mm -126.32 140.47 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.052 0 C-N-CA 122.493 0.317 . . . . 0.0 110.499 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -87.36 131.28 34.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -75.26 -12.95 60.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.92 0.488 . . . . 0.0 111.5 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -89.72 -21.94 22.45 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.13 -14.43 1.79 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 61.67 8.8 2.49 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 112.711 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.36 162.21 23.49 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.77 0.428 . . . . 0.0 110.151 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.4 m -69.47 136.47 51.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.737 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -76.27 164.18 26.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.4 m -77.32 10.05 2.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -156.86 172.05 19.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.46 -165.57 19.71 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.367 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -141.41 144.37 34.43 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -147.0 151.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.751 0.82 . . . . 0.0 109.303 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 94.8 p -141.8 149.27 40.16 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -116.83 159.9 21.66 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -77.26 -13.38 59.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.148 0.499 . . . . 0.0 112.012 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.13 149.57 19.78 Favored Pre-proline 0 N--CA 1.456 -0.158 0 C-N-CA 123.223 0.609 . . . . 0.0 110.965 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -68.11 -21.68 42.25 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.644 2.896 . . . . 0.0 111.94 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.69 -38.53 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 118.534 0.606 . . . . 0.0 111.357 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -76.1 -25.56 55.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.286 0.235 . . . . 0.0 110.769 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.32 -48.16 30.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -66.46 -28.42 68.58 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.764 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.89 76.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.17 -27.13 66.15 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.35 -53.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -67.48 -11.51 58.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.458 0.303 . . . . 0.0 111.163 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.61 -31.88 18.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 119.019 -0.515 . . . . 0.0 112.375 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.4 mtp -128.73 -9.04 5.02 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -61.64 125.11 22.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.27 6.14 89.0 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.824 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.04 119.76 10.73 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.681 1.24 . . . . 0.0 112.333 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -76.92 130.06 37.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.976 0.353 . . . . 0.0 110.963 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -145.09 136.03 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.22 -100.41 0.35 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.1 ptp -139.78 17.21 2.5 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.045 0.938 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -148.02 152.77 37.99 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.825 0.45 . . . . 0.0 110.181 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -93.36 139.52 30.58 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 122.138 -0.351 . . . . 0.0 111.008 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 89.9 mt -68.49 131.16 44.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.709 0.404 . . . . 0.0 110.987 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.413 ' HE3' ' C5 ' ' B' ' 116' ' ' ' U' . 16.6 ttmm -90.82 135.67 33.58 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 170.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.32 136.7 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -152.67 159.81 43.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.651 0.262 . . . . 0.0 111.417 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -75.75 152.31 37.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.254 0.622 . . . . 0.0 109.658 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.522 ' H ' HD23 ' A' ' 104' ' ' LEU . 26.4 ttpp -63.51 157.98 22.16 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.239 0.616 . . . . 0.0 109.859 173.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -60.09 158.86 10.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.934 0.494 . . . . 0.0 110.794 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.2 t -151.8 154.86 37.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.755 0.422 . . . . 0.0 110.817 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -73.04 -10.61 59.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.564 0.346 . . . . 0.0 111.501 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -67.61 -14.62 63.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.067 -0.396 . . . . 0.0 111.681 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -78.65 -28.45 45.42 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.6 t -85.75 -31.13 22.56 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.995 -0.441 . . . . 0.0 111.08 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -76.14 154.22 84.47 Favored Pre-proline 0 N--CA 1.457 -0.085 0 C-N-CA 122.863 0.465 . . . . 0.0 111.207 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.78 -12.42 22.01 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.584 2.856 . . . . 0.0 110.929 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.7 m95 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 117.31 -1.329 . . . . 0.0 111.437 178.612 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.928 0 C5'-C4'-C3' 110.089 -3.608 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . 0.413 ' C5 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.083 0 O4'-C1'-N19 111.834 3.634 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.448 0 C3'-C2'-C1' 99.296 -2.449 . 0.18 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.93 1 C3'-C2'-C1' 105.693 4.659 . 0.345 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . 0.42 " H1'" ' CD1' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -3.008 2 O4'-C1'-N19 112.944 4.744 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mtp . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.03 -150.36 51.81 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.8 m -67.43 -9.82 45.41 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.955 0.377 . . . . 0.0 111.84 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 m 54.1 21.82 3.19 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.493 1.117 . . . . 0.0 113.131 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -154.82 150.17 27.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.561 0.744 . . . . 0.0 109.463 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -144.23 163.78 32.64 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.398 0.679 . . . . 0.0 110.639 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -67.65 -6.67 21.55 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -76.09 -12.66 60.16 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.734 0.414 . . . . 0.0 111.119 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -71.29 149.22 46.37 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.214 0.606 . . . . 0.0 110.08 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -69.87 -13.63 62.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -79.27 -11.65 59.95 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.92 0.488 . . . . 0.0 111.256 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -67.29 154.54 41.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.676 0.391 . . . . 0.0 111.683 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.81 -6.59 87.19 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.79 141.36 57.74 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.239 0.519 . . . . 0.0 110.39 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.06 139.63 11.76 Favored Pre-proline 0 CA--C 1.531 0.232 0 C-N-CA 123.212 0.605 . . . . 0.0 111.125 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.09 145.47 61.15 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.554 2.17 . . . . 0.0 109.939 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -75.93 156.22 34.41 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.687 0.279 . . . . 0.0 111.261 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.29 -2.83 90.32 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.645 -0.53 . . . . 0.0 112.6 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.1 t -66.55 153.29 43.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.777 0.788 . . . . 0.0 111.212 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -155.14 18.44 0.43 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.41 0.684 . . . . 0.0 110.294 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 74.7 mtm -69.2 161.64 28.77 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.847 0.459 . . . . 0.0 111.602 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.467 ' NE2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -63.52 152.63 38.02 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.424 0.689 . . . . 0.0 110.449 178.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -139.52 151.29 46.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.403 0.681 . . . . 0.0 110.293 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -87.96 154.22 20.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.874 0.87 . . . . 0.0 112.51 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.53 -173.7 49.13 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.39 0.519 . . . . 0.0 111.966 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.97 165.68 29.21 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.765 2.977 . . . . 0.0 109.877 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.08 131.26 47.95 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.4 -9.98 69.31 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.41 5.42 51.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.561 0.68 . . . . 0.0 110.969 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -95.52 142.08 28.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.27 159.88 35.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.719 0.771 . . . . 0.0 112.607 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.3 m-85 -122.6 145.89 47.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.824 1.65 . . . . 0.0 114.847 173.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.4 137.46 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.2 m-85 -140.65 179.46 6.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.458 ' CG ' ' HE3' ' A' ' 98' ' ' LYS . 20.1 m170 62.96 17.28 9.93 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.513 1.125 . . . . 0.0 112.924 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.42 142.51 92.18 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.055 0.388 . . . . 0.0 110.165 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.15 168.14 25.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.169 2.58 . . . . 0.0 109.959 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -71.05 -16.93 62.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -76.79 -9.67 58.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -72.62 158.08 36.34 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.1 171.73 33.36 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -59.86 -36.02 76.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -74.32 -29.42 61.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.887 0.475 . . . . 0.0 110.924 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -76.49 -42.42 43.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -71.29 -24.39 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.05 -49.72 73.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -64.9 -24.59 67.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.441 0.296 . . . . 0.0 111.712 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.2 mmm -76.19 -24.2 54.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.385 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 28.7 m-85 -107.32 -12.14 15.41 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.5 mtm -66.71 -31.15 3.83 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.6 Cg_endo -72.44 -10.65 25.72 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 121.986 1.745 . . . . 0.0 112.091 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -87.6 -14.07 41.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.744 0.418 . . . . 0.0 111.807 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.82 -174.74 33.06 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -75.62 106.52 7.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.343 -0.504 . . . . 0.0 110.382 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.4 122.34 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.411 HD11 ' HA ' ' A' ' 78' ' ' ASP . 28.6 mt -87.42 -27.83 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 t -149.8 146.73 27.32 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.915 0.388 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.2 143.38 24.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.166 0.986 . . . . 0.0 108.534 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.53 142.52 15.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.39 0.276 . . . . 0.0 111.565 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.5 t -118.5 131.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 169.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.49 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 40.1 m-85 -75.26 146.63 40.93 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -172.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 mm -133.77 145.69 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.174 0.589 . . . . 0.0 110.094 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -85.45 129.09 34.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.92 -11.29 59.94 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.836 -0.54 . . . . 0.0 111.945 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -90.65 -21.81 21.49 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 -11.41 1.46 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.99 10.53 2.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.581 1.152 . . . . 0.0 112.903 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.96 159.97 23.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.118 0.485 . . . . 0.0 110.006 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -70.07 142.71 52.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.807 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -84.29 -0.8 53.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.679 0.792 . . . . 0.0 111.206 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.2 m 61.34 19.44 10.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.94 170.41 22.19 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.39 -168.12 24.88 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 121.368 0.427 . . . . 0.0 113.568 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -140.92 144.19 35.04 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.968 1.707 . . . . 0.0 114.967 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.1 t -147.39 154.22 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -148.7 145.72 27.8 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.323 0.511 . . . . 0.0 112.107 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -104.91 162.08 13.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' HD11 ' A' ' 56' ' ' ILE . 36.0 t0 -77.18 -11.13 59.78 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 174.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.54 146.8 17.39 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 123.128 0.571 . . . . 0.0 110.61 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.18 -21.83 41.6 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.361 2.707 . . . . 0.0 112.626 -175.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.4 p -63.59 -39.18 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 O-C-N 121.885 -0.51 . . . . 0.0 111.509 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -74.17 -24.55 59.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.103 0.161 . . . . 0.0 110.926 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.69 -48.0 35.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 121.395 -0.122 . . . . 0.0 110.683 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -67.15 -29.62 69.38 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.408 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.01 82.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.74 67.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.82 -52.79 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -68.39 -11.01 59.0 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.383 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.01 -31.56 18.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 51.2 mtp -123.88 -12.31 7.55 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.26 126.75 28.41 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.53 5.17 87.11 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.779 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.07 116.73 7.48 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.813 1.306 . . . . 0.0 110.039 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.67 131.12 40.62 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -144.79 121.61 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.77 -137.52 48.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -86.99 4.8 40.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HE3' ' CG ' ' A' ' 35' ' ' HIS . 29.4 ttpt -147.45 161.75 40.43 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.42 1.009 . . . . 0.0 111.34 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -97.39 144.56 27.01 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.738 0.415 . . . . 0.0 110.671 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.4 126.69 30.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.358 0.263 . . . . 0.0 110.843 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HE3' ' C4 ' ' B' ' 116' ' ' ' U' . 19.9 ttmm -89.57 139.17 30.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.45 138.66 50.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -150.8 162.39 40.83 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -81.94 147.91 29.0 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.99 -0.444 . . . . 0.0 110.326 175.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.48 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.2 tttt -60.19 144.97 48.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -86.73 159.96 18.98 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 120.897 0.38 . . . . 0.0 110.944 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.4 t -80.42 156.48 26.62 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -100.35 -3.48 31.08 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.098 0.559 . . . . 0.0 111.667 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -70.3 -12.81 61.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -111.3 -15.99 13.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.9 t -76.89 -22.97 52.61 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.073 0.549 . . . . 0.0 111.368 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -71.94 150.17 92.67 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.24 0.216 . . . . 0.0 110.667 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.66 -17.7 15.83 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.983 3.122 . . . . 0.0 111.686 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.6 m95 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.243 -1.36 . . . . 0.0 111.927 -177.665 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.575 0 C5'-C4'-C3' 109.777 -3.816 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . 0.48 ' C4 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.127 0 O4'-C1'-N19 111.58 3.38 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.231 0 C3'-C2'-C1' 99.567 -2.148 . 0.036 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.903 2 C3'-C2'-C1' 105.517 4.463 . 0.412 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . 0.49 " H1'" ' CD1' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.876 2 C5'-C4'-C3' 108.693 -4.538 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 110.54 -0.17 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.17 -6.6 88.83 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.3 p -155.88 171.98 19.14 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.776 0.83 . . . . 0.0 109.67 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.1 m 53.52 30.25 10.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.049 0.54 . . . . 0.0 112.212 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -65.75 160.01 23.89 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.98 0.512 . . . . 0.0 110.905 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -67.21 -12.17 59.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.518 0.727 . . . . 0.0 112.518 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -154.81 175.29 13.92 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.215 0.461 . . . . 0.0 110.629 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -141.99 13.03 2.05 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.388 0.675 . . . . 0.0 111.298 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -68.54 174.08 4.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.237 0.615 . . . . 0.0 110.563 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -57.86 -29.05 64.7 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.331 0.253 . . . . 0.0 111.026 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.1 t 58.54 165.11 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.104 1.362 . . . . 0.0 114.28 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.1 p -83.35 -3.92 57.97 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.422 0.689 . . . . 0.0 110.522 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.22 -3.59 5.19 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.0 tp -74.4 -22.7 59.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.528 0.664 . . . . 0.0 111.442 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -68.12 136.93 91.73 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 122.684 0.394 . . . . 0.0 111.393 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.26 -9.38 23.54 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.165 2.577 . . . . 0.0 112.411 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -11.89 61.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.543 0.737 . . . . 0.0 110.902 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.48 15.41 78.24 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.7 t 59.87 156.83 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.504 1.522 . . . . 0.0 113.538 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -80.25 -4.72 54.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.639 0.775 . . . . 0.0 111.716 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.6 ptp -64.8 155.53 33.61 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.867 0.365 . . . . 0.0 110.486 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 22' ' ' GLN . 3.3 pm0 -64.8 151.78 44.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.114 0.566 . . . . 0.0 110.99 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -133.13 154.97 50.1 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.615 0.766 . . . . 0.0 109.752 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -142.41 154.92 45.01 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.815 0.446 . . . . 0.0 111.376 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.01 -154.64 29.98 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.07 177.33 5.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.944 3.096 . . . . 0.0 110.52 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.97 137.43 58.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 110.632 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.24 -1.84 86.1 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.346 0.498 . . . . 0.0 112.561 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.28 36.62 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.757 . . . . 0.0 111.617 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.21 140.48 29.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 111.324 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.1 mt -128.28 152.82 47.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 27.7 m-85 -108.5 140.84 41.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 113.939 169.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.18 123.55 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 23.3 m-85 -126.54 178.04 6.13 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.9 m170 66.1 15.29 10.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.949 1.7 . . . . 0.0 113.091 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.63 137.11 88.11 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.594 0.358 . . . . 0.0 110.183 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.35 173.28 14.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.465 2.777 . . . . 0.0 111.272 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -65.41 -20.81 66.53 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -74.33 -6.92 50.85 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -78.55 158.08 28.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.03 174.98 36.88 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -59.72 -39.1 83.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.009 0.524 . . . . 0.0 110.671 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -75.65 -38.97 58.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -74.03 -25.31 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.06 -52.05 52.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -64.5 -22.82 67.07 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.359 0.264 . . . . 0.0 111.634 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.6 tpp -76.82 -28.21 55.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.091 0.156 . . . . 0.0 110.785 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.275 25.0 m-85 -104.88 -11.47 16.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.48 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.2 mtm -66.84 -30.99 3.6 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.5 Cg_endo -72.85 -10.36 24.75 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 121.822 1.686 . . . . 0.0 112.18 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.33 -15.77 39.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.691 0.397 . . . . 0.0 112.033 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.36 -173.31 34.21 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -77.96 102.53 7.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.389 -0.477 . . . . 0.0 110.47 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -81.59 124.13 38.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.58 -30.2 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -154.02 148.5 26.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.671 0.389 . . . . 0.0 110.506 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.1 138.6 17.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HE3' ' CZ ' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.01 145.15 18.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.353 0.261 . . . . 0.0 111.133 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.8 t -111.02 135.5 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CZ ' ' HE3' ' A' ' 59' ' ' LYS . 83.8 m-85 -65.95 150.88 47.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.21 142.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.922 0.489 . . . . 0.0 110.442 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -88.21 131.55 34.7 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -74.96 -12.3 60.31 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.618 0.367 . . . . 0.0 111.756 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -90.41 -21.99 21.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.06 -14.92 1.77 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 61.78 9.39 2.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.326 1.051 . . . . 0.0 112.802 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.59 160.76 23.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.853 0.359 . . . . 0.0 110.366 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.4 m -68.33 135.54 52.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.34 0.256 . . . . 0.0 110.826 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -78.61 168.09 20.28 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.9 m -76.72 15.11 0.69 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -160.13 172.11 18.05 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.55 -173.11 23.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.298 0.951 . . . . 0.0 112.58 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CE1' ' N1 ' ' B' ' 118' ' ' ' A' . 6.0 t80 -142.01 142.63 32.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.725 1.61 . . . . 0.0 114.978 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -145.66 153.53 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.881 0.872 . . . . 0.0 110.368 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.8 t -147.2 146.47 29.84 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.747 -0.595 . . . . 0.0 112.584 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -111.73 168.68 9.37 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -81.68 -9.74 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.43 151.38 27.12 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 123.434 0.693 . . . . 0.0 111.061 177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -71.59 -18.38 29.14 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.069 2.513 . . . . 0.0 111.52 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.2 t -63.28 -45.9 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 118.39 0.541 . . . . 0.0 111.135 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 m -70.81 -26.55 63.35 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.1 -47.28 52.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.92 -28.21 68.11 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.077 0.399 . . . . 0.0 111.094 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.64 -42.0 78.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.25 65.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.4 mt -66.43 -51.04 62.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.05 -11.81 61.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.62 -28.09 19.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 13.0 ttm -120.6 -23.25 6.11 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -57.95 126.39 27.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.81 3.48 88.01 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.771 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -64.42 121.08 13.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.162 1.481 . . . . 0.0 110.927 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -76.93 124.37 27.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.637 0.256 . . . . 0.0 111.621 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 tt -161.06 136.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.816 0.846 . . . . 0.0 109.762 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.87 39.4 97.34 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.668 -0.645 . . . . 0.0 112.8 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.4 mtt 62.06 16.16 7.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.901 0.88 . . . . 0.0 113.229 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -141.45 179.47 6.78 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.895 1.278 . . . . 0.0 109.297 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -118.07 138.13 52.45 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.23 0.212 . . . . 0.0 110.503 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.02 129.44 40.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -92.23 136.17 33.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.36 139.71 49.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -155.37 158.69 39.08 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.737 0.303 . . . . 0.0 111.545 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.7 155.23 37.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.346 0.658 . . . . 0.0 111.12 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.455 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.9 tttt -69.58 164.59 22.94 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.959 0.903 . . . . 0.0 109.772 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -60.9 154.4 22.32 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 117.91 0.323 . . . . 0.0 110.753 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.0 t -70.72 158.74 35.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.105 0.562 . . . . 0.0 111.033 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -68.64 -12.57 61.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.262 0.225 . . . . 0.0 111.088 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.46 -3.95 58.06 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.432 0.293 . . . . 0.0 110.596 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -131.81 -2.13 3.73 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 89.4 p -77.92 -0.4 27.38 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.767 -0.583 . . . . 0.0 111.21 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 157.24 73.21 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 124.035 0.934 . . . . 0.0 111.857 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.83 -14.18 17.42 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 124.006 3.138 . . . . 0.0 112.245 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.9 m95 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.722 -1.132 . . . . 0.0 112.87 -177.119 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.877 1 C5'-C4'-C3' 108.971 -4.353 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.138 0 O4'-C1'-N19 110.306 2.106 . 0.091 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.823 0 C5'-C4'-C3' 111.774 -2.484 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . 0.486 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.928 2 O4'-C1'-N19 112.638 4.438 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.076 2 C5'-C4'-C3' 109.315 -4.123 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.74 169.13 38.34 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m 55.74 13.29 1.01 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.449 1.1 . . . . 0.0 113.827 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.5 t -163.57 157.42 19.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.516 0.727 . . . . 0.0 109.95 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -71.96 -13.7 61.7 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.207 0.203 . . . . 0.0 110.617 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.485 ' CG ' ' H ' ' A' ' 7' ' ' HIS . 68.5 t60 57.53 -177.02 0.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.399 1.08 . . . . 0.0 111.971 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.485 ' H ' ' CG ' ' A' ' 6' ' ' HIS . 45.2 m80 -71.71 4.9 2.82 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.269 0.628 . . . . 0.0 111.748 176.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.6 t60 60.86 167.0 0.09 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.243 1.417 . . . . 0.0 112.599 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -73.19 159.41 33.53 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.166 0.586 . . . . 0.0 111.045 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 60.74 166.41 0.08 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.739 1.216 . . . . 0.0 112.245 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.2 t -69.01 -18.7 64.08 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.96 -0.462 . . . . 0.0 110.954 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 t 57.68 18.2 4.59 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.204 1.002 . . . . 0.0 112.373 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.9 177.01 50.98 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.27 163.92 26.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 111.46 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.39 138.67 12.19 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 123.415 0.686 . . . . 0.0 110.411 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.47 138.34 83.88 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.838 2.359 . . . . 0.0 111.703 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.9 mmt-85 -82.79 170.19 15.31 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.86 0.464 . . . . 0.0 110.552 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.78 -5.94 70.81 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.25 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.2 p -81.43 165.88 20.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.523 0.729 . . . . 0.0 111.107 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -138.64 10.05 2.67 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.224 0.609 . . . . 0.0 111.517 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -74.41 -8.22 55.55 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.961 0.504 . . . . 0.0 111.877 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -86.94 142.76 27.76 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 120.713 0.292 . . . . 0.0 111.259 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 3.5 mppt? -142.25 158.99 43.11 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.388 1.075 . . . . 0.0 109.303 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -141.65 148.65 39.5 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.679 0.392 . . . . 0.0 111.139 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.67 -167.87 42.8 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.06 172.83 11.28 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.922 3.082 . . . . 0.0 110.854 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -63.53 138.74 58.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.095 -0.378 . . . . 0.0 111.04 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.81 -0.73 89.36 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.392 -0.367 . . . . 0.0 112.384 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.01 31.96 4.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.821 0.849 . . . . 0.0 111.544 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.06 140.55 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.179 -0.326 . . . . 0.0 111.168 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.7 mt -125.8 159.0 33.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.978 0.894 . . . . 0.0 113.153 -171.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -118.13 144.7 45.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.974 1.709 . . . . 0.0 114.443 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.86 136.57 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -141.16 179.93 6.47 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.4 m170 63.38 14.88 8.27 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.252 1.421 . . . . 0.0 112.911 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.05 143.32 96.02 Favored Pre-proline 0 N--CA 1.457 -0.121 0 CA-C-N 117.977 0.353 . . . . 0.0 110.132 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.44 168.0 24.77 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.952 2.435 . . . . 0.0 109.892 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -67.79 -17.82 64.66 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.019 0.527 . . . . 0.0 111.93 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -77.2 -10.22 59.27 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -70.05 158.01 36.48 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 175.95 35.14 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.76 -36.11 73.84 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.263 0.531 . . . . 0.0 110.629 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -80.26 -32.92 38.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 110.908 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -73.22 -38.43 66.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 tt -76.05 -25.17 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.6 tp -66.08 -52.79 45.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -68.5 -22.27 64.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 tpp -72.86 -26.6 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 21.5 m-85 -106.12 -12.81 15.63 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.465 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 48.2 mtm -66.92 -29.8 2.86 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.3 Cg_endo -72.96 -8.97 23.09 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.211 1.825 . . . . 0.0 112.111 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -86.87 -15.02 40.33 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.952 0.342 . . . . 0.0 111.778 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.95 -172.65 32.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -76.16 102.68 5.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 117.107 0.453 . . . . 0.0 109.904 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.63 126.91 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.3 mt -85.92 -30.67 6.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 122.884 0.474 . . . . 0.0 110.671 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -159.5 157.41 29.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.35 0.26 . . . . 0.0 110.694 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.16 142.95 25.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -157.81 134.51 9.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.894 0.478 . . . . 0.0 110.98 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -110.22 131.89 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -75.02 149.24 39.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 123.032 0.533 . . . . 0.0 109.711 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -90.23 138.65 31.35 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.62 -10.08 59.61 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -92.28 -22.96 19.46 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -13.23 2.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 t30 62.12 8.11 2.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.674 1.19 . . . . 0.0 111.875 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.02 162.16 19.45 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.891 0.476 . . . . 0.0 109.826 174.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -66.47 140.41 58.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.35 -0.219 . . . . 0.0 111.159 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -80.6 13.26 2.61 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.6 0.36 . . . . 0.0 111.742 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.1 m 62.09 20.99 12.07 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.49 169.26 24.69 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.96 -172.56 29.53 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 121.636 0.576 . . . . 0.0 113.186 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -137.25 142.36 42.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.091 1.756 . . . . 0.0 114.722 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -144.61 153.42 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 t -143.36 149.46 37.75 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.073 0.397 . . . . 0.0 111.74 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -115.17 159.67 20.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.12 -14.58 61.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.22 0.533 . . . . 0.0 112.083 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.02 149.57 21.01 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.526 0.73 . . . . 0.0 110.685 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.91 -20.47 38.95 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.377 2.718 . . . . 0.0 112.204 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.31 -39.82 86.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.551 0.614 . . . . 0.0 111.737 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.3 m -73.34 -25.84 60.78 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.1 -46.43 51.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -66.4 -30.19 70.52 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 122.038 -0.414 . . . . 0.0 110.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.39 -41.51 80.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.74 -26.22 66.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.72 -51.93 56.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -68.49 -10.84 58.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.16 -27.98 17.36 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.9 mmm -120.29 -18.54 7.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -66.32 133.3 50.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.21 86.42 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.785 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -64.6 117.67 7.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.529 1.165 . . . . 0.0 110.448 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -75.39 130.06 38.37 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.108 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -146.19 124.97 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.4 -142.5 47.97 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 61.5 mtt -86.91 8.99 20.76 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -140.87 179.14 6.89 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.059 0.544 . . . . 0.0 111.41 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -118.97 142.96 47.32 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 110.069 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.36 130.95 45.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.683 0.278 . . . . 0.0 111.208 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -90.72 135.73 33.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.9 t -134.84 139.49 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.84 160.68 43.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.742 0.305 . . . . 0.0 111.432 -174.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.32 149.11 40.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.444 ' H ' HD23 ' A' ' 104' ' ' LEU . 62.8 tttm -62.86 151.19 39.82 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.708 0.403 . . . . 0.0 109.918 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -63.78 158.57 21.46 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.472 0.309 . . . . 0.0 110.866 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.2 t -64.8 151.72 44.62 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.712 0.405 . . . . 0.0 111.457 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.473 ' H ' ' HD3' ' A' ' 108' ' ' LYS . 0.1 OUTLIER -74.41 -12.22 60.45 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.816 0.446 . . . . 0.0 110.985 176.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -65.77 -14.96 62.36 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.357 0.263 . . . . 0.0 111.404 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -80.82 -9.69 59.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.6 p -125.92 -31.17 2.92 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -138.82 158.46 69.93 Favored Pre-proline 0 CA--C 1.527 0.072 0 C-N-CA 123.5 0.72 . . . . 0.0 110.999 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -80.23 4.66 6.62 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.829 3.019 . . . . 0.0 110.659 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 117.061 -1.447 . . . . 0.0 110.103 -177.518 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.776 0 O4'-C1'-N19 111.421 3.221 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.043 0 O4'-C1'-N19 111.72 3.52 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.829 0 O4'-C1'-N19 111.962 3.762 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 2 C3'-C2'-C1' 105.566 4.518 . 0.51 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 1 C5'-C4'-C3' 109.216 -4.189 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mmm . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.71 165.52 53.68 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.4 p -71.95 -16.88 62.1 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 122.339 -0.507 . . . . 0.0 111.618 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p -81.96 -13.91 56.8 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -78.44 -8.21 58.25 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.619 0.368 . . . . 0.0 111.937 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -80.7 6.43 12.82 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.036 0.38 . . . . 0.0 111.678 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.492 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 9.9 t-160 -149.64 167.87 25.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.233 0.613 . . . . 0.0 110.013 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.492 ' H ' ' CD2' ' A' ' 7' ' ' HIS . 34.7 m80 -67.0 157.84 32.43 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.819 0.448 . . . . 0.0 111.027 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -71.82 160.2 33.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.33 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -73.73 -21.36 60.24 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.881 0.472 . . . . 0.0 111.09 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.4 t -66.76 148.48 51.87 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.759 0.423 . . . . 0.0 111.425 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.2 m -78.61 -1.9 36.43 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 122.824 0.45 . . . . 0.0 111.723 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.46 -171.66 54.2 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.6 tp -150.55 148.61 28.89 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.732 0.413 . . . . 0.0 110.415 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 p -153.83 137.28 10.36 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.364 0.665 . . . . 0.0 109.653 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.71 136.57 33.46 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.741 2.294 . . . . 0.0 110.356 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 21.5 mmt85 -148.7 160.95 42.68 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.635 0.774 . . . . 0.0 111.608 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.81 122.38 0.63 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.7 t 58.55 178.81 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.575 1.15 . . . . 0.0 112.236 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -83.27 -3.22 57.22 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.958 0.903 . . . . 0.0 111.899 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.5 mmt -64.25 155.45 31.94 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.92 0.488 . . . . 0.0 111.233 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -73.56 153.45 40.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.138 0.575 . . . . 0.0 112.482 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -126.21 159.47 32.9 Favored 'General case' 0 C--O 1.228 -0.035 0 C-N-CA 123.907 0.883 . . . . 0.0 110.008 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -127.67 151.69 48.64 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.584 0.354 . . . . 0.0 111.169 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.58 -172.72 34.97 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.0 174.8 7.31 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.753 2.969 . . . . 0.0 110.443 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -61.1 135.08 57.66 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.124 -0.36 . . . . 0.0 110.386 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.76 -0.69 89.44 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.557 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.76 0.34 28.12 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.866 0.833 . . . . 0.0 112.785 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -99.73 146.21 26.79 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.205 0.457 . . . . 0.0 109.802 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.467 HD13 ' HB1' ' A' ' 83' ' ' ALA . 1.1 mp -136.16 156.52 48.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.993 0.901 . . . . 0.0 112.823 -171.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 15.1 m-85 -124.98 147.6 48.84 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.71 1.604 . . . . 0.0 114.465 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.62 132.71 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 5.8 m-85 -136.54 177.45 7.84 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 7.2 m170 64.63 16.14 10.14 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.768 1.627 . . . . 0.0 112.57 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.8 145.22 96.7 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 122.801 0.44 . . . . 0.0 110.205 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.81 160.49 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.068 2.512 . . . . 0.0 108.95 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -73.85 -5.21 39.56 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.11 -10.46 59.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.059 0.391 . . . . 0.0 111.431 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.5 158.25 36.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -155.79 177.46 32.89 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -57.43 -42.58 82.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -79.98 -27.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.476 0.179 . . . . 0.0 111.107 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 73.4 m-20 -72.28 -39.65 68.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 tt -76.71 -23.93 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.9 tp -66.6 -53.18 37.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -64.7 -23.0 67.11 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.295 0.238 . . . . 0.0 111.474 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.4 tpp -75.73 -29.45 58.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.047 0.139 . . . . 0.0 110.702 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.305 31.5 m-85 -104.95 -9.35 17.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 118.402 2.741 . . . . 0.0 118.402 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -67.44 -28.73 2.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 50' ' ' MET . 97.8 Cg_endo -72.19 -10.67 26.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 122.374 1.883 . . . . 0.0 111.787 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -85.76 -14.79 44.16 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.33 -171.74 32.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.53 102.84 6.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.447 -0.443 . . . . 0.0 110.684 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.2 t -83.92 122.85 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -79.69 -34.98 16.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -157.71 156.1 31.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.075 0.464 . . . . 0.0 110.527 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 137.95 15.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.522 0.729 . . . . 0.0 109.048 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.59 134.13 8.76 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.512 0.196 . . . . 0.0 111.517 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.5 t -94.45 140.6 16.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -69.67 151.29 46.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -126.85 143.07 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 122.869 0.467 . . . . 0.0 109.975 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -91.59 130.64 37.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.14 -10.09 59.14 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.158 -0.339 . . . . 0.0 111.745 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -87.98 -22.54 24.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.24 0.616 . . . . 0.0 112.384 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -137.35 -14.08 1.52 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 61.65 8.2 2.23 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.882 1.273 . . . . 0.0 113.105 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.74 159.91 23.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.747 0.419 . . . . 0.0 109.878 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -71.24 135.04 47.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.535 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -76.03 166.92 22.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.008 0.432 . . . . 0.0 110.506 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.7 p -79.01 19.38 0.54 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -160.23 172.04 18.11 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.8 -171.9 27.38 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.528 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -136.37 144.88 44.81 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.579 1.551 . . . . 0.0 115.182 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -147.39 152.53 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.095 0.958 . . . . 0.0 108.431 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.4 p -143.45 147.34 34.42 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.876 -0.515 . . . . 0.0 112.023 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -113.79 159.94 19.24 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.32 -12.42 60.0 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.05 150.08 21.93 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 122.988 0.515 . . . . 0.0 110.886 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.1 -21.28 36.79 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.46 2.773 . . . . 0.0 112.296 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.34 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 118.72 0.691 . . . . 0.0 111.519 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -75.39 -25.92 58.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.376 0.27 . . . . 0.0 110.677 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.467 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -72.91 -49.92 26.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -68.85 -26.63 65.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 117.741 0.246 . . . . 0.0 110.483 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.73 -41.76 78.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.54 -27.14 66.71 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.3 mt -67.33 -52.07 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.34 -12.53 61.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.288 0.235 . . . . 0.0 111.259 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.93 -31.37 19.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 53.3 mtp -126.01 -9.59 6.56 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.21 125.68 24.88 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.01 87.43 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.854 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -63.73 119.44 9.93 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.639 1.22 . . . . 0.0 111.519 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -75.92 129.61 37.21 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.277 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.1 tt -144.64 120.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.75 -141.9 47.22 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 74.0 mtm -87.59 12.5 12.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -145.02 164.56 30.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.88 0.763 . . . . 0.0 110.673 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -107.1 141.63 38.05 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.855 0.462 . . . . 0.0 110.808 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 87.6 mt -66.43 140.86 58.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.889 0.475 . . . . 0.0 111.442 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -101.94 141.18 35.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.93 137.08 52.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -151.73 160.64 43.52 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 120.887 0.375 . . . . 0.0 111.573 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.21 145.68 32.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.81 0.444 . . . . 0.0 110.463 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -66.25 159.26 26.93 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -60.36 155.38 18.11 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.1 p -67.14 157.61 33.25 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -68.86 -10.19 55.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -86.8 -17.39 33.58 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.836 0.289 . . . . 0.0 111.276 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -80.69 -20.0 43.92 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.6 m -89.36 -11.95 41.8 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.611 0.365 . . . . 0.0 111.757 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -69.2 152.2 96.73 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.839 0.456 . . . . 0.0 111.128 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.27 -13.3 20.91 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.814 3.009 . . . . 0.0 111.488 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 97.4 m95 . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.726 -1.131 . . . . 0.0 112.601 -179.024 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.713 0 O4'-C1'-N19 112.197 3.997 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.977 0 O4'-C1'-N19 111.033 2.833 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.491 0 C1'-O4'-C4' 106.7 -3.222 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . 0.49 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.032 1 O4'-C1'-N19 112.604 4.404 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.844 2 O4'-C1'-N19 113.54 5.34 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 120.347 0.118 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.3 178.66 48.63 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 t -155.86 157.87 37.11 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.192 0.597 . . . . 0.0 109.96 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.2 p -70.31 162.64 28.15 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.806 0.442 . . . . 0.0 110.984 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -69.79 161.38 29.94 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.801 0.44 . . . . 0.0 111.023 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.0 m80 59.06 169.36 0.06 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.926 1.29 . . . . 0.0 113.278 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -77.86 -8.5 58.15 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.169 0.588 . . . . 0.0 111.921 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -145.61 161.29 40.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.506 0.722 . . . . 0.0 110.769 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -153.25 167.27 29.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.32 0.648 . . . . 0.0 110.319 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -156.64 171.1 20.93 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.368 0.667 . . . . 0.0 110.122 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.4 t -155.34 160.7 40.93 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 122.89 0.476 . . . . 0.0 110.179 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -69.69 155.96 39.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.202 0.525 . . . . 0.0 110.845 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.99 1.95 57.11 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.879 -0.401 . . . . 0.0 112.98 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 65.8 tp -72.68 145.61 47.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.802 0.801 . . . . 0.0 110.44 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 17' ' ' ARG . 12.4 t -140.16 132.89 14.84 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 123.558 0.743 . . . . 0.0 110.525 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.21 -9.78 23.61 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.268 2.645 . . . . 0.0 112.543 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' H ' HG12 ' A' ' 15' ' ' VAL . 25.5 mmt180 -71.54 159.94 33.57 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.982 0.513 . . . . 0.0 111.706 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.77 -37.82 0.03 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.97 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.2 p -164.29 -43.49 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.737 0.768 . . . . 0.0 111.321 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.7 m80 50.79 28.16 3.49 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.25 158.51 28.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.94 0.4 . . . . 0.0 111.063 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -88.47 132.84 34.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.441 -174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -150.05 159.79 44.14 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 125.128 1.371 . . . . 0.0 109.548 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -136.86 158.94 43.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.702 0.763 . . . . 0.0 111.568 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.34 -156.54 26.71 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.308 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.34 158.33 55.67 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.928 2.419 . . . . 0.0 108.948 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -63.5 129.38 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.12 -11.57 60.35 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.06 19.34 6.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.673 0.737 . . . . 0.0 110.417 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.14 142.35 47.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -169.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -127.9 159.85 33.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.015 0.912 . . . . 0.0 113.026 -171.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -125.46 144.05 50.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.411 1.884 . . . . 0.0 114.55 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.3 137.8 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.8 179.71 6.55 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.513 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.4 m170 64.7 17.12 10.78 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.246 1.418 . . . . 0.0 113.05 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.06 139.3 87.66 Favored Pre-proline 0 CA--C 1.529 0.146 0 O-C-N 122.165 -0.335 . . . . 0.0 110.111 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.71 172.13 16.42 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.449 2.766 . . . . 0.0 111.06 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -70.53 -13.09 61.97 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -82.37 -7.08 59.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -77.2 158.44 30.33 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.27 174.76 35.49 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -58.74 -38.34 78.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -74.97 -29.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.631 0.373 . . . . 0.0 111.032 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.65 -42.52 58.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.9 tt -72.55 -24.81 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.31 -50.96 67.99 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -64.52 -23.85 67.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.536 0.334 . . . . 0.0 111.797 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.4 mmm -77.61 -23.83 49.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.634 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.28 33.8 m-85 -108.56 -10.68 15.21 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.451 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.3 mtm -66.23 -31.96 5.02 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.5 Cg_endo -73.15 -9.69 23.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 121.706 1.645 . . . . 0.0 111.779 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -86.97 -14.72 40.91 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.792 0.437 . . . . 0.0 112.079 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.3 -172.6 32.87 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.57 102.05 5.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.387 -0.478 . . . . 0.0 110.47 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -80.77 120.62 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.61 -31.47 14.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -157.98 155.04 28.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.39 0.276 . . . . 0.0 110.834 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.38 29.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 109.346 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -156.99 141.33 16.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.836 0.454 . . . . 0.0 111.516 -174.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.06 130.21 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 168.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -76.44 142.96 40.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.4 mm -132.74 144.18 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.664 0.386 . . . . 0.0 110.534 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' CA ' ' HE2' ' A' ' 70' ' ' LYS . 61.0 t0 -85.93 130.5 34.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.511 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -79.13 -10.65 59.88 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.036 -0.415 . . . . 0.0 111.576 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -90.01 -22.14 22.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -136.76 -10.92 1.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.74 6.87 1.73 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.362 1.065 . . . . 0.0 112.692 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -79.6 158.21 27.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.8 t -71.43 143.75 50.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HE2' ' CA ' ' A' ' 63' ' ' ASP . 71.6 mmtt -77.1 3.34 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.593 0.757 . . . . 0.0 110.704 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.3 m 62.65 20.1 11.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -157.59 169.91 23.59 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.66 -169.0 23.35 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.991 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -141.5 141.91 33.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.6 t -147.25 152.52 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 t -147.94 149.06 31.51 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.692 -0.63 . . . . 0.0 111.934 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.87 163.12 14.56 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -79.48 -9.92 59.7 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.423 0.289 . . . . 0.0 110.319 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.3 149.05 19.76 Favored Pre-proline 0 N--CA 1.453 -0.284 0 O-C-N 121.852 -0.53 . . . . 0.0 111.478 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.61 -19.21 42.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.658 2.905 . . . . 0.0 112.356 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.2 -39.92 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.724 -0.61 . . . . 0.0 111.789 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -74.65 -24.64 58.85 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.389 0.276 . . . . 0.0 110.535 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.6 39.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -68.0 -28.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.963 -0.461 . . . . 0.0 111.087 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.99 -42.34 80.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.145 -0.347 . . . . 0.0 110.122 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.25 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.66 -51.2 53.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.86 -11.98 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.75 -0.204 . . . . 0.0 111.407 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.65 -31.44 17.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 52.9 mtp -124.1 -10.92 7.59 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -62.49 126.23 26.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.1 5.75 87.2 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.148 -0.806 . . . . 0.0 112.792 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -65.23 117.32 7.63 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.764 1.282 . . . . 0.0 109.934 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -75.26 129.43 37.44 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.169 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.5 tt -145.05 119.85 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.72 -142.65 46.96 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 ptp -84.39 8.95 14.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 43.8 tttp -146.89 165.75 28.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.753 0.706 . . . . 0.0 110.428 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -104.49 143.18 33.38 Favored 'General case' 0 C--O 1.229 -0.017 0 C-N-CA 122.731 0.413 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.31 126.32 27.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.198 0.199 . . . . 0.0 110.801 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HE3' ' C5 ' ' B' ' 116' ' ' ' U' . 21.0 ttmm -87.67 136.47 32.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 171.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.73 139.29 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -148.55 161.47 41.6 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.726 0.298 . . . . 0.0 111.405 -172.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -83.74 151.12 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 104' ' ' LEU . 78.9 tttt -59.86 148.51 34.52 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.869 0.868 . . . . 0.0 110.053 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -70.3 156.17 39.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.924 0.392 . . . . 0.0 110.484 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.3 t -68.03 157.8 34.35 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.492 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -69.47 -20.12 63.75 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 122.258 -0.276 . . . . 0.0 110.758 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -78.41 -17.99 55.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.743 0.417 . . . . 0.0 110.214 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -103.51 -1.64 28.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.7 m -87.26 -5.03 59.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.031 0.532 . . . . 0.0 111.47 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -66.6 151.72 96.01 Favored Pre-proline 0 CA--C 1.528 0.101 0 C-N-CA 123.201 0.601 . . . . 0.0 110.438 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.48 -15.24 22.23 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.709 2.94 . . . . 0.0 111.527 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.9 m95 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.865 -179.587 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . 0.499 ' C6 ' H5'' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.414 -3.259 0 O4'-C1'-N19 111.638 3.438 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . 0.457 ' C5 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.005 0 C5'-C4'-C3' 112.45 -2.033 . 0.095 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.175 0 O4'-C1'-N19 110.415 2.215 . 0.032 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . 0.441 " H4'" " H5'" ' B' ' 119' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.615 2 C3'-C2'-C1' 105.522 4.469 . 0.41 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . 0.441 " H5'" " H4'" ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.572 1 O4'-C1'-N19 113.693 5.493 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttm . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.05 -0.024 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.02 159.86 32.06 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.5 p -81.28 -5.08 57.41 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.06 0.544 . . . . 0.0 112.034 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -154.99 154.48 32.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.802 0.441 . . . . 0.0 110.246 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -146.52 162.47 38.28 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.579 0.752 . . . . 0.0 110.218 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -154.2 157.72 39.23 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 123.097 0.559 . . . . 0.0 109.836 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -71.37 162.72 28.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.332 0.653 . . . . 0.0 111.649 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 57.11 -175.87 0.06 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.46 1.104 . . . . 0.0 112.81 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -150.38 163.61 37.92 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.262 0.625 . . . . 0.0 109.525 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -64.13 -23.76 67.44 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.766 0.426 . . . . 0.0 111.304 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.6 t -159.13 139.55 12.3 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.636 0.375 . . . . 0.0 111.064 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.6 p -91.28 -10.15 42.48 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.64 0.376 . . . . 0.0 110.94 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.57 -1.82 77.1 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.39 134.62 54.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 117.339 0.569 . . . . 0.0 110.666 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 m -80.46 160.37 67.61 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.449 0.699 . . . . 0.0 112.694 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.2 129.24 33.8 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.506 2.804 . . . . 0.0 111.859 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.54 176.86 10.59 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 124.087 0.955 . . . . 0.0 109.883 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.49 151.39 23.65 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.3 m 57.53 150.56 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.407 1.483 . . . . 0.0 114.972 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -84.93 -17.15 38.67 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.6 mtm -77.8 -15.31 59.18 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.916 0.486 . . . . 0.0 111.816 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -106.19 152.29 23.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 159.5 44.06 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.752 0.421 . . . . 0.0 110.919 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -112.44 164.32 13.41 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.975 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.52 -171.6 36.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.34 178.53 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.07 3.18 . . . . 0.0 110.637 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -58.3 134.7 56.8 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.087 -0.383 . . . . 0.0 110.935 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 0.43 88.64 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.829 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.02 8.76 34.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 117.826 0.813 . . . . 0.0 113.166 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -112.28 139.93 47.42 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.16 0.436 . . . . 0.0 110.453 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.62 160.89 30.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.007 0.908 . . . . 0.0 112.936 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 20.2 m-85 -128.35 141.98 51.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.533 1.933 . . . . 0.0 114.647 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.56 137.62 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.1 m-85 -141.33 178.38 7.46 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.447 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 17.1 m170 64.12 18.71 11.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.883 1.273 . . . . 0.0 112.961 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.89 145.43 98.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HG2' ' CD2' ' A' ' 40' ' ' PHE . 90.5 Cg_endo -72.32 163.45 38.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.867 2.378 . . . . 0.0 109.682 174.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -69.67 -16.42 63.35 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.87 -9.28 59.43 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.813 -0.554 . . . . 0.0 112.259 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.402 ' CD2' ' HG2' ' A' ' 37' ' ' PRO . 4.0 m-85 -73.13 158.27 35.63 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 175.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.26 175.7 33.88 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -57.19 -39.62 75.75 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -74.79 -30.46 61.43 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.003 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -76.02 -38.85 56.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -73.56 -25.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.6 -51.36 63.11 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -65.21 -22.37 66.88 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.2 tpp -77.15 -27.73 53.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.396 0.278 . . . . 0.0 110.555 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.284 25.3 m-85 -105.03 -12.21 16.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 118.0 2.593 . . . . 0.0 118.0 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 58.4 mtm -66.17 -31.23 4.28 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 94.1 Cg_endo -72.33 -10.15 25.22 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.907 1.717 . . . . 0.0 112.072 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.33 -15.02 41.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.842 0.457 . . . . 0.0 111.708 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.29 -173.53 32.81 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -77.04 102.79 6.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.497 -0.413 . . . . 0.0 110.421 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.87 123.79 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.1 mt -83.89 -33.33 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 t -152.41 151.17 30.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.721 0.408 . . . . 0.0 110.794 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.08 140.64 17.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.405 0.682 . . . . 0.0 109.455 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' HE3' ' N3 ' ' B' ' 119' ' ' ' A' . 0.0 OUTLIER -158.61 161.72 37.25 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 120.811 0.338 . . . . 0.0 110.842 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.94 139.19 52.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.411 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 48.4 m-85 -74.53 142.67 44.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 mm -131.91 142.08 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 124.017 0.927 . . . . 0.0 108.554 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -80.78 127.35 32.41 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.566 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -73.22 -9.47 58.74 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.082 -0.386 . . . . 0.0 111.717 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -94.73 -23.6 17.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.19 -10.5 2.57 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.1 t30 61.81 11.25 3.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.737 1.215 . . . . 0.0 111.895 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.7 mt -86.02 160.15 19.4 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.887 0.475 . . . . 0.0 109.891 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.5 t -69.56 145.33 52.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.597 0.236 . . . . 0.0 111.43 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 61' ' ' PHE . 52.2 mtmt -98.04 15.29 24.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.147 0.579 . . . . 0.0 111.195 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.6 p 52.13 29.75 6.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.405 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.8 p90 -155.06 168.96 25.27 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.55 -174.34 27.14 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.273 0.374 . . . . 0.0 112.955 -173.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -139.69 140.75 36.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.261 1.424 . . . . 0.0 114.46 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -146.36 153.74 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 98.0 p -147.89 153.0 38.53 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 111.532 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -122.54 164.66 17.72 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -80.08 -9.59 59.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.32 151.02 24.89 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.932 0.493 . . . . 0.0 111.275 176.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.38 -19.5 37.84 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.31 2.673 . . . . 0.0 111.633 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.96 -46.57 95.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 118.548 0.613 . . . . 0.0 111.026 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 m -70.91 -25.93 62.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.129 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.79 -49.03 42.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -68.17 -27.23 66.23 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 117.936 0.334 . . . . 0.0 110.674 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.9 75.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.25 70.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.4 mt -65.99 -50.47 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -69.43 -11.16 60.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.243 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.88 -27.39 21.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.6 ttm -120.86 -21.04 6.73 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -58.83 123.34 16.13 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 6.04 88.48 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.424 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -67.29 142.83 56.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.759 1.279 . . . . 0.0 108.486 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -95.92 128.58 42.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.938 0.335 . . . . 0.0 110.701 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.36 136.88 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.29 -113.35 5.07 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.4 mtm -126.86 14.42 7.43 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.573 0.749 . . . . 0.0 112.282 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 56.5 tttp -151.24 144.54 24.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.309 0.504 . . . . 0.0 110.783 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -82.63 143.3 31.08 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.416 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.0 mm? -67.98 130.4 42.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.346 0.258 . . . . 0.0 110.496 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -92.02 138.11 31.81 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.71 141.15 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.44 0.296 . . . . 0.0 110.418 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -148.62 161.78 41.02 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.64 0.257 . . . . 0.0 110.87 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 tt -90.13 140.04 30.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -63.68 156.57 26.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.46 0.573 . . . . 0.0 109.62 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 106' ' ' ARG . 67.5 mtt85 -58.39 146.07 36.11 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.8 p -65.77 151.7 46.02 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.188 0.518 . . . . 0.0 111.374 -175.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -69.73 -7.82 42.69 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.331 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -89.3 -9.23 51.32 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.306 0.642 . . . . 0.0 111.565 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.23 -24.28 1.86 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.7 p -71.78 -19.2 62.04 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 122.482 0.313 . . . . 0.0 111.668 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.18 154.15 92.27 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.31 0.644 . . . . 0.0 109.839 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -71.57 -14.53 30.53 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.338 2.692 . . . . 0.0 111.613 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 89.4 m95 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.145 -1.407 . . . . 0.0 112.338 177.284 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.694 0 C5'-C4'-C3' 111.248 -2.834 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.113 0 C5'-C4'-C3' 112.57 -1.954 . 0.248 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.203 0 C5'-C4'-C3' 111.857 -2.429 . 0.04 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . 0.513 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.656 0 C3'-C2'-C1' 105.037 3.93 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . 0.44 ' C8 ' H5'' ' B' ' 119' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.965 1 C5'-C4'-C3' 108.619 -4.587 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 119.958 -0.067 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.13 171.49 55.14 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m -75.4 -11.33 60.02 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.0 p -155.18 13.08 0.37 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.594 0.358 . . . . 0.0 111.78 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -153.41 163.46 39.9 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.967 0.507 . . . . 0.0 110.798 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -142.92 173.05 11.89 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.441 0.696 . . . . 0.0 110.528 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -136.01 162.57 32.52 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.261 0.624 . . . . 0.0 110.268 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -155.36 172.49 18.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.091 0.556 . . . . 0.0 110.452 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -152.77 162.85 40.74 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.303 0.641 . . . . 0.0 110.461 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -73.87 151.27 40.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.941 0.401 . . . . 0.0 111.133 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -158.55 158.09 33.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.356 0.662 . . . . 0.0 109.816 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.6 t -67.31 145.68 54.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.603 0.361 . . . . 0.0 111.017 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.34 -170.3 34.47 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.9 tp -151.17 142.85 23.69 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.167 0.587 . . . . 0.0 109.801 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 17' ' ' ARG . 4.6 p -69.65 135.32 88.18 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.77 -9.59 22.61 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.312 2.675 . . . . 0.0 111.939 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.425 ' H ' HG22 ' A' ' 15' ' ' VAL . 16.7 tpt180 -67.95 133.51 49.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.624 0.37 . . . . 0.0 110.228 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.66 1.13 44.13 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.571 -0.572 . . . . 0.0 112.742 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 t -71.66 159.26 34.71 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 117.995 0.898 . . . . 0.0 111.03 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -70.85 -11.72 61.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.149 0.579 . . . . 0.0 111.499 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.7 mtm -78.2 139.0 38.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.496 0.319 . . . . 0.0 111.139 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -98.04 152.05 19.7 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.295 0.638 . . . . 0.0 109.563 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -111.69 159.18 18.47 Favored 'General case' 0 C--O 1.23 0.039 0 C-N-CA 122.943 0.497 . . . . 0.0 111.054 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -141.86 155.57 45.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.189 0.519 . . . . 0.0 111.607 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.48 -152.38 28.81 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.37 179.23 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.695 2.93 . . . . 0.0 111.172 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.84 135.98 57.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.947 -0.471 . . . . 0.0 111.551 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.15 68.09 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.478 0.561 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.11 39.76 1.0 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.665 0.732 . . . . 0.0 112.013 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.09 140.03 29.23 Favored 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.723 -0.611 . . . . 0.0 111.75 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -128.76 153.77 47.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.931 0.872 . . . . 0.0 113.152 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 16.1 m-85 -110.99 146.87 35.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.562 1.545 . . . . 0.0 114.152 170.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -139.01 124.74 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.4 m-85 -131.28 179.28 6.11 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 17.1 m170 63.32 16.12 9.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.348 1.459 . . . . 0.0 112.335 -176.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.49 144.38 94.25 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.137 0.575 . . . . 0.0 110.329 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.83 162.91 36.65 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.374 2.716 . . . . 0.0 109.248 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -73.46 -6.22 44.98 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -75.68 -9.99 59.05 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.994 0.361 . . . . 0.0 111.241 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -73.39 158.3 35.28 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.41 176.54 33.75 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -57.24 -39.01 74.7 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 117.158 0.479 . . . . 0.0 111.975 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -80.02 -33.21 39.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.585 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -72.04 -38.81 69.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -74.34 -28.35 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.3 tp -66.25 -52.23 49.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -63.91 -22.91 67.14 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.555 0.342 . . . . 0.0 111.688 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -78.38 -26.04 46.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.645 0.202 . . . . 0.0 110.654 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.296 31.3 m-85 -104.93 -10.53 17.22 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 56.6 mtm -66.97 -29.32 2.56 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 50' ' ' MET . 84.3 Cg_endo -71.05 -13.11 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.893 1.712 . . . . 0.0 111.906 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -84.35 -15.46 46.4 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 155.19 -175.06 33.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -75.32 105.53 6.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.281 -0.541 . . . . 0.0 110.77 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.04 126.71 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.3 -30.43 5.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 120.487 0.184 . . . . 0.0 110.578 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -154.6 150.43 27.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.726 0.411 . . . . 0.0 110.577 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -158.83 141.54 14.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.383 0.673 . . . . 0.0 109.496 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.557 ' HE3' ' CD2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -156.45 153.26 28.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.43 0.292 . . . . 0.0 110.292 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 t -107.71 142.87 19.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD2' ' HE3' ' A' ' 59' ' ' LYS . 69.3 m-85 -69.72 148.73 48.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.8 mm -133.68 146.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.148 0.579 . . . . 0.0 109.965 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -95.19 132.89 39.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -77.36 -12.91 60.01 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.067 0.547 . . . . 0.0 111.75 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -89.78 -23.82 21.65 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.62 -13.43 2.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.2 t30 61.54 10.84 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 112.22 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.86 154.56 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.673 0.389 . . . . 0.0 110.219 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -70.49 134.39 47.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.425 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -84.23 163.69 19.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.105 0.478 . . . . 0.0 110.451 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.6 m -78.87 17.67 0.7 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE1' ' CE1' ' A' ' 61' ' ' PHE . 3.5 p90 -156.59 170.32 22.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.77 -177.59 29.15 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.753 1.168 . . . . 0.0 111.896 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.425 ' CE1' ' N1 ' ' B' ' 118' ' ' ' A' . 6.7 t80 -139.69 144.57 37.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.74 151.95 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.803 0.841 . . . . 0.0 110.082 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 t -143.4 144.0 31.86 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -106.21 164.35 12.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -80.89 -9.22 59.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.271 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.75 150.43 20.36 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 123.138 0.575 . . . . 0.0 111.096 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.69 -18.35 28.84 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.125 2.55 . . . . 0.0 111.858 -177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.9 -44.77 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 O-C-N 121.817 -0.552 . . . . 0.0 111.282 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -70.65 -26.26 63.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.63 -48.04 35.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -66.07 -28.51 68.89 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.062 -0.399 . . . . 0.0 110.816 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.67 -43.59 75.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.228 -0.295 . . . . 0.0 110.322 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.41 -25.67 66.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.8 mt -66.98 -52.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -66.88 -13.73 61.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.365 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.98 -32.95 18.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.8 mtp -123.82 -11.91 7.63 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -61.85 125.24 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.62 5.96 88.99 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.303 -0.72 . . . . 0.0 112.798 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.12 125.15 22.86 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.46 1.13 . . . . 0.0 112.031 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -78.22 128.38 33.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.685 0.279 . . . . 0.0 110.846 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -149.56 136.51 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.98 -111.1 2.81 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.0 ptp -130.42 15.47 5.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.13 0.572 . . . . 0.0 111.811 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -150.83 142.42 23.57 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.483 0.313 . . . . 0.0 110.291 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -84.41 145.13 28.35 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 122.505 -0.122 . . . . 0.0 111.181 -176.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 81.4 mt -70.78 131.82 44.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.572 0.349 . . . . 0.0 111.647 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -91.32 138.6 31.46 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 170.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.97 137.38 50.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -155.12 160.79 41.22 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.865 0.302 . . . . 0.0 111.715 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -74.8 156.23 36.73 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.37 0.668 . . . . 0.0 110.692 176.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.46 ' H ' HD23 ' A' ' 104' ' ' LEU . 87.4 tttt -67.03 154.41 41.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.43 0.692 . . . . 0.0 109.534 173.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -61.23 148.95 39.24 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-O 120.868 0.366 . . . . 0.0 110.66 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.2 t -154.45 158.4 39.88 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.953 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -75.17 -7.16 53.05 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.559 0.343 . . . . 0.0 111.036 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -69.32 -21.16 63.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.281 -0.262 . . . . 0.0 110.562 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -85.1 -17.61 36.8 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.9 m -80.01 -9.14 59.67 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 122.127 -0.358 . . . . 0.0 111.301 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -67.8 151.61 97.04 Favored Pre-proline 0 N--CA 1.456 -0.168 0 C-N-CA 122.886 0.475 . . . . 0.0 110.753 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.86 -14.55 21.45 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.572 2.848 . . . . 0.0 111.244 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.7 m95 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.708 -1.139 . . . . 0.0 112.24 -179.848 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.858 0 C5'-C4'-C3' 110.239 -3.507 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.954 0 O4'-C1'-N19 111.191 2.991 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 2 O4'-C1'-N19 112.55 4.35 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . 0.425 ' N1 ' ' CE1' ' A' ' 74' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.08 2 C3'-C2'-C1' 105.4 4.333 . 0.558 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.67 2 O4'-C1'-N19 112.66 4.46 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.502 ' HG3' ' H ' ' A' ' 3' ' ' SER . 17.3 tpt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.89 -2.43 57.47 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.783 -0.454 . . . . 0.0 113.332 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.502 ' H ' ' HG3' ' A' ' 1' ' ' MET . 44.6 t -155.18 161.59 41.17 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.933 0.866 . . . . 0.0 110.311 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 t -154.75 150.66 27.81 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.056 0.542 . . . . 0.0 109.938 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.8 t60 60.01 165.64 0.07 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.903 1.281 . . . . 0.0 112.63 -174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -80.53 149.51 29.95 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.776 -0.577 . . . . 0.0 111.395 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -150.67 165.95 31.85 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 124.099 0.96 . . . . 0.0 110.039 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -72.38 9.14 1.1 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.197 0.599 . . . . 0.0 112.006 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -144.57 5.12 1.2 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.626 0.77 . . . . 0.0 111.822 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -71.26 156.39 39.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.203 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.5 t -156.86 157.34 34.73 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.969 0.508 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.4 t -68.98 157.52 36.58 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.66 0.384 . . . . 0.0 111.441 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.13 -13.31 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 tp -71.13 145.46 49.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.545 0.673 . . . . 0.0 110.131 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 17' ' ' ARG . 11.4 t -66.68 131.35 94.04 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 122.443 0.297 . . . . 0.0 111.12 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.18 -13.24 28.37 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.128 2.552 . . . . 0.0 112.472 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.455 ' H ' HG12 ' A' ' 15' ' ' VAL . 2.0 tmm_? -71.58 136.36 47.4 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.745 0.418 . . . . 0.0 110.694 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.43 168.2 31.07 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.1 t -160.43 165.09 31.69 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.053 0.541 . . . . 0.0 110.371 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -73.82 -6.04 44.62 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.195 0.598 . . . . 0.0 111.533 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.5 mtt -69.6 167.04 17.72 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.271 0.629 . . . . 0.0 111.822 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -67.62 152.6 45.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.591 178.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.72 158.14 16.94 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 122.905 0.482 . . . . 0.0 110.52 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -141.16 151.03 43.52 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.116 0.566 . . . . 0.0 110.736 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.42 -155.2 31.47 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.41 176.7 6.17 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.949 3.099 . . . . 0.0 110.962 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -60.95 137.01 58.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.891 -0.505 . . . . 0.0 111.504 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.05 -2.87 73.61 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.637 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.13 39.24 1.04 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.419 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.65 139.42 29.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.765 -0.584 . . . . 0.0 111.552 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -128.31 155.03 45.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.757 0.789 . . . . 0.0 112.934 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 14.2 m-85 -112.27 149.15 32.75 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.746 1.618 . . . . 0.0 114.355 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -139.01 136.23 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 6.6 m-85 -142.4 177.64 8.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 12.7 m170 62.73 16.9 9.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.611 1.564 . . . . 0.0 112.639 -176.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.46 145.04 98.26 Favored Pre-proline 0 CA--C 1.53 0.191 0 O-C-N 122.079 -0.388 . . . . 0.0 110.047 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.34 164.9 34.25 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.842 2.361 . . . . 0.0 109.507 172.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.91 -14.79 62.89 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.25 -8.84 57.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.55 158.23 36.58 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.75 35.29 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.8 -36.9 75.22 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.506 0.653 . . . . 0.0 110.442 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -78.67 -32.62 47.24 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.398 0.279 . . . . 0.0 110.869 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -75.0 -38.8 61.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.1 tt -74.61 -25.8 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.39 -49.89 61.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -64.7 -23.84 67.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.745 0.418 . . . . 0.0 111.558 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.6 tpt -79.89 -25.61 40.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.511 -0.118 . . . . 0.0 110.767 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.293 31.3 m-85 -105.92 -7.76 18.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 118.178 2.658 . . . . 0.0 118.178 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 50.1 mtm -66.49 -30.83 3.72 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.5 Cg_endo -72.82 -10.99 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 CA-C-N 121.943 1.73 . . . . 0.0 111.842 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -82.48 -19.96 37.79 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.76 -167.96 31.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -78.2 99.59 6.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.466 -0.432 . . . . 0.0 110.527 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -87.48 130.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 174.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -90.68 -27.81 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 122.592 0.357 . . . . 0.0 110.76 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 t -155.9 150.8 26.33 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.633 0.373 . . . . 0.0 110.334 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.46 147.03 27.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.377 0.671 . . . . 0.0 109.387 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -157.38 137.88 12.97 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.682 0.393 . . . . 0.0 111.445 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -111.93 136.41 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.466 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 49.5 m-85 -78.92 147.33 33.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -173.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -132.58 144.97 35.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.063 0.545 . . . . 0.0 110.305 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -90.34 133.16 35.16 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -76.98 -12.56 59.96 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.784 0.434 . . . . 0.0 111.865 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -88.95 -23.92 22.56 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.12 -13.48 2.11 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.0 t30 63.68 8.34 3.66 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.12 161.08 22.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.911 0.484 . . . . 0.0 110.038 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -70.52 140.91 51.94 Favored 'General case' 0 CA--C 1.523 -0.062 0 CA-C-O 120.753 0.311 . . . . 0.0 111.052 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -82.59 6.04 18.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m 61.49 22.51 12.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.404 ' CZ ' ' CD2' ' A' ' 61' ' ' PHE . 3.1 p90 -154.62 169.11 24.64 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.01 -172.28 28.12 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 121.566 0.537 . . . . 0.0 113.185 -174.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.82 143.01 31.96 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.806 1.642 . . . . 0.0 114.713 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -145.99 153.57 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 109.527 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.2 t -143.01 145.13 32.63 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -109.34 164.04 12.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -78.36 -13.21 59.95 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 112.278 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.02 148.11 18.23 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 123.246 0.618 . . . . 0.0 111.17 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.69 -18.54 32.56 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.468 2.779 . . . . 0.0 112.06 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.27 -43.03 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 118.34 0.518 . . . . 0.0 110.705 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.1 t -70.68 -32.78 70.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.04 74.67 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -67.88 -28.09 67.22 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.901 -0.5 . . . . 0.0 110.962 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.92 -43.05 72.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.44 -26.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.3 mt -67.73 -51.51 49.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -67.84 -11.22 58.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.86 -0.154 . . . . 0.0 111.284 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.89 -31.33 16.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 49.4 mtp -125.41 -12.2 6.78 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.98 125.86 25.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.87 6.54 89.36 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.228 -0.762 . . . . 0.0 113.008 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 120.42 11.62 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.693 1.247 . . . . 0.0 111.483 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -76.39 129.63 36.86 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 tt -144.87 120.72 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.27 -140.64 46.6 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.0 mmt -88.52 12.96 13.06 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -146.5 162.59 37.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.848 0.749 . . . . 0.0 111.049 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -105.76 141.27 37.47 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 122.545 0.338 . . . . 0.0 110.946 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 91.5 mt -66.65 133.76 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.749 0.419 . . . . 0.0 111.195 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -92.0 137.89 31.99 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.3 t -134.97 137.13 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -151.4 161.3 42.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.4 OUTLIER -75.77 153.83 36.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.469 0.708 . . . . 0.0 110.409 177.287 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.504 ' H ' HD23 ' A' ' 104' ' ' LEU . 87.1 tttt -68.33 158.0 34.43 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.222 0.609 . . . . 0.0 109.834 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -146.45 160.39 42.15 Favored 'General case' 0 CA--C 1.526 0.04 0 C-N-CA 123.314 0.646 . . . . 0.0 110.541 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.0 t -62.31 154.51 27.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 122.863 0.465 . . . . 0.0 111.117 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -71.65 -6.31 40.06 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.465 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -67.07 -15.36 63.67 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.224 -0.298 . . . . 0.0 110.417 175.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -93.55 -10.97 32.98 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.8 t -80.8 -11.82 59.54 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 122.952 0.501 . . . . 0.0 111.14 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -62.75 153.67 78.03 Favored Pre-proline 0 CA--C 1.534 0.342 0 O-C-N 122.18 -0.325 . . . . 0.0 110.548 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.08 -15.63 23.11 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.706 2.937 . . . . 0.0 111.779 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 117.4 -1.286 . . . . 0.0 112.391 -179.134 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 C5'-C4'-C3' 110.327 -3.449 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.091 0 O4'-C1'-N19 111.07 2.87 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . 0.401 " H4'" " H5'" ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.39 1 O4'-C1'-N19 112.654 4.454 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . 0.401 " H5'" " H4'" ' B' ' 117' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.793 2 C3'-C2'-C1' 105.782 4.758 . 0.251 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . 0.466 " H1'" ' CD1' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.928 2 C5'-C4'-C3' 108.696 -4.536 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.758 -0.09 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.51 -5.62 89.76 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.9 p -69.97 160.37 32.03 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 117.651 0.725 . . . . 0.0 111.091 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.6 p -155.99 167.4 30.54 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.737 0.415 . . . . 0.0 110.225 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -153.25 164.42 38.13 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.098 0.559 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -85.63 -4.08 59.06 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.312 0.645 . . . . 0.0 112.476 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -75.66 152.9 37.49 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.988 0.358 . . . . 0.0 111.506 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -148.42 155.52 41.32 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.663 0.785 . . . . 0.0 110.541 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -150.04 -4.15 0.36 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.851 0.461 . . . . 0.0 111.416 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -74.5 166.88 22.79 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.169 0.588 . . . . 0.0 111.087 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.5 t -156.23 159.93 39.35 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 123.104 0.562 . . . . 0.0 109.782 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.7 t -69.45 140.75 54.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.235 -0.29 . . . . 0.0 110.806 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.48 4.77 58.21 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.745 -0.475 . . . . 0.0 112.983 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.8 tp -72.13 -21.36 61.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.132 0.966 . . . . 0.0 111.499 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 17' ' ' ARG . 11.8 t -69.31 136.63 88.86 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 123.22 0.608 . . . . 0.0 111.377 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 51.3 Cg_exo -58.45 -13.43 16.87 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.855 3.037 . . . . 0.0 114.1 176.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HD2' ' H ' ' A' ' 18' ' ' GLY . 16.8 tpt180 -67.31 150.56 48.85 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.176 0.591 . . . . 0.0 111.25 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.443 ' H ' ' HD2' ' A' ' 17' ' ' ARG . . . -156.76 173.41 34.46 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.5 p -158.13 159.78 36.57 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.131 0.572 . . . . 0.0 110.356 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -80.38 -26.86 38.36 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.47 0.308 . . . . 0.0 111.705 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.8 mtm 55.25 -178.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.242 1.017 . . . . 0.0 113.227 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -136.16 152.27 50.63 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.312 0.645 . . . . 0.0 110.35 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -132.34 159.58 38.79 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.86 0.864 . . . . 0.0 110.15 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -124.27 164.37 19.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 -151.2 25.12 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.79 169.43 17.65 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.808 3.005 . . . . 0.0 110.232 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.83 137.96 58.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.946 -0.471 . . . . 0.0 110.71 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.77 -6.96 79.15 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.156 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.42 39.9 1.06 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.602 0.701 . . . . 0.0 110.418 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.36 28.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.004 -0.435 . . . . 0.0 111.131 -175.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -126.05 158.4 35.49 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 18.5 m-85 -117.59 139.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.94 1.696 . . . . 0.0 113.71 171.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.72 139.66 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 72' ' ' PHE . 9.8 m-85 -141.7 175.13 9.95 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -176.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 m170 65.42 16.3 10.46 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 113.001 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.16 140.93 93.51 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 122.82 0.448 . . . . 0.0 109.919 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.18 162.88 40.41 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.915 2.41 . . . . 0.0 109.552 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -71.44 -7.19 45.81 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.23 -9.42 58.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 122.055 -0.403 . . . . 0.0 111.054 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -74.06 158.36 34.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.26 173.94 35.44 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -57.16 -39.49 75.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -75.79 -29.24 58.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.097 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.41 -39.61 46.45 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 tt -73.6 -24.65 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.17 -52.0 57.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.65 -23.62 67.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.613 0.365 . . . . 0.0 111.518 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 tpp -75.7 -28.09 58.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.15 0.18 . . . . 0.0 110.672 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.276 22.6 m-85 -104.12 -11.69 17.17 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 117.878 2.547 . . . . 0.0 117.878 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 57.6 mtm -66.8 -31.3 3.92 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.8 Cg_endo -73.01 -10.0 24.15 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.068 1.774 . . . . 0.0 111.881 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.28 -13.81 45.57 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.09 -173.57 32.66 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -75.94 101.32 5.15 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.333 -0.51 . . . . 0.0 110.223 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -79.07 127.75 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.8 mt -83.84 -32.95 8.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.416 0.287 . . . . 0.0 110.379 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -164.9 159.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.94 24.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.423 0.689 . . . . 0.0 109.893 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 4.9 tmmm? -158.7 145.72 17.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.707 0.403 . . . . 0.0 111.172 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.93 138.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 76.5 m-85 -73.27 144.72 46.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.23 144.33 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.204 0.601 . . . . 0.0 110.197 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.96 130.3 34.99 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -76.09 -12.79 60.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.08 -0.387 . . . . 0.0 111.672 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -89.17 -23.71 22.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -133.17 -12.55 2.81 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.5 7.92 2.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.684 1.194 . . . . 0.0 112.021 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.24 160.45 22.98 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.3 t -70.57 141.37 51.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.792 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -78.32 6.94 7.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.64 0.376 . . . . 0.0 111.352 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.9 m 63.21 24.77 14.51 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 34' ' ' TYR . 4.8 p90 -157.44 167.68 29.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.28 -173.41 24.8 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 121.531 0.517 . . . . 0.0 113.697 -173.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -139.72 142.68 36.83 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.371 1.868 . . . . 0.0 114.971 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -146.77 152.74 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.878 0.871 . . . . 0.0 109.689 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -141.23 149.45 41.37 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.179 0.445 . . . . 0.0 112.163 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.03 162.42 16.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -76.88 -12.56 59.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.537 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.06 150.8 23.27 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 123.298 0.639 . . . . 0.0 111.176 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.67 -18.61 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.964 2.443 . . . . 0.0 111.73 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.37 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 CA-C-N 118.214 0.461 . . . . 0.0 111.095 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -71.02 -26.39 63.09 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.858 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.87 -47.28 53.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -65.91 -30.53 71.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.13 0.423 . . . . 0.0 110.968 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.69 -42.37 82.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.04 -27.68 67.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.9 mt -66.1 -51.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.63 -12.22 61.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.04 21.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.4 ttm -120.63 -21.77 6.61 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.79 124.35 18.88 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.01 84.97 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.183 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -64.93 118.2 8.71 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.043 1.421 . . . . 0.0 110.501 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -77.35 129.69 36.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 110.353 -176.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 tt -150.44 136.09 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.39 -112.52 4.96 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.05 14.98 8.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.0 112.728 -178.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -144.38 172.66 12.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.124 0.97 . . . . 0.0 111.135 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -107.48 139.67 41.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.06 125.08 24.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.73 0.3 . . . . 0.0 110.979 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -87.26 142.82 27.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.0 t -134.95 140.19 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.673 0.389 . . . . 0.0 109.967 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -149.07 152.05 35.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.98 0.354 . . . . 0.0 110.974 -175.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -71.92 148.49 45.99 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.214 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.432 ' H ' HD23 ' A' ' 104' ' ' LEU . 86.8 tttt -66.1 162.05 20.46 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.309 0.644 . . . . 0.0 109.392 173.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -59.24 157.06 11.28 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.7 p -151.74 166.0 32.69 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 122.47 0.308 . . . . 0.0 110.763 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.56 -17.48 63.98 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.492 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -69.34 -24.98 63.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.582 0.353 . . . . 0.0 110.124 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -97.55 -6.91 32.51 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -75.82 -30.88 59.16 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.192 0.197 . . . . 0.0 110.88 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -81.59 151.43 68.38 Favored Pre-proline 0 CA--C 1.529 0.173 0 C-N-CA 123.053 0.541 . . . . 0.0 110.513 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.69 -16.31 16.66 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.722 2.948 . . . . 0.0 111.795 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 92.8 m95 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 117.52 -1.228 . . . . 0.0 111.795 -178.349 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . 0.535 ' C6 ' H5'' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 C5'-C4'-C3' 109.824 -3.784 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.173 0 O4'-C1'-N19 110.319 2.119 . 0.033 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.924 0 C5'-C4'-C3' 110.545 -3.303 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.889 1 C5'-C4'-C3' 106.893 -5.738 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.674 1 C5'-C4'-C3' 108.83 -4.447 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.718 -0.105 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.49 165.77 54.52 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -77.12 -17.3 58.74 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.78 -0.247 . . . . 0.0 111.368 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.3 p -71.56 160.14 33.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.173 0.511 . . . . 0.0 111.35 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -69.28 154.08 42.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.221 0.609 . . . . 0.0 110.964 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.24 -5.78 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.917 0.487 . . . . 0.0 111.668 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -74.56 -5.42 42.77 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.7 0.4 . . . . 0.0 111.866 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -75.28 -16.7 60.42 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.473 0.309 . . . . 0.0 111.587 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.68 158.47 32.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.058 0.39 . . . . 0.0 111.274 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -154.01 155.34 35.37 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.096 0.558 . . . . 0.0 109.712 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -71.25 -5.01 28.9 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t 56.66 23.09 7.41 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.002 0.921 . . . . 0.0 112.266 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.38 169.3 54.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.2 tp -154.67 147.06 23.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.951 0.501 . . . . 0.0 110.015 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 17' ' ' ARG . 6.9 p -153.16 134.84 8.68 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 122.914 0.486 . . . . 0.0 111.223 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.03 -9.79 22.39 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.199 2.599 . . . . 0.0 112.338 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.474 ' H ' HG22 ' A' ' 15' ' ' VAL . 1.1 tmt_? 51.56 77.41 0.14 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.709 1.204 . . . . 0.0 110.508 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.38 161.26 38.72 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.249 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 t -160.65 -179.49 7.66 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.535 0.734 . . . . 0.0 109.81 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -75.57 24.02 0.12 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.031 0.932 . . . . 0.0 112.562 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.0 mtm -65.49 -25.52 67.52 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 121.875 -0.515 . . . . 0.0 111.88 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -85.66 130.52 34.55 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -86.2 158.47 19.73 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.686 0.395 . . . . 0.0 111.192 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -135.84 155.62 50.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.67 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.996 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.73 176.38 6.04 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.58 3.52 . . . . 0.0 110.476 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.6 134.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.991 -0.443 . . . . 0.0 111.147 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.04 0.12 84.8 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.628 -0.54 . . . . 0.0 112.857 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 -0.38 57.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 117.887 0.843 . . . . 0.0 112.193 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -107.72 145.81 32.96 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.6 mt -131.28 149.07 52.71 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 105' ' ' LYS . 21.9 m-85 -97.82 142.35 29.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.927 1.691 . . . . 0.0 112.866 168.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.11 130.04 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -134.41 179.73 6.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 15.2 m170 64.37 15.55 9.57 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.82 1.648 . . . . 0.0 113.03 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.39 139.51 86.94 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.32 165.05 32.73 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.609 2.873 . . . . 0.0 109.991 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -72.57 -7.14 48.63 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -75.99 -9.78 58.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.138 0.427 . . . . 0.0 110.743 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -75.98 158.12 32.31 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.72 175.73 34.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -56.87 -41.64 78.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -80.82 -26.6 36.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.591 0.234 . . . . 0.0 110.966 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 75.4 m-20 -74.08 -38.47 63.91 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.5 tt -74.69 -25.49 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.5 tp -65.98 -52.19 51.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -64.65 -23.54 67.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.637 0.375 . . . . 0.0 111.595 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.4 tpp -76.58 -27.93 56.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.132 0.173 . . . . 0.0 110.753 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.268 22.0 m-85 -104.68 -11.72 16.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.6 mtm -66.08 -31.7 4.86 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 50' ' ' MET . 86.1 Cg_endo -72.46 -9.43 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.881 1.707 . . . . 0.0 111.733 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.81 -14.97 43.48 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.726 0.411 . . . . 0.0 111.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.48 -171.2 32.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.6 102.9 6.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.663 -0.316 . . . . 0.0 110.344 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -79.13 129.25 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mt -87.39 -33.82 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 122.301 0.241 . . . . 0.0 110.703 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.4 t -157.85 155.48 29.75 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.695 0.398 . . . . 0.0 110.239 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.34 138.26 17.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.339 0.656 . . . . 0.0 109.408 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.539 ' HE3' ' CE2' ' A' ' 61' ' ' PHE . 5.4 tmmm? -159.93 143.29 14.07 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.739 0.416 . . . . 0.0 111.081 -176.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.8 140.01 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.539 ' CE2' ' HE3' ' A' ' 59' ' ' LYS . 78.8 m-85 -72.41 149.43 44.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.44 143.7 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.797 0.839 . . . . 0.0 109.112 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -82.48 128.36 34.19 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.87 -11.15 59.92 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.297 -0.252 . . . . 0.0 111.478 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.23 -22.17 19.18 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -136.44 -10.79 1.89 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 61.68 9.6 2.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.375 1.07 . . . . 0.0 112.984 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.4 153.47 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.161 -0.337 . . . . 0.0 110.153 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.6 t -70.3 137.29 50.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.569 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -83.05 167.5 17.82 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.147 0.499 . . . . 0.0 110.668 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.15 18.18 1.79 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.23 170.39 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.57 -168.68 21.08 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.602 0.62 . . . . 0.0 112.979 -173.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -143.96 142.03 30.51 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -146.02 153.03 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.122 0.969 . . . . 0.0 109.531 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.9 p -142.1 150.85 41.71 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.768 0.427 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -117.53 162.02 18.67 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -77.25 -15.43 59.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.77 150.9 25.57 Favored Pre-proline 0 N--CA 1.451 -0.389 0 C-N-CA 123.193 0.597 . . . . 0.0 110.848 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.93 -23.22 34.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.015 2.477 . . . . 0.0 112.177 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.64 -38.29 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.444 0.565 . . . . 0.0 111.548 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -76.21 -26.59 56.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.318 -0.239 . . . . 0.0 110.876 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.86 -47.43 30.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -68.24 -26.97 65.96 Favored 'General case' 0 C--O 1.231 0.112 0 O-C-N 122.243 -0.286 . . . . 0.0 110.258 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.02 73.93 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -27.78 68.21 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 119.383 -0.342 . . . . 0.0 111.84 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.3 mt -64.69 -52.21 57.51 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.23 -11.53 57.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.805 -0.14 . . . . 0.0 111.186 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.07 -29.22 15.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.0 mmm -120.71 -18.27 7.75 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.17 134.86 53.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.98 2.38 77.4 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.505 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.42 117.9 7.96 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.553 1.176 . . . . 0.0 110.742 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -74.41 129.65 38.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.487 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.9 tt -146.76 124.27 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.71 -145.36 49.83 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -173.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.27 9.85 11.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.578 0.751 . . . . 0.0 112.698 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -139.38 178.97 6.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.672 0.669 . . . . 0.0 111.514 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -118.79 145.08 45.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.596 0.758 . . . . 0.0 109.966 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 88.5 mt -67.07 133.87 50.74 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 122.496 0.318 . . . . 0.0 110.966 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.48 133.1 41.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -135.22 140.05 45.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -153.16 159.44 42.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.547 0.339 . . . . 0.0 110.695 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.31 130.06 41.93 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.267 0.627 . . . . 0.0 109.98 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.41 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . 59.6 tttp -87.1 124.36 33.16 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.04 0.536 . . . . 0.0 112.086 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -76.27 159.56 30.48 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.434 0.694 . . . . 0.0 110.766 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.2 t -73.77 156.15 38.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.751 0.42 . . . . 0.0 110.964 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.605 ' HA ' ' HE2' ' A' ' 108' ' ' LYS . 9.1 mmpt? -72.79 -1.54 16.99 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.025 0.53 . . . . 0.0 111.997 176.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -66.39 -20.08 65.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -80.66 -19.46 45.21 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.1 m -85.37 -6.09 59.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.844 0.458 . . . . 0.0 111.671 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -68.77 155.48 93.09 Favored Pre-proline 0 N--CA 1.457 -0.106 0 C-N-CA 122.828 0.451 . . . . 0.0 111.785 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.35 -15.63 15.78 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.731 2.954 . . . . 0.0 111.241 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.3 p90 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.734 -1.603 . . . . 0.0 112.638 -177.787 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.024 1 C5'-C4'-C3' 109.413 -4.058 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.225 0 O4'-C1'-N19 110.434 2.234 . 0.078 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.921 1 C3'-C2'-C1' 105.271 4.19 . 0.115 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . 0.467 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.796 2 O4'-C1'-N19 113.319 5.119 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 1 C5'-C4'-C3' 109.014 -4.324 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 120.404 0.145 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.32 -7.03 87.97 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.678 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.7 p 52.53 21.49 1.82 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.229 1.412 . . . . 0.0 113.333 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.0 m -64.86 154.86 35.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.885 0.474 . . . . 0.0 111.105 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -154.49 -6.01 0.15 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.735 0.414 . . . . 0.0 111.236 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -81.6 -10.29 59.47 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.092 0.557 . . . . 0.0 111.65 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -74.65 157.19 35.77 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.895 0.379 . . . . 0.0 110.739 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -72.27 160.13 32.9 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.857 0.463 . . . . 0.0 110.721 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -150.57 1.72 0.45 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.427 0.291 . . . . 0.0 111.77 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -70.01 -7.77 43.69 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.138 0.426 . . . . 0.0 111.688 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.3 t -73.31 -20.15 60.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.597 0.359 . . . . 0.0 110.858 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -76.74 140.7 40.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.72 0.408 . . . . 0.0 110.416 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.56 -168.11 39.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.62 140.25 56.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p -64.54 132.1 95.29 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -68.04 -12.76 36.24 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.2 2.6 . . . . 0.0 112.095 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -23.49 62.64 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.523 0.329 . . . . 0.0 110.598 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.18 -61.85 0.93 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 m -158.48 154.22 26.43 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 123.572 0.749 . . . . 0.0 110.836 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -96.11 -12.32 24.97 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.58 0.352 . . . . 0.0 111.348 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -75.13 162.72 28.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.26 0.624 . . . . 0.0 111.103 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.475 ' NE2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -65.19 151.3 46.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.882 0.473 . . . . 0.0 110.89 178.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -150.44 142.9 24.39 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.635 0.774 . . . . 0.0 108.927 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -101.09 152.72 20.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.078 0.551 . . . . 0.0 111.632 -171.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.45 -164.41 30.71 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.04 170.44 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.488 2.792 . . . . 0.0 110.254 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -64.32 138.76 58.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.961 -0.462 . . . . 0.0 110.017 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.62 -1.67 87.18 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.541 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -105.95 13.2 29.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.717 0.758 . . . . 0.0 112.327 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -113.9 138.81 49.81 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.696 0.398 . . . . 0.0 110.186 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.8 mt -123.6 156.59 35.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 122.076 0.941 . . . . 0.0 113.115 -174.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -117.21 143.17 46.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.973 1.709 . . . . 0.0 114.016 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 HD21 ' A' ' 36' ' ' LEU . 3.0 mp -137.64 128.36 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.73 171.17 14.22 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.413 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 18.3 m170 74.15 20.67 2.67 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.209 1.803 . . . . 0.0 112.77 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.617 HD23 ' HA ' ' A' ' 72' ' ' PHE . 2.7 mm? -70.4 142.8 89.75 Favored Pre-proline 0 N--CA 1.454 -0.235 0 C-N-CA 123.166 0.586 . . . . 0.0 109.957 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.45 162.78 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.586 2.858 . . . . 0.0 108.991 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.82 -8.05 54.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -76.88 -9.94 59.03 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.266 0.484 . . . . 0.0 110.789 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.479 ' CD1' HD12 ' A' ' 36' ' ' LEU . 5.5 m-85 -75.67 158.44 32.35 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.82 174.92 33.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 8.5 p30 -60.8 -35.58 76.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -74.36 -29.19 61.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.18 0.592 . . . . 0.0 111.213 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -79.05 -42.08 27.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -70.81 -23.06 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.2 -49.61 75.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -65.31 -23.67 67.08 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.601 0.361 . . . . 0.0 111.641 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.3 mmm -77.15 -22.44 52.54 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.638 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.262 28.1 m-85 -110.1 -10.57 14.67 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 118.093 2.627 . . . . 0.0 118.093 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.437 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 52.1 mtm -66.21 -32.64 5.74 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 50' ' ' MET . 91.8 Cg_endo -74.4 -8.19 20.45 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 121.715 1.648 . . . . 0.0 112.055 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -86.79 -15.58 38.86 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.97 -172.35 33.3 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -75.93 103.09 5.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.208 -0.583 . . . . 0.0 110.516 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 122.56 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.5 mt -81.64 -30.83 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.05 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.8 t -158.72 154.58 26.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.055 0.455 . . . . 0.0 111.102 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.52 146.33 31.39 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.964 0.906 . . . . 0.0 108.603 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 42' ' ' ASP . 14.3 tppt? -157.96 145.35 18.25 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -121.73 132.83 69.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -69.71 155.07 41.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -134.08 143.76 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.949 0.5 . . . . 0.0 109.845 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -88.08 132.18 34.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -77.72 -13.06 60.01 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.839 0.456 . . . . 0.0 111.408 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -91.13 -22.27 20.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.276 0.63 . . . . 0.0 112.677 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.7 -12.85 2.0 Allowed 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -174.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 60.52 8.72 1.78 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.647 1.179 . . . . 0.0 112.911 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.46 156.65 30.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.966 0.348 . . . . 0.0 110.739 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.9 t -71.31 135.27 47.31 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.907 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.89 162.75 26.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.084 0.553 . . . . 0.0 110.822 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -81.28 11.0 4.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.617 ' HA ' HD23 ' A' ' 36' ' ' LEU . 4.6 p90 -157.79 172.94 17.58 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.43 -163.86 16.11 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.778 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.26 147.6 35.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.869 1.667 . . . . 0.0 115.404 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.6 t -146.2 152.14 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 t -141.2 143.9 34.46 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.25 159.17 19.61 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -76.23 -11.92 60.0 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.153 0.501 . . . . 0.0 111.847 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.86 149.7 21.43 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 123.168 0.587 . . . . 0.0 110.886 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.08 -18.23 35.63 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.344 2.696 . . . . 0.0 112.214 -177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.41 -46.27 95.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 118.297 0.499 . . . . 0.0 110.758 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.6 m -70.87 -24.04 62.42 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.186 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.6 -48.07 35.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.911 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -67.58 -28.99 68.23 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.045 0.384 . . . . 0.0 110.852 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.64 80.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.36 66.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.871 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.6 mt -65.85 -51.15 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 118.796 0.726 . . . . 0.0 109.173 174.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -68.23 -11.07 58.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.419 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.91 -26.77 16.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 89.2 mmm -120.65 -14.71 8.56 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.07 132.65 48.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.62 4.06 87.35 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.774 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -63.23 117.64 6.85 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.578 1.189 . . . . 0.0 109.977 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -77.37 130.93 37.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.115 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.97 134.25 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.45 -108.31 1.89 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 65.2 mtt -130.57 17.76 5.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.561 0.745 . . . . 0.0 111.516 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 55.3 tttp -146.59 155.84 42.78 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.69 0.396 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -98.12 140.64 32.14 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.699 -0.626 . . . . 0.0 111.196 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.02 131.58 46.15 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.713 0.405 . . . . 0.0 111.287 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.517 ' HE3' ' C4 ' ' B' ' 116' ' ' ' U' . 18.2 ttmm -92.8 139.12 30.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 172.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.0 t -134.83 141.01 44.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-N 118.047 0.385 . . . . 0.0 110.376 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -155.03 163.53 40.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.917 0.326 . . . . 0.0 111.785 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.44 148.66 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.562 0.745 . . . . 0.0 110.259 175.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -68.36 155.37 39.93 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -59.56 138.39 57.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.017 0.371 . . . . 0.0 111.375 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -74.13 166.58 23.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.724 0.81 . . . . 0.0 109.739 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.74 -19.94 66.07 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.874 -0.516 . . . . 0.0 111.239 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -77.29 -29.06 53.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -103.74 0.17 30.16 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.3 p -68.72 -20.64 64.41 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.148 0.579 . . . . 0.0 111.271 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -138.12 152.99 72.9 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 123.791 0.836 . . . . 0.0 110.732 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.08 -13.97 21.1 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.558 2.839 . . . . 0.0 111.16 177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.1 m95 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.528 -1.225 . . . . 0.0 112.138 179.747 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 C5'-C4'-C3' 109.981 -3.679 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . 0.517 ' C4 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.758 1 C5'-C4'-C3' 108.258 -4.828 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.123 0 C5'-C4'-C3' 109.639 -3.907 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.69 2 C3'-C2'-C1' 105.624 4.582 . 0.305 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 2 C5'-C4'-C3' 109.31 -4.127 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 120.443 0.163 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.25 178.74 48.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.6 t -156.11 160.75 40.21 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.316 0.646 . . . . 0.0 110.15 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.7 t -67.23 152.65 45.35 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.928 0.491 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -155.55 150.6 26.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.968 0.507 . . . . 0.0 110.184 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -154.86 161.64 41.38 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.114 0.566 . . . . 0.0 110.251 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -155.37 165.68 35.88 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 123.053 0.541 . . . . 0.0 110.345 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -151.68 -12.12 0.2 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.392 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -76.02 159.06 31.2 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.974 0.51 . . . . 0.0 110.764 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -73.46 164.11 27.11 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.084 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 t -66.18 152.64 44.37 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.192 0.597 . . . . 0.0 111.141 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.7 t -69.27 -14.31 62.88 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.774 0.429 . . . . 0.0 110.778 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.1 -1.68 80.62 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.973 -0.348 . . . . 0.0 112.232 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.4 tp -63.88 143.94 57.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.834 0.817 . . . . 0.0 110.823 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -152.21 139.13 12.36 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.449 0.699 . . . . 0.0 110.599 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.74 146.71 73.68 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.915 2.41 . . . . 0.0 111.319 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 73.5 mmt-85 -146.82 151.21 36.75 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.364 1.065 . . . . 0.0 110.596 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.43 -21.03 3.07 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.436 1.017 . . . . 0.0 111.892 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 94.7 p -167.3 165.21 15.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.862 0.865 . . . . 0.0 109.487 177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -77.87 -17.2 57.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.156 0.183 . . . . 0.0 110.941 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.2 ptp 44.35 32.91 0.77 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 125.911 1.684 . . . . 0.0 114.108 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.429 ' H ' ' CD ' ' A' ' 22' ' ' GLN . 2.8 pm0 -52.41 142.9 16.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.053 0.941 . . . . 0.0 110.859 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -84.99 159.93 20.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.435 0.694 . . . . 0.0 110.385 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -138.08 149.59 46.12 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.581 0.353 . . . . 0.0 110.677 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.77 41.44 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 177.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.3 167.2 24.51 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.409 2.739 . . . . 0.0 109.881 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.42 136.51 57.94 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.09 -0.381 . . . . 0.0 110.091 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 -10.56 73.99 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.132 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.33 6.67 48.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.031 0.532 . . . . 0.0 111.133 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.11 145.51 24.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.92 151.85 49.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.017 0.913 . . . . 0.0 113.097 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.74 145.12 45.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.542 1.937 . . . . 0.0 114.553 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.73 136.7 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.11 178.44 7.17 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.461 ' CE1' ' HE3' ' A' ' 98' ' ' LYS . 21.2 m170 63.88 15.92 9.46 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.31 1.444 . . . . 0.0 112.798 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.43 142.79 94.79 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 117.902 0.319 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.66 166.69 28.68 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.907 2.405 . . . . 0.0 109.566 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -71.2 -14.24 62.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.34 -10.02 59.08 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.84 158.14 36.89 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 175.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.22 177.7 34.8 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -57.32 -40.67 78.41 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -84.95 -26.26 27.29 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.378 -0.201 . . . . 0.0 111.055 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -74.18 -38.28 63.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 tt -75.41 -26.34 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.57 -53.35 53.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -64.23 -23.05 67.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.821 0.448 . . . . 0.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.6 tpt -79.05 -25.09 43.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 122.267 -0.271 . . . . 0.0 110.506 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.266 29.0 m-85 -105.83 -10.96 16.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 -178.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.466 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 53.8 mtm -66.63 -29.56 2.85 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 50' ' ' MET . 92.2 Cg_endo -72.47 -8.42 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 CA-C-N 121.951 1.733 . . . . 0.0 112.167 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -89.42 -12.07 41.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.959 0.504 . . . . 0.0 111.208 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.49 -176.17 31.6 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -77.96 101.67 6.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.236 -0.567 . . . . 0.0 110.506 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.02 123.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -85.22 -30.84 6.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.9 t -152.85 151.69 30.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 110.661 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.41 136.32 13.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.87 0.868 . . . . 0.0 108.865 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -158.5 131.05 7.02 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.511 0.196 . . . . 0.0 110.583 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -95.68 134.36 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -69.53 144.64 53.08 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mm -133.19 144.55 36.0 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 123.168 0.587 . . . . 0.0 109.979 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -88.89 130.69 35.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.454 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -75.54 -11.46 60.03 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.994 -0.441 . . . . 0.0 111.251 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -89.84 -21.86 22.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -135.8 -13.72 1.92 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 61.2 9.12 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.338 1.055 . . . . 0.0 112.954 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -82.25 160.01 23.07 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.709 0.404 . . . . 0.0 109.996 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.2 t -69.51 139.99 53.89 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.341 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -82.53 6.4 17.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.7 m 60.87 22.64 12.72 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -155.59 168.41 27.23 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -161.24 -172.12 28.16 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.796 -0.565 . . . . 0.0 113.714 -173.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -136.75 144.38 43.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.151 1.78 . . . . 0.0 114.877 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.1 t -148.33 153.37 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 91.1 p -146.46 146.64 30.63 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.831 -0.543 . . . . 0.0 112.295 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.46 164.83 12.32 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.64 -11.15 59.96 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.54 149.92 23.71 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 122.984 0.514 . . . . 0.0 110.785 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.29 -18.1 39.4 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.099 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.61 -46.56 94.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 CA-C-N 118.466 0.576 . . . . 0.0 110.83 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -71.33 -25.36 62.37 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.518 0.327 . . . . 0.0 111.04 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.71 -47.69 52.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.045 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -68.49 -27.83 66.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.143 0.428 . . . . 0.0 110.711 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -40.66 81.45 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.02 66.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.678 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.4 mt -67.3 -52.23 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -68.51 -11.8 60.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.338 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.55 -27.7 17.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 89.0 mmm -120.4 -18.29 7.94 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -65.68 131.81 47.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.07 8.59 85.18 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 119.089 -0.839 . . . . 0.0 112.51 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -66.38 114.58 5.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.807 1.303 . . . . 0.0 109.103 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.4 129.1 37.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.436 0.562 . . . . 0.0 110.956 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 tt -145.14 122.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.18 -143.3 48.34 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 72.5 mtm -86.1 12.53 9.41 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE3' ' CE1' ' A' ' 35' ' ' HIS . 42.7 tttp -147.06 170.45 17.11 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.698 0.681 . . . . 0.0 110.356 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -111.99 140.7 46.44 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 122.937 0.495 . . . . 0.0 109.902 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.29 132.7 49.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.272 0.229 . . . . 0.0 111.233 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.491 ' HE3' ' C5 ' ' B' ' 116' ' ' ' U' . 19.1 ttmm -95.58 139.05 32.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 67.3 t -135.24 140.08 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.057 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -154.31 163.7 39.74 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -79.85 150.78 30.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.491 0.717 . . . . 0.0 110.629 175.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.444 ' H ' HD23 ' A' ' 104' ' ' LEU . 64.4 tttp -69.18 154.34 42.2 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.3 mmm-85 -62.78 155.83 25.59 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.718 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -154.06 166.2 33.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.314 0.646 . . . . 0.0 109.951 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -65.67 -11.19 42.89 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.979 -0.451 . . . . 0.0 110.644 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -84.55 -9.22 58.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.63 0.772 . . . . 0.0 112.634 177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -133.52 -9.99 2.83 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.8 t -70.03 -14.46 62.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.572 0.749 . . . . 0.0 111.521 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -65.81 153.89 90.15 Favored Pre-proline 0 C--N 1.34 0.172 0 C-N-CA 123.002 0.521 . . . . 0.0 111.096 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.9 5.19 5.86 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 124.367 3.378 . . . . 0.0 110.86 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.396 -177.154 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . 0.479 H5'' ' C6 ' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 O4'-C1'-N19 111.811 3.611 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . 0.491 ' C5 ' ' HE3' ' A' ' 101' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.035 0 O4'-C1'-N19 110.466 2.266 . 0.094 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.398 0 C3'-C2'-C1' 98.734 -3.073 . 0.072 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 2 O4'-C1'-N19 113.303 5.103 . 0.436 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 1 C5'-C4'-C3' 108.959 -4.361 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 tpp . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.321 0.105 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.48 -12.07 72.86 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.9 -0.389 . . . . 0.0 112.951 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -75.74 -5.64 46.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.68 0.74 . . . . 0.0 111.472 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.2 t 61.95 153.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.228 1.411 . . . . 0.0 113.548 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -82.17 43.78 0.82 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.731 0.812 . . . . 0.0 110.298 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 60.07 15.82 5.43 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 124.786 1.234 . . . . 0.0 113.325 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -83.09 -30.36 28.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.347 -0.221 . . . . 0.0 110.643 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -82.38 -26.97 32.39 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.377 0.271 . . . . 0.0 110.347 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -86.07 174.66 9.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.236 0.615 . . . . 0.0 110.805 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -63.86 153.48 36.64 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -61.41 -26.17 67.68 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.944 0.497 . . . . 0.0 112.144 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.8 p -66.29 -16.76 64.3 Favored 'General case' 0 C--O 1.231 0.106 0 O-C-N 122.049 -0.407 . . . . 0.0 111.435 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 -22.74 52.01 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.9 tp -83.55 -33.61 25.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.32 0.56 . . . . 0.0 110.11 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.1 132.54 5.24 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.969 0.508 . . . . 0.0 111.04 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.56 150.44 40.47 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.101 2.534 . . . . 0.0 110.558 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.84 171.95 18.54 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.318 0.647 . . . . 0.0 109.594 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.72 144.76 10.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 t 58.74 163.75 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.46 1.504 . . . . 0.0 114.005 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -88.46 -10.01 50.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.957 0.903 . . . . 0.0 111.792 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mtm -72.14 164.48 26.13 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.823 0.345 . . . . 0.0 111.385 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -71.35 152.07 43.53 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.553 0.741 . . . . 0.0 109.938 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -100.65 153.52 19.35 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.964 0.411 . . . . 0.0 111.378 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -115.84 151.53 35.08 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.184 0.594 . . . . 0.0 111.143 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.45 -179.07 46.7 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.69 -178.52 1.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.071 3.181 . . . . 0.0 110.376 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.61 131.14 49.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.117 -0.364 . . . . 0.0 111.019 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.04 1.79 85.9 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 119.526 -0.597 . . . . 0.0 113.189 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.88 7.41 44.93 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -109.67 139.11 45.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.327 0.512 . . . . 0.0 110.359 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.4 mt -126.15 159.37 33.1 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -117.36 141.8 47.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.967 1.707 . . . . 0.0 114.582 171.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.08 132.37 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -135.53 179.97 6.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.0 m170 65.15 23.39 12.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.149 1.379 . . . . 0.0 112.747 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.17 136.46 72.58 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 122.828 0.451 . . . . 0.0 110.326 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.78 168.86 23.44 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.537 2.825 . . . . 0.0 110.313 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -69.37 -11.32 60.71 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -80.02 -7.27 58.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -76.1 158.18 32.06 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.94 174.91 35.27 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.85 -36.03 73.91 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 117.202 0.501 . . . . 0.0 110.864 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -78.62 -33.97 46.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.29 0.236 . . . . 0.0 110.886 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -71.28 -39.29 71.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 tt -75.74 -26.74 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.446 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.4 tm? -65.16 -53.81 39.34 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.556 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 tpt -72.81 -26.65 61.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 25.0 m-85 -103.52 -9.27 19.44 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.457 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 44.7 mtm -66.78 -31.33 3.96 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 50' ' ' MET . 76.9 Cg_endo -71.53 -8.18 22.73 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 121.959 1.735 . . . . 0.0 111.667 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -89.07 -14.76 35.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.825 0.45 . . . . 0.0 110.885 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.88 -174.33 30.95 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -75.25 105.56 6.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.364 -0.492 . . . . 0.0 110.668 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.73 123.69 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.5 mt -82.17 -34.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 O-C-N 122.211 -0.306 . . . . 0.0 110.292 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -156.14 156.86 34.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.415 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -153.33 148.03 26.3 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.682 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.11 131.75 6.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.624 0.369 . . . . 0.0 111.014 -174.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -102.92 129.36 54.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CD2' " H1'" ' B' ' 119' ' ' ' A' . 41.9 m-85 -74.32 149.16 40.77 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -174.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 mm -132.95 153.32 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.776 0.43 . . . . 0.0 110.466 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HE3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -80.04 -10.73 59.79 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -86.24 -23.59 26.35 Favored 'General case' 0 C--O 1.23 0.039 0 C-N-CA 122.817 0.447 . . . . 0.0 112.126 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.0 -14.71 1.36 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -173.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 61.4 6.95 1.56 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.043 0.937 . . . . 0.0 112.812 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.35 162.74 25.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.3 t -67.99 141.75 56.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 110.474 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -73.44 6.39 3.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 111.384 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.8 p 58.35 20.78 7.64 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.491 1.916 . . . . 0.0 112.687 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.19 169.93 23.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.36 -170.23 26.86 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 121.467 0.482 . . . . 0.0 112.404 -175.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -137.63 141.45 41.21 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.664 1.586 . . . . 0.0 114.905 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.8 t -145.12 152.08 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.6 p -143.3 149.57 38.01 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-O 120.923 0.392 . . . . 0.0 112.003 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -114.85 162.54 16.76 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -78.3 -11.04 59.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 174.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.69 150.28 20.22 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.557 0.743 . . . . 0.0 110.767 176.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.0 -20.57 38.26 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.311 2.674 . . . . 0.0 112.057 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.2 -45.13 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 CA-C-N 118.42 0.554 . . . . 0.0 111.09 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -71.58 -27.3 63.04 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.91 -48.13 39.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -67.0 -27.61 67.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.035 -0.416 . . . . 0.0 110.802 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.16 73.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.12 -27.31 66.35 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.99 -51.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -68.28 -12.02 60.36 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.161 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.46 -32.85 20.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.008 -0.52 . . . . 0.0 112.379 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.2 mtp -123.2 -14.77 7.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.23 126.67 28.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.38 2.38 90.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.802 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -62.27 138.75 58.48 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -92.64 130.79 38.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.782 0.719 . . . . 0.0 111.656 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.6 tt -144.83 123.98 6.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.33 -143.66 48.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.1 mmt -84.91 9.2 15.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.659 0.783 . . . . 0.0 113.075 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -140.67 179.11 6.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.554 0.616 . . . . 0.0 111.214 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -118.82 147.74 43.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.016 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.41 124.34 19.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.038 0.935 . . . . 0.0 109.331 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -94.38 130.42 40.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.95 137.64 51.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 122.243 0.217 . . . . 0.0 110.52 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -153.7 161.25 42.29 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 122.395 -0.191 . . . . 0.0 111.152 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -74.86 154.49 38.22 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.582 ' H ' HD23 ' A' ' 104' ' ' LEU . 57.2 tttp -61.53 151.96 31.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.6 0.36 . . . . 0.0 110.327 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -64.55 160.3 19.82 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.549 0.34 . . . . 0.0 110.684 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.9 m -63.11 143.86 57.42 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.588 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.01 -8.08 52.47 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -67.26 -17.08 64.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.373 -0.204 . . . . 0.0 110.984 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -80.87 -17.28 51.18 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 t -86.92 -18.08 31.67 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.012 0.525 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -68.09 151.46 97.19 Favored Pre-proline 0 C--N 1.34 0.176 0 C-N-CA 123.133 0.573 . . . . 0.0 110.987 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.04 -5.2 15.66 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.109 3.206 . . . . 0.0 112.608 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.908 -1.52 . . . . 0.0 112.798 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.864 0 O4'-C1'-N19 110.732 2.532 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.3 0 O4'-C1'-N19 110.517 2.317 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.223 0 C3'-C2'-C1' 98.501 -3.332 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.709 2 C3'-C2'-C1' 105.544 4.493 . 0.382 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . 0.491 " H1'" ' CD2' ' A' ' 61' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.882 2 O4'-C1'-N19 112.766 4.566 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.06 9.32 0.09 OUTLIER Glycine 0 CA--C 1.53 0.991 0 CA-C-O 120.037 -0.313 . . . . 0.0 112.319 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -65.98 159.72 25.17 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.502 0.651 . . . . 0.0 111.198 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 t -153.56 157.69 40.1 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.119 0.568 . . . . 0.0 110.276 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -71.99 159.28 34.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.978 0.511 . . . . 0.0 111.376 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -71.01 159.13 35.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.37 0.668 . . . . 0.0 111.131 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -69.36 154.92 41.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.728 0.411 . . . . 0.0 111.128 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -156.07 162.17 40.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.193 0.597 . . . . 0.0 110.273 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -91.44 -1.29 57.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.189 0.596 . . . . 0.0 111.94 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -68.08 150.88 47.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.966 0.348 . . . . 0.0 110.839 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.5 p -154.69 164.59 38.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.016 0.526 . . . . 0.0 110.611 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.6 t -154.89 165.31 37.08 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.666 0.786 . . . . 0.0 109.944 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.95 -154.46 30.63 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.78 165.12 13.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.598 0.359 . . . . 0.0 111.912 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.9 138.95 14.76 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.365 0.666 . . . . 0.0 110.28 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.2 22.55 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.242 3.295 . . . . 0.0 112.856 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -134.0 168.45 18.77 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.493 0.717 . . . . 0.0 111.128 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.4 -9.69 77.95 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.443 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 95.1 p -160.11 166.75 29.22 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.658 0.729 . . . . 0.0 110.479 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -82.7 4.34 25.43 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.0 0.52 . . . . 0.0 111.927 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.5 mtm -69.29 173.24 5.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.1 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -58.5 143.31 46.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.628 0.771 . . . . 0.0 111.362 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.65 159.08 19.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.481 0.712 . . . . 0.0 110.761 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -140.33 150.28 43.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.831 0.452 . . . . 0.0 111.046 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 -160.73 35.24 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.87 178.75 3.74 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.042 3.161 . . . . 0.0 110.522 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -60.71 136.09 57.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.961 -0.462 . . . . 0.0 111.328 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.67 -1.67 71.63 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.334 0.492 . . . . 0.0 112.725 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.99 38.76 1.03 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 111.346 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.64 144.59 31.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.029 -0.419 . . . . 0.0 111.308 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.7 mt -129.87 158.07 40.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 25.2 m-85 -112.64 143.83 43.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.407 1.483 . . . . 0.0 114.233 170.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.85 124.95 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 32' ' ' PHE . 7.8 m-85 -129.19 179.48 5.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m170 64.02 15.95 9.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.598 1.559 . . . . 0.0 112.335 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.57 141.39 90.47 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 122.842 0.457 . . . . 0.0 110.557 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.88 165.23 32.65 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.307 2.671 . . . . 0.0 109.415 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.47 -5.86 45.0 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -77.62 -9.2 58.82 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.033 0.379 . . . . 0.0 111.423 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -75.22 158.17 33.36 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.4 175.54 34.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -58.48 -37.35 75.34 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.531 0.665 . . . . 0.0 110.287 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.36 -33.27 37.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.605 0.241 . . . . 0.0 110.914 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -72.73 -38.52 67.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 tt -74.79 -26.13 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.91 -53.26 41.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.513 0.325 . . . . 0.0 111.257 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.2 tpt -80.62 -24.71 38.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.953 0.101 . . . . 0.0 110.748 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 90' ' ' MET 0.262 21.3 m-85 -104.63 -12.32 16.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -179.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.479 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.9 mtm -66.39 -29.87 3.16 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.9 Cg_endo -71.66 -9.68 25.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 122.068 1.774 . . . . 0.0 111.694 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -87.77 -13.62 41.83 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.094 0.406 . . . . 0.0 111.502 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.32 -175.01 31.9 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -75.45 103.25 5.5 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.552 -0.381 . . . . 0.0 110.484 -177.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.6 t -86.05 124.78 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.5 mt -86.31 -29.32 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 O-C-N 122.43 -0.169 . . . . 0.0 110.585 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -156.51 154.9 31.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.66 149.11 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.68 0.792 . . . . 0.0 109.361 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.423 ' HE2' ' N3 ' ' B' ' 119' ' ' ' A' . 54.0 tptt -158.31 139.22 13.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.556 0.342 . . . . 0.0 111.658 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 t -118.15 131.04 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.402 ' CD1' " H1'" ' B' ' 119' ' ' ' A' . 42.8 m-85 -71.73 156.48 39.29 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -174.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mm -133.29 145.35 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 C-N-CA 122.823 0.449 . . . . 0.0 110.027 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -88.4 132.13 34.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -79.04 -14.18 59.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.889 0.476 . . . . 0.0 111.595 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -89.61 -23.64 21.89 Favored 'General case' 0 C--N 1.335 -0.063 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -134.35 -11.76 2.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.4 t30 62.0 10.51 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.346 1.059 . . . . 0.0 111.839 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.64 156.37 27.66 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.942 -0.474 . . . . 0.0 110.01 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.6 t -71.29 139.64 50.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.786 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.87 163.89 24.93 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.861 0.464 . . . . 0.0 110.873 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.6 m -84.32 13.18 5.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -158.91 171.98 19.05 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.41 -166.06 18.47 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.511 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.36 142.88 30.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.17 152.81 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.704 0.802 . . . . 0.0 109.782 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.8 t -144.02 141.08 29.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -104.8 162.69 13.09 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -77.99 -12.49 59.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 111.491 174.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.97 149.9 20.44 Favored Pre-proline 0 N--CA 1.451 -0.404 0 C-N-CA 123.088 0.555 . . . . 0.0 110.613 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.92 -21.62 32.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.066 2.511 . . . . 0.0 112.341 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.2 -39.28 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.879 -0.513 . . . . 0.0 111.837 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -73.77 -25.33 60.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.182 0.193 . . . . 0.0 110.586 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.01 -45.84 55.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.29 -30.63 71.09 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.9 0.318 . . . . 0.0 110.875 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.52 82.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.28 -26.37 65.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.4 mt -65.52 -53.07 43.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -67.9 -11.3 58.43 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.99 -29.29 16.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 92.9 mmm -120.43 -16.96 8.29 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -65.0 132.59 49.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 4.83 84.75 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.048 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -63.66 122.83 17.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.727 1.263 . . . . 0.0 111.419 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -76.52 128.96 35.77 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.791 0.329 . . . . 0.0 110.854 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -151.76 136.91 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.6 -111.77 3.5 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 24.2 ptp -128.7 13.66 6.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.174 0.59 . . . . 0.0 111.89 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -151.85 142.16 22.44 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.169 0.44 . . . . 0.0 110.636 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -81.85 144.7 30.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.243 -0.286 . . . . 0.0 110.702 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.83 127.16 31.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.309 0.244 . . . . 0.0 111.037 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.62 138.31 31.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.21 140.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -153.71 157.23 39.2 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 122.352 -0.217 . . . . 0.0 111.277 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -78.3 151.79 32.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.002 0.521 . . . . 0.0 109.781 174.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.495 ' H ' HD23 ' A' ' 104' ' ' LEU . 59.7 tttp -66.88 147.77 52.81 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.4 ptt85 -76.03 156.57 33.88 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 120.629 0.252 . . . . 0.0 110.917 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -67.99 151.92 46.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.485 0.314 . . . . 0.0 111.141 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.4 ' HG3' ' H ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -72.37 -4.69 31.47 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 177.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.47 -18.66 60.59 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -79.93 -12.74 59.71 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.1 t -84.75 -17.61 37.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.941 0.496 . . . . 0.0 110.499 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 34.4 mmtp -69.98 157.88 88.67 Favored Pre-proline 0 N--CA 1.456 -0.156 0 C-N-CA 123.516 0.727 . . . . 0.0 110.744 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 112' ' ' LYS . 89.9 Cg_endo -75.63 -16.05 19.06 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.679 2.919 . . . . 0.0 111.679 -178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 3.2 p90 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 116.805 -1.569 . . . . 0.0 112.665 -177.519 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.873 0 C5'-C4'-C3' 109.923 -3.718 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.055 0 O4'-C1'-N19 109.906 1.706 . 0.032 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.244 0 C3'-C2'-C1' 99.552 -2.165 . 0.023 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.743 2 C3'-C2'-C1' 105.82 4.8 . 0.353 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . 0.423 ' N3 ' ' HE2' ' A' ' 59' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.894 2 C5'-C4'-C3' 108.155 -4.896 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.586 0.231 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.73 -178.48 48.07 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -67.83 156.66 36.58 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.615 0.366 . . . . 0.0 111.239 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.7 t -155.2 157.0 36.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.247 0.619 . . . . 0.0 110.443 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -155.53 158.69 38.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.194 0.598 . . . . 0.0 110.448 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -154.31 156.92 37.84 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.308 0.643 . . . . 0.0 110.349 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -72.31 158.45 35.79 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.873 0.469 . . . . 0.0 111.248 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -70.44 157.51 37.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.081 0.552 . . . . 0.0 111.036 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -155.18 -29.28 0.1 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.575 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -76.36 -14.22 60.1 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.622 0.369 . . . . 0.0 111.569 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m -69.78 158.43 35.46 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.956 0.502 . . . . 0.0 110.937 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.6 t -73.96 -7.25 51.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.797 0.439 . . . . 0.0 111.589 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.89 -0.89 76.48 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.312 0.482 . . . . 0.0 112.557 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.32 142.69 53.99 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.739 0.77 . . . . 0.0 110.062 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 17' ' ' ARG . 5.8 p -67.7 133.99 92.47 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.415 0.286 . . . . 0.0 111.67 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' C ' ' H ' ' A' ' 18' ' ' GLY . 89.3 Cg_endo -73.6 -9.97 23.2 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.019 2.479 . . . . 0.0 112.066 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.426 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER 61.37 -14.89 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.158 1.783 . . . . 0.0 113.697 -178.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 16' ' ' PRO . . . 83.58 148.67 8.52 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.5 t -78.54 160.58 27.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.915 0.486 . . . . 0.0 110.702 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -76.79 -8.86 58.11 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.576 0.351 . . . . 0.0 110.471 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.3 mtm 57.05 27.88 14.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -66.98 152.29 46.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.189 -0.319 . . . . 0.0 110.522 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -108.74 159.74 16.52 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.556 0.742 . . . . 0.0 112.263 -170.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -131.5 153.03 50.22 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.914 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.44 -165.78 30.92 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.588 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -69.88 177.5 5.6 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.127 3.218 . . . . 0.0 110.403 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -60.67 137.4 58.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.903 -0.498 . . . . 0.0 110.855 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.91 -3.53 83.51 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.672 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.94 -0.28 39.76 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.679 0.74 . . . . 0.0 112.703 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -102.54 136.26 42.68 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 118.213 0.461 . . . . 0.0 110.314 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 49.5 mt -124.18 154.58 39.88 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.892 0.853 . . . . 0.0 113.135 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -116.06 145.91 42.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.931 1.692 . . . . 0.0 114.011 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.43 137.82 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.57 176.35 8.96 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 100' ' ' LEU . 9.4 m170 65.93 16.1 10.33 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.181 1.392 . . . . 0.0 112.644 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.3 146.19 98.76 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.709 0.403 . . . . 0.0 110.075 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 169.16 22.82 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.319 2.68 . . . . 0.0 109.833 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -68.47 -19.29 64.54 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.872 0.469 . . . . 0.0 112.206 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.0 -10.57 59.66 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -69.99 158.03 36.39 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.24 175.5 35.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -58.38 -35.74 72.44 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 117.466 0.633 . . . . 0.0 110.031 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -79.76 -33.16 40.89 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.913 0.485 . . . . 0.0 111.085 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -75.11 -39.04 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.2 tt -74.35 -24.96 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.6 tp -65.27 -52.29 55.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -65.22 -22.27 66.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.566 0.346 . . . . 0.0 111.382 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.2 tpp -78.24 -26.78 47.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.269 0.228 . . . . 0.0 110.713 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.266 22.9 m-85 -105.77 -11.57 16.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.458 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.5 mtm -66.91 -31.0 3.56 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 50' ' ' MET . 81.4 Cg_endo -71.97 -9.2 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.745 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -82.78 -24.32 33.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.74 0.416 . . . . 0.0 111.981 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 158.57 -163.52 33.09 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.96 103.04 10.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 117.556 0.678 . . . . 0.0 110.972 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.4 t -82.4 121.55 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.66 -32.87 14.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -157.83 152.4 24.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.965 0.506 . . . . 0.0 111.239 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.09 146.74 31.96 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.891 0.876 . . . . 0.0 109.068 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.457 ' HE2' ' N3 ' ' B' ' 119' ' ' ' A' . 52.9 tptt -156.79 139.26 14.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.76 0.424 . . . . 0.0 111.598 -172.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.45 129.19 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 168.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -72.18 147.84 46.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.5 mm -132.36 141.17 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.819 0.448 . . . . 0.0 110.461 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -90.12 134.85 34.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -77.64 -12.22 59.95 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.65 0.38 . . . . 0.0 111.755 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -87.9 -22.54 24.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.12 -14.64 1.78 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 62.12 8.2 2.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.506 1.122 . . . . 0.0 112.717 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.7 mt -82.42 161.0 22.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 122.814 0.445 . . . . 0.0 110.329 175.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.5 t -66.87 138.54 57.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -77.56 8.91 3.76 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.009 0.524 . . . . 0.0 111.619 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.5 m 61.91 23.08 13.52 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -156.5 167.45 30.41 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.21 -170.79 24.19 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 121.581 0.545 . . . . 0.0 113.433 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -142.39 142.67 32.44 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.224 1.81 . . . . 0.0 114.744 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.1 t -146.05 153.41 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.5 t -143.31 146.92 33.99 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -117.86 165.57 13.51 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -80.63 -13.31 59.14 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.03 148.58 21.7 Favored Pre-proline 0 C--O 1.233 0.205 0 C-N-CA 123.256 0.623 . . . . 0.0 111.378 176.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.86 -23.11 41.72 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.508 2.805 . . . . 0.0 112.132 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.74 -38.66 80.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 O-C-N 121.802 -0.561 . . . . 0.0 111.232 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.6 t -74.72 -29.79 61.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.319 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.31 -48.01 37.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -66.26 -28.57 68.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.262 -0.274 . . . . 0.0 110.727 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.57 73.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.47 -26.56 68.49 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mt -65.68 -51.87 57.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 CA-C-N 118.836 0.744 . . . . 0.0 109.001 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -66.89 -11.81 57.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.37 -27.38 16.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 91.5 mmm -120.54 -17.27 8.14 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.67 134.66 53.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.72 2.39 85.55 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.839 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -67.37 120.02 13.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.814 1.307 . . . . 0.0 110.675 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -78.76 126.87 31.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.907 0.384 . . . . 0.0 111.63 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.6 tt -155.69 135.72 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.442 0.697 . . . . 0.0 109.567 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.72 31.82 76.74 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.518 -0.739 . . . . 0.0 111.828 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.5 mtm 64.64 22.19 12.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -144.75 155.81 43.73 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -97.95 134.62 40.81 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.376 -0.828 . . . . 0.0 111.159 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.8 mt -64.73 130.99 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.66 0.267 . . . . 0.0 111.351 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.52 137.39 32.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.7 t -134.36 135.33 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -150.31 160.51 43.66 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.699 0.227 . . . . 0.0 111.564 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -76.6 149.29 36.58 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.01 0.524 . . . . 0.0 110.002 177.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.477 ' H ' HD23 ' A' ' 104' ' ' LEU . 85.5 tttt -61.52 140.9 58.03 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -75.62 159.47 31.16 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.786 0.327 . . . . 0.0 110.828 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.9 t -66.37 158.49 29.12 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.544 0.338 . . . . 0.0 110.236 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -16.41 63.81 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 122.388 -0.195 . . . . 0.0 111.277 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -85.43 -16.3 40.17 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.61 0.364 . . . . 0.0 111.002 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -86.94 -10.88 52.18 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.9 t -88.76 -17.98 28.71 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.028 0.531 . . . . 0.0 110.784 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.86 151.63 96.24 Favored Pre-proline 0 C--O 1.233 0.227 0 C-N-CA 123.192 0.597 . . . . 0.0 111.214 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.24 -14.01 20.75 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.866 3.044 . . . . 0.0 111.219 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.9 m95 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.993 -179.717 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.186 0 C5'-C4'-C3' 109.694 -3.871 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 O4'-C1'-N19 110.779 2.579 . 0.046 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 C5'-C4'-C3' 109.676 -3.882 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 2 O4'-C1'-N19 112.994 4.794 . 0.517 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . 0.457 ' N3 ' ' HE2' ' A' ' 59' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.119 2 C5'-C4'-C3' 109.054 -4.297 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.273 0.082 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.99 8.74 86.91 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.942 -0.365 . . . . 0.0 112.373 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -72.51 -4.8 32.69 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.603 0.761 . . . . 0.0 112.425 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.5 p -155.85 167.57 30.0 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.299 0.64 . . . . 0.0 110.188 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -69.03 162.64 26.44 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 122.954 0.501 . . . . 0.0 110.971 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -70.91 164.17 25.94 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.061 0.458 . . . . 0.0 111.059 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -66.65 157.27 32.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.839 0.456 . . . . 0.0 111.101 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -80.6 -5.58 57.06 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.807 0.443 . . . . 0.0 111.394 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -77.86 12.63 1.65 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.434 0.694 . . . . 0.0 112.005 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -66.23 168.1 9.19 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.261 0.625 . . . . 0.0 111.207 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.3 t 56.54 25.81 10.25 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.983 0.913 . . . . 0.0 112.21 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.4 p -70.96 -11.15 60.81 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.074 0.549 . . . . 0.0 111.635 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.37 4.14 73.23 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.889 -0.395 . . . . 0.0 112.375 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.83 143.47 57.45 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.656 0.728 . . . . 0.0 110.52 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -155.5 143.01 13.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.96 -20.78 54.87 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.562 2.841 . . . . 0.0 114.181 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.18 151.72 19.75 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 122.722 0.409 . . . . 0.0 110.486 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.92 16.34 0.92 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 t -153.1 -167.28 2.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.94 0.896 . . . . 0.0 108.859 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -68.34 -2.65 8.84 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.78 -0.575 . . . . 0.0 111.817 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.1 ptp -65.77 171.08 4.57 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.705 0.802 . . . . 0.0 110.38 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.7 152.46 37.84 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.666 0.386 . . . . 0.0 110.872 -177.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -141.01 140.63 34.35 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -101.69 154.19 19.1 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.76 -156.3 20.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.08 175.94 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.94 3.094 . . . . 0.0 110.48 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.44 139.83 58.81 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.87 0.06 88.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.79 -0.45 . . . . 0.0 112.733 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.72 14.76 30.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.613 0.706 . . . . 0.0 112.893 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -119.14 138.62 52.79 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 118.427 0.558 . . . . 0.0 110.588 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.1 mt -125.42 156.88 38.15 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -173.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -117.1 141.42 48.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.844 1.658 . . . . 0.0 113.806 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.38 140.73 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -144.93 176.57 9.38 Favored 'General case' 0 CA--C 1.527 0.067 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.443 ' CG ' ' HE2' ' A' ' 98' ' ' LYS . 16.6 m170 63.97 16.74 10.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.901 1.68 . . . . 0.0 112.984 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.0 mt -68.06 141.5 94.28 Favored Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.45 163.03 39.78 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.988 2.459 . . . . 0.0 109.524 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -71.72 -7.62 49.16 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -78.56 -10.56 59.77 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.091 -0.381 . . . . 0.0 111.134 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.99 158.5 35.34 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 44' ' ' ASP . . . -157.8 174.92 35.17 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -56.82 -38.98 73.37 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -75.7 -33.21 60.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.784 0.433 . . . . 0.0 111.255 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 73.5 m-20 -71.55 -38.73 70.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 tt -76.52 -24.55 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.449 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.4 tm? -64.91 -53.62 43.56 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -69.66 -23.37 63.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 tpp -71.58 -27.9 63.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.283 18.6 m-85 -102.3 -10.08 19.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.44 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 46.2 mtm -65.83 -32.28 5.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 50' ' ' MET . 95.1 Cg_endo -72.33 -8.15 22.18 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.692 1.64 . . . . 0.0 111.894 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -89.34 -14.18 36.24 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.663 0.385 . . . . 0.0 111.342 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.92 -171.92 31.96 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -77.77 103.09 7.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.39 -0.477 . . . . 0.0 110.373 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -81.66 124.24 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.56 -37.45 16.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -158.44 157.1 31.57 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.478 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.46 146.82 23.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.84 144.0 16.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.692 0.397 . . . . 0.0 111.143 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.25 139.74 38.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 172.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -75.53 146.69 40.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.5 mm -132.85 143.65 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 123.246 0.619 . . . . 0.0 110.303 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -90.56 131.7 36.14 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -78.38 -9.39 59.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.9 -0.5 . . . . 0.0 111.536 -179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -88.77 -22.26 23.38 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -136.92 -12.72 1.69 Allowed 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 62.29 7.37 2.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.415 1.086 . . . . 0.0 112.815 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.46 161.07 22.55 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 t -70.71 142.06 51.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.925 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -78.13 8.76 4.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.543 0.337 . . . . 0.0 111.501 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 85.4 m 62.4 26.19 15.62 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -156.5 165.99 34.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.0 -179.54 27.71 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 121.548 0.527 . . . . 0.0 113.543 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.29 139.72 37.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.163 1.785 . . . . 0.0 113.987 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.35 152.97 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 123.628 0.771 . . . . 0.0 109.669 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.0 t -141.35 143.51 34.05 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.54 0.336 . . . . 0.0 111.898 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -111.88 159.83 17.98 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -75.91 -13.45 60.26 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.68 150.47 23.2 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.545 0.738 . . . . 0.0 110.756 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.9 -22.11 31.92 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.256 2.637 . . . . 0.0 112.465 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.3 -38.91 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 118.336 0.516 . . . . 0.0 111.704 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.7 m -74.3 -25.74 59.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.132 0.173 . . . . 0.0 110.631 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.78 -46.79 43.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -66.81 -30.43 70.62 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 122.271 -0.268 . . . . 0.0 110.737 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.29 80.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -26.75 65.59 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.14 -51.82 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -67.56 -12.09 59.57 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.31 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.74 -28.82 17.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 95.1 mmm -120.4 -17.3 8.21 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.88 133.07 51.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.55 2.19 87.55 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.894 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.41 119.05 10.29 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.57 1.185 . . . . 0.0 110.168 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -78.68 126.94 31.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.036 -0.415 . . . . 0.0 111.378 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.7 tt -155.91 135.14 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 123.307 0.643 . . . . 0.0 109.743 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.12 32.25 75.49 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.416 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm 63.03 24.52 14.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.066 0.947 . . . . 0.0 113.381 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HE2' ' CG ' ' A' ' 35' ' ' HIS . 85.2 tttt -144.99 151.48 38.65 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -96.31 134.09 39.87 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 121.51 -0.744 . . . . 0.0 110.393 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 83.0 mt -64.52 125.94 26.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.22 0.208 . . . . 0.0 110.789 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -87.93 139.19 30.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.82 139.48 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -149.21 156.52 42.28 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.743 0.306 . . . . 0.0 111.265 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.514 HD23 ' H ' ' A' ' 105' ' ' LYS . 0.9 OUTLIER -74.2 147.99 42.03 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.814 0.445 . . . . 0.0 109.952 176.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.514 ' H ' HD23 ' A' ' 104' ' ' LEU . 84.6 tttt -61.97 157.05 19.53 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.963 0.505 . . . . 0.0 110.785 175.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.439 ' HG2' ' H3 ' ' B' ' 117' ' ' ' U' . 11.2 ptp180 -141.12 160.51 39.94 Favored 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 124.215 1.006 . . . . 0.0 109.118 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 t -62.88 153.09 34.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.2 -19.91 63.14 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.261 -0.275 . . . . 0.0 110.61 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -80.65 -15.98 55.19 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.599 0.359 . . . . 0.0 110.55 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -102.21 -4.91 25.01 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -91.76 -2.35 56.99 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.944 0.497 . . . . 0.0 111.359 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -138.08 152.03 71.08 Favored Pre-proline 0 CA--C 1.529 0.161 0 C-N-CA 123.189 0.596 . . . . 0.0 110.767 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.93 -15.52 20.88 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.691 2.927 . . . . 0.0 111.142 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 94.9 m95 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.173 -1.394 . . . . 0.0 111.624 -179.926 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.46 0 C5'-C4'-C3' 109.686 -3.876 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.484 0 O4'-C1'-N19 110.869 2.669 . 0.166 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' ' U' . . . . . 0.439 ' H3 ' ' HG2' ' A' ' 106' ' ' ARG . . . . . . . . 0 O4'--C4' 1.417 -3.041 0 C5'-C4'-C3' 110.469 -3.354 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' ' A' . . . . . 0.464 ' C8 ' H5'' ' B' ' 118' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.997 2 O4'-C1'-N19 113.379 5.179 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.443 1 C5'-C4'-C3' 109.305 -4.13 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 stop_ save_